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1    Introduction and Goals 
 
 
Many of biologically important molecules such as drugs and natural products accommodate a 
heterocyclic moiety in their framework. Within the class of small, nitrogen-containing heterocycles, 
aziridines and azetidines comprise a remarkable group of strained compounds with diverse synthetic 
and biological applications.  
As powerful alkylating agents, aziridines have an inherent in vivo potency, often based primarily on 
toxicity rather than specific activity.
1
 There are, however, several classes of aziridine-containing 
natural products, for example pertaining to the Mitosane 1 and Azinomycin family 2 (Figure 1), with 
anti-tumor and antibiotic activity.
2
  
N N Z
O
O
NH2
O
X OY
1
Mitomycins A-C
X = OMe, NH2; Y = H, Me;
Z = H, Me
N
HO
N
H
O
R
O
H
N
O
O
AcO
OMeO O
H
Azinomycins A-B
R = H, CHO
2
H
H
 
Figure 1 
However, aziridines showed to be much more valuable as versatile synthons to access a window of 
different synthetically and biologically important molecules.
3
 In terms of synthetic transformation, their 
utility relates to selective ring-opening reactions.
4
 The transformations of these strain-loaded three-
membered rings (113 kJ/mol)
5
 allow for regio- and stereoselective installation of a wide range of 
functional groups in a 1,2-relationship with respect to the nitrogen atom.  
Aziridines are also useful intermediates in the synthesis of a whole variety of natural products, such as 
the Amaryllidaceae alkaloid crinine 3
6
 and 2-benzylisoquinoline alkaloids sendaverine and corgoine 4a 
and 4b
7
 (Figure 2). 
O
O N
OH
3
Crinine
N
MeO
HO
OR
4a Sendaverine (R = Me)
4b Corgoine (R = H)  
Figure 2 
Aziridines can be classified as "activated" and "non-activated" depending on the type of the substituent 
on the ring nitrogen atom. Activated aziridines, bearing an electron-withdrawing group at the nitrogen, 
can easily be opened without prior activation. On the other hand, non-activated aziridines, containing 
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an electron-donating group at the nitrogen atom, have to be activated through quaternization prior to 
nucleophilic ring opening. The chemistry of non-activated aziridines is far less explored as compared 
to the chemistry of activated aziridines,
4,5a, 8
 and therefore the main goal of this PhD thesis is to further 
investigate and expand the synthetic potential of this interesting class of compounds. 
Next to aziridines, their higher homologues, i.e. azetidines, also exhibit a wide range of biological 
activities,
9
 in addition to their peculiar chemical properties associated with the ring strain.
10
 L-
Azetidine-2-carboxylic acid 5 (Figure 3), the first azetidine natural product that has been discovered, 
was isolated from Convallaria majalis (lily of the valley) in 1955.
11
 The research into the role of this 
molecule has shown it to be important for the inhibition of the proliferation of Escherichia coli, 
alteration of the structure of collagen, keratin and hemoglobin in human proteins, and teratogenic 
effects and various malformations in animals.
10d
 Examples of other natural products containing an 
azetidine ring include mugineic acid 6, 2’-deoxymugineic acid 7 and nicotianamine 8, which are 
produced in plants to aid in the uptake of iron for chlorophyll biosynthesis.
12
 Penaresidin A and B (9 
and 10) have also been the targets of several syntheses, as they have been found to exhibit biological 
activity in the activation of ATPase in actomycin.
13
 The most recently reported natural product 
containing the azetidine moiety, calydaphninone 11, was isolated from the leaves and twigs of 
Daphniphyllum calycillum in 2007.
14
 This molecule, containing a 4-azatricyclo[5.2.2.0]undecane core, 
represents one of the most complex azetidine-containing natural products known to date. 
 
NH
COOH
5
L-Aze
N
HOOC
R
COOH
N
H
COOH
OH
6 (R = OH), mugineic acid
7 (R = H), 2'-deoxymugineic acid
N
HOOC COOH
N
H
COOH
NH2
8
nicotianamine
NH
HO
HO
OH
NH
HO
OH
OH
9
penaresidin A
10
penaresidin B
N
O
H
HO
COOH
H
11
calydaphninone
H
 
Figure 3 
 
Among synthetically obtained azetidines, 3-substituted azetidines have been shown to possess a wide 
range of biological activities. For example, 1-cyclohexyl-3-guanidinoazetidine 12 exhibits 
antihypertensive activity,
15
 and various 3-carbamoyl-oxy-substituted azetidines 13 have been used in 
a primary pharmacological screening showing tranquillising activity on the central nervous system of 
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the tested animals.
16
 Furthermore, azetidine 14 and derivatives have been shown to behave as CNS 
stimulants devoid of peripheral anticholinergic activity,
17
 and 1,3,3-trinitroazetidine (TNAZ) 15 is a 
member of an important class of explosives and propellants
18
 (Figure 4). 
 
 
Figure 4 
 
In light of the diverse synthetic and biological applications of azetidine-containing compounds, many 
efforts will be devoted to the synthesis of novel classes of functionalized azetidines and their further 
transformations in this doctoral study. 
 
In the first part of this PhD thesis, the reactivity and synthetic potential of 2-(bromomethyl)aziridines 16 
toward ring transformation and ring opening will be investigated. Aziridines 16 have proven to be 
valuable synthons for the preparation of wide variety of azaheterocyclic compounds and ring-opened 
amines such as cyclopropanes 17,
19
 morpholines 18,
20
 pyrrolizidines 19,
21
 2-iminopyrrolidines 20,
21
 2-
imino-1,3-thiazoli(di)nes 21
22
 and piperidine derivatives 22
23
 (Scheme 1). In addition, the nucleophilic 
substitution of bromide in 2-(bromomethyl)aziridines with various heteroatom nucleophiles
20,22,24
 and 
carbon nucleophiles
19,25
 has provided a convenient access toward a variety of 2-substituted aziridines 
23.  
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Scheme 1 
 
In comparison to the huge number of reports on the ring opening of aziridines by other nucleophiles, 
their ring opening by hydrides has received very limited interest in the literature despite the synthetic 
potential of this approach. It should be mentioned that LiAlH4 has been mainly used to reduce 
functional groups in compounds incorporating an aziridine unit without affecting the three-membered 
ring itself.
26
  
Bearing in mind the lack of studies concerning the behavior of non-activated aziridines with respect to 
LiAlH4, the reactivity of 2-(bromomethyl)aziridines 24 (R = Br) and 2-(acetoxymethyl)aziridines 24 (R = 
OAc) toward LiAlH4 will be studied in the first part of this PhD thesis. In this way, the reductive 
cleavage of these substrates 24 could provide an access toward biologically and synthetically relevant 
species such as isopropylamines 25 (R = H) and useful β-amino alcohols 25 (R = OH) through an 
unprecedented hydride-induced ring opening of non-activated aziridines (Scheme 2). β-Amino 
alcohols are applied extensively in organic chemistry as a building blocks in designing natural and 
biologically active substances,
27
 and their chiral versions are also used in catalytic asymmetric 
synthesis.
28
 Compounds 25 (R = OH) could then be further used as suitable substrates for the 
preparation of six-membered oxazaheterocycles 26, known to be formed in the reaction with glyoxal.
29
 
In light of the importance of chirality in medicinal chemistry, the synthesis of enantiopure amino 
alcohols 28 and morpholin-2-ones 29 will be explored starting from the commercially available 2-
(hydroxymethyl)aziridines 27 using the same synthetic approach (Scheme 2). 
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Scheme 2 
 
The ring opening of aziridinium salts by halides constitutes a convenient approach towards -halo 
amines, which are generally recognized as useful building blocks in organic chemistry and valuable 
targets in medicinal chemistry (nitrogen mustards – chemotherapy agents).
30
 The issue of 
regioselectivity in the ring opening of 2-substituted non-activated aziridines by halides has been 
addressed in a few literature reports,
31
 however, up to now no systematic study has been performed in 
which aziridinium substrates derived from non-activated aziridines are subjected to ring opening by 
fluoride, chloride, bromide and iodide. 
Therefore, in the second part of this work, a systematic study on the ring opening of in situ generated 
aziridinium salts 30 by halides will be investigated. The ring opening of aziridinium salts 30 can occur 
at the unsubstituted (path a) or the substituted aziridine carbon atom (path b), leading either to primary 
halides 31 (path a) or secondary halides 32 (path b). As the selective synthesis of secondary bromides 
has been reported before upon treatment of aziridinium salts 30 with benzyl bromide,
31c
 the scope and 
underlying factors will be studied thoroughly in this part. 
 
 
Scheme 3 
 
As mentioned before, the reactivity of 2-(bromomethyl)aziridines 16, prepared by NaBH4-reduction of 
N-alkylidene-(2,3-dibromopropyl)amines 32 (R
2
 = H) in methanol under reflux has been the subject of 
many literature reports from the Department of Sustainable Organic Chemistry and Technology. In a 
preliminary study,
32
 it has been shown that structurally similar N-alkylidene-(2,3-dibromo-2-
methylpropyl)amines 33 (R
2
 = Me) afforded 3-methoxyazetidines 34 under the same reaction 
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conditions (Scheme 4). In addition, a single example of the synthesis of aziridines 36 starting from 2-
methylacrolein 35, using bromination, imination and subsequent NaBH4-mediated ring closure of the 
corresponding imines at room temperature has been provided (Scheme 4).
33
 
Therefore, in order to elucidate this unexpected reactivity of imines 33 (R
2
 = Me), and to assess the 
influence of an additional methyl substituent in substrates 33 (R
2
 = Me) on the reaction outcome, the 
kinetically controlled synthesis of 2-bromomethyl-2-methylaziridines 36 will be investigated in the third 
part of this PhD thesis. Subsequently, the ring expansion of aziridines 36 to azetidines 37 could be 
then investigated by heating these species 36 in methanol under reflux. In addition, high-level 
molecular modeling calculations at the Center for Molecular Modeling (UGent) will be employed for the 
theoretical elucidation of the reaction mechanism. 
 
 
Scheme 4 
 
In addition, the reactivity of 2-bromomethyl-2-methylaziridines 36 toward oxygen, sulfur, and carbon 
nucleophiles in different solvent systems will be investigated. In this way, aziridines 36 could provide 
an access to novel functionalized aziridines 38 via direct nucleophilic substitution or to azetidines 39 
via ring expansion (Scheme 5). Given the peculiar nature of aziridine to azetidine ring expansions, 
particular attention will be devoted to unravel this unknown chemistry from both, an experimental and 
theoretical point of view. 
 
 
Scheme 5 
 
The last part of this PhD thesis will be devoted to the synthesis and functionalization of 3-
ethylideneazetidines 43, obtained from the corresponding 3-bromo-3-ethylazetidines 42 through 
dehydrobromination, which could be prepared by the ring expansion of 2-bromomethyl-2-
methylaziridines 41 (Scheme 6). Although the combination of two functionalities, i.e., an azetidine 
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moiety and an exocyclic double bond, might result in unstable structures, azetidines 43 might still be 
considered as valuable substrates for further elaboration.  
 
Scheme 6 
In that respect, two aspects of the reactivity of 3-ethylideneazetidines 43 could then be studied 
separately, i.e., the activation and subsequent ring opening of the azetidine moiety on the one hand, 
and functionalization of the exocyclic double bond on the other. In this way, azetidines 43 could 
provide an entry toward novel allylic amines 44, 3-halo-3-(1-haloethyl)azetidines 45 and different 
spirocyclic building blocks 46 and 47 (Scheme 7).  
 
Scheme 7 
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2  Literature review 
 
 
In this chapter, a literature review on the ring opening of non-activated 2-substituted aziridines via 
intermediate aziridinium salts will be dealt with. Emphasis will be put on the relationship between the 
observed regioselectivity and inherent structural features such as the nature of the C2 aziridine 
substituent and the nature of the electrophile and the nucleophile. 
   
 Regioselectivity in the ring opening of non-activated aziridines34 
 
2.1 Introduction 
 
The aziridine moiety represents one of the most valuable three-membered ring systems in organic 
chemistry,
3a,4,5a,8,35
 and the regiocontrolled ring opening of C-substituted aziridines constitutes a 
powerful approach toward the preparation of a large variety of functionalized nitrogen-containing target 
compounds.
36
 The ring opening of activated aziridines, i.e. aziridines bearing an electron-withdrawing 
group at nitrogen, has been studied intensively in that respect, showing the regiochemical pathway to 
be independent from the structural features of these aziridines as well as from the nature of the 
participating nucleophiles.
4a
 In that respect, the regioselectivity in the ring-opening reactions of 2-
substituted activated aziridines has been shown to be quite straightforward, mostly involving the 
nucleophilic attack at the less hindered aziridine carbon atom,
37
 with some exceptional cases 
comprising the nucleophilic attack at the allylic and benzylic position of the aziridine moiety.
38 
 
In recent years, non-activated aziridines, which have to be activated prior to ring opening due to the 
presence of an electron-donating substituent at nitrogen, have also shown considerable attention as 
valuable intermediates for further synthetic elaboration. Moreover, the reactivity and applications of non-
activated aziridines often appear to be different as compared to activated aziridines and epoxides, 
providing interesting opportunities for the selective synthesis of a variety of functionalized amines 
through intermediate aziridinium ions. It should be mentioned that the ring opening of aziridinium ions 
obtained through cyclization of β-amino alcohols has been covered recently in a comprehensive way.
39
 
If non-activated, 2-substituted aziridines 48 are used, the issue of regioselectivity in the ring opening of 
the corresponding intermediate aziridinium salts 49 becomes important, since two regioisomeric ring-
opened amines can be obtained. As depicted in Scheme 8, ring opening of aziridinium salts 49 can 
occur at the unsubstituted (path a) or at the substituted (path b) aziridine carbon atom, leading either to 
α-branched amines 50 (path a) or to β-branched amines 51 (path b). 
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Scheme 8 
 
In the following paragraphs, literature reports on the ring opening of non-activated 2-substituted 
aziridines will be organized at first according to the nature of the substrate, i.e., distinction will be 
made between the reactivity of 2-(1-alkenyl)-, 2-aryl-, 2-acyl- and 2-alkylaziridines. Within these 
sections, the information will be subdivided based on the type of electrophile used for the activation of 
the aziridine moiety, i.e., the use of Lewis acids (N-complexation), carbonyl electrophiles (N-acylation, 
N-alkoxycarbonylation or related approaches), acids (N-protonation), alkyl halides or alkyl triflates (N-
alkylation), and silylation reagents (N-silylation).  
 
 
2.2 Activation and ring opening of 2-(1-alkenyl)aziridines 
 
When the R
2 
substituent in aziridines 48 (Scheme 8) is a 1-alkenyl group, the nucleophilic attack 
generally occurs at the more substituted carbon atom of the aziridine moiety. Although very few 
reports on the ring opening of this type of aziridines are available in the literature, all the examples 
give a straightforward picture regarding their regioselective ring opening, which seems to be 
independent of the type of nucleophile and electrophile used in these reactions. The observed 
regioselectivity can be rationalized considering the allylic activation in these compounds (resonance 
stabilization of the developing carbenium ion at C2), which has also been described in the ring-
opening reactions of vinyloxirane and activated vinylaziridine derivatives.
40
 
 
2.2.1   Aziridinium ion formation through N-alkoxycarbonylation 
 
A single report considering the ring opening of 2-(1-alkenyl)aziridines through N-alkoxycarbonylation 
has been provided by Ha et al.,
41
 in which the transformation of 2-vinylaziridines 52, prepared from the 
corresponding aldehydes via a Horner–Wadsworth–Emmons reaction or a Wittig reaction, toward 
oxazolidin-2-ones 55 has been investigated. The reaction of aziridines 52 with methyl chloroformate 
was shown to proceed via cyclization of chlorocarbamates 54 (Scheme 9). The identification of 
intermediates 54 suggested that the reaction comprised a double SN2 inversion process. Thus, N-
methoxycarbonylation provided the activated aziridinium species 53, which underwent a regioselective 
C2-N bond cleavage by the chloride ion via an SN2 process. Subsequently, intramolecular cyclization 
of the carbamate 54 (implying a second SN2 process) furnished oxazolidin-2-ones 55 in good yields 
with a net retention of configuration at C2 as defined in aziridines 52 (Scheme 9). 
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Scheme 9 
 
 
2.2.2   Aziridinium ion formation through N-alkylation 
 
The ring opening of aziridinium species 57, obtained by N-methylation of the chiral 2-alkenylaziridine 
56 using methyl trifluoromethanesulfonate (MeOTf), follows the same route as the N-
alkoxycarbonylation approach (Scheme 9), giving rise to β-branched ring-opening products 58 via ring 
opening at C2. The reaction showed complete regio- and stereoselectivity toward the synthesis of a 
variety of optically pure amines 58 (Scheme 10).
42
  
 
 
Scheme 10 
 
2.2.3   Activation and ring opening of 2-(1-alkenyl)aziridines via silylation  
 
Even though the nature of trimethylsilyl reagents is different as compared to other electrophiles used 
for the activation of the aziridine moiety, ring opening of non-activated 2-alkenylaziridines has been 
shown to be successful in the presence of TMSN3 (trimethylsilyl azide), resulting in the formation of the 
corresponding C2 ring-opening products. 
For example, the reaction of 2-(1-alkenyl)aziridines 59 with TMSN3 furnished 1-amino-2-azido-3-
alkenes 60 after regioselective cleavage of the C2-N bond (Scheme 11).
43
 The latter azides 60 were 
subsequently used for the synthesis of 1,2-diaminoalkanes 61 via azide reduction and alkene 
hydrogenation.  
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Scheme 11 
 
2.3 Activation and ring opening of 2-arylaziridines 
 
Analysis of a large number of reported examples revealed the more hindered aziridine carbon atom in 
2-arylaziridinium salts to be the more favorable place for nucleophilic attack, furnishing the C2 ring-
opening products as the single or the major regioisomers. In general, activation of 2-phenylaziridines 
through complexation of the aziridine moiety with Lewis acids is followed by nucleophilic attack at the 
more substituted carbon atom (benzylic position). In a single example, the Lewis acid-catalyzed ring 
opening of 2-(2-pyridyl)aziridines gave either one or two regioisomers depending on the reaction 
conditions used, while acylation and protonation of 2-arylaziridines furnished only the C2 ring-opening 
products. 
 
2.3.1   Aziridinium ion formation through N-complexation with Lewis acids 
 
The reaction of 2-phenylaziridines 62 (optically pure or racemic) with different nucleophiles and Lewis 
acids gave amines 64 regio- and stereospecifically as a result of the nucleophilic attack at the benzylic 
position of the corresponding aziridinium complexes 63 (Scheme 12). For example, the ZnCl2-
catalyzed and B(C6F5)3-catalyzed reaction of 1-benzyl-2-phenylaziridine (62, R = Bn) with aliphatic and 
aromatic thiols afforded 2-benzylamino-1-phenylethyl sulfides (64, Nu = SR) in good yields (78-
89%).
44,45
 In that paper, previously reported results were revised,
46
 in which the synthesis of the 
amines derived from attack at the C3 carbon atom was reported. In addition to the ZnCl2-catalyzed 
reaction, the same C2-regioselectivity has also been observed in Bi(OTf)3- and Sc(OTf)3-catalyzed 
reactions of the same aziridine 62 (R = Bn) with aliphatic as well as aromatic thiols, providing high 
yields of only one regioisomer 64.
47
 The reaction of 2-phenylaziridines 62 with aromatic amines in the 
presence of Sn(OTf)2 or Cu(OTf)2 as catalysts again gave the products derived from nucleophilic attack 
at the benzylic position of the aziridinium intermediates 63.
48
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Scheme 12 
 
As compared to the reactivity of 2-phenyl-substituted aziridines 62, the regioselectivity in the reactions 
of 2-(2-pyridyl)-substituted aziridine 65 with a variety of different N-, S-, and O-nucleophiles was not 
always straightforward.
49
 It was shown that the ring opening of aziridine 65 gave the products 66, 
resulting from nucleophilic attack at the more substituted aziridine carbon, either exclusively or 
together with the alternative regioisomeric products 67 depending on the type of nucleophile, Lewis 
acid and solvent used (Scheme 13). The ring opening of 2-(2-pyridyl)aziridine 65 with 
heteronucleophiles applying optimized experimental conditions, i.e., in an acetonitrile-water mixture as 
the solvent and in the presence of a catalytic amount of cerium(III) chloride heptahydrate, proved to be 
a useful route toward a variety of difunctionalized pyridines. For example, using these conditions, the 
ring opening of aziridine 65 with NaN3 was straightforward, giving regioisomer 66 as a single product. 
Reactions with other nucleophiles such as water, amines and thiols also gave the C2 ring-opening 
products 66 as the major regioisomers. On the other hand, higher amounts of regioisomers 67 were 
reported when LiClO4 or Zn(OTf)2 were used to catalyze the ring opening of aziridine 65. In this way, it 
was possible to modify the regioselectivity of the ring-opening process by the proper choice of the 
reagent, Lewis acid and solvent.
49
 Nevertheless, it should be noted that complexation of the Lewis 
acid with both nitrogen atoms might have a profound influence on the reaction outcome of the above-
described ring-opening reactions, making a general conclusion on the regioselectivity regarding the 
ring opening of 2-(2-pyridyl)aziridine 65 premature.  
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Scheme 13 
 
2.3.2   Aziridinium ion formation through N-carbamoylation or N-acylation 
 
The reactions of above mentioned chiral 2-(2-pyridyl)-substituted aziridines 65 with an excess of both 
carbonyldiimidazole (CDI) and reactive alkyl halides, performed with the intention to prepare 
halogenated products resulting from the ring opening of the aziridine by the halide ion, have been 
evaluated by the same group.
50
 In this study, it has been observed that when methyl iodide was used, 
optically pure non-halogenated oxazolidin-2-one 70 was formed. In order to explain the presence of 
this compound, the iodide 69, derived from nucleophilic attack at the more substituted carbon atom of 
acylated aziridinium species 68, was proposed as an intermediate (Scheme 14). At the same time, 
intramolecular nucleophilic addition of the remote hydroxyl group across the carbonyl moiety in 
intermediate 68 furnished the oxazolidinone ring. Subsequently, the intermediate (hetero)benzylic 
iodide 69 has been proposed to be reduced by the excess of iodide affording oxazolidin-2-one 70. The 
reducing properties of the iodide ion and of hydrogen iodide in this type of transformations had already 
been reported in the literature.
51
  
 
 
Scheme 14 
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In order to account for the proposed mechanism, the aziridine 65 has been treated separately with 
either CDI and an excess of allyl bromide in acetonitrile at room temperature, or with two equiv of 
acetyl chloride, furnishing compounds 71 and 72, respectively (Scheme 15). Both products resulted 
from the fission of the benzylic C2-N bond by bromide or chloride in the intermediate aziridinium salt.
50
  
 
 
Scheme 15 
 
2.3.3   Aziridinium ion formation through N-protonation 
 
In accordance with the previously described results, the acid-mediated ring opening of 2-arylaziridines 
has been shown to result in the formation of the corresponding C2 ring-opening products, either as 
single isomers or, in exceptional cases, together with small amounts of the C3 ring-opening products. 
Thus, when 2-(2-pyridyl)aziridine 65 was protonated with an excess of hydrogen iodide, the amine 74 
was obtained (Scheme 16).
50
 The presence of this amine has been explained to be mediated by the 
formation of the intermediate β-iodoamine 73, resulting from iodide attack at the more substituted 
carbon atom of aziridine 65, and further reduction by the excess of hydrogen iodide through a 
halophilic reaction and subsequent protonation to form the amine 74. 
 
 
 
Scheme 16 
 
Moreover, after heating a mixture of the same aziridine 65 and p-toluenesulfonic acid (20 mol%) in a 
9:1 acetonitrile-water system at reflux temperature for 6 h, a mixture of the regioisomeric ring-opening 
products 66 and 67 (82:18) was obtained, which were separated by column chromatography (Scheme 
13).
49 
  
Similarly, the reaction of 1-benzyl-2-phenylaziridine 62 with aliphatic and aromatic acids in acetonitrile 
gave the amino esters 76 as the major isomers furnished by nucleophilic attack of the corresponding 
carboxylates at the benzylic position of aziridinium species 75 (Scheme 17).
52
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Scheme 17 
 
In addition, a mixture of a 2-arylaziridine, p-toluidine and silica gel (activated at 120°C under vacuum 
for 6 h) has been reported to afford the corresponding vicinal diamine as a result of the exclusive 
attack at the more hindered carbon atom of the aziridine ring,
53
 and hydrogen fluoride has also been 
described to combine regiospecifically with 2-phenylaziridines to give secondary fluorides in good 
yields.
54
 
In accordance with these results, the synthesis of isochromans 81, resulting from the cyclization of a 
number of 1-methylaziridines 77 using several proton sources (TFA, (COOH)2, HCOOH, H2SO4) and 
different solvents (THF, CH3CN, Et2O, dioxane/H2O), has been elucidated.
55
 Acetic acid, either as a 
proton source or as a solvent, at room temperature proved to be superior for the preparation of 
isochromans 81. Two plausible reaction mechanisms are depicted in Scheme 18. The first approach 
involves nitrogen protonation and ring opening at the benzylic carbon atom by the remote hydroxyl 
group (path a), whereas the second pathway involves the intermediacy of an acetate 79 (path b) 
followed by nucleophilic displacement of acetic acid by the hydroxyl group. In both cases, the 
nucleophilic attack occurs at the benzylic position of the aziridine ring. Determination of the 
stereochemistry of the obtained products 81 showed pathway a to be the predominant one.
55   
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Scheme 18 
 
Finally, the in situ activation of the aziridine moiety in the transformation of 2-aryl-3-
(hydroxymethyl)aziridines into 2-amino-3-aryl-3-methoxypropane-1-ols was assigned to hydrogen 
bridge formation between the aziridine nitrogen and methanol. It has been shown that also in this case 
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the reaction proceeds through regio- and stereoselective ring opening at the benzylic position of the 
corresponding aziridine moiety.
56
   
 
2.3.4   Activation and ring opening of 2-arylaziridines via silylation  
 
The same regioselectivity has been observed in the case of ring opening of 2-(2-pyridyl)aziridine 65 by 
TMSN3, providing the C2 ring-opening product 66 as the major isomer (Scheme 19).
49
  
 
 
Scheme 19 
 
2.4 Activation and ring opening of 2-acylaziridines 
 
The regioselectivity of the ring opening of 2-acylaziridines appears to be both nucleophile- and 
electrophile-dependent. However, in most cases the products obtained result from the attack at the 
more hindered aziridinium carbon atom (i.e., the α-carbon atom with respect to the carbonyl moiety), 
especially when the nucleophile is an azide, halide or cyanide ion. On the other hand, the reactions of 
2-acylaziridines with alcohols gave rise to ring opening at the less hindered aziridine carbon atom.  
 
 
2.4.1 Aziridinium ion formation through N-complexation with Lewis acids 
 
The ring-opening reactions of 2-(alkoxycarbonyl)aziridines 82 using various alcohols turned out to be 
regioselective, giving rise to α-amino esters 84. This reaction proceeded through nucleophilic attack at 
the less hindered side of the aziridinium moiety in intermediates 83 (Scheme 20).
57
 In addition, the 
ring-opening reactions of aziridine-2-carboxamide, aziridine-2-carboxylate and 2-acetylaziridines by 
water and different alcohols, promoted by the presence of BF3·Et2O, have been shown to follow the 
same regioselectivity.
58
  
 
 
Scheme 20 
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A nucleophile-dependent regioselectivity has been observed in ring-opening reactions of 2-
carbamoylaziridine 85, described by Gotor et al.
59
 Aziridine 85 was heated under reflux in methanol in 
the presence of a diethyl ether-boron(III) fluoride complex (Scheme 21), leading to a 3:1 mixture of the 
C2 and C3 ring-opening products, respectively, from which the former, i.e., enantiopure α-amino 
amide (S)-86, was isolated in 61% yield. On the other hand, when aziridine 85 was reacted with 
sodium azide and aluminium(III) chloride in aqueous ethanol, the formation of a 1:2.5 mixture of 
azides 88 and 89 was observed (Scheme 21).
59  
 
 
Scheme 21 
 
The ring opening of t-butyl N-benzylaziridine-2-carboxylate 90 with a higher order butylcuprate or 
nBuMgCl in the presence of BF3·Et2O has been studied by Baldwin et al.
60
 However, a mixture of 
products 91 and 92 in low yields was observed resulting from attack of the organometallic reagent at 
both C2 and C3 of the corresponding aziridinium intermediate (Scheme 22).  
 
 
Scheme 22 
 
2.4.2 Aziridinium ion formation through N-acylation or N-alkoxycarbonylation 
 
Various 2-acylaziridines 93 have been subjected to reactions with different acyl chlorides 94 to furnish 
β-amino-α-chlorocarbonyl compounds 96 in a regioselective and stereospecific way (Scheme 23).
61
 
The acyl chlorides were able to both activate the aziridine ring and to provide the nucleophile leading 
to the ring-opening reactions. The ring nitrogen reacts readily with acyl chlorides toward intermediate 
aziridinium ions 95, which are highly activated and smoothly react with the incoming chloride 
nucleophile. All ring-opening reactions were shown to be highly selective in terms of regio- and 
stereochemistry, implying that the bond between C2 and the ring nitrogen was labile and that the 
reaction proceeded with complete inversion of the configuration at C2.  
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Scheme 23 
 
As previously described for 2-vinylaziridines 52 (Scheme 9), the synthesis of oxazolidin-2-ones can 
also derive from N-methoxycarbonylation of 2-acyl- or 2-(alkoxycarbonyl)aziridines 97. 
Methoxycarbonylation of the nucleophilic nitrogen of aziridines 97 gave aziridinium ions 98, which 
were regioselectively attacked by the resulting chloride anion to give the chlorides 99. 
Chlorosubstituted intermediates 99 were then converted into oxazolidin-2-ones 100 through an 
intramolecular SN2 reaction (Scheme 24). The formation of the aziridinium intermediates 98 was also 
evidenced by the isolation of an intermediate 99 (R = OEt) when the reaction was performed in 
toluene instead of acetonitrile. Furthermore, when carbamate 99 (R = OEt) was heated under reflux in 
acetonitrile, oxazolidinone 100 was formed in an excellent yield.
41 
 
 
Scheme 24 
 
2.4.3 Aziridinium ion formation through N-protonation 
 
The ring-opening reactions of enantiomerically pure 2-acyl- and 2-(alkoxycarbonyl)aziridines 101 and 
102 with azide in an aqueous acidic medium (pH = 4, adjusted by the addition of sulfuric acid) have 
been described to proceed efficiently and stereoselectively to give 3-amino-2-azidoketones 103 or 3-
amino-2-azidopropionates 104, respectively, in the presence of 10 mol% of AlCl3·6H2O (Scheme 
25).
62
 Bearing in mind the low activity of AlCl3·6H2O as a Lewis acid, the presence of sulfuric acid 
(which was used to adjust pH) is considered to be responsible for the activation of the aziridine moiety 
through N-protonation.  
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Scheme 25 
 
To assign the absolute configuration of aziridine 105, this compound has been treated with 20% 
HClO4 to obtain the ring-opened product 107, which was subsequently transformed to the tert-butyl 
ester of D-serine 108 in quantitative yield (Scheme 26).
63
 In this approach, water attacked the 
nonsubstituted carbon atom of the intermediate aziridinium ion 106 to furnish β-aminoalcohol 107. 
However, the C3 regioselectivity in this case could be also attributed to the Lewis acid character of 
HClO4 rather than only protonation of nitrogen in aziridine 105. 
 
 
Scheme 26 
 
On the other hand, the selective ring opening of aziridine 109 (or its epimeric version) can be 
explained by an SN2 mechanism in which the chloride ion attacks at C2 with inversion of 
stereochemistry (Scheme 27).
64
 The regiospecific ring opening by the chloride ion can be further 
rationalized considering an enhanced electrophilicity at C2 due to intramolecular hydrogen bonding 
between the carbonyl and the hydroxyl group.  
 
 
Scheme 27 
 
In analogy with the previous example, nucleophilic attack by bromide (from hydrobromic acid) at the 
more hindered side of the aziridine ring has been shown to occur in the regiospecific ring opening of 2-
acylaziridines providing the corresponding bromoesters through N-protonation.
65
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2.4.4 Aziridinium ion formation through N-alkylation 
 
The presence of an ethoxycarbonyl substituent in aziridines 93 contributes to the activation of the 
bond between C2 and the ring nitrogen toward approaching nucleophiles. First, the ring is further 
activated by N-methylation using methyl triflate, followed by ring opening of aziridinium salt 111 by 
different nucleophiles to yield the ring-opened products 112. The attack was shown to occur 
regioselectively at the more hindered carbon atom of the aziridine ring (Scheme 28).
42 
 
 
Scheme 28 
 
In addition, aziridines 113 have been treated with methyl fluorosulfonate to afford the corresponding 
aziridinium salts 114 in high yields,
66
 which were characterized by ring-opening reactions using lithium 
chloride. In accordance with the above-mentioned reactions, the attack occurred at the more hindered 
side furnishing isomers 115, while only in one case (R
1
 = OEt, R
2
 = Me) the isomer 116 was present 
as well in 5% (Scheme 29).  
 
 
Scheme 29 
 
2.5 Activation and ring opening of 2-alkylaziridines 
 
The regioselectivity of the ring opening of 2-alkylaziridines has been the topic of a considerable 
number of literature reports, giving a better insight into the reactivity of this type of aziridines, which is 
mostly influenced by the nature of the nucleophile and the type of electrophile used for the activation 
of the aziridine moiety. It has been observed that protonic acid- and Lewis acid-catalyzed reactions 
result mainly in the ring opening of the aziridine moiety at the less hindered aziridinium carbon atom. 
The ring opening with acyl halides, which act at the same time as the activator of the aziridine moiety 
and the source of the nucleophile, gave mixtures of both regioisomers, with the C2 ring-opening 
product as the major component. When phosgene, carbon dioxide or acetic acid were used to activate 
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the ring, the less substituted carbon atom appeared to be the more favored place for nucleophilic 
attack. On the other hand, it was shown that ring opening of 2-alkylaziridines is nucleophile-dependent 
when the aziridine ring is activated via alkylation. Thus, if bromide, iodide and chloride are used as 
nucleophiles in benzyl bromide- or methyltriflate-activated reactions, the aziridine moiety was 
regioselectively opened at the C2 position through thermodynamic control. However, with the fluoride 
ion as the nucleophile, both regioisomers were formed, with a major amount of the C3 ring-opened 
product. The reactions with other nucleophiles such as amines, azide or alcohols proceeded mainly 
through nucleophilic attack at the non-substituted aziridine carbon atom. 
 
2.5.1 Aziridinium ion formation through N-complexation with Lewis acids 
 
The reaction of 2-alkylaziridines 117 with aromatic amines provided 1,2-diamines 118 after 
nucleophilic attack of the amine at the less substituted aziridine carbon atom (Scheme 30).
48
 A 
peculiar feature of this reaction is the fact that only aromatic amines successfully opened the 
aziridines. Aliphatic amines, such as diethylamine, n-butylamine, benzylamine and pyrrolidine, failed to 
react with aziridines 117 at room temperature for one day in the presence of a catalytic amount of 
copper(II) or tin(II) triflate. It was assumed that a “loose” complex of an aromatic amine and the 
catalyst coordinated with the aziridine nitrogen and initiated the ring-opening reaction. Aliphatic 
amines - by virtue of their higher basicity - made stronger complexes to the copper(II) and tin(II) triflate 
which failed to activate the aziridine.
48 
 
 
Scheme 30 
 
The same regioselectivity was observed in the BF3·Et2O-mediated ring opening of 2-
(hydroxymethyl)aziridines 119 and 2-(aminomethyl)aziridines 121 (Scheme 31) by different alcohols, 
providing an entry toward α-branched amines 120 and 122 through ring opening by methanol or i-
BuOH at C3.
57,59
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Scheme 31 
 
The ring opening of 2-butylaziridine 123 with thiol in the presence of a catalytic amount of ZnCl2 has 
been shown to follow the same route as in previous examples furnishing thioether 124 in 95% yield 
(Scheme 32).
46  
 
 
Scheme 32 
 
Besides, the aziridine ring of 1-(2-methoxy-1-phenylethyl)-2-methylaziridine has been opened at the 
C3 position with lithium dimethylcuprate in the presence of BF3·Et2O.
67
  
 
However, Uneyama et al.
68
 have reported the unsuccessful transformation of chiral 2-
(trifluoromethyl)aziridines 125 toward ring-opened products by using Lewis acids as catalyst and 
aliphatic amines as nucleophiles (Scheme 33). In this case, the reduced basicity of the aziridine 
nitrogen atom due to the strong electron-withdrawing effect of the CF3 group clearly hampered the 
formation of aziridinium-like intermediates. 
 
 
Scheme 33 
 
In the next part, the regioselectivity in the ring opening of 2-(1-aminoalkyl)aziridines 126 was 
described to be dependent on the type of nucleophile used to open the aziridinium moiety. In a 
Chapter 2  Literature Review 
24 
 
detailed study, Cancellon et al.
69
 have reported on the ring opening of aziridines 126 by alcohols and 
carboxylic acids in the presence of BF3·Et2O, providing C2 (129) and C3 (130) ring-opening products, 
respectively (Scheme 34). It was suggested that, after coordination of the aziridine nitrogen to the 
Lewis acid, an intramolecular ring opening at C2 by nucleophilic attack of the dibenzylamino group 
afforded the aziridinium salts 128 with inversion of configuration. Alcohols (R
3
OH) induced ring 
opening of aziridinium salts 128 to afford 2-alkoxy-1,3-diamines 130, with a second inversion of 
configuration at the C2. In the case of t-butylalcohol (R
3
 = tBu) the reaction takes place through 127 
due to steric hindrance. In the presence of a carboxylic acid, the prevalence of intermediates 128 may 
be diminished due to protonation of the dibenzylamino group, reducing its ability to open the aziridine 
to form 128, which resulted in the nucleophilic attack of carboxylic acid at the less hindered carbon 
atom of intermediate 127.  
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Scheme 34 
 
Furthermore, the use of iodide as a nucleophile in the ring-opening reaction of aziridines 131 in the 
presence of BF3·Et2O gave 4-phenylbut-3-en-1,2-diamines 135 (Scheme 35). It was assumed that the 
iodide attacks the aziridine ring at C3 affording iodo diamines 133. These intermediates are prone to 
undergo ring closure to produce azetidinium salts 134, which undergo a spontaneous α-elimination 
yielding chiral diamines 135.
69 
However, the possible complexation of both nitrogen atoms in aziridine 
131 with the Lewis acid might influence the regiochemical pathway in this reaction.  
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Scheme 35 
 
The ring opening of 2-(1-aminoalkyl)aziridines 131 by other nucleophiles has also been studied by the 
same group. For example, the BF3·Et2O-mediated ring-opening reactions of aziridines 131 with water 
has been shown to be completely regio- and stereoselective, involving ring opening at C2 and 
retention of configuration at this center.
70
  
Furthermore, the reaction of 2-(1-aminoalkyl)aziridines 126 (R
1
 = Me, BnOCH2) with one equiv of a 
thiol also proceeded regio- and stereoselectively, and it was shown that one alkylthio group was 
incorporated in the final product 136.
71
 When slightly modified reaction conditions (i.e., 3 equiv of 
thiols, BF3·Et2O and reflux) were applied to aziridines 126 (R
1
 = Bn, iBu), (2S,3S)-2,3-
bis(alkylthio)alkan-1-amines 137 were isolated instead (Scheme 36). 
1
H and 
13
C NMR analyses of 
compounds 137 showed the incorporation of two alkylthio groups and the disappearance of signals 
corresponding to the dibenzylamino group. No other regio- or diastereoisomers were observed in the 
crude reaction mixtures. It has been demonstrated that the regioselectivity of this reaction is also 
dependent on the nature of the substituent R
1
.  
 
 
Scheme 36 
 
Although this particular example falls outside the scope of this review, the participation of the C2 
aziridine substituent in ring openings has also been shown in the reaction of epoxyaziridine 138 with 
primary amines in the presence of lithium perchlorate. The reaction has been carried out with total 
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chemo- and regioselectivity, affording chiral polyfunctionalized piperidines 141 as the sole products in 
good yields.
72
 The formation of compounds 141 can be explained by amine-induced ring opening of 
the oxirane ring at the less hindered position to afford diamino alcohols 139 (Scheme 37). 
Theoretically, this intermediate could further react through aziridine ring opening by the hydroxyl group 
or through the amine function, yielding tetrahydrofurans, pyrrolidines, or piperidines. However, 
trisubstituted piperidines 141 were detected as the sole reaction products. Apparently, the terminal 
amino group in intermediate 140 participates in an intramolecular nucleophilic attack across the 
aziridine ring - probably activated by the Lewis acid, although previous reports suggested 
otherwise
69,70
 - at the less hindered position, affording the piperidine ring system.  
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Scheme 37 
 
2.5.2 Aziridinium ion formation through N-acylation or N-carboxylation 
 
In comparison with acid- and Lewis acid-catalyzed reactions, the ring opening of 2-alkylaziridines with 
acyl halides showed to be less straightforward, providing either single C2 ring-opening products or 
regioisomeric mixtures depending on the type of electrophile for the activation of the aziridine moiety. 
Treatment of 2-(cyanomethyl)aziridines 142 with an acid chloride in dichloromethane resulted in a 
mixture of β-chloroamine derivates 144 as the major constituents and regioisomers 145 as the minor 
products (Scheme 38).
73
 The acid chloride readily reacts with the basic nitrogen lone pair of aziridines 
142, affording highly electrophilic aziridinium intermediates 143 which are prone to undergo ring 
opening by the in situ liberated chloride anion. A distinct preferential attack of chloride at the more 
hindered aziridine carbon was observed, affording mainly N-(2-chloro-3-cyanopropyl)amides 144 in 
good yields. The formation of the minor regioisomers 145 is the result of the ring opening of 
aziridinium salts 143 at the less hindered position.  
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Scheme 38 
 
Applying the same reasoning, Higashiyama et al.
74
 have explained a new method for the preparation 
of chiral β-amino alcohols 150 through a regio- and stereocontrolled ring opening of chiral aziridines 
146. The high regio- and stereocontrol of this transformation is probably due to the intermediacy of N-
acylaziridinium salts 147 resulting from the reaction with acetyl chloride (Scheme 39). Subsequently, 
these N-acylaziridinium salts 147 undergo a ring-opening reaction via an anti-attack of chloride at the 
C2 position. Next, the resulting N-acyl-β-chloroamines 148 are readily converted into the transient 
oxazolinium derivatives 149 through internal chloride displacement by the oxygen nucleophile. Finally 
the oxazolinium derivative 149 is hydrolized to yield β-amino alcohols 150 as the major products.  
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Scheme 39 
 
However, when phosgene, carbon dioxide or carbonyldiimidazole (CDI) were used to activate the ring, 
the less substituted carbon atom appeared to be the more favored place for nucleophilic attack. Thus, 
a highly regioselective nucleophilic ring opening of 2-(1-hydroxyalkyl)aziridines 152 in the presence of 
phosgene has been observed to afford oxazolidinones 154 (Scheme 40).
75
 Phosgene acts as a 
cyclizing agent of the amino alcohol moiety to form reactive cyclic carbamates 153, which suffer from 
ring opening by the chloride ion at the less hindered side of the aziridine moiety to form oxazolidinones 
154. In the same manner, 2-(aminomethyl)aziridines have been converted to valuable 4,5-
disubstituted imidazolin-2-ones by treatment with triphosgene and NaH in THF.
76
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Scheme 40 
 
In a similar way, the same oxazolidinone derivatives have been prepared starting from 2-
(hydroxymethyl)aziridines and iodotrimethylsilane in the presence of carbonyldiimidazole (CDI).
77
  
Finally, in order to explain the conversion of enantiomerically pure 2-methylaziridines 155 into 
oxazolidinones 158 using CO2, Pinhas and Hancock suggested two possible mechanisms, one of 
which is shown in Scheme 41.
78 
This approach concerns the reaction of CO2 with the aziridine 
nitrogen atom (N-carboxylation) to give aziridinium ion 156, which then undergoes ring opening by 
iodide to generate intermediate 157. Spontaneous cyclization of the latter intermediate produces 4-
methyloxazolidinone 158 as the major regioisomer. In addition, to a minor extent, the aziridinium salt 
156 is attacked at the more hindered carbon atom and gives the isomeric 5-methyloxazolidinone as 
the final product. In light of the known reactivity of non-activated aziridines, however, the addition of 
aziridine 155 across CO2 is highly unlikely. Thus, the other proposed pathway, consisting of the initial 
ring opening of aziridine 155 by iodide to form the corresponding β-iodoamine, followed by addition of 
this lithium amide across CO2 and subsequent ring closure, seems to be much more plausible. In 
addition to the proposed routes, the alternative way for the formation of the corresponding products via 
[2+3] cycloaddition should not be completely excluded.  
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Scheme 41 
 
2.5.3 Aziridinium ion formation through N-protonation 
 
In general, the ring-opening reactions of 2-alkylaziridines 159 in the presence of different acids take 
place with high regioselectivity, revealing the C3 position of the aziridine ring as the most favorable 
place for nucleophilic attack (Scheme 42).  
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For example, the ring opening of 2-alkylaziridines 162 by acetic acid in dichloromethane has been 
shown to be a very efficient method for the regioselective formation of β-amino alcohol derivatives 
164, indicating that acetate attacks the less sterically hindered C3 position of the intermediate 
aziridinium salts 163 (Scheme 43).
28a,79,80,81,82,83,84,85,86,87
  
 
 
Scheme 43 
In addition, Higashiyama et al.
74
 have performed a number of reactions on the chiral 2-alkyl-
substituted aziridines 146 using acetic acid to yield the ring-opening products 165 after C3-N bond 
cleavage of the aziridine ring. In most cases, these reactions showed excellent regioselectivity, except 
in the case of a sterically small substituent (R = Me, ratio 165/166 = 89/11) (Scheme 44).  
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Also, 1-benzyl-2-(trifluoromethyl)aziridine 125 was shown to be a good substrate for acid-promoted 
ring-opening reactions with different nucleophiles, furnishing β-cleaved products 168 (β-amino halides, 
alcohols, ethers, sulfide and selenides) in good yields (40-98%) (Scheme 45).
68
 Therein, it has been 
observed that sulfuric acid-catalyzed ring opening of aziridine 125 by EtOH and ring-opening reactions 
of the same aziridine 125 by PhSH, promoted by sulfuric or trifluoromethanesulfonic acid, resulted in 
higher yields of the corresponding β-aminoethers 168 (Nu = OEt) or β-aminosulfides 168 (Nu = SPh), 
respectively.
68
 In addition, the ring opening of racemic analogues of aziridine 125 with acetic acid 
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resulted in a slower formation (up to 7 days) of amines 168 (Nu = OAc), probably due to the weaker 
acidity of acetic acid.
88
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Recently, ring opening of 1-arylmethyl-2-(cyanomethyl)aziridines 142 with HBr has been reported to 
afford 3-(arylmethyl)amino-4-bromobutyronitriles 170 via regiospecific ring opening at the 
unsubstituted aziridine carbon atom of the intermediate aziridinum salts 169 (Scheme 46).
31a
  
 
 
Scheme 46 
 
Furthermore, the ring-opening reaction of chiral α,β-diaminonitrile 171 with 4-chlorothiophenol afforded 
the corresponding α-(N-sulfinylamino)-β-benzylaminonitrile 172 in 82% yield (Scheme 47).
89
  
 
 
Scheme 47 
 
In the same manner, the treatment of 2-(hydroxymethyl)aziridines with thiophenol has been described 
to lead to the exclusive formation of the ring-opened β-amino alcohols after attack of the thiolate anion 
at the less sterically hindered C3 position.
90,91
 The nitrogen atom of an aziridine is a sufficiently stong 
base to pick up the proton from the thiol, resulting in an aziridinium intermediate which is further 
attacked by thiophenolate ion. A kinetic study of this ring-opening reaction showed that the reaction 
rate increases with the acidity of thiols.
31a
 Following the same regiospecific route, the reaction of 
enantiomerically pure 2-(hydroxymethyl)aziridines with acetic acid or thiophenols has been used as an 
efficient protocol for preparing optically active oxazolidinones.
75
   
Chapter 2  Literature Review 
31 
 
A highly C3 regioselective ring opening has also been observed in the reactions of 2-
(aminomethyl)aziridines with alcohols in the presence of one equiv of p-toluenesulfonic acid in 
CH3CN/ROH (7/1).
69
 The same aziridines were also reacted with water in the presence of p-
toluenesulfonic acid to afford 2,3-diaminoalkan-1-ols in high yields. Depending on the conditions 
applied, small amounts of the C2 ring-opening products were isolated in some cases.
70
  
In a recent report,
24b
 2-(aminomethyl)aziridines 173, prepared via nucleophilic substitution of 2-
(bromomethyl)aziridines
22,25b
 with different amines, were subjected to the diethylamine/diethylamine 
hydrochloride system in acetonitrile using microwave irradiation. In this way, biologically relevant 
1,2,3-triaminopropanes 175 were formed after ring opening of intermediate activated species 174 at 
the unhindered carbon atom of the aziridinium ion (path a, Scheme 48). However, in the case of 2-
(N,N-diethylaminomethyl)aziridines 173 (R
1 
= R
2
 = Et), a mixture of regioisomers (175/177 = 3/2) was 
obtained. This was explained by an additional rearrangement of aziridinium salts 174 to the 
corresponding 1,1-diethylaziridinium intermediates 176, which were subsequently attacked by 
diethylamine at C3 to furnish 1-(arylmethyl)amino-2,3-bis(N,N-diethylamino)propanes 177 (path b, 
Scheme 48).  
 
 
Scheme 48 
 
2.5.4 Aziridinium ion formation through N-alkylation 
 
2-(Bromomethyl)-, 2-(aryloxymethyl)-, 2-(alkanoyloxymethyl)-, 2-(cyanomethyl)-, and 2-(2-
cyanoethyl)aziridines 178 show the same reactivity toward arylmethyl bromides 179 in acetonitrile, 
giving a regiospecific ring opening of the intermediate aziridinium salts 180 by bromide attack at the 
more hindered aziridine carbon atom, affording ring-opened products 181 in high purity (Scheme 49). 
For example, treatment of 1-arylmethyl-2-(cyanomethyl)aziridines 178 (R
2
 = CN) with benzyl bromide 
179 (R
3
 = H) in acetonitrile afforded 4-amino-3-bromobutanenitriles 181,
31a,b
 and 2-(2-
cyanoethyl)aziridines 178 (R
2
 = CH2CN) afforded novel 5-amino-4-bromopentanenenitriles 181 in 
excellent yields after reflux for 5 h.
19
 4-Amino-3-bromobutanenitriles 181 (R
2
 = CN) could be further 
transformed into 3,4-diaminobutanenitriles via nucleophilic attack of pyrrolidine at the more hindered 
carbon atom of the same aziridinium intermediate 180.
31b
 Analogously, treatment of 2-
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(aryloxymethyl)aziridines 178 (R
2
 = OAr) with benzyl bromide in acetonitrile also afforded N-(2-bromo-
3-aryloxypropyl)amines 181 as the sole reaction products.
92
  
 
 
Scheme 49 
 
Aziridine ring opening at the more substituted carbon atom of the aziridine moiety has also been 
observed in a study on enantiomerically pure 2-(aryloxymethyl)aziridines.
31c
 The same observations 
were deduced in the case of 2-(bromomethyl)-
93
 and 2-(alkanoyloxymethyl)aziridines,
94
 affording 1-
[di(arylmethyl)amino]-2,3-dibromopropanes and N-(2-bromo-3-alkanoyloxypropyl)amines, respectively, 
upon treatment with benzyl bromide in acetonitrile. 
In accordance with these results, chiral aziridines 146 have been shown to afford β-bromoamines 183 
upon treatment with benzyl bromide by C2-N bond cleavage of the aziridinium salts 182. Next, 
treatment of β-bromoamines 183 with 2% aqueous sulfuric acid at 90 °C for 4 h gave, through 
formation of the same intermediates 182, the β-amino alcohols 184 in good yields via ring opening at 
C2 (Scheme 50).
74 
However, the formation of 184 via a direct bromide displacement in substrates 183 
should not be excluded. 
 
Chapter 2  Literature Review 
33 
 
PhCH2Br 2% aq. H2SO4 +
146
182
183 (90-93%)
182
184 (95-99%) 185 (0-5%)R = Me, Et, Pr, iPr
10 equiv
acetone, N2 
60 oC, 12 h
90 oC, 4 hN
OMe
Ph
R
N Ph
MeO
Ph
R
Br
N
Ph
MeO
Ph
R
H2O
N
R
Br
Ph
OMe
Ph
N
R
OH
Ph
OMe
Ph
N
Ph
OH
R
Ph
MeO
R
R
R
R
R
S
S
R
 
Scheme 50 
 
When (2R)-[(1R)-phenylethyl]-2-(methoxymethyl)aziridine 186 was treated with methyl 
trifluoromethanesulfonate (CH3OTf), followed by reaction with different nucleophiles such as N3
-
, AcO
-
, 
CN
-
, morpholine, BnNH2 and H
-
, single regioisomers 188 were obtained through ring opening at the 
less hindered side (C3) (Scheme 51).
42
  
 
 
Scheme 51 
 
The C3 regioselectivity has been observed in the methylation of the nitrogen atom of 2-
(trifluoromethyl)aziridine 125 by either MeI·AgBF4 or Me3O
+
·BF4
-
 to form the intermediate aziridinium 
salt 189, which is then ring opened by various nucleophiles at the less hindered carbon atom to afford 
chiral amines 190 (Scheme 52).
68 
 
 
 
Scheme 52 
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Although N-methylation is useful to induce ring opening, it is less suitable if further synthetic 
elaboration is required because of the associated difficulty in the deprotection. Therefore, N-allylation 
and N-tritylation of aziridine 125 have been investigated in the same work.
69
 To prepare practically 
useful N-protected compounds, allyl iodide was allowed to react with aziridine 125 in the presence of 
AgBF4. The generated aziridinium salt 191 was then quenched with nBuNH2, resulting in the 
production of diamine 192 in 48% yield (Scheme 53). Alternatively, the trityl group was introduced 
using Ph3C·BF4 in CH3CN. The aziridinium salt 193 underwent a Ritter type reaction with CH3CN, and 
subsequent cyclization produced imidazoline 195 in 60% yield. In addition, the successful C3-
regioselective ring opening of racemic variants of aziridine 125 via N-benzylation and subsequent ring 
opening by iodide has also been reported recently.
88 
 
 
 
 
Scheme 53 
 
In a recent report, intramolecular alkylation of aziridines 196 (or their diastereomeric counterparts), 
prepared via alkylation of 2-(2-cyano-2-phenylethyl)aziridines
19a
 with 1-bromo-2-chloroethane, was 
shown to be useful for the preparation of stereodefined piperidines 198 after regiospecific nucleophilic 
attack by chloride at the less hindered carbon atom of the aziridine moiety in bicyclic aziridinium 
intermediates 197 (Scheme 54).
23
 Bicyclic aziridinium intermediates have frequently been reported in 
the literature, although usually they are formed through nucleophilic displacement within other 
azaheterocyclic ring systems such as 2-(halomethyl)aziridines,
95
 -pyrrolidines
96
 and -piperidines.
97
 
These examples fall outside the scope of this review and will thus not be dealt with here.  
 
 
Scheme 54 
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Bearing in mind the above-described reports, it can be concluded that regioselectivity in the ring 
opening of 2-alkylaziridines, activated through alkylation, is dependent on the substrate, nucleophile 
and alkylating reagent used in these reactions. 
 
2.5.5 Activation and ring opening of 2-alkylaziridines via silylation  
 
It has been reported that 2-alkylaziridines undergo ring opening at the less substituted aziridine carbon 
atom upon treatment with TMSN3, which has been used for the activation of the aziridine ring and to 
provide azide as a nitrogen source to attack one of the aziridine carbon atoms. For example, the ring 
opening of 2-alkylaziridines 199 with TMSN3 in MeCN using 5 mol% of Sn(OTf)2 has been shown to 
be very effective and provided high yields of the corresponding azides 200, resulting from azide attack 
at the less hindered side of the aziridine ring (Scheme 55).
98
 
 
 
Scheme 55 
 
Similarly, the ring opening of chiral 2-(1-hydroxyalkyl)aziridines 201 has been shown to give β-
azidoamines 203 through C3-N bond cleavage by the azide nucleophile (Scheme 56).
99
 Furthermore, 
aziridines 201 can be regioselectively opened with iodide from iodotrimethylsilane (TMSI) to yield β-
iodoamines through C3 ring opening.
99
  
 
 
Scheme 56 
 
The same behavior of 2-alkylaziridines has also been described in the synthesis of bicyclic triazoles 
207, which were obtained when chiral 1-(aziridin-2-yl)propargylic alcohols 204 were reacted with 
azidotrimethylsilane (Scheme 57).
100 
It
 
has been suggested that the silylation of the aziridine nitrogen 
atom provided the activated aziridinium species 205, which were then regioselectively opened through 
fission of the C3-N bond by nucleophilic attack of the in situ liberated azide toward azido alcohols 206. 
Consequently, an intramolecular 1,3-dipolar cycloaddition efficiently converted azido alkynes 206 to 
the corresponding bicyclic triazoles 207.  
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Finally, in a report by Wróblewski et al.,
101
 the regioselective ring opening of chiral 2-substituted 
aziridinephosphonates 208 has been investigated. After optimizing the reaction conditions, 3-azido-1-
hydroxyphosphonates 211 (or their O-TMS derivatives) were obtained in high yields. Whereas initially 
N-silylated aziridinium species 210 could be invoked as intermediates, the authors suggested an 
alternative pathway involving silylation of the hydroxyl group in phosphonates 208 or hydrolysis of 
trimethylsilyl azide with adventitious water to produce hydrogen azide, which transforms the aziridine 
ring into intermediate aziridinium ions through N-protonation. Under these conditions, regiospecific 
ring opening by azide at the C3 position takes place (Scheme 58).
101
 
 
 
Scheme  58 
 
2.6 Theoretical aspects and insights obtained via computational chemistry 
 
In recent years, high-level computational analyses have been deployed successfully to shed more 
light on the reactivity profile of aziridinium intermediates and to provide a rationale for experimentally 
observed regio- and stereochemical preferences in their ring opening reactions.
31,102
 In this section, a 
short overview of recent achievements in that respect are presented.  
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The nucleophile-dependent regioselectivity in the ring opening of the chiral 1-benzyl-1-(α(R)-
methylbenzyl)-2(S)-(phenoxymethyl)aziridinium ion (i, Figure 5) has been subjected to several 
computational studies, to rationalize the observed experimental outcomes. Intramolecular π-π 
stacking interactions among aromatic substituents were identified and suggested to add stability to 
these intermediate species. T-stacking interactions were shown to be more favourable than parallel-
displaced conformations (ii and iii, Figure 5).
96
 Another critical aspect in simulations was the effective 
inclusion of the solvent environment, since nucleophilic substitution reactions are known to be highly 
influenced by the nature of the solvent. The qualitative picture of the energy landscapes were shown 
to be significantly dependent on the inclusion of solvent and in the absence of these critical stabilizing 
effects, experimentally observed regioselectivities could not be reproduced.  
 
 
i) 
 
 
ii) 
 
 
 
iii) 
 
Figure 5. Intramolecular π-π stacking in 1-benzyl-1-(α(R)-methylbenzyl)-2(S)-(phenoxymethyl)aziridinium ion. ii) 
T-stacking iii) Parallel-displaced 
 
The role of the nucleophile was investigated by considering hydride donors (borohydride and 
aluminium hydride) as well as halides and their propensities for attacking the unsubstituted (pathway 
a) versus substituted (pathway b) aziridine carbons (Scheme 59).  
 
 
Scheme 59 
 
In the case of hydride donors (BH4
-
 and AlH4
-
), the attack at the unhindered ring carbon of the 1-
benzyl-1-(α(R)-methylbenzyl)-2(S)-(phenoxymethyl)aziridinium ion, was shown to be the kinetic route 
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and incidentally led to the thermodynamically favourable product (Figure 6),
96,102b
 as observed 
experimentally.  
 
 
 
 
 
i) 
 
 
 
 
 
ii) 
 
 
  
Figure 6. i) Free energy profile for the hydride-induced ring opening of the 1-benzyl-1-(α(R)-methylbenzyl)-2(S)-
(phenoxymethyl)aziridinium ion at the unhindered (pathway a) and hindered (pathway b) ring carbons. ii) 
Transition state geometry for borohydride attack at unhindered aziridine carbon. 
(SCS-MP2/6-31++G(d,p))//B3LYP/6-31++G(d,p) at 298 K and 1 atm) 
BH4-Ts-a, BH4-Ts-b – transition states for hydride (from NaBH4) attack via pathways a and b, respectively 
AlH4-Ts-a, AlH4-Ts-b – transition states for hydride (from LiAlH4) attack via pathways a and b, respectively 
 
 
The overall picture for halide-induced ring opening showed that the unhindered route (pathway a) is 
always kinetically preferred, yet the hindered route leads to the thermodynamic product (Figure 7). 
However, the eventual outcome depends on the hardness/softness and leaving group ability of the 
nucleophile (halide). If the nucleophile is a good leaving group (soft nucleophile, bromide), back 
reaction barriers are sufficiently low to allow equilibration and the thermodynamic product will prevail. 
If the nucleophile is a poor leaving group (hard nucleophile, fluoride), the back reaction is unlikely and 
the kinetic route will dictate the reaction outcome.  
 
 
 BH4-TS-a 
Chapter 2  Literature Review 
39 
 
 
 
 
 
Figure 7. Free energy profile for the halide-induced ring opening of the 1-methyl-1-(α(R)-methylbenzyl)-2(R)-
(methoxymethyl)aziridinium ion at the unhindered (pathway a) and hindered (pathway b) ring carbons.  
(MPW1B95/6-31++G(d,p)//B3LYP/6-31++G(d,p) at 298 K and 1 atm)  
F-Ts-a, F-Ts-b – transition states for fluoride attack via pathways a and b, respectively; F-P-a, F-P-b-products of 
fluoride attack via pathways a and b, respectively. Cl-Ts-a, Cl-Ts-b – transition states for chloride attack via 
pathways a and b, respectively; Cl-P-a, Cl-P-b-products of chloride attack via pathways a and b, respectively. Br-
Ts-a, Br-Ts-b – transition states for bromide attack via pathways a and b, respectively; Br-P-a, Br-P-b-products of 
bromide attack via pathways a and b, respectively 
 
For the chloride case, equilibration is slow, and therefore the kinetic product is initially observed during 
the reaction. However, the final product is dictated by thermodynamic stability. In the case of bromide,  
equilibration is so rapid that the initial formation of the kinetic product is not observed and the 
thermodynamic product forms immediately. Theoretical results were in perfect agreement with 
experimental findings, also pointing to the well-known trend in nucleophile strength and leaving group 
ability throughout the halide series. Explicit solvation (Figure 8, acetonitrile molecules) was used to 
stabilize ionic species, as this was proven to significantly influence the energy landscape of SN2 
reactions.
31,96 
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a) 
 
 
 
 
b) 
 
Figure 8. Transition state geometries for bromide attack on the a) unhindered b) hindered carbon atom of the 1-
methyl-1-(α(R)-methylbenzyl)-2(R)-(methoxymethyl)aziridinium ion. 
(MPW1B95/6-31++G(d,p)//B3LYP/6-31++G(d,p)) 
 
 
2.7 Conclusion 
 
The ring-opening reactions of non-activated 2-substituted aziridines 48 have been described in a large 
number of reports, providing an insight into the regioselectivity depending on the nature of the 
nucleophile, the type of activation of the aziridine moiety and the nature of the substituents on the 
aziridine ring. These reactions proceed via formation of intermediate aziridinium ions 49, which are 
then opened at the more (path a) or/and the less substituted carbon atom (path b) toward amines 50 
and 51, respectively (Scheme 8). Based on these data, a general overview is provided in Table 1 as a 
practical guide. Bearing this in mind, it might be possible to predict a regioselective preference for 
other so far unexamined ring-opening reactions of non-activated 2-substituted aziridines as well.  
 
 
Scheme 8. 
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Table 1. Regioselectivity in the ring opening of non-activated 2-substituted aziridines depending on the 
substrate and the electrophile  
 
E
+
 
        R
2
 
LA RC
+
=O H
+
 R
+
 TMS
+
 
-CH=CH2, 
-CH=CH-COOEt 
C2
b 
C2 C2
b
 C2 C2 
Aryl C2  C2 C2 C2
b 
C2
b 
COR, COOR, CONH2 C3 C2 C2 C2       C2 
 
alkyl C3 C2 and/or C3 C3 C3
a 
C3 
a
only halides attack the C2 position 
b
proposed regioselectivity (no experimental data available) 
 
In this PhD thesis, the ring opening of non-activated aziridines (via intermediate aziridinium salts) will 
be employed as a powerful tool for the transformation of these strained species into a wide range of 
synthetically and biologically interesting nitrogen-containing scaffolds. 
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3  Results and Discussion 
 
3.1 Microwave-assisted regioselective ring opening of non-activated aziridines 
by lithium aluminium hydride103 
 
The aziridine moiety represents a valuable three-membered ring system in organic chemistry due to 
its versatility as a building block for the preparation of a large variety of amines via ring opening and 
ring expansion.
3a,4a,b,5a,35b,e,104,105
 In the chapter ‘Literature Review’, the regioselectivity of the ring 
opening of 2-substituted non-activated aziridines was discussed, showing this class of aziridines to be 
fruitful synthons for further chemical transformation. 
In comparison to the huge number of reports on the ring opening of aziridines by other nucleophiles, 
their ring opening by hydrides has received very limited interest in the literature despite the synthetic 
potential of this approach. The intermediacy of aziridines in direct, non-regioselective ring-opening 
reactions by LiAlH4 has been proposed in an early paper, in which the reduction of N-(1,1-dichloro-2-
alkylidene)anilines was investigated,
106
 and has also been deduced indirectly from the experiments of 
Suzuki.
107
 In addition, in one recent report,
108 
the reduction of 2-methyl-1-phenylaziridine with LiAlH4 in 
THF yielded a mixture of ring-opened amines (derived from hydride attack at both the more and the 
less hindered aziridine carbon atom in a 1:2 ratio, respectively) yet showed to be slow and not 
complete after heating under reflux for 20 hours. Furthermore, the contribution of the electron-
withdrawing effect of the phenyl group at nitrogen, facilitating ring opening of the aziridine moiety, 
should not be neglected in this particular case. In addition to the above-mentioned reports, the ring 
opening of reactive 2-chloroaziridine intermediates by LiAlH4 has also been described.
109
  
It should be stressed that several syntheses of aziridines have been reported in the literature based on 
the reduction of suitable substrates, such as α-halo imines,
110
 vinyl azides,
111
 oximes
112
 and 
azirines,
113
 by nucleophilic complex hydrides. Recently, the reductive ring opening of highly 
electrophilic aziridinium salts by hydrides has been reported to afford 2-aminopropanes through 
regiospecific ring opening at the unsubstituted position.
102
 However, up to now, LiAlH4 has been 
mainly used to reduce functional groups in compounds incorporating an aziridine unit without affecting 
the three-membered ring itself,
26
 and the hydride-promoted ring opening of non-activated aziridines 
has not been described in the literature so far. The lack of studies concerning the reduction of 
aziridines by LiAlH4 is remarkable in view of the large number of papers on the reductive ring opening 
of their oxygen counterparts, oxiranes. 
Therefore, in this section, special attention was devoted to the LiAlH4-promoted ring opening of non-
activated 2-subtituted aziridines toward biologically and synthetically relevant species.  
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3.1.1 Ring opening of 2-(bromomethyl)aziridines with LiAlH4  
 
As mentioned in the section 1 "Introduction and goals", 1-arylmethyl-2-(bromomethyl)aziridines 16 
have proven to be valuable synthons for the preparation of wide variety of azaheterocyclic compounds 
and amines derived from their ring opening.
24c,92,93,114
 These substrates were prepared by an efficient 
three-step procedure, comprising the initial imination of benzaldehydes 212a-d with 1 equiv of 
allylamine in the presence of 1.5 equiv of MgSO4 in CH2Cl2 for 1 hour under reflux. Subsequent 
bromination of imines 213a-d with 1 equiv of Br2 in CH2Cl2 at room temperature for 1 hour furnished 
dibromoimines 214a-d in nearly quantitative yields (95-99%, Scheme 60). Finally, the reductive 
cyclization of brominated imines 214a-d with 2 molar equiv of NaBH4 in MeOH under reflux for 2 hours 
resulted in the formation of aziridines 16a-d in high yields (89-94%) and excellent purity.
22,25b,115
  
 
 
Scheme 60 
 
In order to evaluate the unexplored reactivity of 2-(bromomethyl)aziridines 16 toward LiAlH4, aziridines 
16a,b were treated with two molar equivalents of LiAlH4 in dry Et2O under reflux for 2-15 hours. The 
reaction resulted in complex mixtures, in which signals pertaining to the corresponding allylamines 
217, 2-methylaziridines 218 and isopropylamines 219 were detected (based on NMR and LC-MS) 
(Scheme 61). Changing the reaction conditions, i.e., the temperature and the reaction time, resulted in 
a different and sometimes unpredictable reaction outcome (Table 2). 
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Scheme 61 
 
Table 2. Treatment of 2-(bromomethyl)aziridines 16a,b with 2 molar equiv LiAlH4 
Compound Reaction conditions Result 
16a Et2O, r.t., 15 h 15-20% of 217 + side products 
16a Et2O, Δ, 15 h 217 (12%)/218 (48%) : 1/4 + side products 
16b Et2O, Δ, 2 h 217 (15%)/218 (45%) : 1/3 + side products 
16b Et2O, Δ, 2.5 h 218 (52%)/219 (30%) : 1.7/1 + side products 
 
 
The formation of amines 217 can be explained by a LiAlH4-induced debromination of aziridines 16 via 
a nucleophilic or a radical reaction,
116
 followed by ring opening of the intermediate aziridinylmethyl 
anion 215 or aziridinylmethyl radical 216 to give the corresponding amines 217 after aqueous work up 
(Scheme 61). 
After a number of attempts to optimize the reaction conditions, the reaction of aziridines 16a-d with 2 
molar equiv of LiAlH4 in dry Et2O under reflux for 3-6 hours afforded N-arylmethyl-N-isopropylamines 
219 as the sole reaction products quite unexpectedly in high yields (80-84%) (Scheme 62). Again, the 
suggested mechanistic pathway for this transformation consists of an initial reductive debromination of 
2-(bromomethyl)aziridines 16 toward 2-methylaziridines 218 through the action of LiAlH4, either via a 
nucleophilic or a radical reaction.
116
 Subsequently, reductive ring opening takes place via nucleophilic 
attack of a hydride ion (from LiAlH4) at the less substituted carbon atom of the aziridine moiety in 
intermediates 220. Apparently, the reducing agent acts both as the activator of the aziridine ring 
(through coordination of aluminium with nitrogen)
68,108
 and as the provider of the nucleophile (hydride) 
which opens up the ring at the less hindered position (Scheme 62). However, the alternative 
mechanistic pathway comprising an initial hydride attack at the less hindered position of the aziridine 
moiety of 2-(bromomethyl)aziridines 16 yielding the corresponding ring-opened intermediates, and 
their subsequent ring closure toward 2-methylaziridines 218, should not be neglected. Although 
attempts to isolate 2-methylaziridine 218
117
  by column chromatography on silica gel failed, their 
intermediacy was acknowledged by 
1
H NMR, 
13
C NMR and MS analysis of some of the crude reaction 
mixtures.  
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Scheme 62 
 
Additionally, in order to confirm the structure of N-arylmethyl-N-isopropylamines 219, an independent 
synthesis of N-(4-methoxybenzyl)-N-isopropylamine 219d was performed. Condensation of 4-
methoxybenzaldehyde 212d with 1.05 equiv of iPrNH2 in CH2Cl2 in the presence of MgSO4 afforded 
the corresponding imine 221 in 75% yield after six hours under reflux, which was then reduced using 
two molar equiv of NaBH4 in MeOH for two hours under reflux, furnishing N-(4-methoxybenzyl)-N-
isopropylamine 219d in 96% yield (Scheme 63). The spectral data of amine 219d obtained via both 
routes were judged to be identical. 
  
Scheme 63 
Apart from amines 219, which can of course easily be prepared via other routes, this methodology 
holds significant synthetic potential for the preparation of a large variety of amines in a convenient way 
through reductive ring opening of the appropriate aziridine derivatives, which will be the topic of the 
following paragraphs. 
 
 
3.1.2 Ring opening of 2-(acetoxymethyl)aziridines with LiAlH4 
 
The utility of this LiAlH4-promoted ring opening of non-activated aziridines was also demonstrated by 
the synthesis of versatile β-amino alcohols starting from 2-(acetoxymethyl)aziridines.  
1-Arylmethyl-2-(acetoxymethyl)aziridines 222 were smoothly prepared upon treatment of 2-
(bromomethyl)aziridines 16a-d with an excess (1.5 equiv) of sodium acetate in DMSO at 100 °C for 15 
hours (Scheme 64). The reaction provided almost pure acetates 222a-d suitable for further elaboration 
without prior purification. However, for full characterization, aziridines 222 were purified by column 
chromatography on silica gel, affording analytically pure samples.  
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Further treatment of 2-(acetoxymethyl)aziridines 222 with two molar equiv of LiAlH4 in Et2O and 
heating for six hours under reflux provided crude mixtures containing mainly aziridinyl alcohols 223, 
and no traces of ring opened β-amino alcohols 224 were detected. Increasing the reaction time to 24-
62 hours led to partial formation of β-amino alcohols 224 (~50%). It was shown that, in order to obtain 
β-amino alcohols 224 in reasonable yields, a reflux time of several days (4-5) was required (Table 3). 
 
Table 3. Treatment of 2-(acetoxymethyl)aziridines 222 with 2 molar equiv LiAlH4  
Compound Reaction conditions Result 
222b Et2O, Δ, 15 h 70% of 223b + side products 
222a Et2O, Δ, 20 h 76% of 223a + side products 
222a Et2O, Δ, 1.5 h 15% of 224a + side products 
222c Et2O, Δ, 7 d 85% of 224c + side products 
222d Et2O, Δ, 4 d 223d + 224d + side products 
222d THF, Δ, 6 d 90% of 224d + side products 
222c Et2O, Δ, 5 d 85% of 224c + side products 
222b Et2O, Δ, 5 d 65% of 224b + side products 
 
 
In order to overcome this major drawback, the reaction mixture was subjected to microwave irradiation  
(CAUTION!). Gratifyingly, after heating aziridines 222 in THF at 130 °C for two hours (220 Wmax) in the 
presence of two molar equiv of LiAlH4, only the corresponding β-amino alcohols 224 were formed in 
high purity without traces of 2-(hydroxymethyl)aziridines 223 (Scheme 64). Thus, the nucleophilic 
attack of hydride at the less substituted carbon atom of aziridines 223 was confirmed and, as a result, 
β-amino alcohols 224 were obtained in high yields after purification by column chromatography on 
silica gel. In this way, 2-aminopropan-1-ols 224 were formed selectively through complete regio- and 
stereoselective conversion of 2-(hydroxymethyl)aziridines 223. Although several useful routes for the 
synthesis of β-amino alcohols are available in the literature,
28a,40a,118
 some of these approaches suffer 
from (minor) drawbacks such as low regioselectivity, cumbrous substrate synthesis or low substrate 
stability. The synthesis of β-amino alcohols 224 through microwave-assisted ring opening of aziridines 
222 utilizing LiAlH4 satisfies the requirements for a generally applicable route, i.e., the use of 
commercially available starting compounds, complete regio- and stereoselectivity and high energy 
efficiency. Thus, the presented methodology can be regarded as a complementary approach or a 
worthy alternative for other known routes. β-Amino alcohols are applied extensively in organic 
synthesis as a building blocks in designing natural and biologically active substances,
27,28a,39,119
 and 
their chiral versions are also used in catalytic asymmetric synthesis.
28
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Scheme 64 
 
3.1.3 Synthesis of 5-methylmorpholin-2-ones from β-amino alcohols 
 
The reactivity of β-amino alcohols toward the synthesis of the corresponding 1,4-oxazin-2-ones upon 
the condensation with glyoxal was a subject of a number of literature reports.
120
 In the next part, 2-
aminopropan-1-ols 224 were also shown to be suitable intermediates for the construction of 5-
methylmorpholin-2-ones,
29
 which are known as fruitful substrates for the synthesis of biologically 
relevant compounds.
121
  
Thus, 2-(arylmethylamino)propan-1-ols 224a-d were dissolved in THF and treated with three equiv of 
glyoxal. After heating these mixtures for 2-3 hours, 5-methylmorpholin-2-ones 228a-d were obtained in 
good yields (Scheme 65), and column chromatography on silica gel provided analytically pure 
compounds suitable for full characterization. The mechanism of the formation of morpholin-2-ones 228 
could be explained by the initial formation of iminium salt 225, which undergoes an intramolecular 
nucleophilic addition of the hydroxyl group to the carbonyl group to give the cyclic iminium 
intermediate 226, which rearranges to the more stable enamine 227 to provide morpholin-2-one 228 
as the final product.         
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Scheme 65 
 
 
3.1.4 Synthesis of enantiopure β-amino alcohols and 5-methylmorpholin-2-ones  
 
Given the intermediacy of 2-(hydroxymethyl)aziridines 223 in the conversion of acetates 222 into 
alcohols 224, efforts were devoted to the evaluation of chiral 2-(hydroxymethyl)aziridines as 
substrates for a LiAlH4-promoted reductive ring opening. In the literature, only a few studies have been 
made on ring-opening reactions of non-activated enantiomerically pure 2-
(hydroxymethyl)aziridines.
79,84,85,118a,122 
For example, the catalytic hydrogenation of 2-
(aziridinyl)methanols 229a and 229b in EtOH using Pd(OH)2 has provided β-amino alcohols 230a and 
230b in good yields.
122
 Recently, the preparation of chiral β-amino alcohols via regio- and 
stereocontrolled ring-opening reactions of chiral aziridines has been examined.
74
 This approach 
comprised the reaction of 2-alkylaziridines with acetic acid to yield the ring-opening products with 
excellent regioselectivity, which were then treated with LiAlH4 or Pd(OH)2 to provide the corresponding 
β-amino alcohols. On the other hand, the reaction of the same chiral aziridines with acetyl chloride 
followed by treatment with water gave isomeric β-amino alcohols through oxazoline intermediates.
74 
In 
addition, the reaction of the latter chiral aziridines with benzyl bromide followed by the treatment with 
sulfuric acid gave secondary β-amino alcohols via ring opening at the substituted aziridine carbon 
atom. 
Many β-amino alcohols are biologically active and play very important roles in living organisms.
123
 
Therefore, the syntheses of enantiomerically pure amino alcohols are becoming important areas of 
research. Among those, Ephedra alkaloids (Figure 9) are attractive targets because of their biological 
and medicinal activities. These compounds have long been used in China to treat bronchial asthma, 
hay fever, and other allergic reactions, and large quantities are produced in Western countries to 
relieve mucous membrane congestion.
124
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OH
NHR
CH3
R = CH3 ((1R,2S)-(-)-ephedrine) 
R = H ((1R,2S)-(-)-norephedrine)
R = CH3 ((1S,2S)-(+)-pseudoephedrine)
R = H ((1S,2S)-(-)-norpseudoephedrine) 
Figure 9 
 
In this part, the synthesis of enantiopure 2-aminopropan-1-ols by means of LiAlH4-promoted reduction 
of chiral 2-(hydroxymethyl)aziridines 229a and 229b was successfully examined. After failing to 
prepare amines 230a and 230b upon treatment with two molar equiv of LiAlH4 under reflux for several 
days in THF and toluene (Table 4), the mixture of aziridines 229 and two molar equiv of LiAlH4 in THF 
was subjected to microwave conditions (160 °C, 220 Wmax, two hours). Fortunately, full and selective 
conversion of aziridines 229a and 229b into enantiopure 2-aminopropan-1-ols 230a and 230b as 
single stereoisomers was obtained (Scheme 66). 
 
Table 4. Treatment of 2-(hydroxymethyl)aziridines 229 with 2 molar equiv LiAlH4  
Compound Reaction conditions Result 
229a Et2O, Δ, 6 h no reaction 
229a THF, Δ, 10 d no reaction 
229a toluene, Δ, 3 h no reaction 
229b THF, Δ, 2 d no reaction 
229b toluene, Δ, 5-10 d complex mixture 
 
Again, the mechanism comprises coordination of aluminium with the aziridine nitrogen atom, enabling 
C(3)-N bond cleavage induced by nucleophilic attack of a hydride ion to furnish the corresponding 
ring-opened product. The bond cleavage showed to be highly regioselective, since hydride attack only 
occured at the less hindered position. Furthermore, the ring opening reaction of chiral aziridines 229 
proceeded not only with high regioselectivity, as it also furnished the corresponding enantiopure amino 
alcohols 230a and 230b with full retention of configuration. 
The preparation of enantiopure six-membered oxazaheterocycles has received significant attention, 
for example due to their high potential as chiral substrates. In particular, chiral morpholin-2-ones have 
been used in the asymmetric synthesis of α-amino acids
121a,b
 and other natural products.
121c,d,e
 In the 
present study, enantiopure 5-methylmorpholin-2-ones were prepared by condensation of the 
corresponding chiral amino alcohols with glyoxal. Thus, chiral β-amino alcohols 230a and 230b were 
treated with three equiv of glyoxal (40%), affording enantiopure morpholin-2-ones 231a and 231b 
upon reflux for three hours in THF (Scheme 66). The reaction showed high stereoselectivity since no 
diastereomers were detected in the crude 
1
H NMR spectra, which is in accordance with previously 
reported analogous condensation reactions.
29
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Scheme 66 
 
Attempts to convert enantiopure amino alcohols 230 into chiral 2-methylaziridines were not successful. 
For this purpose, β-amino alcohols 230a and 230b were subjected to Mitsunobu conditions using 1.2 
equiv of PPh3 and 1.2 equiv of diisopropyl azodicarboxylate (or 1.2 equiv of N-bromosuccinimide) in 
THF for 18 hours, or were treated with 1.05 equiv of MsCl and 1.1 equiv of Et3N (or 1.05 equiv of TsCl 
and 0.1 equiv of DMAP) in CH2Cl2 for 4 hours, although in all cases only complex mixtures were 
obtained. 
In addition, the efforts to cleave the 1-phenylethyl group at the nitrogen atom in morpholinone 231a by 
means of hydrogenation using Pd(OH)2 (5-15 mol%) at 5 bar, were not successful, even after 
prolonged reaction times (3 days) (Table 5, Scheme 67). 
 
Scheme 67 
 
Table 5. Attempts to deprotect nitrogen in morpholinone 231a  
Compound Reaction conditions Result 
231a 5mol% Pd(OH)2, EtOAc, 4 bar, 1 d no reaction 
231a 15mol% Pd(OH)2, EtOAc, 5 bar, 3 d no reaction 
 
 
3.1.5 Ring opening of 2-(methoxymethyl)- and 2-(phenoxymethyl)aziridines with LiAlH4 
 
In addition to the use of 2-(acetoxymethyl)- and 2-(hydroxymethyl)aziridines, the LiAlH4-promoted ring 
opening of 2-(methoxymethyl)- and 2-(phenoxymethyl)aziridines 233 and 234 was evaluated applying 
microwave conditions (Scheme 68).  
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2-(Methoxymethyl)aziridines 233a,b were prepared through conversion of 2-(bromomethyl)aziridines 
16 upon treatment with two equiv of sodium methoxide in methanol (2M) under reflux for 15 hours,
125
 
whereas 2-(phenoxymethyl)aziridines 234a-d were obtained by treatment of 2-
(bromomethyl)aziridines 16 with 2.2 equiv of phenol and 5 equiv of K2CO3 in a mixture of DMF and 
acetone (1/1) under reflux for 10-20 hours.
92 
 
Scheme 68 
 
Remarkably, treatment of aziridines 233 with two equiv of LiAlH4 under microwave conditions resulted 
in different reaction products depending on the temperature used. Indeed, treatment of aziridine 
233a,b for 2 hours at 160 °C yielded isopropylamines 219, whereas mainly β-methoxyamines 235a,b 
were obtained after 12 hours at 130 °C (Scheme 69, Table 6). The formation of isopropylamines 219b-
d can be explained considering the initial replacement of the methoxy group by means of LiAlH4 (via a 
nucleophilic or radical pathway) furnishing 2-methylaziridines 218, which subsequently underwent 
reductive ring opening via nucleophilic attack of a hydride ion (from LiAlH4) at the less substituted 
carbon atom of the aziridine moiety. Again, spectroscopic evidence for the intermediacy of 2-
methylaziridines 218 was obtained through careful analysis of the reaction mixtures. Apparently, at 
130 °C nucleophilic aziridine ring opening by hydride took place prior to replacement of the methoxy 
group, and β-methoxyamines 235a,b were obtained as the major components in the reaction mixtures 
(Scheme 69). The reaction of 2-(phenoxymethyl)aziridines 234b,d with two equiv of LiAlH4 surprisingly 
furnished isopropylamines 219 after 6 hours at 160 °C under microwave irradiation. However, when 
these aziridines 234b,d were heated at 130 °C (or 140 °C) for 10-15 hours, 2-methylaziridines 218 
were obtained in a mixture together with starting compounds 234b,d. Increasing the temperature to 
160 °C led to the full conversion of aziridines 234b,d into isopropylamines 219. These observations 
can be explained considering the better leaving group capacities of the phenoxy substituent as 
compared to the methoxy group, resulting in a more rapid formation of intermediate 2-methylaziridines 
218. The unexpected behaviour of the phenoxy group as a leaving group is remarkable, as no other 
reports on the conversion of phenoxyalkanes into the corresponding alkanes using hydride reagents 
have been reported in the literature. Thus, attempts were made to convert n-decylphenyl ether into n-
decane using LiAlH4 under microwave conditions. However, the reaction showed to be potentially 
dangerous under microwave irradiation at 160 °C, leading to an explosive reaction outcome. 
Therefore, this method cannot to be regarded as a general synthetic approach for alkane formation as 
such. 
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Scheme 69 
 
Table 6. LiAlH4-promoted ring opening of aziridines 233 and 234 using microwave irradiation 
 
Compound Reaction conditions Result 
233a 2 equiv LiAlH4, THF, 130 °C, 30 min no reaction 
233a 2 equiv LiAlH4, THF, 130 °C, 10 h 80% of 235a 
233b 2 equiv LiAlH4, THF, 130 °C, 12 h 60% of 235b 
234d 2 equiv LiAlH4, THF, 120 °C, 15 h no reaction 
234d 2 equiv LiAlH4, THF, 130 °C, 12 h complex mixture 
234b 2 equiv LiAlH4, THF, 120 °C, 15 h no reaction 
234b 2 equiv LiAlH4, THF, 140 °C, 10 h complex mixture 
234d 2 equiv LiAlH4, THF, 160 °C, 6 h 52% of 219d 
234b 2 equiv LiAlH4, THF, 160 °C, 6 h 54% of 219c 
 
 
In conclusion, the microwave-assisted reductive ring opening of 2-substituted non-activated aziridines 
utilizing LiAlH4 proceeded smoothly in a highly regio- and stereoselective way, not requiring the 
presence of additional Lewis acids. 2-(Acetoxymethyl)aziridines provided β-amino alcohols upon 
treatment with LiAlH4 under microwave irradiation, which were then used to produce synthetically 
relevant 5-methylmorpholin-2-ones in a straightforward way. Besides, the microwave-assisted 
conversion of chiral aziridine substrates by means of LiAlH4 furnished the corresponding enantiopure 
β-amino alcohols, which were then exposed to glyoxal to give chiral 5(R)- and 5(S)-morpholin-2-ones. 
In addition, 2-(methoxymethyl)aziridines provided isopropylamines or β-methoxyamines upon 
treatment with LiAlH4 under microwave irradiation, depending on the temperature applied. Thus, 
LiAlH4 can be regarded as a useful reagent for a new type of reductive aziridine ring opening in a 
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selective way under microwave conditions, paving the way for a variety of novel applications in organic 
chemistry. 
 
 
3.2 Systematic study of halide-induced ring opening of 2-substituted 
aziridinium salts126  
 
The regio-controlled ring opening of C-substituted aziridines constitutes a powerful approach toward 
the preparation of a large variety of functionalized nitrogen-containing target compounds.
 
In the 
chapter ‘Literature review’ the issue of regioselectivity in the ring opening of 2-substituted aziridinium 
salts, obtained by N-functionalization of neutral aziridines, by different nucleophiles was thoroughly 
discussed. Therein, the relationship between the observed regioselectivity and inherent structural 
features such as the nature of the C2 aziridine substituent and the nature of the electrophile and the 
nucleophile was disclosed. 
The ring opening of aziridinium salts by halides constitutes a convenient approach toward -halo 
amines, which are generally recognized as useful building blocks in organic chemistry
22,115,127 
and 
valuable targets in medicinal chemistry (nitrogen mustards – chemotherapy agents).
128
  
As seen in the previous chapter, intermediate aziridinium salts 236 can be ring opened at the 
unsubstituted (path a) or the substituted aziridine carbon atom (path b), leading either to primary 
halides 237 (path a) or to secondary halides 238 (path b) (Scheme 70). 
 
 
 
Scheme 70 
In the literature, a number of reports are available on the synthesis of -halo amines through ring 
opening of aziridinium salts by halides.
31a,39,68,74,129
 In most cases, 2-vinyl- and 2-arylaziridinium salts 
have been evaluated, in which the regioselectivity is substrate-dictated due to the presence of a 
pronounced electrophilic centre at the substituted aziridine carbon atom. The use of 2-alkyl-substituted 
aziridinium ions has somewhat been neglected in that respect, probably because of the potential 
influence of different parameters such as the type of nucleophile, substrate and solvent on the reaction 
outcome. Whereas the issue of regioselectivity has been addressed in a number of literature reports, 
no systematic study has been performed up to now in which aziridinium substrates are subjected to 
ring opening by fluoride, chloride, bromide and iodide. 
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Therefore, in this part, in situ generated 2-substituted aziridinium salts have been used as 
electrophiles for ring opening by fluoride, chloride, bromide and iodide in acetonitrile in a systematic 
way. 
 
 
3.2.1  Ring opening of 2-aryloxymethyl-1,1-di(arylmethyl)aziridinium salts by halides 
 
In this part, halide-induced ring opening of intermediate 2-aryloxymethyl-1,1-di(arylmethyl)aziridinium 
salts was contemplated. As reported before, 2-(aryloxymethyl)aziridines 234 can be prepared in high 
yields and purity upon treatment of the corresponding 2-(bromomethyl)aziridines 16
22,115a,b
 with two 
equiv of the appropriate potassium phenolate in a DMF/acetone (1/1) solvent system under reflux for 
10-20 hours (Scheme 68).
92
  
Treatment of the aziridines 234 with one equiv of benzyl bromide in acetonitrile is known to afford 
secondary bromides 239 as the sole reaction products in high yields after reflux for five hours 
(Scheme 11, Table 7).
92
 In order to provide an entry into the corresponding fluorides, chlorides and 
iodides as well, β-bromo amines 239 were treated with different halide sources. Thus, both novel β-
chloro amines 240 and β-iodo amines 241 were prepared as the sole reaction products by the use of 
either 10 equiv of tetraethylammonium chloride or 20 equiv of sodium iodide, respectively, in 
acetonitrile after reflux for three hours (Scheme 11, Table 7). The formation of the other regioisomers 
was excluded based on detailed spectroscopic analysis. 
The conversion of β-bromo amines 239 into β-chloro amines 240 using 20 equiv of NaCl instead of 
tetraethylammonium chloride in acetonitrile proceeded very sluggishly, as no conversion occurred 
after heating under reflux for 4 hours and only partial conversion was observed after reflux for 60 
hours. On the other hand, the reaction of β-bromo amines 239 with 10 equiv of tetrabutylammonium 
iodide in acetonitrile appeared to be less successful as compared to the use of sodium iodide, as only 
50% conversion took place after reflux for 7 hours. If 15 equiv of sodium iodide were used instead of 
20 equiv, a longer reaction time (5 hours) was required in order to drive the reaction to completion. 
When β-bromo amines 239 were treated with two equiv of tetrabutylammonium fluoride in acetonitrile, 
however, a mixture of regioisomeric fluorides 242 and 243 were obtained after reflux for 15 hours 
(Scheme 71, Table 7).
94 
In this case, primary fluorides 242 were formed as the major reaction 
products, besides minor amounts of secondary fluorides 243 (ratio 242/243 5-6/1). In order to test the 
reaction outcome as a function of reaction time and temperature, prolonged and elevated reaction 
times were also evaluated. In particular, heating under reflux for 3 days instead of 15 hours did not 
affect the isomeric distribution (ratio 242/243: 5-6/1), and the same conclusion was drawn after 
heating under reflux for 25 hours in DMF. These observations point to the fact that the product 
distribution between primary and secondary fluorides 242 and 243 is not under thermodynamic 
control. 
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Scheme 71 
 
Table 7. Synthesis of β-bromo amines 239, β-chloro amines 240, β-iodo amines 241 and β-fluoro 
amines 242 and 243. 
Entry R
1 
R
2 239 (yield) 240 (yield) 241 (yield) 242 (yield) 243 (yield) 
Ratio
a
 
242/243 
1 2-Cl H 239a (71%) 240a (82%) 241a (89%) 242a (54%) 243a (10%) 5/1 
2 4-Cl H 239b (86%) 240b (79%) 241b (88%) 242b (42%)  243b (8%) 5/1 
3 4-Cl Cl 239c (85%) 240c (83%) 241c (82%) 242c (60%) 243c (10%) 6/1 
4 4-OMe H 239d (84%) 240d (84%) 241d (79%) 242d (61%) 243d (14%) 6/1 
a
 Ratio determined by 
1
H NMR analysis 
 
As observed and investigated before, quaternization and subsequent ring opening of 2-
(aryloxymethyl)aziridines 234 using benzyl bromide produces β-bromo amines 246 through 
regiospecific ring opening of aziridinium salts 244 at the substituted aziridine carbon atom (X = Br, 
path b, Scheme 72).
42,94,102a 
Furthermore, in addition to preliminary findings using other types of 
substrates,
94
 the ring opening of aziridinum intermediates 244 by fluoride afforded a mixture of 
regioisomers in which primary fluorides 245 are predominant (X = F, path a, Scheme 72), pointing to a 
change in regioselectivity as compared to bromide. In previous theoretical studies, it was 
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demonstrated that product stabilities seem to dictate the outcome of the reaction through 
thermodynamic control in the bromide case, whereas difference in barriers for the fluoride case were 
shown to be mainly due to the difference in interaction energies, pointing to the fact that sterics dictate 
the outcome.
102a 
In this study, the formation of β-bromo amines 239, β-chloro amines 240, β-iodo amines 241 and β-
fluoro amines 242 and 243 proceeds through ring opening of the same intermediate aziridinium salts 
244 by different halides (Scheme 72). Apparently, the chloride-
130
 and iodide-promoted ring opening of 
aziridinium ions 244 is controlled by the same factors as compared to bromide-induced ring opening, 
involving attack at the substituted position (X = Cl and I, path b, Scheme 72). Thus, it can be 
concluded that chloride-, bromide- and iodide-promoted ring openings of aziridinium ions 244 are 
under thermodynamic control, eventually leading to the more stable secondary halides 246 as the final 
reaction products. On the other hand, ring opening by fluoride is kinetically controlled, which can be 
rationalized considering the poor leaving group capacity of fluoride as compared to the other halides, 
preventing thermodynamic equilibration. 
 
 
 
Scheme 72 
 
3.2.2 Ring opening of stable 1-methylaziridinium triflates by halides 
 
In order to provide an insight into the potential role of the substrate in the above-described ring 
opening reactions, the synthesis of another type of aziridinium salts has been performed by the group 
of H.-J. Ha (Hankuk University of Foreign studies, Yongin, Korea). Therein, for example, stable 1-
methylaziridinium triflates 187 were prepared through N-methylation of chiral 2-
(methoxymethyl)aziridines 186 upon treatment with 1.1 equiv of methyl trifluoromethanesulfonate in 
acetonitrile for 10 minutes (Scheme 73), and were then evaluated as electrophiles for halide-induced 
ring opening reactions.  
For this purpose, in the group of H.-J. Ha, different tetrabutylammonium halides have been used as 
halide sources for the ring opening of aziridinium triflates 187. First, the reaction of 2-
(methoxymethyl)aziridinium ions 187 with 1.5 equiv of tetrabutylammonium fluoride, chloride, bromide 
or iodide in acetonitrile at room temperature for one hour afforded the corresponding β-halo amines in 
good yields. Interestingly, the same conclusions were drawn as described above, involving the 
selective synthesis of secondary bromide 247a, iodide 247b and chloride 247c as the sole reaction 
products, besides a regioisomeric mixture of primary and secondary fluoride 248d and 247d (3/1) 
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(Scheme 73, Table 8). These observations further consolidate the nucleophile-dependency of ring 
opening reactions of 1,1,3-trialkylaziridinium ions by halides, pointing to a chloride-, bromide- and 
iodide-mediated ring opening under thermodynamic control and a fluoride-induced ring opening under 
kinetic control. 
 
 
 
Scheme 73  
 
Table 8. Ring opening of 1-methylaziridinium triflates 187 by tetrabutylammonium halides.
126
 
Entry Substrate X Product Yield(%) 
1 187 Br
-
 247a 47% 
2 187 I
-
 247b 52% 
3 187 Cl
-
 247c 73% 
4 187 F
-
 248d + 247d 77% (3/1) 
 
 
Interestingly, when aziridinium triflate 187 was treated with 1.5 equiv of NaCl in acetonitrile (20 hours, 
rt) instead of Bu4N
+
Cl
-
, the initial formation of a different reaction product has been observed upon 
chromatographic analysis (TLC), which slowly underwent conversion into secondary β-chloro amine 
247c upon standing at the room temperature (research group of H.-J. Ha). Although purification by 
column chromatography on silica gel failed, the initially formed reaction product could be identified as 
2-amino-3-chloro-1-methoxypropane 248c by 
1
H NMR analysis. Obviously, the latter primary chloride 
comprises the kinetically controlled reaction product obtained through ring opening of aziridinium ion 
187 at the unsubstituted position (route a, Scheme 73), which then rearranges into the more stable 
secondary chloride via a thermodynamic equilibrium. The same observation was made through careful 
analysis of the reaction outcome after treatment of aziridinium triflate 187 with 1.5 equiv of Me4N
+
Cl
-
. It 
should be noted that these findings made by the research group of Prof. Ha comprised the first 
experimental proof for the occurrence of a thermodynamic equilibrium in the halide-induced ring 
opening of 2-alkyl-substituted aziridinium salts.
126
 
 
From these data, it can be concluded that the ring opening of 2-alkyl-substituted aziridinium salts 236 
by chloride, bromide and iodide proceeds under thermodynamic control, where product stabilities 
dictate the outcome of the reaction. Thus, the initially formed kinetic primary halides 237 undergo 
rearrangement into the thermodynamically more stable secondary halides 238 (Scheme 74). Fluoride-
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mediated ring opening, however, is under kinetic control, where the reaction outcome is only dictated 
by steric interactions. 
 
 
 
Scheme 74 
 
3.2.3 Evaluation of halide-induced ring opening of 2-substituted aziridinium salts by 
computational methods 
 
In order to elucidate the factors causing the differences in regioselectivity, a thorough computational 
analysis on the halide-mediated ring opening of 187 has been performed in the Center for Molecular 
Modeling of Ghent University (Prof. V. Van Speybroeck and Prof.  M. Waroquier).
126
 
The potential energy surfaces (PES) for the halide-induced nucleophilic ring opening of 187 through 
pathways a (unhindered) and b (hindered) (see Scheme 74) for all three halides are illustrated in 
Figure 10.  
The overall picture for halide-induced ring opening shows that the unhindered route (pathway a) is 
always kinetically preferred, however, the hindered route leads to the thermodynamic product. The 
eventual outcome depends on the softness and leaving group ability of the nucleophile (halide). If the 
nucleophile is a good leaving group (soft nucleophile, bromide), back reaction barriers are sufficiently 
low to allow equilibration and the thermodynamic product will prevail. If the nucleophile is a poor 
leaving group (hard nucleophile, fluoride), the back reaction is unlikely and the kinetic route will dictate 
the reaction outcome.
126
 Theoretical results are in perfect agreement with experimental findings, also 
pointing to the well-known trend in nucleophile strength and leaving group ability throughout the halide 
series. 
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Figure 10. Potential Energy Surfaces (PES) for the halide-induced nucleophilic ring opening of 187 via 
pathways a (unhindered) and b (hindered). (MPW1B95/6-31++G(d,p)//B3LYP/6-31++G(d,p)). Relative 
energies are given in kJ/mol. 
F-Ts-a, F-Ts-b – transition states for fluoride attack via pathways a and b, respectively; F-P-a, F-P-b-products of 
fluoride attack via pathways a and b, respectively. Cl-Ts-a, Cl-Ts-b – transition states for chloride attack via 
pathways a and b, respectively; Cl-P-a, Cl-P-b-products of chloride attack via pathways a and b, respectively. Br-
Ts-a, Br-Ts-b – transition states for bromide attack via pathways a and b, respectively; Br-P-a, Br-P-b-products of 
bromide attack via pathways a and b, respectively 
 
In summary, the ring opening of 2-alkyl-substituted aziridinium salts by fluoride, chloride, bromide and 
iodide was studied for the first time in a systematic way, pointing to an inherent difference in reactivity 
between fluoride on the one hand and chloride, bromide and iodide on the other. Both experimental 
and computational evidence was provided for the fact that product stabilities dictate the reaction 
outcome through thermodynamic control in the chloride, bromide and iodide case, involving 
rearrangement of the initially formed primary halides to the more stable secondary halides via a 
thermodynamic equilibrium. The ring opening of the same aziridinium salts by fluoride, however, was 
shown to be mediated by steric interactions (kinetic control), as the difference in barriers were mainly 
due to the difference in interaction energies.  
 
 
3.3 Synthesis of 3-methoxyazetidines via an aziridine to azetidine 
rearrangement131 
 
Imines carrying halogens in their side chain display a high intrinsic reactivity, and the selective 
introduction of halogens in imino substrates has led to building blocks with high synthetic potential, as 
shown amply for the useful class of -haloimines.
110a,c,f-i,132
 The halogen can be introduced in the 
aldehyde- (or ketone-) derived part, either before or after imination.
110f-i,132 
On the other hand, 
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examples are known regarding halogenated imines in which the halogen is present in the amine-
derived part.
110e,133
 The latter type of imines is usually accessed through imination of carbonyl 
compounds by means of halogenated (and thus reactive) amines, or via electrophilic addition of, e.g., 
bromine, across N-alkenyl imines. As a subclass, N-alkylidene- and N-arylmethylidene-(2,3-
dibromopropyl)amines comprise useful intermediates for the preparation of azaheterocyclic 
compounds such as aziridines and azetidines.
22,25b,92,115,134
  
Next to the diverse utility of aziridines, also their four-membered ring analogues, azetidines, represent 
an extraordinary class of strained compounds with diverse synthetic and biological applications. In 
addition to their synthetic relevance,
10a-d,f,g,135
 compounds containing an azetidine moiety have been 
shown to possess a wide range of biological activities.
5a,9a,b,136
 In particular, 3-alkoxy- and 3-
aryloxyazetidines (Figure 11) have been described as for example G-protein coupled receptor 
agonists 249,
137
 inhibitors of stearoyl-coenzyme d-9 desaturase 250 and 251,
138
 and antibacterial 
agents 252.
139
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In the previous chapters, the utility of 2-(bromomethyl)aziridines 16 as versatile building blocks to 
provide an entry into functionalized β-amino alcohols, morpholinones and wide range of functionalized 
amines was elaborated. The synthesis of these aziridines 16 was performed by the NaBH4-mediated 
reduction of the corresponding N-alkylidene-(2,3-dibromopropyl)amines 253 (R
1
 = Ar, R
2
 = H) in 
methanol under reflux (Scheme 75). On the other hand, in a preliminary study at the Department of 
Sustainable Organic Chemistry and Technology (UGent), it has been shown that structurally similar N-
alkylidene-(2,3-dibromo-2-methylpropyl)amines 253 (R
1
 = iPr, CHEt2, R
2
 = Me) afforded 3-
methoxyazetidines 254 under the same reaction conditions (Scheme 75). 
Chapter 3  Results and Discussion 
62 
 
It is clear that this unexpected reactivity of imines 253 (R
1
 = iPr, CHEt2, R
2
 = Me) to form azetidines 
254, raised a lot of questions regarding the mechanism of the latter reaction. For this purpose, in the 
next part, the kinetically controlled synthesis of 2-bromomethyl-2-methylaziridines, as potential 
intermediates in this reaction, and their conversion to 3-methoxyazetidines will be discussed 
thoroughly. 
 
 
Scheme 75 
 
 
3.3.1 Evaluation of the synthesis of 3-methoxyazetidines from N-arylmethylidene-(2,3-
dibromo-2-methylpropyl)amines  
 
N-Arylmethylidene-(2,3-dibromo-2-methylpropyl)amines 257a,b were prepared by a procedure 
comprising condensation of 2,3-dibromo-2-methylpropylamine hydrobromide 256 with different 
benzaldehydes 212a,b in the presence of 1 molar equiv of triethylamine and magnesium sulfate in 
dichloromethane after reflux for 1 hour (Scheme 76).
 
The synthesis of 2,3-dibromo-2-
methylpropylamine hydrobromide 256 commenced with the imination of benzaldehyde using 2-
methylallylamine hydrochloride 255 in dichloromethane in the presence of triethylamine and 
magnesium sulfate, followed by bromination of the alkene moiety in the resulting N-(2-methyl-2-
propenyl)imine in dichloromethane and subsequent treatment with 2 equiv of hydrogen bromide (48% 
solution in water) in dichloromethane (two-phase system). In this way, the desired 2,3-dibromo-2-
methylpropylamine 256 was obtained as the corresponding hydrobromide salt in 62% overall yield.  
 
Scheme 76 
 
Despite their reactive nature, imines 257a and 257b were judged to be pure enough to be used in 
further reactions without prior purification (purity >95% based on 
1
H NMR). As already mentioned, N-
alkylidene- and N-arylmethylidene-(2,3-dibromopropyl)amines 253 (R
1
 = H, Scheme 77) have been 
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used as intermediates for the straightforward preparation of 2-(bromomethyl)aziridines 16 via 
reductive 3-exo-tet-cyclization using sodium borohydride in methanol under reflux.
22,25b,92,115
 However, 
when the same methodology was applied to N-arylmethylidene-(2,3-dibromo-2-methylpropyl)amines 
257 (R
1
 = Me, Scheme 77) with the intention to prepare 2-bromomethyl-2-methylaziridines as a novel 
class of substrates, only 3-methoxy-3-methylazetidines 258a,b were obtained instead.
 
Apparently, the 
presence of an additional methyl group (R
2
 = Me) in imines 257 has a profound influence on the 
reaction outcome. In a previous study, treatment of N-alkylidene-(2,2,3-tribromopropyl)amines with 
NaBH4 in methanol has been reported to furnish 3,3-dimethoxyazetidines via double methanolysis,
134
 
although in that case the direct formation of azetidines was foreseen, as nucleophilic substitution at 
the dibrominated carbon atom toward aziridines is unlikely.  
 
 
Scheme 77 
 
From a mechanistic point of view, different pathways can be considered to explain the observed 
reactivity (Scheme 78). Reduction of imines 257 in methanol via hydride addition across the imino 
bond toward amines 259 can either be followed by a 3-exo-tet-cyclization affording 2-bromomethyl-2-
methylaziridines 260 (pathway a) or a 4-exo-tet-cyclization toward 3-bromoazetidines 261 (pathway b). 
Subsequently, both types of β-bromo amines (260 and 261) can be transformed into bicyclic 
aziridinium salts 262 through intramolecular displacement of bromide by the nucleophilic nitrogen 
atom, which stand in equilibrium with the nonbridged carbenium ions 263. Alternatively, the formation 
of carbenium species 263 can be the result of spontaneous expulsion of bromide in 3-bromoazetidines 
261. Ring opening of intermediates 262 by methanol at the more hindered position or solvolysis of 
carbenium species 263 by methanol finally affords 3-methoxyazetidines 258. 
On the basis of previous findings,
140
 the 3-exo-tet-cyclization of amines 259 toward 2-bromomethyl-2-
methylaziridines 260 (pathway a) will probably prevail (kinetic effect). The cyclization of 2-
bromomethyl-2-methylaziridines 260 to strained intermediates 262 stands in contrast with the well-
known chemistry of 2-(bromomethyl)aziridines bearing no additional substituent at the 2-position, as in 
this case the intramolecular cyclization and further transformation has never been 
observed.
22,24c,25b,92,93,114,115,141
 The spontaneous cyclization of 2-bromomethyl-2-methylaziridines 260 
under thermodynamic conditions can be rationalized considering the Thorpe-Ingold effect due to the 
gem-disubstitution at the aziridine carbon atom, resulting in a more favorable geometric positioning of 
the nucleophilic nitrogen atom with respect to the halogenated carbon atom. Alternatively, 2-
bromomethyl-2-methylaziridines 260 can first be transformed into 3-bromoazetidines 261 via a 
concerted mechanism, which comprises simultaneous cleavage and formation of a carbon-nitrogen 
bond along with bromide migration. Furthermore, 3-bromoazetidines 261 can be converted into 3-
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methoxyazetidines 258 either via bicyclic aziridinium salts 262 or via carbenium ions 263. The 
presence and formation of strained intermediates 262 is regarded as reasonable in view of various 
reports involving this type of intermediates. For example, the formation of a bicyclic aziridinium 
intermediate has been suggested in the literature based on the stereospecific transformation of 3-
tosyloxy- and 3-haloazetidines after hydrolysis and substitution reactions, and ring contraction to 
aziridinylmethyl derivatives.
142
 Moreover, it has been established that the substitution of 3-
chloroazetidines with different nucleophiles occurs via formation of an analogous bicyclic intermediate, 
which is then regioselectively opened at the C3 position.
10i
 In light of these reports, the ring opening of 
bicyclic aziridinium salts 262 by methanol is expected to proceed in a regiospecific way at the more 
hindered carbon atom, furnishing 3-methoxyazetidines 258. However, the formation of intermediate 
carbenium species 263 and their subsequent solvolysis by methanol should not be neglected as an 
alternative pathway toward azetidines 258. It is worth mentioning that the isomerization of 2-
(halomethyl)aziridines to 3-haloazetidines has been observed in the literature in only three cases,
143
 
and that isolated examples are known in which ring opening of strained bicyclic intermediates does not 
occur in a regiospecific way.
142c 
 
Scheme 78 
 
3.3.2 Synthesis and ring expansion of 2-bromomethyl-2-methylaziridines 
 
In the next part, a stepwise experimental approach was applied in order to shed more light on the 
underlying reaction mechanism. At first, a kinetically controlled synthesis of 1-arylmethyl-2-
bromomethyl-2-methylaziridines 260 was envisaged starting from α,β-dibromoaldimines 266 (Scheme 
79). The synthesis of 2-bromomethyl-2-methylaziridine 260a, deriving from the corresponding α,β-
dibromoaldimine has previously been performed,
33
 yet this aziridine 260a was present as a minor 
component in a mixture with the corresponding β,γ-dibromoamine. Optimization of the reaction 
conditions was required to furnish aziridines 260 as sole reaction products.  
Bromination of 2-methylpropenal 264 using 1.05 equiv of bromine in dichloromethane afforded the 
corresponding 2,3-dibromopropanal 265 in nearly quantitative yield, which was subsequently 
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condensed with 1 equiv of different N-alkylamines by means of 0.6 equiv of titanium(IV) chloride and 3 
equiv of triethylamine in diethyl ether,
140
 furnishing α,β-dibromoimines 266 in good yields (Scheme 
79). The latter imines 266 were reduced by means of 2 molar equiv of sodium borohydride in 
methanol, resulting in 2-bromomethyl-2-methylaziridines 260 after 36 h at room temperature. 
Alternatively, imines 266 were reduced toward aziridines 260a-d utilizing two molar equiv of sodium 
cyanoborohydride in methanol in the presence of 1 equiv of acetic acid, however, without providing 
better yields. In addition, 2-bromomethyl-2-methylaziridines 260a,b were also obtained through 
reaction of N-arylmethylidene-(2,3-dibromo-2-methylpropyl)-amines 257a and 257b with 2 molar equiv 
of NaBH4 in methanol after 36 h at room temperature. The formation of 2-bromomethyl-2-
methylaziridines 260 from both N-(2,3-dibromo-2-methylpropylidene)amines 266 and N-
arylmethylidene-(2,3-dibromo-2-methylpropyl)amines 257 is rationalized by the intermediacy of the 
same amines 259 (Scheme 78) obtained upon reduction of imines 257 and 266 with NaBH4. From 
these findings, it is clear that aziridines 260 are the kinetic products obtained through NaBH4-mediated 
reduction of imines 257 and 266 in methanol under reflux (Scheme 79). 
 
 
Scheme 79 
 
Non-activated 2-bromomethyl-2-methylaziridines 260 represent a novel class of synthons suitable for 
further elaboration to a variety of nitrogen-containing compounds.  
Under thermodynamic conditions, i.e., treatment of aziridines 260a-d with sodium borohydride in 
methanol under reflux for 48 h, 3-methoxy-3-methylazetidines 258a-d were formed in high yields as 
the sole reaction products (Scheme 79). This prolonged reaction time appeared to be necessary in 
order to drive the reaction to completion. Again, it should be remarked that applying the same reaction 
conditions to 2-(bromomethyl)aziridines 16 without a 2-methyl substituent is known to result in full 
recovery of the starting material. Heating of aziridines 260a in methanol under reflux for 24 h resulted 
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in a complex reaction mixture, pointing to the necessity of a basic environment for this aziridine to 
azetidine rearrangement process. Furthermore, treatment of aziridines 260b with 1.5 equiv of NaOMe 
in MeOH (2 M) furnished azetidine 258b, although a prolonged reaction time was required (72 instead 
of 48 h) (Scheme 80). 
 
Scheme 80 
 
In an attempt to investigate the reactivity of 2-bromomethyl-2-methylaziridines toward thiolates, 
aziridine 260d was treated with 1 equiv of sodium thioethylate (obtained from the reaction of 
ethanethiol with 1.2 equiv of sodium methoxide (2M), in methanol for 3.5 hours under reflux, affording 
2-ethylthiomethyl-2-methylaziridine 267 as the sole product, without traces of the corresponding 
azetidine (Scheme 81). Apparently, in this case, a direct nucleophilic displacement of bromide by the 
highly reactive thiolate happens faster than intramolecular expulsion of bromide by the less 
nucleophilic nitrogen atom.  
 
Scheme 81 
 
3.3.3 Synthesis of chiral 2-bromomethyl-2-methylaziridines and a 3-methoxyazetidine 
 
The above-described synthetic route was also applied for a straightforward synthesis of chiral 2-
bromomethyl-2-methylaziridines. For this purpose, N-(2,3-dibromo-2-methylpropylidene)-1(S)-
phenylethylamine 269 was prepared by imination of 2,3-dibromopropanal 265 with one equiv of (S)-α-
methylbenzylamine 268 in the presence of titanium(IV) choride and triethylamine. Next, imine 67 was 
reduced utilizing two molar equiv of sodium borohydride in methanol, resulting in a mixture of two 
diastereomeric 2-bromomethyl-2-methylaziridines 270 and 271 (~1/1) after 36 hours at room 
temperature (Scheme 82). After successful separation by column chromatography on silica gel, chiral 
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aziridines 270 and 271 were separately subjected to three molar equiv of NaBH4 under reflux in 
methanol for 36 hours. As expected, both reactions provided the same chiral azetidine 272, which can 
be explained considering the loss of chirality of the azetidine carbon atom due to C2-symmetry 
(Scheme 82). 
 
 
 
Scheme 82 
 
Once again, it should be stressed that only three reports are available in the literature describing the 
ring expansion of aziridines toward azetidines,
143
 pointing to the peculiar nature of this type of 
rearrangements (see Scheme below). In these reports, it has been suggested that even some 
monosubstituted aziridines i.e., 2-(chloromethyl)- and 2-(tosyloxymethyl)aziridines A (R
1
 = H, R
2
 = tBu, 
X = OTs, Cl) can undergo ring rearrangement to furnish the corresponding azetidines B (Y = OH, Cl, 
OEt), yet in low yields (4-38%).
143b,c
 In another study, which is more consistent with the findings 
described in this PhD thesis, a facile ring expansion of alkyl 2-(bromomethyl)aziridine-2-carboxylates 
A (R
1
 = COOR
3
, X = Br) to different 3-bromoazetidines C (45-50%) has been reported.
143a
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Deprotection of nitrogen in azetidine 272 by hydrogenation at 3-5 bar using Pd(OH)2 (5-25mol%) in 
EtOAc resulted only in the recovery of the starting material even after 6 days. However, upon addition 
of 1 equiv of (Boc)2O, the Boc-protected azetidine 273 (95%) was obtained as the sole product after 3 
days at 4 bar (Scheme 83).  
 
 
Scheme 83 
 
 
 
3.3.4 Ring expansion of 2-bromomethyl-2-methylaziridines to 3-bromo-3-methylazetidines 
 
In order to evaluate the intrinsic reactivity of 2-bromomethyl-2-methylaziridines 260 toward ring 
expansion, aziridines 260a,b,d were subjected to heating in acetonitile under reflux for 15 hours, 
affording 3-bromoazetidines 261a-c in acceptable yields (70-78%, Scheme 84). It should be 
mentioned that the formation of 3-bromoazetidines 261 was not always straightforward, since this 
azetidine was often present in a mixture with the starting aziridine. Attempts to effect full conversion of 
aziridine 260b in the presence of AgBF4 or KBr resulted in more complex reaction outcomes (Table 9). 
Nevertheless, azetidines 261 were isolated in pure form by column chromatography on silica gel.  
The unprecedented transformation of aziridines 260 into azetidines 261 as the thermodynamic product 
further illustrates the relevance of this aziridine to azetidine ring expansion and can be explained by 
formation of bicyclic aziridinium salt 262 followed by attack of bromide at the more hindered carbon 
atom. Moreover, when 3-bromoazetidine 261b was treated with NaBH4 in methanol under reflux, 3-
methoxy-3-methylazetidine 258b was formed via solvolysis of the same bicyclic intermediate 262 
through ring opening (Scheme 84).
10i,142
 The direct replacement of bromide by methanol in azetidine 
261 via an SN2 protocol should be neglected as an alternative reaction pathway due to the steric 
hindrance at the tertiary carbon center, although SN1 reaction through solvolysis of a tertiary 
carbenium ion might involve a plausible alternative. 
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Scheme 84 
 
Table 9. Synthesis of 3-bromo-3-methylazetidines 260b 
compound conditions result 
260b (R = Me) 0.1-1 equiv AgBF4, Δ, 15 h complex mixture 
260b (R = Me) 0.2-1 equiv KBr, Δ, 15 h 261b + side products 
260b (R = Me) Δ, 15 h 260b + 261b 
260b (R = Me) Δ, 20 h complex mixture 
 
 
It should be mentioned that experiments to prepare 3-bromoazetidine 261b, through LiAlH4- or NaBH4-
mediated reduction of N-(2,3-dibromo-2-methylpropylidene)amine 266b were unsuccessful and 
provided different reaction products such as 3-bromo-2-methyl-propylamine, 2-bromo-1,1-dimethyl-
ethylamine and/or 2-bromomethyl-2-methylaziridine 260b, and no traces of azetidine 261b were 
present.  
 
In summary, a novel aziridine to azetidine rearrangement protocol was established involving the 
conversion of 2-bromomethyl-2-methylaziridines 260, obtained via reductive cyclization of halogenated 
imines 257 or 266, into 3-methoxy-3-methylazetidines 258 through ring opening of bicyclic 
intermediates 262 by methanol upon treatment with NaBH4 in methanol under reflux (Scheme 85). 
Furthermore, the ring expansion of aziridines 260 in acetonitrile under reflux provided a facile entry to 
novel 3-bromoazetidines 261, which can be considered as versatile synthons for further derivatization. 
 
 
Scheme 85 
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The above-described experimental results were also supported by means of high-level molecular 
modeling calculations, performed at the Center for Molecular Modeling of Ghent University. In the next 
part, the most important results and conclusions of this study are highlighted.  
 
3.3.5 Evaluation of the synthesis of 3-methoxyazetidines by computational methods 
 
In Figure 12, free energy profiles and relative energies along the reaction coordinate for the cyclization 
of N-benzyl-N-(2,3-dibromo-2-methylpropyl)amine 259 (R = Ph) to aziridine 260 (pathway a, Scheme 
78), or to azetidine 261 (pathway b, Scheme 78) was depicted. Free energies of activation show that 
pathway a is the kinetically preferred route (∆G
ǂ
 = 16.2 kJ/mol MPW1B95/6-31++G**), which is in 
accordance with experimental findings. Although the azetidinium ion (denoted as 261-H in Figure 12) 
is the thermodynamically preferred product, thermodynamic equilibration is not feasible as the 
aziridinium ion (denoted as 260-H in Figure 12) is immediately deprotonated toward the neutral, non-
activated aziridine 260 (which is thus not able to undergo ring opening by bromide at C2). Therefore, 
aziridine 260 is the preferred product for the cyclization, as observed experimentally.  
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Figure 12. Gibbs free energy profiles for the conversion of N-benzyl-N-(2,3-dibromo-
2-methylpropyl)amine 259 (R = Ph) via pathways a and b (kJ/mol, MPW1B95/6-31++G**). 
B3LYP/6-31++G** geometries. Critical distances in Å. 
 
As previously described in Scheme 78, aziridine 260 is suggested to undergo further cyclization to 
yield the bicyclic aziridinium ion 262, a bicyclic intermediate that will undergo nucleophilic ring opening 
to form azetidine 258. However, as mentioned earlier, 2-(bromomethyl)aziridines 16 were not able to 
undergo ring expansion to form the corresponding azetidines (Scheme 86). The comparison of the 
cyclization pathways (transition state geometries and relative energies) for the formation of the bicyclic 
aziridinium ion 262 and 274 explains the preference of aziridine 260 to undergo ring rearrangement as 
compared to aziridine 16. As mentioned before, this difference can be rationalized considering the 
Thorpe-Ingold effect due to the gem-disubstitution at the aziridine carbon atom, resulting in a more 
favorable geometry for nucleophilic attack.
144
  
 
 
 
Scheme 86 
 
Replacement of the methyl group at the 2-position of aziridine 260 by a hydrogen atom increases the 
distance between the nucleophilic nitrogen atom and the halogenated carbon atom in aziridine 16, as 
shown in Figure 13, which in turn gives rise to a reduced reactivity. 
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Figure 13. Invertomers of 260 and 16 
 
 
As suggested earlier, bicyclic aziridinium ion 262 can be in equilibrium with its non-bridged carbenium 
ion counterpart 263 (Scheme 87, Figure 14). The difference in relative stabilities of bicyclic aziridinium 
ion 262 and cyclic carbenium ion 263 shows that the former, where all atoms have full octet structure 
is far more stable than the latter.  
 
 
Scheme 87 
 
 
 
Figure 14. Gibbs free energy profile for the 58 to 59 equilibration (kJ/mol, CPCM (ε = 32.6) 
MPW1B95/6-31++G**). 
B3LYP/6-31++G** geometries. Critical distances in Å. Atomic charges in italic. 
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Therefore, the reaction is expected to proceed through the bicyclic aziridinium ion 262, and the 
carbenium species 263 is less likely to be formed or will be short-lived. Next, the computational study 
also showed that the bicyclic intermediates 262 easily undergoes ring opening to form azetidines 258 
and 261. 
The transformation of 262 to azetidines 261 is energetically more favorable (ΔΔG = 38.9 kJ/mol 
MPW1B95/ 6-31þþG**), since the bromide anion — solvated or not — is a stronger nucleophile than 
neutral methanol. However, the reaction conditions highly favor the formation of 3-methoxyazetidines 
258 since the concentration of methanol is much higher than that of bromide. In the absence of 
methanol, azetidine 261 should be the observed product, as was experimentally shown (Scheme 84). 
 
Computational analysis of the possible reaction pathways proposed in Scheme 78 (R = Ph) has 
revealed that pathway a is the kinetically preferred route and aziridine 260 is the subsequent product 
for the cyclization, as observed experimentally. Unlike aziridines 16, which lack an additional 
substituent at the 2-position, aziridine 260 then undergoes further cyclization to yield the bicyclic 
aziridinium ion 262, a strained intermediate, which can undergo nucleophile-induced ring opening to 
form azetidines 258 or 261, depending on the relative abundance of the nucleophilic entity.  
 
3.3.6 Ring opening of 2-bromomethyl-2-methylaziridines  
 
As seen before, ring opening of aziridines provides an efficient and easy approach toward a variety of 
amines via regio- and stereoselective ring-opening reactions with nucleophiles. Therefore, in order to 
gain insights into the reactivity of 2-bromomethyl-2-methylaziridines toward ring opening with different 
halides (bromide and chloride), a number of reactions were performed.  
First, treatment of 2-bromomethyl-2-methylaziridines 260b,c with 1 equiv of benzyl bromide in 
acetonitrile for 1-2.5 days under reflux afforded the corresponding amines 275a,b in high yields (86-
89%). The regioselectivity in this reaction was in accordance with the previously observed ring 
opening of 2-substituted non-activated aziridines with benzyl bromide through ring opening at the 
substituted aziridine carbon.
31b,c,35,92,93,94 
Furthermore, the reaction of aziridine 260c with 1.2 equiv of 
HBr (33% in HOAc) in CH2Cl2 for 1 day under reflux furnished the amine 276, again as a consequence 
of the ring opening of the aziridine moiety at the more substituted carbon atom in aziridinium ions 277 
(Scheme 88). This result showed, however, the opposite regioselectivity with respect to the ring 
opening of 2-(cyanomethyl)aziridines with HBr.
31a
 The preference for the attack of bromide at the more 
substituted carbon atom of aziridines 260 in both cases (with HBr and benzyl bromide) could be 
explained considering a more pronounced development of a positive charge in the intermediate 
aziridinium ions 277 as compared to the corresponding monosubstituted aziridinium ions. This leads to 
an increased electrophilicity of the more substituted carbon atom of the aziridine moiety, which is then 
attacked by the approaching nucleophile. In fact, the ring opening of aziridines 260b,c could also 
occur via a clean SN1 mechanism as well through neutralization of a tertiary carbenium ions 278.  
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Scheme 88 
Next, the ring opening of aziridines 260b,c with 2 equiv of HCl (3M) in water for 3 hours under reflux 
resulted in the formation of a single regioisomer. Close inspection of 
13
C NMR data suggested the 
formation of amines 279a,b instead of isomer 283, which was surprising bearing in mind the opposite 
regioselectivity in case of ring opening with HBr. In order to confirm the proposed structure, the 
resulted mixture was subjected to a number of experiments.  
Treatment of amine 279b with 1 equiv of TosCl and 3 equiv of Et3N in CH2Cl2 for 2 hours at room 
temperature gave a complex mixture for further elucidation. Furthermore, the reaction of amine 279b 
with 2.2 equiv of KCN in DMSO for 5 hours at 60-70°C provided a mixture of 2-chloromethyl-2-
methylaziridine 281 and 2-(cyanomethyl)aziridine 282 (281/282 = 1/3, Scheme 89). The presence of 
aziridine 282 could be explained either by a direct displacement of chloride by the cyanide ion in 
aziridine 281, or by a ring closure of the initially formed 4-chloro-3-(2-chlorophenylamino)-3-
methylbutyronitrile 280 (Scheme 89). 
 
Scheme 89 
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Finally, amine 279b was subjected to 1.1 equiv of KOtBu in THF for 3 hours under reflux to furnish 
aziridine 281, confirmed by means of NMR and MS analysis (Scheme 90). Alternatively, aziridine 281 
could also be formed by nucleophilic substitution of bromide by chloride in initially formed aziridine 
260c, which could derive from the other regioisomer 283. In order to exclude this possibility, aziridine 
260c was treated with 1 equiv of KCl in THF for 3 hours under reflux, furnishing a complex mixture in 
which no signs of aziridine 281 were detected.  
 
Scheme 90 
From the above-described reactions, it can be deduced that the regioselectivity in the ring opening of 
2-bromomethyl-2-methylaziridines 63 is not always straightforward and strongly dependent on both 
the type of activation (protonation or alkylation) and the type of nucleophile (chloride or bromide) used. 
Although these reactions are not the subject of further elaboration within this PhD thesis, it is clear that 
the factors governing the regioselectivity in these aziridinium ion ring openings should be inspected in 
more detail in order to use these transformations in a predictive way. 
 
3.4 Solvent-controlled selective transformation of 2-bromomethyl-2-
methylaziridines to functionalized aziridines and azetidines145 
 
In the course of this thesis, the synthetic relevance of 2-(bromomethyl)aziridines as starting synthons 
for the preparation of α-branched and β-branched amines, β-amino alcohols and morpholinones was 
described. Moreover, a high synthetic potential of 2-bromomethyl-2-methylaziridines with respect to 
their ring expansion to 3-substituted azetidines was shown, making these substrates valuable for 
further elaboration. In particular, examples of the ring rearrangement of 2-bromomethyl-2-
methylaziridines to the corresponding 3-bromo-3-methylazetidines upon heating in acetonitrile were 
highlighted. The isomerization of 2-(halomethyl)aziridines to 3-haloazetidines has been observed in 
the literature in only a few exceptional cases,
140,146
 pointing to the peculiar nature of this type of 
rearrangement. 
The limited number of reports regarding aziridine to azetidine ring expansions
143
 and the mainly 
unexplored synthetic potential of 2-bromomethyl-2-methylaziridines creates opportunities to access 
different classes of 3-functionalized azetidines in an efficient way. As already mentioned, 3-substituted 
azetidines represent valuable class of compounds with diverse biological activities.
5a,9
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Therefore, in this part, the reactivity of 2-bromomethyl-2-methylaziridines toward different oxygen, 
sulfur and carbon nucleophiles in different solvent systems will be envisaged.  
 
3.4.1 Synthesis of functionalized aziridines and azetidines 
 
In light of above-described aziridine ring expansion, the intrinsic reactivity of 2-bromomethyl-2-
methylaziridines 63 to undergo a ring rearrangement was further investigated utilizing a variety of 
different nucleophiles such as thiocyanate, cyanide, phenoxide and acetate in order to assess the 
scope of this transformation with respect to carbon and heteroatom nucleophiles. 
First, aziridines 260a,b,d were treated with 1 equiv of potassium thiocyanate (KSCN) in acetonitrile at 
reflux temperature for 2-4 hours, furnishing mixtures of 3-methyl-3-thiocyanatoazetidines 284a-c and 
2-methyl-2-(thiocyanatomethyl)aziridines 285a-c, with azetidines 284a-c being the major products 
(ratio 284/285 = 50-67/50-33, Scheme 91). From these mixtures, azetidines 284a-c were isolated in 
pure form by preparative TLC chromatography on silica gel. Several experiments were performed to 
optimize the reaction conditions. Surprisingly, when aziridines 260a,b,d were treated with 1 equiv of 
KSCN in DMF at 60-70 °C for 15-20 hours aziridines 285a-c were obtained as the sole reaction 
products, giving rise to a new and straightforward synthetic methodology for the selective preparation 
of either aziridines in DMF and azetidines in acetonitrile. Aziridines 285a-c were then successfully 
purified by means of column chromatography on silica gel in order to obtain analytically pure samples. 
It should be noted that aziridines 285a-c were susceptible to partial decomposition during the 
chromatographic purification process.  
 
Scheme 91 
Bearing in mind the different reactivity profile of aziridines 260 toward KSCN in different solvents 
(MeCN versus DMF), 2-bromomethyl-2-methylaziridines 260b,d were then treated with other 
nucleophiles such as cyanide, phenoxide and acetate
 
both in MeCN and DMF as the solvent medium. 
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After treatment of aziridines 260b,d with 2 equiv of KCN in MeCN for 26 hours at reflux temperature, 
only 3-cyano-3-methylazetidines 286a,b were obtained, whereas the same reaction in DMF gave 
exclusively 2-cyanomethyl-2-methylaziridines 287a,b after 16 hours at 50-60 °C (Scheme 92). As in 
the case of thiocyanate (Nu = SCN), the reaction outcome was shown to be dictated by the solvent 
used in these reactions, providing an efficient method for the synthesis of new functionalized aziridines 
and azetidines in a selective way. Azetidines 286a,b and aziridines 287a,b were purified by means of 
column chromatography on silica gel in order to provide analytically pure samples. 
 
Scheme 92 
The reaction of aziridines 260b,d with 2.2 equiv of phenol and 5 equiv of K2CO3 in MeCN for 20-24 
hours was not so straightforward and gave mixtures of 3-methyl-3-phenoxyazetidines 288a,b and 2-
methyl-2-(phenoxymethyl)aziridines 289a,b, in which azetidines 288a,b were present as the major 
isomers (ratio 288/289 = 57-67/43-33, Scheme 93). These compounds were separated and isolated 
by means of column chromatography (SiO2). On the other hand, treatment of aziridines 260b,c with 
2.2 equiv of phenol and 5 equiv of K2CO3 in DMF for 14-17 hours at 50 °C provided 2-methyl-2-
(phenoxymethyl)aziridines 289a,b as the major products, and only small amounts (~10%) of azetidine 
288a,b were observed. However, the purification by silica gel column chromatography did not provide 
completely pure products due to co-elution of an unidentified side product in small quantities (10-
15%).  
 
Scheme 93 
Finally, when aziridines 260b,d were subjected to 1.1 equiv of NaOAc in MeCN for 22-24 hours at 
reflux temperature, 3-acetoxy-3-methylazetidines 290a,b were produced without traces of the 
corresponding aziridines (Scheme 94). On the other hand, the reaction of the same aziridines 260b,d 
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with 1.1 equiv of NaOAc in DMF for 16-20 hours resulted in complex mixtures, in which the presence 
of 2-acetoxymethyl-2-methylaziridines 291a,b (30-40%) as well as 3-acetoxy-3-methylazetidines 
290a,b (10-20%) was acknowledged by means of 
1
H NMR analysis. It should be mentioned that the 
reaction with NaOAc provided a unique case of noteworthy amounts of azetidine formation in DMF as 
the solvent, while in all other cases (except in the case of a small amount of azetidine 288b) the 
formation of azetidines using DMF as the solvent was not observed.  
N
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Scheme 94 
After several attempts to optimize the reaction conditions in different solvents (DMF and DMSO), at 
different temperatures (r.t. to 100 °C), and by using additional reagents (such as AgBF4), aziridines 
291a,b were finally obtained as the major compounds (ratio 290/291 = 20-25/80-75) after treatment of 
aziridines 260b,d with 1.1 equiv of NaOAc in DMSO at room temperature for 3-5 days (Scheme 95, 
Table 10). Higher temperatures (>30 °C) yielded complete conversion of the starting aziridines 260b,d 
only after a few hours, however at the expense of the selectivity of this reaction (ratio 290/291 = 40-
50/60-50). From these mixtures, aziridines 291a,b could not be isolated in completely pure form by 
means of column chromatography on silica gel due to co-elution of azetidines 290a,b and small 
amounts of some side products (10-15%).  
N
Br
1.1 equiv NaOAc
R
R = Me, OMe
see Table 10 N
OAc
R
side products+ N
OAc
R
+
260b,d 290a,b (10-20%)291a,b (50-80%)  
Scheme 95 
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Table 10. Synthesis of 2-acetoxymethyl-2-methylaziridines 291a,b 
compound conditions result 
260b 1 equiv AgBF4, DMF, 60 °C, 3 h complex mixture 
260d 0.1 equiv AgBF4, DMSO, r.t., 2 days 290b+ 291b + side products 
260d 1 equiv AgNO3, DMSO, r.t., 31 h complex mixture 
260b DMSO, 50 °C, 1 h 290/291 = 40/60 
260d DMSO, 60 °C, 2 h 290/291 = 50/50 
260b DMSO, r.t., 5 d 290/291 = 20/80 
260d DMSO, r.t., 3 d 290/291 = 25/75 
 
It should be mentioned that the ratio aziridine/azetidine in all cases was determined by detailed 
spectroscopic analysis (
1
H NMR) of the crude reaction mixtures. After purification, the structures of the 
pure azetidines and aziridines were then confirmed by means of different characterization methods (
1
H 
NMR, 
13
C NMR, IR, MS). 
In summary, the selective transformation of aziridines 260 toward either azetidines 292 in acetonitrile 
or aziridines 293 in dimethylformamide (Scheme 96) provides interesting opportunities for further 
elaboration to valuable azaheterocycles. 
 
Scheme 96 
 
3.4.2 Evaluation of the reaction mechanisms for the formation of aziridines and azetidines 
From a mechanistic point of view, different pathways can be considered to explain the synthesis of 
functionalized aziridines and azetidines starting from 2-bromomethyl-2-methylaziridines 260. An 
overview of possible reactivity profiles of aziridines 260 in MeCN is presented in Scheme 97. Bearing 
in mind the previously described intermediacy of bicyclic aziridinium ions in the synthesis of 3-
methoxy-3-methylazetidines starting from 2-bromomethyl-2-methylaziridines,
 
the nucleophilic attack at 
the more hindered carbon atom of the strained intermediates 262 (path b, Scheme 97) is considered 
to be the most plausible route for the formation of 3-substituted azetidines 292 in MeCN. This fact is 
also in accordance with the ring transformation of 2-bromomethyl-2-methylaziridines 260a-c in MeCN 
at reflux temperature (Scheme 84). It should be noted that in some cases the formation of aziridines 
(285a-c and 289a,b) was observed as well (33-50%). The presence of these aziridines in MeCN-
mediated reactions can be attributed to nucleophilic attack at the less-hindered carbon atom of the 
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bicyclic aziridinium ions 262 (path a, Scheme 97), taking into account a few isolated literature 
examples on the ring opening of strained bicyclic intermediates.
142c
 However, direct nucleophilic 
displacement of bromide in 2-bromomethyl-2-methylaziridines 260 by the nucleophile (path c, Scheme 
97) will most probably prevail as the pathway toward substituted aziridines 293. 
 
Scheme 97 
The proposed mechanistic pathways for the selective formation of aziridines 293 in DMF are depicted 
in Scheme 98. Herein, two different routes can be considered, involving either direct SN2 displacement 
of bromide by the approaching nucleophile (path a, intermediate 294, Scheme 98) or via the formation 
of primary carbenium ions 295 (SN1 mechanism, path b, Scheme 98), which might be stabilized by the 
nitrogen lone pair through anchimeric assistance. The formation of aziridines 293 via nucleophilic 
attack at the less-substituted carbon atom of bicyclic aziridinium intermediates 262 (path a, Scheme 
97) in DMF should not be completely neglected, although the fact that aziridines 260 do not rearrange 
into azetidines 261 upon heating in DMF for several hours suggests that no bicyclic aziridinium 
species 262 are formed in these reactions.  
 
Scheme 98 
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In order to shed more light on the remarkable preference for the formation of azetidines in MeCN and 
aziridines in DMF (Schemes 97 and 98), some computational analyses were performed at the Center 
of Molecular Modeling of Ghent University.
145
 
In this study, a different close-packing (as a measure to indicate how free the nucleophiles are to 
attack and how willing the nucleophuge is to leave) of the nucleophiles (CN
-
 and SCN
-
), the 
nucleophuge Br
-
 or even the bicyclic aziridinium intermediate 262 by DMF and MeCN was investigated 
by calculating and comparing their coordination solvation energies (CSE’s). 
The high-level molecular modeling calculations showed that the stronger coordination and better 
stabilization of CN
-
 by MeCN as compared to DMF can point to a lower reactivity, hence allowing the 
formation of azetidine 292 via formation of the bicyclic intermediate 262. Since CN
-
 is less stabilized in 
DMF, it will be more reactive and hence, nucleophilic substitution of aziridine 260 will lead to aziridine 
293. The weaker coordination of SCN
-
 by MeCN, compared to CN
-
, could explain why both the 
formation of the bicyclic intermediate 262 and nucleophilic substitution in the aziridine 260 are possible 
for SCN
-
 in MeCN. Finally, the stronger coordination of Br
-
 by MeCN can improve its leaving group 
capacity and thus help in the formation of the bicyclic intermediate 262. 
 
3.4.3 Reactivity of 3-bromo-3-methylazetidines
147
 
As discussed before (section 3.3.4), a peculiar, thermodynamically controlled rearrangement of 2-
bromomethyl-2-methylaziridines in acetonitrile provided a general access to novel 3-bromo-3-
methylazetidines. The broad synthetic potential of 3-haloazetidines has been demonstrated in the 
literature in terms of their nucleophilic substitution with different nucleophiles.
148
 
However, the reactivity profile of 3-bromo-3-methylazetidines as useful synthons in organic chemistry 
has not been studied so far. Therefore, a number of reactions were performed in order to assess the 
propensity of azetidines 261 to undergo nucleophilic substitution at the 3-position to access a window 
of novel 3-functionalized azetidines. 
Thus, treatment of azetidine 261b with 2.2 equiv of phenol and 5 equiv of K2CO3 in MeCN for 4 hours 
under reflux afforded the corresponding 3-aryloxyazetidine 288b in high yield (Scheme 99). In a 
similar manner, the reaction of azetidine 261b with 5 equiv of KOH in H2O/CH2Cl2 (9/1) mixture for 10 
hours under reflux resulted in the formation of 3-hydroxyazetidine 296. The above-described findings 
support the suitability of 3-bromo-3-methylazetidines as substrates for nucleophilic substitutions by 
oxygen-centered nucleophiles. 
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Scheme 99 
In the literature, it is known that azetidine-3-carbonitriles can be prepared via nucleophilic substitution 
of 3-mesyloxy- and 3-tosyloxyazetidines.
15,142c,149 
In that respect, 3-bromo-3-methylazetidine 261b was 
also shown to be a good substrate for the synthesis of azetidine-3-carbonitrile 286b upon treatment 
with 1.5 equiv of KCN in acetonitrile under reflux for 15 hours (Scheme 100). Azetidine 286b was 
purified by means of column chromatography on silica gel to obtain an analytically pure sample. The 
hydrolysis of the cyano group in azetidine 286b can provide an access toward cyclic amino acids 
which can be considered as analogues of azetidine-2-carboxylic acid, a natural molecule isolated from 
Convallaria majalis (lily of the valley) and endowed with impressive biological activities such as the 
inhibition of the proliferation of Escherichia coli, alteration of the structure of collagen, keratin and 
hemoglobin in human proteins, and teratogenic effects and various malformations in animals.
10d
 
Therefore, a number of experiments were performed for the hydrolysis of the cyano group in 1-(4-
methylbenzyl)azetidine-3-carbonitrile 286a (Table 11). The reaction of azetidine 286a with 4 equiv of 
HCl (3M) in water for 2 days under reflux resulted in the recovery of the starting product. Heating the 
mixture under microwave conditions (150 °C, 1h, 150 W) gave a complex mixture, probably as the 
result of the ring opening of the azetidine moiety. The treatment of azetidine 286a in basic conditions 
using 5 equiv of Ba(OH)2 in dioxane for 15 hours at 100 °C, or microwave-induced irradiation (150 °C, 
1 h), again afforded only the starting material 286a.  
Finally, treatment of azetidine 286a with 5 equiv of KOH in EtOH/H2O (5/1) under microwave 
irradiation (150 °C, 10 min, 150 W) and subsequent neutralization with a solution of hydrochloric acid 
(1 M) gave a mixture of amino acid 297 and the corresponding amide 298 (297/298 = 3/2, Scheme 
100). Prolonging the reaction time in the latter case (150 °C, 20 min, 150 W), gave amino acid 297 as 
the sole product (96%, based on NMR). Both the amide 298 and acid 297 could be isolated by means 
of a suitable extraction procedure with CH2Cl2. 
Interestingly, two isomeric structures (ratio 3/2) of azetidine 297 were observed upon NMR analysis 
(CD3OD), which can be attributed to the zwitterionic nature of this compound providing two 
diastereomeric counterparts. The purification of amino acid 297 on Dowex H
+
 (NH4OH) afforded 
ammonium 3-methyl-1-(4-methylbenzyl)azetidine-3-carboxylate 299 as a single isomer in pure form 
(Scheme 100).
 
These observations further support the synthetic utility of 3-bromo-3-methylazetidines 
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as substrates for nucleophilic displacements, i.e., toward the synthesis of versatile 3-methylazetidine-
3-carbonitriles. 
1.5 equiv KCN
MeCN, , 15 h N
CN
conditions
see Table 11
N O
O
Dowex (H+)
N O
O
NH4
261b 286a (80%)
297 (50-95%)
H
(NH4OH, 1N)
299 (85%)
N NH2
O
+
298 (0-40%)
N
Br
 
Scheme 100 
 
Table 11. Hydrolysis of the cyano group in azetidine 286a 
Conditions   286a → 297 result 
4 equiv HCl (3M), H2O, Δ, 2 days no reaction 
4 equiv HCl (3M), H2O, MW, 1h, 150 °C complex mixture 
5 equiv Ba(OH)2, dioxane, MW, 1 h, 150 °C + neutralization no reaction 
5 equiv KOH, EtOH/H2O (5/1), MW, 10 min, 150 °C + neutralization 297 (55%) + 298 (40%) 
5 equiv KOH, EtOH/H2O (5/1), MW, 20 min, 150 °C + neutralization 297 (96%) 
 
In conclusion, 3-bromo-3-methylazetidines 261 were shown to easily undergo nucleophilic substitution 
with different nucleophiles, providing a convenient method for the preparation of new synthetically and 
biologically attractive 3-substituted azetidines such as 3-aryloxy-, 3-hydroxy-, 3-cyanoazetidines. 
 
3.5 Synthesis and reactivity of 3-ethylideneazetidines  
 
Next to the synthetic utility of 3-bromo-3-methylazetidines as building blocks for the preparation of 3-
functionalized azetidines, this type of azetidines can also be considered as synthons for the 
preparation of the corresponding 3-methyleneazetidines as versatile synthetic intermediates. In 
preliminary research performed at the Department of Sustainable Organic Chemistry and Technology 
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(UGent), similar substrates, i.e., 1-t-butyl-3-methylene- and 1-t-butyl-3-ethylideneazetidine, were 
prepared starting from the corresponding 3-bromoazetidines,
33
 although the reactivity of these species 
has not been explored so far. 
3-Alkylideneazetidines are strained cyclic allylamines, and only limited information on the reactivity of 
this class of compounds is available in the literature.
150
 In most cases, the 3-alkylideneazetidine 
moiety was incorporated in the structure of more complex molecules,
151
 and no special attention has 
been devoted to the chemical nature of this strained system. In addition, the introduction of 
conformational constraint at the 3-position of azetidine rings is known to increase the potency of 
human and rat FAAH inhibitors
152
 and showed to be an important structural feature of some drugs.
153
 
Two main approaches to produce 3-alkylideneazetidines comprise the Wittig olefination of the 
corresponding azetidin-3-ones
150b,d,e
 and dehalogenation of different 3-halo-3-(1-
haloalkyl)azetidines.
150d 
 
In this section, a facile and efficient synthesis of novel 3-ethylideneazetidines is reported starting from 
the corresponding 3-bromo-3-ethylazetidines. Although the combination of two functionalities, i.e., an 
azetidine moiety and an exocyclic double bond, might result in unstable structures, this type of 
substrates are considered to be valuable for further elaboration. In this part of this PhD thesis, two 
aspects of the reactivity of 3-ethylideneazetidines were separately studied, i.e., the activation and 
subsequent ring opening of the azetidine moiety on the one hand, and functionalization of the 
exocyclic double bond on the other. 
The synthesis and reactivity of structurally similar 2-alkylideneazetidines (cyclic enamines) has been 
the subject of previous studies.
10k,154
 These azetidines were shown to be good substrates in various 
cycloaddition reactions
154d
 and ring rearrangements.
154a,c,155
 However, it is expected that 3-
alkylideneazetidines bearing an less reactive and sterically hindered double bond exhibit a different 
reactivity profile as compared to 2-alkylideneazetidines, which display the chemical properties of 
strained cyclic enamines. Therefore, in addition to the development of an efficient synthesis of 3-
ethylideneazetidines, the main objective of this study was to elaborate the hitherto unexplored 
reactivity of these azetidines, which, in spite of their poor intrinsic reactivity, can still be regarded as 
versatile synthetic intermediates in heterocyclic chemistry. 
 
3.5.1 Synthesis of 3-ethylideneazetidines 
 
Thus, 3-bromo-3-ethylazetidines 305 were selected as potentially eligible substrates for the 
preparation of novel 3-ethylideneazetidines, and these azetidines 305 were obtained following the 
procedure reported for the synthesis of 3-bromo-3-methylazetidines 261. In that respect, bromination 
of 2-ethylpropenal 300 using 1 equiv of bromine in dichloromethane aﬀorded the corresponding 2,3-
dibromopropanal 301 in nearly quantitative yield, which was subsequently condensed with 1 equiv of 
different N-(arylmethyl)amines using 0.6 equiv of titanium(IV) chloride and 3 equiv of triethylamine in 
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diethyl ether, furnishing α,β-dibromoimines 302a,b in good yields (Scheme 101). The latter imines 302 
were reduced by means of 2 molar equiv of sodium borohydride in methanol, resulting in 2-
bromomethyl-2-ethylaziridines 303a,b as a mixture of invertomers after 1-2 days at room temperature. 
Subsequently, heating of aziridines 303 in acetonitrile under reflux for 15 hours afforded 3-bromo-3-
ethylazetidines 305a,b in nearly quantitative yields. In analogy with the synthesis of 3-bromo-3-
methylazetidines 261, the aziridine 303 to azetidine 305 ring expansion can be explained by 
intermediacy of bicyclic aziridinium species 304, which were attacked at the more hindered carbon 
atom to provide azetidines 305. Furthermore, in analogy with the previously reported synthesis of 3-
methoxy-3-methylazetidines 258 (Scheme 79), treatment of aziridine 303a with 3 molar equiv of 
NaBH4 in MeOH for 2 days under reflux furnished 3-ethyl-3-methoxyazetidine 306 as the single 
product through the formation of the same intermediates 304 (Scheme 101). 
 
Scheme 101 
The synthesis of 3-ethylideneazetidines 307a,b starting from 3-bromo-3-ethylazetidines 305, however, 
was not as straightforward as initially anticipated, and several attempts were performed to optimize the 
reaction conditions. Treatment of azetidine 305a with different bases such as KOtBu, LDA and NaH in 
tetrahydrofuran at room temperature or under reflux gave no reaction after stirring for one day, 
resulting in the recovery of the substrate (Table 12). 
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Table 12. Treatment of 3-bromo-3-ethylazetidines 305a with different bases 
Compound Base Reaction conditions Conversion 
305a 1 equiv KOtBu THF, r.t., 15 h No reaction 
305a 1 equiv KOtBu THF, Δ, 15 h No reaction 
305a 1 equiv LDA THF, Δ, 15 h No reaction 
305a 1 equiv NaH THF, Δ, 15 h No reaction 
305a 5 equiv KOtBu tBuOH, Δ, 20 h 308/307a/309 = 3.4/1.5/1 
 
The reaction of 3-bromo-3-ethylazetidine 305a with 5 equiv of KOtBu in tBuOH (instead of THF) under 
reflux for 20 hours gave a mixture of 1-benzyl-3-ethylazetidin-3-ol 308, 1-benzyl-3-ethylideneazetidine 
307a and 3-(tert-butoxy)-3-ethylazetidine 309 (308/307a/309 = 3.4/1.5/1) (Scheme 102). The presence 
of azetidines 309 and 308 could be explained by the nucleophilic attack of either tert-butoxide or 
hydroxide (due to the presence of adventitious water) at the bicyclic aziridinium intermediate 304. 
Finally, using 1.5 equiv of KOtBu in THF and heating under microwave irradiation for 10 min at 120 °C 
selectively provided 3-ethylideneazetidines 307a,b in excellent yields (Scheme 102). 
N
Br
1.5 equiv KOtBu
MW, 120 °C 
10 min, THF
N
305a,b 307a (R = H, 92%)
307b (R =Me, 94%)
N
O
N
+
308/307a/309 = 3.4/1.5/1
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tBuOH, , 20h
R R
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+
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N
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Scheme 102 
3.5.2 Reactivity study of 3-ethylideneazetidines 
A small number of literature reports reveal the potential of spiro azetidines
156
 to acquire a prominent 
place within the class of bioactive spiro heterocycles. In particular, the biological activity of spiro 
azetidines 310 containing a piperidine moiety as blockers of voltage-gated calcium channels has been 
reported.
157
 Furthermore, adamantane-based spiro azetidines 311 and 312 (Figure 15) have been 
evaluated as potential anti-influenza A drugs.
158
 In that respect, next to the reactivity of azetidines 307 
toward ring opening, the preparation of new classes of spiro azaheterocycles starting from 3-
ethylideneazetidines 307 will be evaluated in the following section. 
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Figure 15 
As already mentioned, the study of the reactivity of 3-ethylideneazetidines was expected to be a quite 
challenging task bearing in mind the sterically hindered and poorly reactive double bond. This feature 
was evidenced by many attempts to directly functionalize the olefinic moiety and to provide an access 
toward different biologically interesting spiro compounds. For example, the treatment of 3-
ethylideneazetidine 307a with 2 equiv of trichloroacetyl chloride, 4 equiv of Zn-Cu couple and 2 equiv 
of 1,2-dimethoxyethane in Et2O under nitrogen atmosphere
159
 resulted in the full recovery of the 
starting material after 3 days, and no traces of the corresponding cyclobutanone 313 were observed. 
The reaction with 3-6 equiv of diazomethane in Et2O at room temperature for several hours
160
 or the 
reaction with 1-3 equiv of tosylazides 314a,b in THF at room temperature or under reflux
115b
 for 5 days 
gave no conversion of the starting azetidine 307a. Azetidine 307a was also shown to be unreactive 
toward [N-(p-nitrophenylsulfonyl)imino]phenyliodinane (Ph=INNs) in the presence of a catalytic 
amount of Cu(OTf)2 in acetonitrile under reflux for 1 day (Scheme 103, Table 13).
161
  
 
Scheme 103 
Table 13. Attempts to functionalize 3-ethylideneazetidine 307a  
Compound Reaction conditions Conversion 
307a 
2 equiv Cl3CCOCl, 4 equiv Zn-Cu couple  
2 equiv 1,2-dimethoxyethane, N2, Et2O, Δ, 3d    
No reaction 
307a 1 equiv 314a, THF, r.t., 5d No reaction 
307a 1 equiv 314a, THF, Δ, 5d No reaction 
307a 1 equiv 314b, THF, Δ, 5d No reaction 
307a 3 equiv CH2N2, Et2O, r.t., 2d No reaction 
307a 1.5 equiv Ph=INNs, 0.15 equiv Cu(OTf)2, MeCN, Δ, 1d No reaction 
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When azetidine 307a was added to a mixture of 1.3 equiv of benzyloxy- or methoxyacetyl chloride 315 
and 3 equiv of Et3N in CH2Cl2 and stirred at room temperature for 15 hours in an attempt to effect 
cycloaddition, the corresponding ring-opened amides 318a,b were formed instead (ratio 318a/318b = 
1/1, based on 
1
H NMR) (Scheme 104). Apparently, the initial attack of the nucleophilic nitrogen to the 
in situ formed ketene 316 and subsequent ring opening of the azetidine moiety prevailed over the 
premised cycloaddition reaction due to the presence of a less reactive and sterically hindered double 
bond in azetidine 307a. 
 
RO
Cl
O
3 equiv Et3N
CH2Cl2, r.t.
0 °C - r.t., 15 h
O
O
R
N
1.3 equiv
CH2Cl2, 15h, r.t.
N
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O
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Cl
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O
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O
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Scheme 104 
In order to evaluate a possible nitrone-olefin [3+2]-cycloaddition, N-oxide 320 was synthesized by 
treatment of diethylamine 319 with 2.2 equiv of H2O2 (30% in H2O) and a catalytic amount (4-5 mol%) 
of SeO2 in methanol at room temperature for 4 hours. Addition of 2 equiv of this nitrone 320 to a 
methanolic solution of azetidine 307a and heating under reflux for 2 days, however, did not result in 
the corresponding spiroisoxazolidines 321 and/or 322 (Scheme 105, Table 14). The failure to perform 
this reaction showed that azetidines 307 do not exhibit the same reactivity behaviour with respect to 
[3+2]-cycloadditions as their structurally related 3-methylidene-β-lactams.
162
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Scheme 105 
In addition, also the Diels-Alder reaction of azetidines 307a,b with cyclopentadiene or with the highly 
reactive Danishefsky’s diene ((E)-1-methoxy-3-trimethylsilyloxy-1,3-butadiene) resulted in full recovery 
of the substrate (Table 14).  
Table 14. Reactivity of 3-ethylideneazetidine 307a,b toward [2+2]- and [3+2]- cycloadditions 
Compound Reaction conditions Conversion 
307a 1 equiv 320, MeOH, r.t., 2d No reaction 
307a 1 equiv 320, MeOH, Δ, 2d No reaction 
307a 3 equiv cyclopentadiene, CH2Cl2, 0 °C, 5h No reaction 
307b 3 equiv cyclopentadiene, CH2Cl2, r.t., 5d No reaction 
307b 
3 equiv Danishefsky’s diene ((E)-1-methoxy-3-
trimethylsilyloxy-1,3-butadiene), CH2Cl2, r.t., 2d 
No reaction 
 
 
Furthermore, the electron-poor double bond of azetidine 307 was, as expected, not able to react with 
soft electrophiles such as benzaldehyde or methyl vinyl ketone. It is clear that the peculiar nature of 
the alkenyl functionality in 3-ethylideneazetidines represents a limiting factor to functionalize these 
azetidines through standard types of double bond transformations.  
However, in spite of the limited reactivity of 3-ethylideneazetidines 307, many additional efforts were 
made to prove this class of compounds interesting for further elaboration. For this purpose, the 
reactivity profile of azetidines 307a,b was assessed from two approaches, i.e., evaluation of the 
reactivity of the strained azetidine moiety toward ring opening and evaluation of electrophilic additions 
to the exocyclic double bond. 
Bearing in mind the presence of an electron-donating substituent at the azetidine nitrogen atom, these 
species had to be activated in order to effect ring opening. Acetylation of nitrogen with 1.5 equiv of 
acetyl chloride in CH2Cl2 and subsequent ring opening of the azetidine moiety by the expelled chloride 
ion afforded a mixture of E and Z ring-opened amines 323a,b (E/Z = 1/1) after 15 hours under reflux 
(Scheme 106). In a similar way, the reaction of 307a with 1 equiv benzyl bromide in acetonitrile gave a 
mixture of the corresponding unsaturated amines 324a,b after 15 hours under reflux. These reactions 
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were straightforward and resulted in a complete conversion of the starting material, although 
inseparable mixtures of amines were obtained.  
 
Scheme 106 
Although it was expected that these reactions would give rise to mixtures of geometrical isomers, the 
presence of different chemical shift in NMR could also be explained by hindered rotation around the 
amide bond in acetamides 318 and 323. Therefore, the mixture of amines 323a,b was subjected to the 
hydrogenation reaction with 6 mol% of Pd/C at 1 bar for 1.5 days, yet only a complex mixture was 
obtained, without the presence of the corresponding amine 325 (Scheme 107).  
 
Scheme 107 
In addition, the treatment of azetidine 307a,b with 1.5 equiv of methyl chloroformate in acetonitrile for 
15 hours under reflux resulted in a mixture of amines 326a,b (Scheme 108). Upon heating of this 
mixture under microwave irradiation (140 °C, 30 min, 150 W) in DMF, a mixture of the corresponding 
cyclic carbamates 327a,b was obtained through 6-exo-tet cyclization.
163
 These cyclic carbamates can 
be regarded as interesting compounds with a variety of applications, most notably as precursors for 
1,3-amino alcohols,
164
 as chiral auxiliaries,
165
 and as the core substructure in a number of biologically 
active compounds.
166
 The subsequent hydrogenation of the double bond in 327a,b (H2, 1 bar, 20 min-
1.5 d) gave a complex mixture in which no traces of 1,3-oxazinan-2-one 328 were detected (Scheme 
108). 
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Scheme 108 
It should be mentioned that the hydrogenation of azetidine 307b in ethyl acetate in the presence of 6 
mol% of Pd/C (10% wt) at 5 bar for 3 days at room temperature afforded 1-benzyl-3-ethylazetidine 329 
as the single product (Scheme 109). 
 
 
Scheme 109 
 
In the second part of this work, the reactivity of the double bond in azetidines 307 toward different 
electrophilic reagents was investigated. At first, azetidine 307a was subjected to 1 equiv of Br2 in 
CH2Cl2 for 5 min to 1 hour, yet only complex mixtures were obtained (Table 15). The attempts to 
prepare halohydrines 330 by treatment of azetidine 307a with 1 equiv of NBS in a water/THF (1/1) 
solution for 10 min to 2 days proceeded sluggishly and gave mixtures of multiple products, in which 
halohydrine 330 and 3-hydroxy-3-(hydroxymethyl)azetidine 331 could be detected based on LC-MS 
and 
1
H NMR analysis (Scheme 110, Table 15). The outcome of this reaction was shown to be hardly 
controllable and also dependent on the purity of NBS. 
Chapter 3  Results and Discussion 
92 
 
 
Scheme 110 
Table 15. Reactions of 3-ethylideneazetidine 307a with Br2 and NBS 
Compound Reaction conditions Conversion 
307a 1 equiv Br2, CH2Cl2, r.t., 1 h Complex mixture 
307a 1 equiv Br2, CH2Cl2, r.t., 10 min Complex mixture 
307a 1 equiv NBS, H2O/THF (1/1), r.t., 2 d No reaction 
307a 1 equiv NBS, H2O/THF (1/1), Δ, 2 d Complex mixture 
 
On the other hand, selective access to the functionalized dibrominated azetidine 332 was achieved by 
the reaction of azetidine 307a with 2 equiv of NBS in CHCl3 or CH2Cl2 under reflux for 15 hours to 1 
day. Apparently, the small amount of bromine - released from NBS - was able to react with azetidine 
307a to afford 3-bromo-3-(1-bromoethyl)azetidine 332, however, in variable yields dependent on the 
purity of NBS (Scheme 111). 
 
Scheme 111 
After the unsuccessful attempt to prepare halohydrines as precursors of the corresponding spiranic 
epoxy azetidines, a direct epoxidation of the double bond in azetidine 307a with mCPBA in CH2Cl2 
could provide an alternative route toward these strained spirocyclic compounds. For this purpose, two 
reaction conditions were initially investigated (Table 16). Upon treatment of azetidine 307a with 1 or 2 
equiv of mCPBA in CH2Cl2 at room temperature or under reflux, the starting azetidine or complex 
mixtures were obtained. This can be explained by the propensity of the nucleophilic nitrogen to react 
with mCPBA to form the corresponding N-oxides, which then underwent further reactions.  
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Table 16. Reaction of azetidine 307a with mCPBA 
Compound Reaction conditions Conversion 
307a 1 equiv mCPBA, CH2Cl2, r.t., 1 d No reaction 
307a 1 equiv mCPBA, CH2Cl2, Δ, 1 d Complex mixture 
 
In order to prevent the formation of N-oxides, the azetidine nitrogen atom was protonated by 
introducing gaseous HCl to the solution of azetidine 307a in CH2Cl2 for 10 min, after which 1 equiv of 
mCPBA was added. Instead of the expected spirocyclic azetidinyl epoxide, 3-chloro-3-(1-
chloroethyl)azetidine 333 was obtained instead (Scheme 112), probably as the result of the 
electrophilic addition of in situ formed Cl2 
167
 to the double bond.  
1) HCl(g), 10 min 
CH2Cl2
2) 1 equiv mCPBA
 CH2Cl2, , 1 d
N
Cl
ClN
333 (92%)
307a
3) aq NaHCO3 (work up)
 
Scheme 112 
The vicinally dihalogenated azetidines 332 and 333 were subsequently subjected to nucleophilic 
substitution reactions with benzylamine and KCN in acetonitrile under reflux or applying microwave 
irradiation and in the presence of a catalytic amount of silver salts (Ag2CO3) or NaI. Unfortunately, 
these reactions resulted in the recovery of the starting materials or gave complex mixtures as a result 
of decomposition (Table 17). 
Table 17. Reaction of azetidines 332 and 333  
Compound Reaction conditions Conversion 
332 1 equiv BnNH2, 0.5 equiv NaI, MeCN, Δ, 3 d No reaction 
332 1 equiv BnNH2, 1 equiv Ag2CO3, MeCN, Δ, 3 d Complex mixture 
333  2 equiv KCN, 0.1 equiv Ag2CO3, MeCN, Δ, 15 h No reaction 
333  2 equiv KCN, 1 equiv Ag2CO3, MeCN, MW, 150 °C, 15 min Complex mixture 
 
In a final attempt, the azetidine nitrogen atom was protected by addition of 1 equiv of pTsOH in 
CH2Cl2. Subsequent addition of 1.5 equiv of mCPBA and heating under reflux for 15 hours afforded 
very unstable azetidine-3-ols 334a,b. However, immediate treatment of these azetidines 334 with 1 
equiv of NaH in THF for 15 hours at room temperature provided the target 1-oxa-5-
azaspiro[2,3]hexanes 335a,b in very high yields (Scheme 113).  
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Scheme 113 
These novel strained spirocyclic systems showed a considerable stability as they were purified by 
means of column chromatography on basic Al2O3 to provide analytically pure samples. As expected, 
the purification on slightly acidic silica gel column resulted in decomposition. This reaction can be 
considered as a very useful and efficient synthetic approach toward interesting new aza-spirocyclic 
building blocks. The synthesis of the spiranic azetidinyl epoxide moiety has received only limited 
attention in the literature.
168
 These compounds were shown to be very useful intermediates for the 
preparation of different biologically active molecules.
169
 In general, the synthesis and reactivity of 
different azaspirocyclic scaffolds represent a challenging task for organic chemists and has lately been 
the subject of significant interest.
168a,170
 
Bearing in mind that a number of azaspirocyles containing an azetidine moiety can be considered as 
structural surrogates of commonly employed saturated heterocycles with beneficial inherent structural 
features, further efforts were devoted to expand the family of novel spiroazetidine building blocks.  
Attempts to perform a cyclopropanation of the double bond in azetidine 307a under Simmons-Smith 
conditions (4 equiv Et2Zn, 2 equiv CH2I2, 2 equiv TFA)
171
 in CH2Cl2 gave complex mixtures (Table 18). 
Table 18. Cyclopropanation of azetidines 307a under the Simmons-Smith conditions 
Compound Reaction conditions Conversion 
307a 4 equiv Et2Zn, 2 equiv CH2I2, CH2Cl2, r.t., 3.5 h Complex mixture 
307a 4 equiv Et2Zn, 2 equiv CH2I2, 2 equiv TFA, CH2Cl2, r.t., 3.5 h Complex mixture 
 
In analogy with the epoxidation of azetidine 307a, the direct aziridination of the double bond could 
provide an access to novel spirocyclic 1,5-diazaspiro[2.3]hexanes 336 (Scheme 114). Treatment of 
azetidine 307a with 1 equiv of NBS and 1-2 equiv of Chloramine-T, a nitrene precursor,
172
 in 
acetonitrile under reflux for 1-2 days afforded only small amounts of 3-bromo-3-(1-
bromoethyl)azetidine 332, and no traces of the corresponding spiro compounds were detected. A 
complex mixture was also obtained with 0.1 equiv of phenyltrimethylammonium tribromide (PTAB) and 
1.1 equiv of Chloramine-T in acetonitrile
173
 at room temperature for 1 day (Table 19).  
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Scheme 114 
Table 19. Attempted aziridination of the double bond in azetidine 307a with Chloramine-T 
Compound Reaction conditions Conversion 
307a 1 equiv NBS, 1 equiv Chloramine-T, MeCN, r.t., 5 h No reaction 
307a 1 equiv NBS, 1 equiv Chloramine-T, MeCN, r.t., 2 d No reaction 
307a  1 equiv NBS, 2 equiv Chloramine-T, MeCN, Δ, 2 d Azetidine 332 (32%) 
307a  0.1 equiv PTAB, 1.1 equiv Chloramine-T, MeCN, r.t., 2 d Complex mixture 
 
An alternative route to the synthesis of the spiranyl aziridinyl azetidine core structure could comprise 
the ring opening of epoxides 335b with an appropriate amine (iPrNH2) in the presence of BF3·Et2O, 
followed by subsequent ring closure of the resulting amino alcohols under the Mitsunobu conditions. 
Although the epoxide ring opening was shown to be successful, the drawback of this procedure for the 
preparation of 1,5-diazaspiro[2.3]hexane 338 involved a very low stability of thus obtained β-amino 
alcohol 337, which underwent immediate decomposition (Scheme 115, Table 20). 
 
Scheme 115 
Table 20. Attempts to synthesize β-amino alcohol 337 from epoxide 335b 
Compound Reaction conditions Conversion 
335b 1 equiv BnNH2, 0.1 equiv BF3·Et2O, THF, r.t., 1 d Complex mixture 
335b 3 equiv iPrNH2, 1 equiv BF3·Et2O, THF, r.t., 1 d No reaction 
335b  5 equiv iPrNH2, 1 equiv BF3·Et2O, THF, Δ, 1 d 337 (70%) 
335b  1.5 equiv nPrNH2, 1 equiv BF3·Et2O, THF, Δ, 1 d Complex mixture 
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On the other hand, the ring opening of epoxide 335b with 3 equiv of NaN3 and 2 equiv of NH4Cl in a 
acetone/water (8/1) mixture afforded the corresponding azide 339 after 15 hours under reflux (Scheme 
116). However, the subsequent ring closure of 339 with 1.2 equiv of Ph3P in THF under reflux gave a 
complex mixture after 17 hours.  
 
Scheme 116 
In a final part, dihydroxylation of the double bond in azetidines 307a,b with 1.1 equiv of N-
methylmorpholine-N-oxide (NMO) and a catalytic amount of OsO4 (5-6 mol%) in acetone/water (4/1) 
for 4 hours at room temperature, followed by an aqueous work up, furnished dihydroxyazetidines 
340a,b in good yields (Scheme 117). These new azetidines were purified by means of column 
chromatography on silica gel (CH2Cl2/MeOH = 9/1) to provide analytically pure samples. 
Unfortunately, glycol cleavage in azetidine 340a with 1-1.5 equiv of NaIO4 in THF/H2O (3/1) in order to 
prepare azetidine-3-one 341 resulted in complex reaction mixtures, and ozonolysis of the double bond 
in 3-etylideneazetidine 307a did not provide a suitable alternative in that respect (Table 21).  
 
Scheme 117 
Table 21. Attempts to synthesize azetidine-3-one 341 from diol 340a or azetidine 307a 
Compound Reaction conditions Conversion 
340a 1 equiv NaIO4, THF/H2O (3/1), r.t., 1h Complex mixture 
340a 1 equiv NaIO4, THF/H2O (3/1), r.t., 1h Complex mixture 
307a  O3, CH2Cl2, -78 °C, 10 min, then 5 equiv (CH3)2S Complex mixture 
307a  O3, CH2Cl2, -78 °C, 10 min, then 5 equiv (CH3)2S  Complex mixture 
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In order to provide an entry to a different class of azaspirocyclic building blocks, azetidines 340b were 
treated with 1.1 equiv of pTsOH and 5 equiv of CuSO4 in acetone to successfully afford the 
corresponding novel 5,7-dioxa-2-azaspiro[3.4]octane 342 after stirring for 1 day under reflux (Scheme 
118). This spirocyclic core structure was found to be present in a number of spiro lactames, suitable 
for the further chemical transformations.
174
 
 
Scheme 118 
Furthermore, treatment of azetidines 340b with 1 equiv of NaH and 3 equiv of Et3N in CH2Cl2 for 5 min 
at 0 °C followed by addition of 1 equiv of oxalyl chloride furnished new 5,7-dioxa-2-
azaspiro[3,4]octane-6-one 345 after 15 hours at room temperature (Scheme 119). The formation of 
these cyclic carbonate could be explained by the initial formation of intermediate 343, which was then 
rearranged to azetidine 345 after expulsion of carbon monoxide and chloride.
175
  
 
Scheme 119 
It can be concluded that, in spite of a significant number of unsuccessful reactions, 3-
ethylideneazetidines can still be regarded as versatile synthons to access a window of novel ring-
opened amines, cyclic carbamates, functionalized azetidines and different spirocyclic building blocks.  
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4  Perspectives 
 
In this PhD thesis, the efficient synthesis of 2-bromomethyl-2-methylaziridines as versatile building 
blocks was reported starting from 2-methylpropenal. In light of the broad synthetic potential of these 
synthons, the reactivity study of structurally related 2-(bromomethyl)aziridines 347 bearing an 
additional methyl group could provide a fruitful research area.  
In analogy with the preparation of 2-bromomethyl-2-methylaziridines, the synthesis of 2-(1-
bromoethyl)-2-methylaziridines 347 starting from the corresponding 2-methylbut-2-enal 346 could be 
performed. The treatment of these aziridines with an appropriate base (KOtBu, LDA..) could provide 
an access to 2-vinylaziridines 348, being suitable substrates for further conversions through 
interception of highly reactive strained intermediates obtained by means of double bond 
functionalization. Given the increasing number of reports concerning the reactivity of 2-
vinylaziridines,
43,176
 these substrates are regarded as promising species for further elaboration. In this 
way, a novel strategy toward the synthesis of other relevant target compounds such as α-branched 
and β-branched amines 349 and 350, functionalized azetidines 351, cyclobutanes 352, pyrrolidines 
353, recognized as potential fungicides, antidepressants and β-blockers, could be devised (Scheme 
120). 
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Scheme 120 
 
As mentioned before, 3-substituted azetidines represent versatile building blocks in heterocyclic 
chemistry with diverse synthetic and biological properties. Next to a high number of biologically 
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relevant 3-functionalized azetidines,
148
 the introduction of
 
an azetidine moiety into the structure of a 
molecule can also result in an increased biological activity.
 
For example, different 3-sulfenylazetidine 
and 3-aminoazetidine derivatives have been introduced into ﬂuoroquinolone carboxylic acids to afford 
the corresponding ﬂuoroquinolone antibiotics with improved biological properties.
177
 In addition, the 
importance of 3-sulfenylazetidines can be also seen in the development of new carbapenem 
antibiotics, where the synthesis of 3-mercapto-1-(1,3-thiazolin-2-yl)azetidine, starting from 
benzylamine and epichlorohydrin, has been reported.
178
 
In order to provide an efficient access to a novel class of 3-sulfenylazetidines 357, deprotection of the 
benzyl group in 3-bromoazetidines 261 or 305, nucleophilic replacement of bromide in azetidine 354 
with different S-centered nucleophiles, and subsequent condensation of azetidines 355 with 2-
methylthio-2-thiazoline 356 could be performed. In this way, 3-sulfenyl-1-(1,3-thiazolin-2-yl)azetidines 
357 could be obtained as analogs of carbapenem antibiotics (Scheme 121)  
 
Scheme 121 
 
Furthermore, 3-ethylideneazetidines 307 might be suitable synthons for the preparation of the 
corresponding 3-vinylazetidines 358 by treatment with strong base (LDA, Schlosser’s base). Further 
functionalization of azetidine 358 could afford 3-(1,2-dibromoethyl)azetidines 359 upon reaction with 
Br2, 3-(oxiran-2-yl)azetidines 360 in the reaction with mCPBA and azetidine-3-carboxaldehydes 361 
via oxidation of the double bond (Scheme 122). These substrates could then be used to access a 
range of novel synthetically and biologically interesting molecules pertaining to the oxetane, 
tetrahydrofuran and pyran family. 
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5  Experimental part 
 
5.1 General methods 
 
Diethyl ether, tetrahydrofuran and toluene were distilled from sodium or sodium benzophenone ketyl, 
while dichloromethane was distilled from calcium hydride prior to use. Commercially available solvents 
and reagents were purchased from Sigma-Aldrich or Acros and used as such without further 
purification unless stated otherwise. 
The purification of reaction mixtures was performed by column chromatography using a glass column 
filled with silica gel (Fluka, pore size 60 Å, 70-230 mesh, particle size 63-200 μm). Solvent systems 
were determined via initial TLC analysis on glass plates, coated with silica gel (Merck, Kieselgel 
60F254, precoated 250 μm) using UV light or coloring with a potassium permanganate solution as 
detection methods. Preparative TLC analyses were performed on preparative TLC plates (Analtech, 
precoated 2000 μm). The compounds to be separated are applied as long streaks and after 
development recovered by scraping the adsorbent layers from the plate in the region of interest and 
eluting the separated material from the adsorbent using a CH2Cl2/MeOH (9/1) solvent mixture. 
High resolution 
1
H NMR (300 MHz) and 
13
C NMR (75 MHz) were recorded on a Jeol Eclipse FT 300 
NMR spectrometer at room temperature unless stated otherwise. Peak assignments were made with 
the aid of DEPT, HSQC and/or 2D-COSY experiments. The compounds were diluted in a deuterated 
solvent, while tetramethylsilane (TMS) was used as an internal standard.   
IR spectra were recorded on a Perkin-Elemer Spectrum BX FT-IR spectrometer. All compounds were 
analysed in neat form with an ATR (Attenuated Total Reflectance) accessory. 
Low resolution mass spectra were recorded via direct injection on an Agilent 1100 series LC-MSD 
type SL mass spectrometer with Electron Spray Ionization Geometry (ESI 70 eV) and using a Mass 
Selective Detector (quadrupole).  
HPLC analyses used for the follow-up of reactions were performed on an Agilent 1200 Series with 
UV/DAD detector. The column was of the type Eclipse Plus C18 (4,6x50 mm, particle size 3,5 μm) or 
Phenomenex Kinetex C18 (4,6x50 mm, particle size 2,6 μm). A general method for these analyses 
uses a gradient-based solvent mixture (MeCN/H2O, from 30% to 100% MeCN), which is suitable for 
good separation and resolution of all peaks. This HPLC apparatus was coupled with an Agilent 1100 
series LC-MSD type VL mass spectrometer with Electron Spray Ionization Geometry (ESI 70 eV) and 
using a Mass Selective Detector (quadrupole).   
Gas chromatography analyses were performed on an Agilent 6890 Series. The column was of the 
type Alltech EC-5 with a film thickness of 0.25 μm (length 30.0 m, i.d. 250 μm) with He as carrier gas. 
The GC was connected to a FID detector (H2 gas). 
Chapter 5  Experimental Part 
104 
 
Melting points of crystalline compounds were measured using a Büchi B-540 apparatus.  
Elemental analyses were obtained by means of a Perkin Elmer series II CHNS/O analyzer 2400. 
High resolution electro spray (ES) mass spectra were obtained with an Agilent Technologies 6210 
Series Time-of-Flight. 
Optical rotations were determined using an JASCO P-2000 series polarimeter.  
All microwave reactions were performed in a CEM Discover Benchmate with a continuous power 
output from 0 to 300 Watt and a self-adjusting, single mode MW cavity. The reactions were performed 
in a 10 mL thick walled Pyrex reaction vessels closed with a ‘snap-on’ septa cap and equipped with a 
small stirring bar, or in a 80 mL thick walled Pyrex reaction vessel connected with the locking cover 
assembly equipped with the thermowell nut. The temperature control uses either a non-contact 
infrared sensor to measure the temperature on the bottom of the vessel or a Fiber Optic temperature 
sensor (Model Discover, 314307), which were used in a feedback loop with the on-board computer to 
regulate the temperature from 25-250 °C by adjusting the power output (1 Watt increments). The 
pressure control, IntelliVentTM Pressure Control System, uses an indirect measurement of the pressure 
by sensing changes in the external deflection of the septa on the top of the sealed pressure vessel. 
Stirring is performed by a rotating magnetic plate located below the floor of microwave cavity. Cooling 
of the vessel after the reaction is performed by a stream of clean air onto the vessel which decreases 
the temperature of a 2 mL solution from 150 °C to 40 °C in less than 120 s. A ramp time of maximum 5 
min is used during which the temperature increases from room temperature to the desired one. This 
temperature is maintained during the course of the reaction for the indicated time.  
 
5.2 Synthesis of 2-acetoxymethyl-1-(arylmethyl)aziridines 222 
 
As a representative example, the synthesis of 2-acetoxymethyl-1-(4-chlorobenzyl)aziridine 222c is 
described here. 2-(Bromomethyl)-1-(4-chlorobenzyl)aziridine 16c (2.60 g, 10 mmol) was added to a 
stirred solution of NaOAc (1.23 g, 1.5 equiv) in DMSO (20 mL) at room temperature, and the mixture 
was heated at 100 °C for 15 h. The reaction mixture was poured into water (20 mL) and extracted with 
Et2O (3 x 20 mL). The combined organic extracts were washed with H2O (2 x 15 mL) and brine (20 
mL). Drying (MgSO4), filtration of the drying agent and evaporation of the solvent afforded 2-
(acetoxymethyl)-1-(4-chlorobenzyl)aziridine  222c (2.16 g, 90%), which was purified by filtration 
through silica gel (hexane/ethyl acetate 2:1) in order to obtain an analytically pure sample.  
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2-(Acetoxymethyl)-1-(4-methylbenzyl)aziridine 222b 
 
Light-yellow oil, Rf = 0.15 (hexane/ethyl acetate 2/1), Yield 83 %. 
1
H NMR (300 MHz, CDCl3) δ 1.51 
(1H, d, J = 6.0 Hz, (HcisCH)CHN), 1.77 (1H, d, J = 3.3 Hz, (HCHtrans)CHN), 1.81–
1.89 (1H, m, NCH), 1.97 (3H, s, CH3CO), 2.34 (3H, s, CH3Ar), 3.30 and 3.54 
(2H, 2 x d, J = 13.2 Hz, (HCH)Ar), 3.82 and 4.17 (2H, 2 x d x d, J = 11.5, 7.2, 4.4 
Hz, (HCH)O), 7.13-7.25 (4H, m, CHarom). 
13
C NMR (75 MHz, CDCl3) δ 20.7 
(CH3CO), 21.1 (CH3Ar), 31.8 (NCH2CH), 36.9 (NCH), 64.0 (NCH2Ar), 66.6 
(CH2O), 128.0 and 129.0 (4 x CHarom), 135.7 and 136.6 (2 x Carom,quat), 170.9 
(CO). IR (neat, cm
-1
): νCO = 1737, νmax = 2924, 1370, 1230, 1032, 802. MS (70 eV): m/z (%): 220 (M
+ 
+ 
1, 100). Anal. Calcd for C13H17NO2: C 71.21, H 7.81, N 6.39. Found: C 71.35, H 8.03, N 6.44. 
 
2-(Acetoxymethyl)-1-(4-chlorobenzyl)aziridine 222c  
 
Light-yellow oil, Rf = 0.12 (hexane/ethyl acetate 2/1), Yield 90%. 
1
H NMR (300 MHz, CDCl3) δ 1.51 
(1H, d, J = 6.6 Hz, (HcisCH)CHN), 1.79 (1H, d, J = 3.9 Hz, (HCHtrans)CHN), 1.80–1.90 (1H, m, NCH), 
1.98 (3H, s, CH3CO), 3.26 and 3.56 (2H, 2 x d, J = 13.8 Hz, (HCH)Ar), 3.79 
and 4.20 (2H, 2 x d x d, J = 11.6, 7.4, 4.4 Hz, (HCH)O), 7.24-7.32 (4H, m, 
CHarom). 
13
C NMR (75 MHz, ref = CDCl3) δ 20.9 (CH3CO), 32.0 (NCH2CH), 
37.2 (NCHCH2), 63.5 (NCH2Ar), 66.6 (CH2O), 128.5 and 129.5 (4 x CHarom), 
132.9 and 137.4 (2 x Carom,quat), 171.0 (CO). IR (neat, cm
-1
): νCO = 1737, νmax = 
2986; 2832, 1491, 1370, 1231, 1087, 1033, 806. MS (70 eV): m/z (%): 240/2 
(M
+ 
+ 1, 100). Anal. Calcd for C12H14ClNO2: C 60.13, H 5.89, N 5.84. Found: C 60.28, H 6.12, N 5.79. 
 
2-(Acetoxymethyl)-1-(4-methoxybenzyl)aziridine 222d 
 
Light-yellow oil, Rf = 0.08 (hexane/ethyl acetate 2/1), Yield 79%. 
1
H NMR (300 MHz, CDCl3) δ 1.51 
(1H, d, J = 6.6 Hz, (HcisCH)CHN), 1.77 (1H, d, J = 3.3 Hz, (HCHtrans)CHN), 
1.79–1.89 (1H, m, NCH), 1.97 (3H, s, CH3CO), 3.26 and 3.52 (2H, 2 x d, J = 
13.0 Hz, (HCH)Ar), 3.80 (3H, s, OCH3),  3.86 and 4.17 (2H, 2 x d x d, J = 
11.6, 7.7, 4.7 Hz, (HCH)O), 6.85-6.88 and 7.25-7.28 (4H, 2 x m, CHarom). 
13
C 
NMR (75 MHz, CDCl3) δ 20.8 (CH3CO), 31.8 (NCH2CH), 36.9 (NCHCH2), 
55.3 (OCH3), 63.6 (NCH2Ar), 66.6 (CH2O), 113.7 and 129.3 (4 x CHarom), 
131.0 (Carom,quat), 158.8 (CaromO), 170.9 (CO). IR (neat, cm
-1
): νCO = 1736, νmax = 2952, 2835, 1511, 
1234, 1031, 818. MS (70 eV): m/z (%): 236 (M
+ 
+ 1, 100). Anal. Calcd for C13H17NO3: C 66.36, H 7.28, 
N 5.95. Found: C 66.45, H 7.57, N 5.81. 
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5.3 Synthesis of 2-(arylmethylamino)propan-1-ols 224  
 
As a representative example, the synthesis of 2-{[(4-chlorophenyl)methyl]amino}propan-1-ol 224c is 
described here. 2-(Acetoxymethyl)-1-(4-chlorobenzyl)aziridine 222c (1.20 g, 5 mmol) was dissolved in 
dry THF (50 mL), after which LiAlH4 (0.38 g, 2 molar equiv) was added in small portions at 0 °C. The 
resulting mixture was then placed in 80 mL sealed vessel, provided with appropriate stirrer bar and 
subjected to microwave conditions (130 °C, 220 Wmax, two hours). Afterward, the reaction mixture was 
poured into water (20 mL) and extracted with Et2O (3 x 20 mL). Drying (MgSO4), filtration of the drying 
agent and evaporation of the solvent afforded 2-{[(4-chlorophenyl)methyl]amino}propan-1-ol 224c 
(0.92 g, 92%), which was purified by filtration through a silica gel column (dichloromethane/methanol 
9:1) in order to obtain an analytically pure sample. CAUTION: strict safety measurements have to be 
applied for LiAlH4-promoted reactions under microwave irradiation in order to cover the risk of 
explosion. 
 
2-{[(4-Methylphenyl)methyl]amino}propan-1-ol 224b 
 
Light-yellow crystals, Rf = 0.17 (dichloromethane/methanol 9/1), Yield 75%. Mp = 71.7-72.2 °C. 
1
H 
NMR (300 MHz, CDCl3) δ 1.07 (3H, d, J = 6.6 Hz, CH3CH), 2.33 (3H, s, CH3Ar), 
2.74 (2H, br s, OH, NH), 2.77–2.88 (1H, m, NHCH), 3.27 and 3.57 (2H, 2 x d x d, 
J = 11.0, 6.9, 3.9 Hz, (HCH)OH), 3.68 and 3.83 (2H, 2 x d, J = 12.9 Hz, 
(HCH)Ar), 7.07-7.25 (4H, m, CHarom). 
13
C NMR (75 MHz, CDCl3) δ 16.7 (CH3CH), 
21.2 (CH3Ar), 50.5 (NCH2Ar), 53.9 (CHNH), 65.2 (CH2OH), 128.4 and 129.3 (4 x 
CHarom), 136.0 and 137.1 (2 x Carom,quat). IR (neat, cm
-1
): νNH,OH = 3277, νmax = 2846, 1460, 1063, 886, 
812. MS (70 eV): m/z (%): 180 (M
+ 
+ 1, 100). Anal. Calcd for C11H17NO: C 73.70, H 9.56, N 7.81. 
Found: C 73.92, H 9.48, N 9.47. 
 
2-{[(4-Chlorophenyl)methyl]amino}propan-1-ol 224c 
 
 Light-yellow crystals, Rf = 0.19 (dichloromethane/methanol 9/1), Yield 92%. Mp = 64.6-65.6 °C. 
1
H 
NMR (300 MHz, CDCl3) δ 1.06 (3H, d, J = 6.6 Hz, CH3CH), 2.31 (2H, br s, OH, 
NH), 2.75-2.85 (1H, m, NHCH), 3.27 and 3.56 (2H, 2 x d x d, J = 10.8, 7.2, 3.8 
Hz, (HCH)OH), 3.68 and 3.83 (2H, 2 x d, J = 13.2 Hz, (HCH)Ar), 7.23-7.33 (4H, 
m, CHarom). 
13
C NMR (75 MHz, ref = CDCl3) δ 17.2 (CH3CH), 50.4 (NCH2Ar), 
53.9 (CHNH), 65.6 (CH2OH), 128.7 and 129.5 (2 x CHarom), 132.9 and 138.8 (2 
x Carom,quat). IR (neat, cm
-1
): νNH,OH = 3312, νmax = 2927, 1491, 1256, 1043, 730. 
MS (70 eV): m/z (%): 200/2 (M
+ 
+ 1, 100). Anal. Calcd for C10H14ClNO: C 60.15, H 7.07, N 7.01. 
Found: C 60.05, H 7.18, N 7.10. 
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2-{[(4-Methoxyphenyl)methyl]amino}propan-1-ol 224d 
 
Light-yellow crystals, Rf = 0.08 (dichloromethane/methanol 9/1), Yield 72%. Mp = 59.4-60.4 °C. 
1
H 
NMR (300 MHz, CDCl3) δ 1.02 (3H, d, J = 7.2 Hz, CH3CH), 1.95 (2H, br s, 
OH, NH), 2.72–2.81 (1H, m, NHCH), 3.20 and 3.52 (2H, 2 x d x d, J = 10.5, 
6.6, 3.9 Hz, (HCH)OH), 3.61 and 3.74 (2H, 2 x d, J = 12.9 Hz, (HCH)Ar), 3.72 
(3H, s, OCH3), 6.78-6.81 and 7.15-7.19 (4H, 2 x m, CHarom). 
13
C NMR (75 
MHz, ref= CDCl3) δ 17.1 (CH3CH), 50.6 (NCH2Ar), 53.7 (CHNH), 55.4 (OCH3), 
65.6 (CH2OH), 113.9 and 129.4 (2 x CHarom), 132.4 (Carom,quat), 158.8 (CaromO). 
IR (neat, cm
-1
): νNH,OH = 3294, νmax = 2834, 1511, 1245, 1034, 819. MS (70 eV): m/z (%): 196 (M
+ 
+ 1, 
100). Anal. Calcd for C11H17NO2: C 67.66, H 8.78, N 7.17. Found: C 67.76, H 8.91, N 7.14. 
 
5.4  Synthesis of optically active 2-aminopropan-1-ols 230  
 
As a representative example, the synthesis of (S)-[1(R)-phenylethylamino]propan-1-ol 230a is 
described here. Aziridine alcohol 229a (0.88 g, 5 mmol) was diluted in dry THF (50 mL), and LiAlH4 
(0.38 g, 2 molar equiv) was added in small portions at 0 °C. The resulting mixture was then placed in 
80 mL sealed vessel, provided with appropriate stirrer bar and subjected to microwave conditions (160 
°C, 220 Wmax, two hours). The resulting reaction mixture was subsequently poured into water (15 mL) 
and extracted with Et2O (3 x 20 mL). Drying (MgSO4), filtration of the drying agent and evaporation of 
the solvent afforded 2(S)-[1(R)-phenylethylamino]propan-1-ol 230a (0.83 g, 93%), which was purified 
by filtration through silica gel (dichloromethane/methanol 9:1) in order to obtain an analytically pure 
sample. 
 
2(S)-[1(R)-Phenylethylamino]propan-1-ol 230a 
 
Colorless liquid, Rf = 0.18 (dichloromethane/methanol 9/1), Yield 93%. [α]D
28
 = + 115.6 (c = 0.41, 
CDCl3). 
1
H NMR (300 MHz, CDCl3) δ 0.98 (d x d, J = 6.9, 1.4 Hz, CH3CHCH2OH), 1.36 (3H, d, J = 6.6 
Hz, CH3CHPh), 2.51–2.61 (1H, m, NHCHCH2OH), 2.55 (2H, br s, OH, NH), 3.16-
3.23 (1H, m, (HCH)OH), 3.40 (1H, d x d, J = 10.8, 4.2 Hz, (HCH)OH), 3.93 (1H, q, J 
= 6.6 Hz, CH3CHAr), 7.19-7.34 (5H, m, CHarom). 
13
C NMR (75 MHz, CDCl3) δ 16.6 
(CH3CHCH2OH), 25.2 (CH3CHPh), 51.4 (NHCHCH2OH), 54.9 (CH3CHAr), 66.5 
(CH2OH), 126.6, 127.1 and 128.6 (5 x CHarom) and 145.1 (Carom,quat). IR (neat, cm
-1
): νNH,OH = 3292, 
νmax = 2965, 1452, 1044, 762, 731, 699. MS (70 eV): m/z (%): 180 (M
+ 
+ 1, 100). Anal. Calcd for 
C11H17NO: C 73.70, H 9.56, N 7.81. Found: C 73.94, H 9.84, N 7.69. 
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2(R)-[1(R)-Phenylethylethylamino]propan-1-ol 230b 
 
White crystals. Rf = 0.08 (dichloromethane/methanol 9/1), Yield 85%. Mp = 49.5-51.1 °C, [α]D
28
 = - 2.3 
(c = 0.36, CDCl3). 
1
H NMR (300 MHz, CDCl3) δ 0.98 (3H, d, J = 6.6 Hz, 
CH3CHCH2OH), 1.35 (3H, d, J = 6.4 Hz, CH3CHPh), 2.30 (2H, br s, OH, NH), 2.68–
2.80 (1H, m, NHCHCH2OH), 3.20 and 3.59 (2H, 2 x d x d, J = 10.5, 6.1, 3.8 Hz, 
(HCH)OH), 3.87 (1H, q, J = 6.4 Hz, CH3CHAr), 7.22-7.36 (5H, m, CHarom). 
13
C NMR 
(75 MHz, CDCl3) δ 18.2 (CH3CHCH2OH), 24.1 (CH3CHPh), 51.6 (NHCHCH2OH), 55.4 (CH3CHAr), 
64.9 (CH2OH), 126.4, 127.1 and 128.6 (5 x CHarom) and 145.9 (Carom,quat). IR (neat, cm
-1
): νNH,OH = 
3292, νmax = 2965, 1452, 1045, 761, 700. MS (70 eV): m/z (%): 180 (M
+ 
+ 1, 100). Anal. Calcd for 
C11H17NO: C 73.70, H 9.56, N 7.81. Found: C 73.78, H 9.72, N 7.82. 
 
 
5.5 Synthesis of 5-methylmorpholin-2-ones 228  
 
As a representative example, the synthesis of 4-(4-methylphenyl)methyl-5-methylmorpholin-2-one 
228b is described here. To a solution of 2-{[(4-methylphenyl)methyl]amino}propan-1-ol 224b (0.72 g, 4 
mmol) in THF (30 mL) an aqueous solution of glyoxal (40%, 1.74 g, 3 equiv) was added, and the 
resulting mixture was heated for 2.5 h under reflux. The reaction mixture was then poured into water 
(20 mL) and extracted with CH2Cl2 (3 x 10 mL). The combined organic layers were dried with 
anhydrous Na2SO4, filtered and evaporated. The crude product was purified by column 
chromatography on silica gel (petroleum ether/ethyl acetate 7/1) in order to obtain an analytically pure 
sample (0.76 g, 87%).  
 
4-(4-Methylphenyl)methyl-5-methylmorpholin-2-one 228b 
 
Yellow liquid, Rf = 0.07 (petroleum ether/ethyl acetate 7/1), Yield 87%. 
1
H NMR (300 MHz, CDCl3) δ 
1.17 (3H, d, J = 6.1 Hz, CH3CH), 2.34 (3H, s, CH3Ar), 2.82–2.92 (1H, m, CHCH3), 
3.11 and 3.43 (2H, 2 x d, J = 18.2 Hz, (HCH)CO), 3.27 and 3.88 (2H, 2 x d, 12.9 Hz, 
(HCH)Ar), 4.09 and 4.34 (2H, 2 x d x d, J = 11.0, 7.7, 3.6 Hz, (HCH)O), 7.09-7.19 
(4H, m, CHarom). 
13
C NMR (75 MHz, CDCl3) δ 12.4 (CH3CH), 21.1 (CH3Ar), 51.1 
(CHCH3), 52.5 (CH2CO), 57.3 (NCH2Ar), 73.7 (CH2O), 128.8 and 129.3 (4 x CHarom), 
133.6 and 137.3 (2 x Carom,quat), 168.2 (CO). IR (neat, cm
-1
): νCO = 1742, νmax = 2923, 
1227, 1055, 807. MS (70 eV): m/z (%): 220 (M
+ 
+ 1, 100). Anal. Calcd for C13H17NO2: C 71.21, H 7.81, 
N 6.39. Found: C 71.47, H 8.06, N 6.27. 
 
4-(4-Chlorophenyl)methyl-5-methylmorpholin-2-one 228c 
 
Yellow solid, Rf = 0.05 (petroleum ether/ethyl acetate 7/1), Yield 83%. Mp = 55.5-58.5 °C. 
1
H NMR 
(300 MHz, CDCl3) δ 1.16 (3H, d, J = 6.0 Hz, CH3CH), 2.84–2.93 (1H, m, CHCH3), 
3.11 and 3.41 (2H, 2 x d, J = 17.6 Hz, (HCH)CO), 3.29 and 3.88 (2H, 2 x d, 13.2 
Hz, (HCH)Ar), 4.09 and 4.35 (2H, 2 x d x d, J = 11.0, 7.7, 3.6 Hz, (HCH)O), 7.23-
7.35 (4H, m, CHarom). 
13
C NMR (75 MHz, ref = CDCl3) δ 12.5 (CH3CH), 51.4 
(CHCH3), 52.6 (CH2CO), 57.1 (NCH2Ar), 73.7 (CH2O), 128.8 and 130.2 (4 x 
NH
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CHarom), 133.4 and 135.6 (2 x Carom,quat), 168.0 (CO). IR (neat, cm
-1
): νCO = 1741, νmax = 2969, 1490, 
1227, 1056, 810. MS (70 eV): m/z (%): 240/2 (M
+ 
+ 1, 100). Anal. Calcd for C12H14ClNO2: C 60.13, H 
5.89, N 5.84. Found: C 60.27, H 6.11, N 5.98. 
 
 
4-(4-Methoxyphenyl)methyl-5-methylmorpholin-2-one 228d 
 
Yellow solid, Rf = 0.05 (petroleum ether/ethyl acetate 7/1), Yield 74%. Mp = 48.3–51.3 °C. 
1
H NMR 
(300 MHz, CDCl3) δ 1.17 (3H, d, J = 6.6 Hz, CH3CH), 2.82–2.92 (1H, m, CHCH3), 
3.11 and 3.43 (2H, 2 x d, J = 17.6 Hz, (HCH)CO), 3.26 and 3.86 (2H, 2 x d, J = 
12.6 Hz, (HCH)Ar), 3.81 (3H, s, CH3O), 4.09 and 4.34 (2H, 2 x d x d, J = 11.0, 
7.7, 3.3 Hz, (HCH)O), 6.84-6.89 and 7.18-7.25 (4H, 2 x m, CHarom). 
13
C NMR (75 
MHz, CDCl3) δ 12.4 (CH3CH), 51.1 (CHCH3), 52.4 (CH2CO), 55.3 (OCH3), 57.0 
(NCH2Ar), 73.7 (CH2O), 114.0 and 130.1 (4 x CHarom), 128.6 (Carom,quat), 161.3 
(CaromO), 167.9 (CO). IR (neat, cm
-1
): νCO = 1739, νmax = 2965, 1511, 1243, 1031, 822. MS (70 eV): m/z 
(%): 236 (M
+ 
+ 1, 100). Anal. Calcd for C13H17NO3: C 66.36, H 7.28, N 5.95. Found: C 66.31, H 7.24, N 
5.88. 
 
5.6 Synthesis of chiral 5-methylmorpholin-2-ones 231  
As a representative example, the synthesis of 5(S)-methyl-4-[1(R)-phenylethyl]morpholin-2-one 231a 
is described here. To a solution of 2(S)-[1(R)-phenylethylamino]propan-1-ol 230a (0.72 g, 4 mmol) in 
THF (30 mL) an aqueous solution of glyoxal (40%, 1.74 g, 3 equiv) was added, and the resulting 
mixture was heated for 3 h under reflux. The reaction mixture was then poured into water (20 mL) and 
extracted with CH2Cl2 (3 x 10 mL). The combined organic layers were dried with anhydrous Na2SO4, 
filtered and evaporated. The crude product was purified by column chromatography on silica gel 
(hexane/ethyl acetate 3:1) in order to obtain an analytically pure sample (0.78 g, 89%). 
 
5(S)-Methyl-4-[1(R)-phenylethyl]morpholin-2-one 231a 
 
Light-yellow solid, Rf =  0.25 (hexane/ethyl acetate 3/1), Yield 89%. Mp = 37.1–40.2 °C, [α]D
28
 =  + 
25.0 (c = 0.44, CDCl3). 
1
H NMR (300 MHz, CDCl3) δ 1.04 (3H, d, J = 6.6 Hz, 
CH3CHCH2), 1.35 (3H, d, J = 6.8 Hz, CH3CHAr), 2.82–2.91 (1H, m, CH2CHCH3), 3.38 
and 3.74 (2H, 2 x d, J = 17.9 Hz, (HCH)CO), 3.66 (1H, q, J = 6.8 Hz, CH3CHAr), 4.00 
and 4.37 (2H, 2 x d x d, J = 11.0, 3.3, 3.3 Hz, (HCH)O), 7.24-7.34 (5H, m, CHarom). 
13
C 
NMR (75 MHz, CDCl3) δ 9.0 (CH3CHCH2), 21.0 (CH3CHAr), 47.2 (CH2CHCH3), 48.3 
(CH2CO), 60.2 (ArCHCH3), 74.1 (CH2O), 127.3, 127.6 and 128.7 (5 x CHarom), 142.7 
(Carom,quat), 168.6 (CO). IR (neat, cm
-1
): νCO = 1737, νmax = 2973, 1224, 1004, 701. MS (70 eV): m/z (%): 
220 (M
+ 
+ 1, 100). Anal. Calcd for C13H17NO2: C 71.21, H 7.81, N 6.39. Found: C 71.27, H 7.93, N 
6.33. 
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5(R)-Methyl-4-[1(R)-phenylethyl]morpholin-2-one 231b 
 
Light-yellow liquid, Rf = 0.18 (hexane/ethyl acetate 3/1), Yield 86%. [α]D
28
 = + 9.6 (c = 0.37, CDCl3). 
1
H 
NMR (300 MHz, CDCl3) δ 1.16 (3H, d, J = 6.6 Hz, CH3CHCH2), 1.34 (3H, d, J = 6.6 
Hz, CH3CHAr), 3.11 and 3.28 (2H, 2 x d, J = 18.2 Hz, (HCH)CO), 3.26–3.36 (1H, m, 
CH2CHCH3), 3.74 (1H, q, J = 6.6 Hz, CH3CHAr), 4.14 and 4.47 (2H, 2 x d x d, J = 
10.8, 5.2, 3.6 Hz, (HCH)O), 7.22-7.39 (5H, m, CHarom). 
13
C NMR (75 MHz, CDCl3) δ 
10.6 (CH3CHCH2), 16.6 (CH3CHAr), 47.6 (CH2CHCH3), 48.3 (CH2CO), 59.1 
(ArCHCH3), 73.9 (CH2O), 127.38, 127.44 and 128.6 (5 x CHarom), 142.8 (Carom,quat), 
168.8 (CO). IR (neat, cm
-1
): νCO = 1740, νmax = 2972, 1206, 1050, 700. MS (70 eV): m/z (%): 220 (M
+ 
+ 
1, 100). Anal. Calcd for C13H17NO2: C 71.21, H 7.81, N 6.39. Found: C 71.01, H 8.00, N 6.52. 
 
 
5.7 Synthesis of 1-methoxypropan-2-amines 235  
 
As a representative example, the synthesis of N-(1-methoxyprop-1-yl)-N-(4-methylbenzyl)amine 235a 
is described here. 2-(Methoxymethyl)-1-(4-methylbenzyl)aziridine 233a (0.96 g, 5 mmol) was 
dissolved in dry THF (25 mL), after which LiAlH4 (0.38 g, 2 molar equiv) was added in small portions at 
0 °C. The resulting mixture was then placed in 80 mL sealed vessel, provided with appropriate stirrer 
bar and subjected to microwave conditions (130 °C, 250 Wmax, 12 h). Afterward, the reaction mixture 
was poured into water (20 mL) and extracted with Et2O (3 x 20 mL). Drying (MgSO4), filtration of the 
drying agent and evaporation of the solvent afforded N-(1-methoxyprop-1-yl)-N-(4-methylbenzyl)amine 
235a (0.27 g, 80%), which was purified by filtration through silica gel column 
(dichloromethane/methanol 9:1) in order to obtain an analytically pure sample. 
 
N-(1-Methoxyprop-1-yl)-N-(4-methylbenzyl)amine 235a 
 
Light-yellow oil, Rf = 0.23 (dichloromethane/methanol 9/1), Yield 80%. 
1
H NMR (300 MHz, CDCl3) δ 
1.06 (3H, d, J = 6.1 Hz, CH3CH), 2.33 (3H, s, CH3Ar), 2.08 (1H, br s, NH), 2.89–2.99 (1H, m, NHCH), 
3.27 and 3.34 (2H, 2 x d x d, J = 9.4, 7.7, 4.4 Hz, (HCH)OCH3), 3.32 (3H, s, 
OCH3), 3.69 and 3.86 (2H, 2 x d, J = 12.9 Hz, (HCH)Ar), 7.12-7.26 (4H, m, 
CHarom).
 13
C NMR (75 MHz, CDCl3) δ 16.9 (CH3CH), 21.1 (CH3Ar), 50.9 
(NCH2Ar), 51.8 (CHNH), 58.9 (OCH3), 77.1 (CH2OCH3), 128.2 and 129.1 (4 x 
CHarom), 136.5 and 137.2 (2 x Carom,quat). IR (neat, cm
-1
): νNH = 3325, νmax = 2923, 
2875, 2826, 1514, 1450, 1373, 1197, 1162, 1106, 805. MS (70 eV): m/z (%): 194 (M
+ 
+ 1, 100). Anal. 
Calcd for C12H19NO: C 74.57, H 9.91, N 7.25. Found: C 74.68, H 9.48, N 7.47.  
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N-(4-Methoxylbenzyl)-N-(1-methoxyprop-1-yl)amine 235b 
 
Dark-yellow oil, Rf = 0.21 (dichloromethane/methanol 9/1), Yield 60%. 
1
H NMR (300 MHz, CDCl3) δ 
1.07 (3H, d, J = 6.1 Hz, CH3CH), 2.24 (1H, br s, NH), 2.89–2.99 (1H, m, 
NHCH), 3.25-3.36 (2H, m, CH2OCH3), 3.67 and 3.83 (2H, 2 x d, J = 12.7 Hz, 
(HCH)Ar), 3.80 (3H, s, OCH3), 6.85-6.88 (4H, m, CHarom).
 13
C NMR (75 MHz, 
CDCl3) δ 16.8 (CH3CH), 50.7 (NCH2Ar), 51.8 (CHNH), 55.3 (OCH3Ar), 58.8 
(CH2OCH3), 77.0 (CH2OCH3), 113.8 and 129.4 (4 x CHarom), 132.4 (Carom,quat), 
158.6 (CaromO). IR (neat, cm
-1
): νNH = 3324, νmax = 2928, 2877, 2832, 1612, 
1511, 1462, 1244, 1105, 1035, 822. MS (70 eV): m/z (%): 210 (M
+ 
+ 1, 100). Anal. Calcd for 
C12H19NO2: C 68.87, H 9.15, N 6.69. Found: C 68.61, H 9.48, N 6.47.  
 
 
 
5.8 Synthesis of 1-arylmethyl-2-(aryloxymethyl)aziridines 234  
 
 
 
As a representative example, the synthesis of 1-[(4-methoxyphenyl)methyl]-2-
(phenoxymethyl)aziridine 234d is described here. 2-Bromomethyl-1-[(4-
methoxyphenyl)methyl]aziridine 16d (1.28 g, 5 mmol) was added to a mixture of phenol (1.03 g, 2.2 
equiv) and K2CO3 (3.45 g, 5 equiv) in a solvent mixture containing acetone and DMF (50 mL, 1:1 v/v), 
and the resulting mixture was heated at reflux for 15 h. Afterward, the reaction mixture was poured 
into brine (50 mL) and extracted with Et2O (3 x 50 mL). Drying (MgSO4), filtration of the drying agent 
and evaporation of the solvent afforded 1-[(4-methoxyphenyl)methyl]-2-(phenoxymethyl)aziridine 
234d, which was purified by column chromatography on silica gel (hexane/ethyl acetate 4/1) to give an 
analytically pure sample (1.17 g, 87%). 
 
 
1-[(4-Chlorophenyl)methyl]-2-(phenoxymethyl)aziridine 234b 
 
Yellow liquid, Rf = 0.28 (hexane/ethyl acetate 4/1), Yield 85%. 
1
H NMR (300 MHz, CDCl3) δ 1.55 (1H, 
d, J = 6.6 Hz, (HcisCH)CHN), 1.85 (1H, d, J = 3.3 Hz, (HCHtrans)CHN), 1.94–
2.03 (1H, m, NCH), 3.43 and 3.49 (2H, 2 x d, J = 13.8 Hz, N(HCH)Ar), 3.89 
and 3.99 (2H, 2 x d x d, J = 10.3, 6.3, 5.0 Hz, (HCH)O), 6.86–6.96 and 
7.22–7.33 (9H, 2 x m, CHarom). 
13
C NMR (75 MHz, CDCl3) δ 31.8 
(NCH2CH), 38.0 (NCH), 63.5 (NCH2Ar), 70.0 (CH2O), 114.6, 120.9, 128.5, 
129.3 and 129.4 (9 x CHarom), 132.8, 137.4 and 158.6 (3 x Carom,quat). IR 
(neat): νmax = 2921, 1599, 1491, 1240, 1086, 1034, 1015, 805, 752, 691 
cm
–1
. MS (70 eV): m/z (%) = 274/6 (M
+ 
+ 1, 100). C16H16ClNO (273.76): calcd. C 70.20, H 5.89, N 
5.12; found C 70.31, H 6.04, N 5.21. 
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2-[(4-Chlorophenoxy)methyl]-1-[(4-chlorophenyl)methyl]aziridine 234c 
 
Yellow liquid, Rf = 0.10 (hexane/ethyl acetate 4/1), Yield 82%. 
1
H NMR (300 MHz, CDCl3) δ 1.55 (1H, 
d, J = 6.6 Hz, (HcisCH)CHN), 1.84 (1H, d, J = 3.3 Hz, (HCHtrans)CHN), 1.91–1.98 (1H, m, NCH), 3.42 
and 3.48 (2H, 2 x d, J = 13.2 Hz, N(HCH)Ar), 3.83 and 3.99 (2 H, 2 x d x 
d, J = 10.4, 6.6, 4.4 Hz, (HCH)O), 6.77–6.80, 7.18–7.21 and 7.27–7.32 
(8H, 3 x m, CHarom). 
13
C NMR (75 MHz, CDCl3) δ 31.7 (NCH2CH), 37.9 
(NCH), 63.5 (NCH2Ar), 70.4 (CH2O), 115.9, 128.5, 129.29, 129.34 (8 x 
CHarom), 125.8, 133.0, 137.3 and 157.3 (4 x Carom,quat). IR (neat): νmax = 
2986, 2923, 2830, 1596, 1489, 1284, 1240, 1171, 1089, 1015, 822, 
806, 668 cm
–1
. MS (70 eV): m/z (%) = 308/10/12 (M
+ 
+ 1, 100). 
C16H15Cl2NO (308.21): calcd. C 62.35, H 4.91, N 4.54; found C 62.42, H 5.23, N 4.45. 
 
 
1-[(4-Methoxyphenyl)methyl]-2-(phenoxymethyl)aziridine 234d 
 
Light-yellow crystals, Rf = 0.11 (hexane/ethyl acetate 4/1), Yield 87 %. 
1
H NMR (300 MHz, CDCl3) δ 
1.52 (1H, d, J = 6.6 Hz, (HcisCH)CHN), 1.79 (1H, d, J = 3.3 Hz, 
(HCHtrans)CHN), 1.86–1.97 (1H, m, NCH), 3.37 and 3.44 (2H, 2 x d, J = 
13.2 Hz, N(HCH)Ar), 3.76 (3H, s, OCH3), 3.91 (2H, d, J = 5.5 Hz, (HCH)O), 
6.81–6.93 and 7.19–7.28 (9H, 2 x m, CHarom). 
13
C NMR (75 MHz, CDCl3) δ 
31.8 (NCH2CH), 37.8 (NCH), 55.2 (OCH3), 63.6 (NCH2Ar), 70.1 (CH2O), 
113.8, 114.6, 120.8, 129.3 and 129.4 (9 x CHarom), 130.0 (Carom,quat), 158.7 
and 158.8 (2 x CaromO). IR (neat): νmax = 2933, 2836, 1609, 1511, 1457, 1243, 1173, 1030, 1018, 809, 
760 cm
–1
. MS (70 eV): m/z (%) = 270 (M
+ 
+ 1, 100). C17H19NO2 (269.34): calcd. C 75.81, H 7.11, N 
5.20; found C 75.67, H 7.27, N 5.08. 
 
 
5.9 Synthesis of N-(3-aryloxy-2-bromopropyl)amines 239 
 
As a representative example the synthesis of N-benzyl-N-(2-bromo-3-phenoxypropyl)-N-(4-
chlorobenzyl)amine 239b is described here. Benzyl bromide (1.71 g, 1 equiv) was added to a solution 
of 1-[(4-chlorophenyl)methyl]-2-(phenoxymethyl)aziridine 234b (2.73 g, 10 mmol) in acetonitrile (50 
mL) at room temperature whilst stirring, and the resulting mixture was heated at reflux for 5 h. 
Afterward, the reaction mixture was poured into water (50 mL) and extracted with Et2O (3 x 50 mL). 
Drying (MgSO4), filtration of the drying agent and evaporation of the solvent afforded N-benzyl-N-(2-
bromo-3-phenoxypropyl)-N-(4-chlorobenzyl)amine 239b, which was purified by column 
chromatography on silica gel (hexane/ethyl acetate 1/1) to obtain an analytically pure sample (3.83 g, 
86%). 
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N-Benzyl-N-(2-bromo-3-phenoxypropyl)-N-(4-chlorobenzyl)amine 239b 
 
Colourless oil, Rf = 0.76 (hexane/ethyl acetate 1/1), Yield 86%. 
1
H NMR (300 MHz, CDCl3) δ 2.91 and 
3.10 (2H, 2 x d x d, J = 13.8, 7.2, 5.5 Hz, N(HCH)CH), 3.53–3.71 (4H, m, 2 x NCH2Ar), 4.07–4.23 (3H, 
m, BrCH and (HCH)O), 6.77–6.80, 6.94–6.99 and 7.22–7.36 (14H, 3 x m, 
CHarom). 
13
C NMR (75 MHz, CDCl3) δ 48.9 (CHBr), 57.8 (NCH2), 58.5 
(NCH2), 59.2 (NCH2), 70.0 (CH2O), 114.6, 121.2, 127.4, 128.4, 128.5, 
129.0, 129.5 and 130.3 (14 x CHarom), 132.9, 137.3, 138.5 and 158.1 (4 x 
Carom,quat). IR (neat): νmax = 2925, 2826, 1736, 1598, 1587, 1491, 1453, 
1240, 1088, 801, 752, 692 cm
–1
. MS (70 eV): m/z (%) = 364/6 (100), 
444/6/8 (M
+ 
+ 1, 15). C23H23BrClNO (444.80): calcd. C 62.11, H 5.21, N 
3.15; found C 62.29, H 5.41, N 3.04. 
 
 
N-Benzyl-N-[2-bromo-3-(4-chlorophenoxy)propyl]-N-(4-chlorobenzyl)amine 239c 
 
Colourless oil, Rf = 0.74 (hexane/ethyl acetate 1/1), Yield 85%. 
1
H NMR (300 MHz, CDCl3) δ 2.90 and 
3.08 (2H, 2 x d x d, J = 13.8, 7.4, 5.8 Hz, N(HCH)CH), 3.52–3.72 (4H, 
m, 2 x NCH2Ar), 4.02–4.14 (3H, m, BrCH and (HCH)O), 6.67–6.71 and 
7.20–7.38 (13H, 2 x m, CHarom). 
13
C NMR (75 MHz, CDCl3) δ 48.5 
(CHBr), 57.7 (NCH2), 58.6 (NCH2), 59.4 (NCH2), 70.2 (CH2O), 115.9, 
127.4, 128.45, 128.53, 129.0, 129.4 and 130.3 (13 x CHarom), 133.0, 
137.3, 138.5, 156.8 and 126.2 (5 x Carom,quat). IR (neat): νmax = 2920, 
2826, 1596, 1490, 1453, 1240, 1090, 821, 801, 740, 697 cm
–1
. MS (70 eV): m/z (%) = 398/400/402 
(M
+ 
+ 1, 100). C23H22BrCl2NO (479.24): calcd. C 57.64, H 4.63, N 2.92; found C 57.79, H 4.95, N 2.81. 
  
 
 
N-Benzyl-N-(2-bromo-3-phenoxypropyl)-N-(4-methoxybenzyl)amine 239d 
 
Colourless oil, Rf = 0.76 (hexane/ethyl acetate 1/1), Yield 84%. 
1
H NMR (300 MHz, CDCl3) δ 2.91 and 
3.08 (2H, 2 x d x d, J = 13.8, 8.3, 5.4 Hz, N(HCH)CH), 3.49–3.74 (4H, 
m, 2 x NCH2Ar), 3.77 (3H, s, OCH3), 4.01–4.24 (3H, m, BrCH and 
(HCH)O), 6.78–6.83, 6.92–6.97 and 7.15–7.39 (14H, 3 x m, CHarom). 
13
C NMR (75 MHz, CDCl3) δ 49.3 (CHBr), 55.2 (NCH2), 57.8 (NCH2), 
58.6 (NCH2), 59.3 (OCH3), 70.2 (CH2O), 113.7, 114.7, 121.1, 127.2, 
128.3, 129.0, 129.4 and 130.2 (14 x CHarom), 130.8 and 138.9, (2 x 
Carom,quat)  158.3 and 158.9 (2 x CaromO). IR (neat): νmax = 2932, 2833, 
1599, 1509, 1495, 1453, 1241, 1172, 1034, 813, 752, 691 cm
–1
. MS (70 eV): m/z (%) = 360 (100), 
440/2 (M
+ 
+ 1, 30). C24H26BrNO2 (440.38): calcd. C 65.46, H 5.95, N 3.18; found C 65.62, H 6.13, N 
3.14. 
 
 
5.10 Synthesis of N-(2-chloro-3-aryloxypropyl)amines 240 
 
As a representative example the synthesis of N-benzyl-N-(2-chloro-3-phenoxypropyl)-N-(4-
methoxybenzyl)amine 240d is described here. Tetraethylammonium chloride (1.66 g, 10 equiv) was 
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added to a solution of N-benzyl-N-(2-bromo-3-phenoxypropyl)-N-(4-methoxybenzyl)amine 239d (0.44 
g, 1 mmol) in acetonitrile (20 mL) at room temperature whilst stirring, and the resulting mixture was 
heated at reflux for 3 h. Afterward, the reaction mixture was poured into water (50 mL) and extracted 
with Et2O (3 x 50 mL). Drying (MgSO4), filtration of the drying agent and evaporation of the solvent 
afforded N-benzyl-N-(2-chloro-3-phenoxypropyl)-N-(4-methoxybenzyl) amine 240d, which was purified 
by column chromatography on silica gel (hexane/ethyl acetate 1/1) to obtain an analytically pure 
sample (0.33 g, 84%). 
 
N-Benzyl-N-(2-chlorobenzyl)-N-(2-chloro-3-phenoxypropyl)amine 240a 
 
Colourless oil, Rf = 0.78 (hexane/ethyl acetate 1/1), Yield 82%. 
1
H NMR (300 MHz, CDCl3) δ 2.87 and 
3.06 (2H, 2 x d x d, J = 13.8, 7.2, 5.5 Hz, N(HCH)CH), 3.61–3.84 (4H, m, 2 x 
NCH2Ar), 3.90–3.96 (1H, m, ClCH), 4.10–4.18 (2H, m, (HCH)O), 6.76–6.78, 
6.92–6.97, 7.13–7.39 and 7.51–7.54 (14H, 4 x m, CHarom). 
13
C NMR (75 
MHz, CDCl3) δ 56.5 (CHCl), 57.0 (NCH2), 57.5 (NCH2), 59.6 (NCH2), 69.9 
(CH2O), 114.6, 121.1, 126.7, 127.3, 128.3, 128.4, 129.1, 129.4, 129.6 and 
131.0 (14 x CHarom), 134.3, 136.4 and 138.5 (3 x Carom,quat), 158.3 (CaromO). 
IR (neat): νmax = 2923, 2849, 1599, 1495, 1453, 1241, 1037, 749, 690 cm
–1
. 
MS (70 eV): m/z (%) = 400/2/4 (M
+ 
+ 1, 100), 364/6 (75). C23H23Cl2NO (400.35): calcd. C 69.00, H 
5.79, N 3.50; found C 69.17, H 5.97, N 3.72. 
 
 
 
N-Benzyl-N-(4-chlorobenzyl)-N-(2-chloro-3-phenoxypropyl)amine 240b 
 
Colourless oil, Rf = 0.79 (hexane/ethyl acetate 1/1), Yield 79%. 
1
H NMR (300 MHz, CDCl3) δ 2.81 and 
3.02 (2H, 2 x d x d, J = 13.8, 7.2, 6.0 Hz, N(HCH)CH), 3.55 and 3.68 (2H, 2 x d, J = 13.5 Hz, 
N(HCH)Ar), 3.59 and 3.64 (2H, 2 x d, J = 13.8 Hz, N(HCH)Ar), 3.96–4.01 
(1H, m, ClCH), 4.05–4.18 (2H, m, CH2O), 6.76–6.79, 6.93–6.98 and 
7.21–7.38 (14H, 3 x m, CHarom). 
13
C NMR (75 MHz, CDCl3) δ 57.1 
(CHCl), 57.4 (NCH2), 58.7 (NCH2), 59.4 (NCH2), 70.0 (CH2O), 114.7, 
121.3, 127.5, 128.5, 128.6, 129.1, 129.6 and 130.4 (14 x CHarom), 133.0, 
137.5 and 138.7 (3 x Carom,quat), 158.3 (CaromO). IR (neat): νmax = 2924, 
2828, 1599, 1588, 1491, 1453, 1241, 1088, 801, 751, 691 cm
–1
. MS (70 
eV): m/z (%) = 400/2/4 (M
+ 
+ 1, 100), 364/6 (60). C23H23Cl2NO (400.35): calcd. C 69.00, H 5.79, N 
3.50; found C 68.92, H 5.94, N 3.55. 
 
 
 
N-Benzyl-N-(4-chlorobenzyl)-N-[2-chloro-3-(4-chlorophenoxy)propyl]amine 240c 
 
Colourless oil, Rf = 0.80 (hexane/ethyl acetate 1/1), Yield 83%. 
1
H NMR (300 MHz, CDCl3) δ 2.80 and 
3.00 (2H, 2 x d x d, J = 13.6, 7.4, 5.5 Hz, N(HCH)CH), 3.51–3.71 (4H, 
m, 2 x NCH2Ar), 3.91–3.96 (1H, m, ClCH), 4.02–4.13 (2H, m, CH2O), 
6.65–6.68 and 7.18–7.31 (13H, 2 x m, CHarom). 
13
C NMR (75 MHz, 
CDCl3) δ 56.7 (CHCl), 57.1 (NCH2), 58.7 (NCH2), 59.4 (NCH2), 70.0 
(CH2O), 115.8, 127.4, 128.4, 128.5, 128.9, 129.3 and 130.2 (13 x 
CHarom), 126.1, 132.9, 137.3 and 138.5 (4 x Carom,quat), 156.8 (CaromO). 
IR (neat): νmax = 2925, 2828, 2359, 1596, 1490, 1453, 1285, 1241, 
O
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1090, 821, 801, 740, 698 cm
–1
. MS (70 eV): m/z (%) = 434/36/38/40 (M
+ 
+ 1, 100), 398/400 (90). 
C23H22Cl3NO (434.79): calcd. C 63.54, H 5.10, N 3.22; found C 63.78, H 5.41, N 3.38. 
 
 
N-Benzyl-N-(2-chloro-3-phenoxypropyl)-N-(4-methoxybenzyl)amine 240d 
 
Colourless oil, Rf = 0.75 (hexane/ethyl acetate 1/1), Yield 84%. 
1
H NMR (300 MHz, CDCl3) δ 2.80 and 
3.00 (2H, 2 x d x d, J = 13.6, 8.0, 5.5 Hz, N(HCH)CH), 3.48–3.75 (4H, m, 2 x NCH2Ar), 3.77 (3H, s, 
OCH3), 3.86–3.95 (1H, m, ClCH), 4.09–4.17 (2H, m, CH2O), 6.78–6.84, 
6.92–6.97 and 7.21–7.32 (14H, 3 x m, CHarom). 
13
C NMR (75 MHz, 
CDCl3) δ 55.2 (CHCl), 57.2 (NCH2), 58.7 (NCH2), 59.3 (NCH2), 70.0 
(CH2O), 113.7, 114.7, 121.1, 127.2, 128.3, 129.0, 129.4 and 130.1 (14 
x CHarom), 130.8 and 138.9 (2 x Carom,quat), 158.3 and 158.8 (2 x 
CaromO). IR (neat): νmax = 2932, 2833, 2342, 1599, 1510, 1495, 1454, 
1241, 1172, 1035, 813, 752, 741, 691 cm
–1
. MS (70 eV): m/z (%) = 360 (100), 396/8 (M
+ 
+ 1, 49). 
C24H26ClNO2 (395.93): calcd. C 72.81, H 6.62, N 3.54; found C 72.94, H 6.82, N 3.40. 
 
 
5.11 Synthesis of N-(2-iodo-3-aryloxypropyl)amines 241 
 
As a representative example the synthesis of N-benzyl-N-(2-chlorobenzyl)-N-(2-iodo-3-
phenoxypropyl)amine 241a is described here. Sodium iodide (3.00 g, 20 equiv) was added to a 
solution of N-benzyl-N-(2-chlorobenzyl)-N-(2-bromo-3-phenoxypropyl)amine 239a (0.44 g, 1 mmol) in 
acetonitrile (20 mL) at room temperature whilst stirring, and the resulting mixture was heated at reflux 
for 3 h. Afterward, the reaction mixture was poured into water (50 mL) and extracted with Et2O (3 x 50 
mL). Drying (MgSO4), filtration of the drying agent and evaporation of the solvent afforded N-benzyl-N-
(2-chlorobenzyl)-N-(2-iodo-3-phenoxypropyl)amine 241a, which was purified by column 
chromatography on silica gel (hexane/ethyl acetate 1/1) to obtain an analytically pure sample (0.40 g, 
89%). 
 
 
N-Benzyl-N-(2-chlorobenzyl)-N-(2-iodo-3-phenoxypropyl)amine 241a 
 
Colourless oil, Rf = 0.76 (hexane/ethyl acetate 1/1), Yield 89%. 
1
H NMR (300 MHz, CDCl3) δ 3.01 and 
3.07 (2H, 2 x d x d, J = 14.0, 8.5, 6.9 Hz, N(HCH)CH), 3.63 and 3.70 (2H, 2 x d, J = 13.2 Hz, 
N(HCH)Ar), 3.74 and 3.81 (2H, 2 x d, J = 14.1 Hz, N(HCH)Ar), 4.05–4.18 
(2H, m, CH2O), 4.22–4.30 (1H, m, ICH), 6.76–6.79, 6.93–6.97, 7.12–7.41 
and 7.54–7.57 (14H, 4 x m, CHarom). 
13
C NMR (75 MHz, CDCl3) δ 28.7 (CHI), 
56.1 (NCH2), 59.4 (NCH2), 59.6 (NCH2), 71.0 (CH2O), 114.8, 121.1, 126.7, 
127.3, 128.3, 128.4, 129.2, 129.4, 129.5 and 131.2 (14 x CHarom), 134.2, 
136.3 and 138.4 (3 x Carom,quat), 158.1 (CaromO). IR (neat): νmax = 2921, 2849, 
1598, 1494, 1453, 1239, 1029, 749, 690 cm
–1
. MS (70 eV): m/z (%) = 364/6 
(100), 492/4 (M
+ 
+ 1, 5). C23H23ClINO (491.80): calcd. C 56.17, H 4.71, N 2.85; found C 55.96, H 4.83, 
N 3.01. 
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N-Benzyl-N-(4-chlorobenzyl)-N-(2-iodo-3-phenoxypropyl)amine 241b 
 
Colourless oil, Rf = 0.77 (hexane/ethyl acetate 1/1), Yield 88%. 
1
H NMR (300 MHz, CDCl3) δ 2.93 and 
3.00 (2H, 2 x d x d, J = 13.8, 7.7, 7.2 Hz, N(HCH)CH), 3.54 and 3.63 (2H, 
2 x d, J = 13.8 Hz, N(HCH)Ar), 3.59 (2H, d, J = 7.7 Hz, N(HCH)Ar), 4.08–
4.20 (2H, m, CH2O), 4.22–4.32 (1H, m, ICH), 6.77–6.81, 6.94–6.99 and 
7.21–7.42 (14H, 3 x m, CHarom). 
13
C NMR (75 MHz, CDCl3) δ 28.7 (CHI), 
58.3 (NCH2), 59.0 (NCH2), 59.3 (NCH2), 71.1 (CH2O), 114.8, 121.3, 
127.5, 128.5, 128.6, 129.1, 129.6 and 130.4 (14 x CHarom), 133.0, 137.4 
and 138.5 (3 x Carom,quat), 158.1 (CaromO). IR (neat): νmax = 2924, 2803, 
1598, 1587, 1491, 1453, 1239, 1088, 800, 751, 690 cm
–1
. MS (70 eV): m/z (%) = 364/6 (100), 492/4 
(M
+ 
+ 1, 8). C23H23ClINO (491.80): calcd. C 56.17, H 4.71, N 2.85; found C 56.19, H 4.88, N 3.04. 
 
 
 
N-Benzyl-N-(4-chlorobenzyl)-N-[3-(4-chlorophenoxy)-2-iodopropyl]amine 241c 
 
Colourless oil, Rf = 0.77 (hexane/ethyl acetate 1/1), Yield 82 %. 
1
H NMR (300 MHz, CDCl3) δ 2.92 and 
2.99 (2H, 2 x d x d, J = 14.0, 8.0, 6.9 Hz, N(HCH)CH), 3.52 and 3.64 
(2H, 2 x d, J = 13.5 Hz, N(HCH)Ar), 3.58 (2H, s, PhCH2N), 4.03–4.14 
(2H, m, CH2O), 4.18–4.26 (1H, m, ICH), 6.67–6.70 and 7.18–7.38 
(13H, 2 x m, CHarom). 
13
C NMR (75 MHz, CDCl3) δ 28.0 (CHI), 58.3 
(NCH2), 59.0 (NCH2), 59.1 (NCH2), 71.1 (CH2O), 115.9, 127.4, 128.4, 
128.5, 129.0, 129.3 and 130.3 (13 x CHarom), 126.1, 132.9, 137.2 and 
138.4 (4 x Carom,quat), 156.6 (CaromO). IR (neat): νmax = 2924, 2804, 
2361, 1596, 1489, 1452, 1238, 1090, 821, 800, 737, 698 cm
–1
. MS (70 eV): m/z (%) = no [M]+, 
398/400/402 (M
+
 – I, 100). C23H22Cl2INO (526.24): calcd. C 52.49, H 4.21, N 2.66; found C 52.36, H 
4.18, N 2.53.  
 
 
 
N-Benzyl-N-(2-iodo-3-phenoxypropyl)-N-(4-methoxybenzyl)amine 241d 
 
Colourless oil, Rf = 0.77 (hexane/ethyl acetate 1/1), Yield 79%. 
1
H NMR (300 MHz, CDCl3) δ 2.95 and 
3.01 (2H, 2 x d x d, J = 13.9, 8.5, 6.6 Hz, N(HCH)CH), 3.48–3.72 (4H, m, 2 x NCH2Ar), 3.76 (3H, s, 
OCH3), 4.01–4.29 (3H, m, ICH and (HCH)O), 6.78–6.83, 6.92–6.97 and 
7.22–7.35 (14H, 3 x m, CHarom). 
13
C NMR (75 MHz, CDCl3) δ 29.1 (CHI), 
55.2 (OCH3), 58.3 (NCH2), 58.9 (NCH2), 59.3 (NCH2), 71.1 (CH2O), 
113.7, 114.7, 121.1, 127.2, 128.3, 129.0, 129.4 and 130.2 (14 x CHarom), 
130.7 and 138.8 (2 x Carom,quat), 158.2 and 158.8 (2 x CaromO). IR (neat): 
νmax = 2928, 2833, 1598, 1509, 1495, 1240, 1171, 1033, 812, 752, 734, 
691 cm
–1
. MS (70 eV): m/z (%) = 360 (100), 488 (M
+ 
+ 1, 10). 
C24H26INO2 (487.38): calcd. C 59.14, H 5.38, N 2.87; found C 59.30, H 5.62, N 3.00. 
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5.12 Synthesis of 2-amino-3-aryloxy-1-fluoropropanes 242 and N-(2-fluoro-3-
aryloxypropyl)amines 243  
 
As a representative example the synthesis of 2-[N-benzyl-N-(2-chlorobenzyl)amino]-1-fluoro-3-
phenoxypropane 242a and N-benzyl-N-(2-chlorobenzyl)-N-(2-fluoro-3-phenoxypropyl)amine 243a is 
described here. TBAF (2.61 g, 2 equiv) was added to a solution of N-benzyl-N-(2-chlorobenzyl)-N-(2-
bromo-3-phenoxypropyl)amine 239a (2.22 g, 5 mmol) in acetonitrile (30 mL) at room temperature 
whilst stirring, and the resulting mixture was heated at reflux for 15 h. Extraction with Et2O (3 x 50 mL), 
drying (MgSO4), filtration of the drying agent and evaporation of the solvent afforded a mixture of 2-[N-
benzyl-N-(2-chlorobenzyl)amino]-1-fluoro-3-phenoxypropane 242a and N-benzyl-N-(2-chlorobenzyl)-
N-(2-fluoro-3-phenoxypropyl)amine 243a in a ratio of 5:1. The two isomers were separated by column 
chromatography (hexane/ethyl acetate 97:3) to furnish compounds 242a (1.04 g, 54%) and 243a (0.19 
g, 10%) as analytically pure samples. 
 
 
2-[N-Benzyl-N-(2-chlorobenzyl)amino]-1-fluoro-3-phenoxypropane 242a 
 
Colourless oil, Rf = 0.17 (hexane/ethyl acetate 97/3), Yield 54%. 
1
H NMR (300 MHz, CDCl3) δ 3.31–
3.44 (1H, m, NCH), 3.88 and 4.01 (4H, 2 x s, 2 x NCH2Ar), 4.20 (2H, d, J = 6.1 
Hz, (HCH)O), 4.77 (2H, d x d, J = 47.4, 5.5 Hz, (HCH)F), 6.86–6.89, 6.91–
6.97, 7.12–7.38 and 7.61–7.63 (14H, 4 x m, CHarom). 
13
C NMR (75 MHz, 
CDCl3) δ 52.2 (NCH2Ar), 55.5 (NCH2Ar), 57.2 (d, J = 18.4 Hz, CHN), 65.3 (d, J 
= 5.8 Hz, CH2O), 82.4 (d, J = 170.7 Hz, CHF), 114.4, 121.0, 126.8, 127.1, 
128.1, 128.3, 128.7, 129.4, 129.5 and 130.5 (14 x CHarom), 134.0, 137.1 and 
139.6 (3 x Carom,quat), 158.5 (CaromO). 
19
F NMR (CCl3F): δ -227.32 (t x d, J = 
48.0, 23.7 Hz, CH2F). IR (neat): νmax = 3062, 3029, 2954, 1599, 1495, 1470, 1241, 1037, 751, 734, 
691 cm
–1
. MS (70 eV): m/z (%) = 384/6 (M
+ 
+ 1, 100). C23H23ClFNO (383.89): calcd. C 71.96, H 6.04, 
N 3.65; found C 71.82, H 6.19, N 3.56. 
 
 
N-Benzyl-N-(2-chlorobenzyl)-N-(2-fluoro-3-phenoxypropyl)amine 243a 
 
Colourless oil, Rf = 0.10 (hexane/ethyl acetate 97/3), Yield 10%. 
1
H NMR (300 MHz, CDCl3) δ 2.84–
2.93 (2H, m, N(HCH)CHF), 3.71 (2H, s, NCH2Ar), 3.82 (2H, s, NCH2Ar), 3.92–4.06 (2H, m, (HCH)O), 
4.80–4.87 and 4.96–5.03 (1H, 2 x m, CHF), 6.78–6.81, 6.92–6.97, 7.15–7.40 
and 7.52–7.55 (14H, 4 x m, CHarom). 
13
C NMR (75 MHz, CDCl3) δ 54.0 (d, J = 
21.9 Hz, NCH2CHF), 56.5 and 59.6 (2 x NCH2Ar), 68.3 (d, J = 23.1 Hz, 
CH2O), 90.9 (d, J = 174.2 Hz, CHF), 114.6, 121.2, 126.8, 127.4, 128.5, 
129.1, 129.5, 129.6, 129.7 and 131.0 (14 x CHarom), 134.3, 136.7 and 138.9 
(3 x Carom,quat), 158.5 (CaromO). 
19
F NMR (CCl3F): δ -188.68 to -188.2 (m, 
CHF). IR (neat): νmax = 2923, 2850, 1598, 1588, 1494, 1443, 1242, 1049, 
1037, 750, 690 cm
–1
. MS (70 eV): m/z (%) = 384/6 (M
+ 
+ 1, 82). 
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2-[N-Benzyl-N-(4-chlorobenzyl)amino]-1-fluoro-3-phenoxypropane 242b 
 
Colourless oil, Rf = 0.35 (hexane/ethyl acetate 96/4), Yield 42%. 
1
H NMR (300 MHz, CDCl3) δ 3.28–
3.43 (1H, m, NCH), 3.82 (2H, s, NCH2Ar), 3.83 (2H, s, NCH2Ar), 4.16 (2H, d, J = 6.1 Hz, (HCH)O), 
4.72 (2H, d x d, J = 47.4, 5.0 Hz, (HCH)F), 6.85–6.88, 6.94–6.99 and 7.22–
7.38 (14H, 3 x m, CHarom). 
13
C NMR (75 MHz, CDCl3) δ 54.7 (NCH2Ar), 55.3 
(NCH2Ar), 56.4 (d, J = 18.5 Hz, CHN), 65.4 (d, J = 6.9 Hz, CH2O), 82.5 (d, J 
= 172.0 Hz, CHF), 114.4, 121.0, 127.2, 128.4, 128.5, 128.6, 129.5 and 
130.0, (14 x CHarom), 132.7, 138.4 and 139.6 (3 x Carom,quat), 158.4 (CaromO). 
19
F NMR (CCl3F): δ -227.30 (t x d, J = 47.3, 22.3 Hz, CH2F). IR (neat): νmax 
= 2928, 2833, 1599, 1588, 1491, 1470, 1241, 1088, 1014, 907, 753, 730, 
691 cm
–1
. MS (70 eV): m/z (%) = 364/6 (100), 384/6 (M
+ 
+ 1, 77). C23H23ClFNO (383.89): calcd. C 
71.96, H 6.04, N 3.65; found C 71.89, H 6.18, N 3.67. 
 
 
 
N-Benzyl-N-(4-chlorobenzyl)-N-(2-fluoro-3-phenoxypropyl)amine 243b 
 
Colourless oil, Rf = 0.28 (hexane/ethyl acetate 96/4), Yield 8%. 
1
H NMR (300 MHz, CDCl3) δ 2.75–
2.95 (2H, m, N(HCH)CHF), 3.65 (2H, s, NCH2Ar), 3.67 (2H, s, NCH2Ar), 3.91–4.06 (2H, m, CH2O), 
4.80–4.86 and 4.93–5.02 (1H, 2 x m, CHF), 6.79–6.82, 6.94–6.99 and 
7.22–7.38 (14H, 3 x m, CHarom). 
13
C NMR (75 MHz, ref = CDCl3) δ 53.7 
(d, J = 21.9 Hz, NCH2CHF), 58.7 (NCH2Ar), 59.4 (NCH2Ar), 68.2 (d, J = 
23.1 Hz, CH2O), 90.9 (d, J = 174.3 Hz, CHF), 114.6, 121.3, 127.4, 128.5, 
128.6, 129.0, 129.6 and 130.3 (14 x CHarom), 132.9, 137.7 and 138.9 (3 x 
Carom,quat), 158.4 (CaromO). 
19
F NMR (CCl3F): δ -188.58 to -188.18 (m, 
CHF). IR (neat): νmax = 2924, 2829, 1598, 1588, 1490, 1453, 1242, 1088, 1014, 801, 752, 691 cm
–1
. 
MS (70 eV): m/z (%) = 364/6 (100), 384/6 (M
+ 
+ 1, 55). 
 
 
 
2-[N-Benzyl-N-(4-chlorobenzyl)amino]-3-(4-chlorophenoxy)-1-fluoropropane 242c 
 
Colourless oil, Rf = 0.33 (hexane/ethyl acetate 96/4), Yield 60%. 
1
H NMR (300 MHz, CDCl3) δ 3.25–
3.40 (1H, m, NCH), 3.81 (2H, s, NCH2Ar), 3.82 (2H, s, NCH2Ar), 4.11 (2H, d, J = 6.0 Hz, (HCH)O), 
4.71 (2H, d x d, J = 47.3, 4.9 Hz, (HCH)F), 6.75–6.80 and 7.19–7.37 
(13H, 2 x m, CHarom). 
13
C NMR (75 MHz, CDCl3) δ 54.7 (NCH2Ar), 55.3 
(NCH2Ar), 56.4 (d, J = 18.5 Hz, CHN), 66.0 (d, J = 7.0 Hz, CH2O), 82.3 
(d, J = 171.9 Hz, CHF), 115.7, 127.2, 128.4, 128.5, 128.6, 129.4 and 
129.9, (13 x CHarom), 125.9, 132.7, 138.3 and 139.4 (4 x Carom,quat), 157.0 
(CaromO). 
19
F NMR (CCl3F): δ -227.31 (t x d, J = 47.3, 22.3 Hz, CH2F). IR 
(neat): νmax = 2930, 2831, 1596, 1588, 1490, 1470, 1241, 1090, 1014, 
1006, 821, 737, 698 cm
–1
. MS (70 eV): m/z (%) = 418/20/22 (M
+ 
+ 1, 100). C23H22Cl2FNO (418.34): 
calcd. C 66.04, H 5.30, N 3.35; found C 66.11, H 5.54, N 3.57. 
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N-Benzyl-N-(4-chlorobenzyl)-N-[3-(4-chlorophenoxy)-2-fluoropropyl]amine 243c 
 
Colourless oil, Rf = 0.27 (hexane/ethyl acetate 96/4), Yield 10%. 
1
H NMR (300 MHz, CDCl3) δ 2.74–
2.96 (2H, m, N(HCH)CHF), 3.64 (2H, s, NCH2Ar), 3.66 (2H, s, 
NCH2Ar), 3.90–4.05 (2H, m, CH2O), 4.75–4.82 and 4.91–5.03 (1H, 2 x 
m, CHF), 6.69–6.72 and 7.20–7.37 (13H, 2 x m, CHarom). 
13
C NMR (75 
MHz, CDCl3) δ 53.4 (d, J = 21.9 Hz, NCH2CHF), 58.7 (NCH2Ar), 59.4 
(NCH2Ar), 68.5 (d, J = 24.2 Hz, CH2O), 90.7 (d, J = 175.4 Hz, CHF), 
115.7, 128.4, 128.5, 128.9, 129.3, 129.6 and 130.2, (13 x CHarom), 
127.3, 132.9, 137.5 and 138.7 (4 x Carom,quat), 156.9 (CaromO). 
19
F NMR 
(CCl3F): δ –188.96 to –188.73 (m, CHF). IR (neat): νmax = 2925, 2828, 1594, 1488, 1452, 1240, 1090, 
1014, 907, 822, 732, 698 cm
–1
. MS (70 eV): m/z (%) = 418/20/22 (M
+ 
+ 1, 100). 
 
 
 
2-[N-Benzyl-N-(4-methoxybenzyl)amino]-1-fluoro-3-phenoxypropane 242d 
 
Colourless oil, Rf = 0.13 (hexane/ethyl acetate 97/3), Yield 61%. 
1
H NMR (300 MHz, CDCl3) δ 3.29–
3.44 (1H, m, NCH), 3.78 (5H, s, NCH2Ar and OCH3), 3.84 (2H, s, NCH2Ar), 4.15 (2H, d, J = 6.6 Hz, 
(HCH)O), 4.71 (2H, d x d, J = 47.6, 5.2 Hz, (HCH)F), 6.83–6.87, 6.92–
6.97 and 7.20–7.39 (14H, 3 x m, CHarom). 
13
C NMR (75 MHz, CDCl3) δ 
54.7 (NCH2Ar), 55.1 (NCH2Ar), 55.2 (OCH3), 56.2 (d, J = 18.5 Hz, CHN), 
65.5 (d, J = 7.0 Hz, CH2O), 82.6 (d, J = 171.9 Hz, CHF), 113.7, 114.4, 
120.9, 127.0, 128.3, 128.6, 129.5 and 129.8 (14 x CHarom), 131.8 and 
140.0 (2 x Carom,quat), 158.5 and 158.7 (2 x CaromO). 
19
F NMR (CCl3F): δ –
227.27 (t x d, J = 47.4, 23.7 Hz, CH2F). IR (neat): νmax = 2917, 2849, 1599, 1510, 1495, 1454, 1241, 
1171, 1035, 831, 819, 753, 737, 691 cm
–1
. MS (70 eV): m/z (%) = 380 (M
+ 
+ 1, 100). C24H26FNO2 
(379.47): calcd. C 75.96, H 6.91, N 3.69; found C 75.77, H 7.03, N 3.51. 
 
 
 
N-Benzyl-N-(2-fluoro-3-phenoxypropyl)-N-(4-methoxybenzyl)amine 243d 
 
Colourless oil, Rf = 0.09 (hexane/ethyl acetate 97/3), Yield 14 %. 
1
H NMR (300 MHz, CDCl3) δ 2.73–
2.94 (2H, m, N(HCH)CHF), 3.61 (2H, s, NCH2Ar), 3.67 (2H, s, NCH2Ar), 3.78 (3H, s, OCH3), 3.94–
4.04 (2H, m, (HCH)O), 4.77–4.83 and 4.93–5.00 (1H, 2 x m, CHF), 
6.78–6.85, 6.93–6.98 and 7.22–7.36 (14H, 3 x m, CHarom). 
13
C NMR 
(75 MHz, CDCl3) δ 53.6 (d, J = 23.1 Hz, NCH2CHF), 55.3 (OCH3), 
58.8 (NCH2Ar), 59.4 (NCH2Ar), 68.5 (d, J = 23.1 Hz, CH2O), 91.0 (d, J 
= 174.2 Hz, CHF), 113.8, 114.6, 121.1, 127.2, 128.4, 129.0, 129.5 and 
130.2 (14 x CHarom), 131.1 and 139.3 (2 x Carom,quat), 158.5 and 158.8 
(2 x CaromO). 
19
F NMR (CCl3F): δ –188.52 to –188.05 (m, CHF). IR 
(neat): νmax = 2951, 2834, 1599, 1510, 1495, 1453, 1243, 1172, 1035, 812, 752, 742, 691 cm
–1
. MS 
(70 eV): m/z (%) = 380 (M
+ 
+ 1, 100). 
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5.13 Synthesis of 2-bromomethyl-2-methylaziridines 260  
 
As a representative example, the synthesis of 2-bromomethyl-1-(4-methoxybenzyl)-2-methylaziridine 
260d is described here. N-(2,3-Dibromo-2-methylpropylidene)-4-methoxybenzylamine 266d
131
 (3.49 g, 
10 mmol) was dissolved in methanol (30 mL), after which NaBH4 (0.76 g, 2 molar equiv) was added in 
small portions at 0 °C and the mixture was stirred for 36 hours at room temperature. The reaction 
mixture was poured into water (20 mL) and extracted with CH2Cl2 (3 x 20 mL). The combined organic 
extracts were washed with H2O (2 x 15 mL) and brine (20 mL). Drying (MgSO4), filtration of the drying 
agent and evaporation of the solvent afforded 2-bromomethyl-1-(4-methoxybenzyl)-2-methylaziridine 
260d (2.36 g, 87%), which was purified by filtration through silica gel (hexane/ethyl acetate 7/1) in 
order to obtain an analytically pure sample. 
 
 
2-Bromomethyl-1-(4-methylbenzyl)-2-methylaziridine 260b 
 
Yellow oil, Rf = 0.16 (hexane/ethyl acetate 9/1), Yield 82%. 
1
H NMR (300 MHz, CDCl3) δ 1.43 (3H, s, 
CCH3), 1.50 (1H, s, (HCH)CN), 1.98 (1H, s, (HCH)CN), 2.33 (3H, s, CH3Ar), 3.28 and 3.36 (2H, 2 x d, 
J = 9.9 Hz, (HCH)Br), 3.50 and 3.71 (2H, 2 x d, J = 13.7 Hz, N(HCH)Ar), 7.13-7.15 
and 7.24-7.26 (4H, 2 x m, CHarom). 
13
C NMR (75 MHz, CDCl3) δ 13.6 (CCH3), 21.1 
(CH3Ar), 40.2 (CCH3), 41.7 (CH2CN), 44.1 (CH2Br), 57.1 (NCH2Ar), 127.7 and 
129.1 (4 x CHarom), 136.5 (2 x Carom,quat). IR (neat): νmax = 3024, 2962, 2922, 2851, 
1671, 1515, 1451, 1384, 1348, 1216, 1167, 1046, 798, 647 cm
-1
. MS m/z (%) 
254/6 (M
+ 
+ 1, 100).  
 
2-Bromomethyl-1-(2-chlorobenzyl)-2-methylaziridine 260c 
 
Yellow oil, Rf = 0.24 (hexane/ethyl acetate 9/1), Yield 85%. 
1
H NMR (300 MHz, CDCl3) δ 1.44 (3H, s, 
CCH3), 1.58 (1H, s, (HCH)CN), 2.07 (1H, s, (HCH)CN), 3.35 and 3.40 (2H, 2 x d, J = 
10.2 Hz, (HCH)Br), 3.63 and 3.85 (2H, 2 x d, J = 15.7 Hz, N(HCH)Ar), 7.20-7.36 and 
7.66-7.69 (4H, 2 x m, CHarom). 
13
C NMR (75 MHz, CDCl3) δ 13.6 (CCH3), 40.2 (CCH3), 
42.0 (CH2CN), 43.9 (CH2Br), 54.3 (NCH2Ar), 126.9, 128.0, 129.0 and 129.1 (4 x 
CHarom), 132.8 (NCH2C), 137.3 (CCl). IR (neat) νmax = 3035, 2964, 1470, 1443, 1386, 
1348, 1218, 1171, 1037, 748, 644 cm
-1
. MS m/z (%) 274/6/8 (M
+ 
+ 1, 100).  
 
2-Bromomethyl-1-(4-methoxybenzyl)-2-methylaziridine 260d 
 
Yellow oil, Rf = 0.10 (hexane/ethyl acetate 7/1), Yield 87%; 
1
H NMR (300 MHz, CDCl3) δ 1.43 (3H, s, 
CCH3), 1.50 (1H, s, (HCH)CN), 1.97 (1H, s, (HCH)CN), 3.29 and 3.34 (2H, 2 x 
d, J = 10.2 Hz, (HCH)Br), 3.47 and 3.69 (2H, 2 x d, J = 13.8 Hz, N(HCH)Ar), 
3.80 (3H, s, OCH3), 6.86-6.89 and 7.27-7.29 (4H, 2 x m, CHarom). 
13
C NMR (75 
MHz, CDCl3) δ 13.6 (CCH3), 40.2 (CCH3), 41.7 (CH2CN), 44.2 (CH2Br), 55.3 
(OCH3), 56.8 (NCH2Ar), 113.8 and 129.0 (4 x CHarom), 131.7 (Carom,quat), 158.6 
(CaromO); IR (neat) νmax = 3030, 2959, 2933, 2834, 1612, 1511, 1463, 1244, 1172, 1034, 819, 644 cm
-1
. 
MS m/z (%) 270/2 (M
+ 
+ 1, 100).  
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5.14 Synthesis of optically active 2-bromomethyl-2-methylaziridines 270 and 
271 
 
N-(2,3-Dibromo-2-methylpropylidene)-1(S)-phenylethylamine 269 (3.33 g, 10 mmol) was dissolved in 
methanol (30 mL), after which NaBH4 (0.76 g, 2 molar equiv) was added in small portions at 0 °C and 
the mixture was stirred for 36 hours at room temperature. The reaction mixture was poured into water 
(20 mL) and extracted with CH2Cl2 (3 x 20 mL). The combined organic extracts were washed with H2O 
(2 x 15 mL) and brine (20 mL). Drying (MgSO4), filtration of the drying agent and evaporation of the 
solvent afforded a mixture of 2(R)-2-bromomethyl-1-[1(S)-phenylethyl]-2-methylaziridine and 2(S)-2-
bromomethyl-1-[1(S)-phenylethyl]-2-methylaziridine 270 and 271 (2.42 g, 95%), which were separated 
by silica gel column chromatography (petroleum ether/ethyl acetate 9:1) in order to obtain analytically 
pure samples.  
 
 
2(R)-2-Bromomethyl-1-[1(S)-phenylethyl]-2-methylaziridine 270 and 2(S)-2-bromomethyl-1-[1(S)-
phenylethyl]-2-methylaziridine 271 
 
N
Br
S
S
N
Br
S
R
and
 
 
Light yellow oil, Rf = 0.28 (petroleum ether/ethyl acetate 9/1), Yield 45%. [α]D
28
 =  -48.4 (c = 0.05, 
CDCl3). 
1
H NMR (300 MHz, CDCl3) 1.38 (1H, s, (HCH)CN), 1.43 (3H, d, J = 6.6 Hz, CHCH3), 1.51 (3H, 
s, CH3Ar),  1.79 (1H, s, (HCH)CN), 3.10 (1H, q, J = 6.6 Hz, CHCH3),  3.25 and 3.46 (2H, 2 x d, J = 9.9 
Hz, (HCH)Br), 7.25-7.40 (5H, m, CHarom); 
13
C NMR (75 MHz, CDCl3) δ 13.4 (CCH3), 24.6 (CHCH3), 
40.6 (CH2CN), 41.1 (CCH3), 44.9 (CH2Br), 61.6 (NCH2Ar), 127.0 and 128.3 (5 x CHarom), 145.0 
(Carom,quat). IR (neat) νmax = 3027, 2969, 2927, 2866, 1449, 1348, 1222, 1172, 755, 699, 646 cm
-1
. MS 
m/z (%) 254/6 (M
+ 
+ 1, 100). Anal. Calcd for C12H16BrN: C, 56.71; H, 6.35; N, 5.51. Found: C, 56.35; 
H, 6.63; N, 5.44. 
 
 
Light yellow oil, Rf = 0.15 (petroleum ether/ethyl acetate 9/1), Yield 42%. [α]D
28
 =  -44.2 (c = 0.06, 
CDCl3); 
1
H NMR (300 MHz, CDCl3) 1.21 (3H, s, CCH3), 1.40 (3H, d, J = 6.6 Hz, CHCH3), 1.48 (1H, s, 
(HCH)CN), 2.00 (1H, s, (HCH)CN), 3.16 (1H, q, J = 6.6 Hz, CHCH3),  3.22 and 3.34 (2H, 2 x d, J = 9.9 
Hz, CH2Br), 7.23-7.39 (5H, m, CHarom); 
13
C NMR (75 MHz, CDCl3) δ 13.6 (CCH3), 24.7 (CHCH3), 40.3 
(CH2CN), 41.0 (CCH3), 43.6 (CH2Br), 62.8 (NCH2Ar), 126.5, 126.8 and 128.3 (5 x CHarom), 145.4 
(Carom,quat). IR (neat) νmax = 3028, 2967, 2926, 2866, 1450, 1349, 1217, 1173, 757, 699, 646 cm
-1
. MS 
m/z (%) 254/6 (M
+ 
+ 1, 100). Anal. Calcd for C12H16BrN: C, 56.71; H, 6.35; N, 5.51. Found: C, 56.62; 
H, 6.55; N, 5.46. 
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5.15 Synthesis of 3-methoxy-3-methylazetidines 258 from 2-bromomethyl-2-
methylaziridines 
As a representative example, the synthesis of 1-(2-chlorobenzyl)-3-methoxy-3-methylazetidine 258c is 
described here. 2-Bromomethyl-1-(2-chlorobenzyl)-2-methylaziridine 260c (2.76 g, 10 mmol) was 
dissolved in methanol (30 mL), after which NaBH4 (1.13 g, 3 molar equiv) was added in small portions 
at 0 °C and the mixture was heated for 48 hours under reflux. The reaction mixture was poured into 
water (20 mL) and extracted with CH2Cl2 (3 x 20 mL). The combined organic extracts were washed 
with H2O (2 x 15 mL) and brine (20 mL). Drying (MgSO4), filtration of the drying agent and evaporation 
of the solvent afforded 1-(2-chlorobenzyl)-3-methoxy-3-methylazetidine 258c (2.01 g, 89%), which 
was purified by filtration through silica gel (ether/hexane 10:1) in order to obtain an analytically pure 
sample. 
 
 
1-(2-Chlorobenzyl)-3-methoxy-3-methylazetidine 258c  
 
Yellow oil, Rf = 0.15 (ether/hexane 10/1); Yield 89%; 
1
H NMR (300 MHz, CDCl3) δ 1.51 (3H, s, CCH3), 
3.16 (2H, d, J = 8.3 Hz, 2 x (HCH)Cquat), 3.31 (2H, d, J = 8.3 Hz, 2 x (HCH)Cquat), 3.21 
(3H, s, C(CH3)OCH3), 3.79 (2H, s, NCH2Ar), 7.14-7.42 (4H, m, CHarom). 
13
C NMR (75 
MHz, ref = CDCl3) δ 21.8 (CCH3), 50.6 (C(CH3)OCH3), 60.2 (NCH2Ar), 65.0 
(CH2NCH2), 73.0 (C(CH3)OCH3), 126.8, 127.8, 129.3 and 129.4 (4 x CHarom), 133.5 
and 136.3 (2 x Carom,quat). IR (neat) νmax = 2968, 2930, 2827, 1469, 1443, 1371, 1359, 
1232, 1067, 1050, 1038, 748 cm
-1
. MS m/z (%) 226/8 (M
+ 
+ 1, 100).  
 
 
1-(4-Methoxybenzyl)-3-methoxy-3-methylazetidine 258d 
 
Yellow oil, Rf = 0.17 (ether/hexane 10/1), Yield 87%; 
1
H NMR (300 MHz, CDCl3) δ 1.47 (3H, s, CCH3), 
3.04 (2H, d, J = 7.7 Hz, 2 x (HCH)Cquat), 3.21 (2H, d, J = 7.7 Hz, 2 x (HCH)Cquat), 3.18 
(3H, s, C(CH3)OCH3), 3.60 (2H, s, NCH2Ar), 3.79 (3H, s, OCH3Ar), 6.83-6.86 and 7.19-
7.22 (4H, 2 x m, CHarom). 
13
C NMR (75 MHz, CDCl3) δ 21.6 (CCH3), 50.4 (C(CH3)OCH3), 
55.2 (OCH3Ar), 63.1 (NCH2Ar), 64.5 (CH2CquatCH2), 72.8 (C(CH3)OCH3), 113.7 and 129.6 
(4 x CHarom), 130.4 (Carom,quat), 158.7 (Carom,O). IR (neat) νmax = 2933, 2833, 1611, 1511, 
1463, 1241, 1173, 1065, 1034, 820 cm
-1
. MS m/z (%) 222 (M
+ 
+ 1, 100).  
 
 
 
5.16 Synthesis of 3-methoxy-3-methyl-1-[1(S)-phenylethyl]azetidine 272 
 
The mixture of 2(R)-2-bromomethyl-1-[1(S)-phenylethyl]-2-methylaziridine and 2(S)-2-bromomethyl-1-
[1(S)-phenylethyl]-2-methylaziridine 270  and 271 (2.55 g, 10 mmol) was dissolved in methanol (30 
mL), after which NaBH4 (1.13 g, 3 molar equiv) was added in small portions at 0 °C and the mixture 
was heated for 36 hours under reflux. Afterward, the reaction mixture was poured into water (20 mL) 
N
OMe
Cl
N
OMe
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and extracted with CH2Cl2 (3 x 20 mL). The combined organic extracts were washed with H2O (2 x 15 
mL) and brine (20 mL). Drying (MgSO4), filtration of the drying agent and evaporation of the solvent 
afforded 3-methoxy-3-methyl-1-[1(S)-phenylethyl]azetidine 272 (1.97 g, 96%), which was purified by 
filtration through silica gel (ether/hexane 10:1) in order to obtain an analytically pure sample. 
 
 
3-Methoxy-3-methyl-1-[1(S)-phenylethyl]azetidine 272 
 
Light yellow oil, Rf = 0.23 (ether/hexane 10:1), Yield 96%. [α]D
28
 = -51.6 (c = 0.05, CDCl3). 
1
H NMR 
(300 MHz, CDCl3) δ 1.22 (3H, d, J = 6.6 Hz, CHCH3), 1.46 (3H, s, CCH3), 2.93 and 
2.99 (2H, 2 x d, J = 7.5 Hz, CH2N), 3.05 and 3.27 (2H, 2 x d, J = 7.4 Hz, CH2N), 3.18 
(3H, s, OCH3), 3.33 (1H, q, J = 6.6 Hz, CHCH3), 7.20-7.33 (5H, m, CHarom). 
13
C NMR 
(75 MHz, ref = CDCl3) δ 21.6 (CHCH3), 21.8 (CCH3), 50.5 (OCH3), 63.7 and 63.8 
(CH2NCH2), 68.9 (CH(CH3)Ph), 71.9 (C(CH3)OCH3), 127.1, 127.3 and 128.4 (5 x CHarom), 143.8 
(Carom,quat). IR (neat) νmax = 2966, 2929, 2825, 1451, 1370, 1235, 1067, 762, 700 cm
-1
. MS m/z (%) 206 
(M
+ 
+ 1, 100). Anal. Calcd for C13H19NO: C, 76.06; H, 9.33; N, 6.82. Found: C, 76.15; H, 9.60; N, 6.69. 
 
 
 
5.17 Synthesis of 3-methoxy-3-methylazetidines 258 starting from imines 266 
 
As a representative example, the synthesis of N-cyclohexyl-3-methoxy-3-methylazetidine 258f is 
described here. N-Cyclohexyl-(2,3-dibromo-2-methyl-propylidene)amine 266f
131
 (3.08 g, 10 mmol) was 
dissolved in methanol (30 mL), after which NaBH4 (0.95 g, 2.5 molar equiv) was added in small 
portions at 0 °C and the mixture was heated for 24 hours under reflux. The reaction mixture was 
poured into water (20 mL) and extracted with CH2Cl2 (3 x 20 mL). The combined organic extracts were 
washed with H2O (2 x 15 mL) and brine (20 mL). Drying (MgSO4), filtration of the drying agent and 
evaporation of the solvent afforded N-cyclohexyl-3-methoxy-3-methylazetidine 258f (1.67 g, 91%). 
 
N-Isopropyl-3-methoxy-3-methylazetidine 258e 
 
Light yellow oil, Yield 89%. 
1
H NMR (300 MHz, CDCl3) δ 0.90 (6H, d, J = 6.0 Hz, (CH3)2CH), 1.42 (3H, 
s, CCH3), 2.28 (1H, quintet, J = 6.0 Hz, CH(CH3)2), 2.95 (2H, d, J = 8.0 Hz, 2 x 
(HCH)Cquat), 3.15 (2H, d, J = 8.0 Hz, 2 x (HCH)Cquat), 3.14 (3H, s, OCH3). 
13
C NMR (75 
MHz, ref = CDCl3) δ 19.8 ((CH3)2CH), 21.7 (CCH3), 50.4 (OCH3), 59.0 ((CH3)2CH), 63.5 
(CH2NCH2), 71.5 (CCH3). IR (neat) νmax = 2972, 2930, 2824, 1453, 1368, 1337, 1240, 
1070 cm
-1
. MS m/z (%) 144 (M
+ 
+ 1, 100).  
 
N-Cyclohexyl-3-methoxy-3-methylazetidine 258f  
 
Light yellow oil, Yield 91%. 
1
H NMR (300 MHz, CDCl3) δ 1.46 (3H, s, CCH3), 0.88-1.03, 
1.10-1.25, 1.59-1.62 and 1.71-1.82 and (10H, 2 x m, (CH2)5), 1.92-2.01 (1H, m, CH), 
3.01 (2H, d, J = 8.0 Hz, 2 x (HCH)Cquat), 3.19 (2H, d, J = 8.0 Hz, 2 x (HCH)Cquat), 3.19 
N
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(3H, s, OCH3). 
13
C NMR (75 MHz, ref = CDCl3) δ 21.7 (CCH3), 24.6 (2 x CH2), 25.2 (CH2), 29.9 (2 x 
CH2), 50.4 (OCH3), 63.0 (2 x CH2N), 67.4 (CH), 72.3 (CCH3). IR (neat) νmax = 2925, 2853, 2824, 1448, 
1370, 1248, 1227, 1069 cm
-1
. MS m/z (%) 184 (M
+ 
+ 1, 100).  
 
5.18 Synthesis of 2-ethylthiomethyl-2-methylaziridine 267 
 
To a solution of NaOMe in methanol (2M, 2.22 mL, 4,4 mmol) ethanethiol (0.23 g, 1 equiv) was added 
and the resulting mixture was stirred for 40 min at room temperature. After this time 1 equiv of 2-
bromomethyl-1-(4-methoxybenzyl)-2-methylaziridine 260d (1.00 g, 0.0037 mol) was added and the 
mixture was heated for 3.5 hours under reflux. The reaction mixture was poured into water (20 mL) 
and extracted with CH2Cl2 (3 x 20 mL). The combined organic extracts were washed with H2O (2 x 15 
mL) and brine (20 mL). Drying (MgSO4), filtration of the drying agent and evaporation of the solvent 
afforded 2-ethylthiomethyl-2-methylaziridine 267 (0.99 g, 89%). 
 
 
2-Ethylthiomethyl-2-methylaziridine 267 
 
Yellow oil, Yield 89%. 
1
H NMR (300 MHz, CDCl3) δ 1.22 (3H, t, J = 7.4 Hz, CH3CH2), 1.31 (1H, s, 
(HCH)CquatN), 1.40 (3H, s, CCH3), 1.87 (1H, s, (HCH)CquatN), 2.51-2.66 (4H, m, 2 x 
CH2S), 3.46 and 3.67 (2H, 2 x d, J = 13.2 Hz, N(HCH)Ar), 3.80 (3H, s, OCH3), 6.85-
6.89 and 7.26-7.29 (4H, 2 x m, CHarom). 
13
C NMR (75 MHz, ref = CDCl3) δ 14.3 
(CCH3), 15.0 (CH3CH2), 26.5 (SCH2CH3), 39.8 (CCH3), 40.2 (CH2CquatN), 42.9 
(CCH2S), 55.4 (OCH3), 56.6 (NCH2Ar), 113.9 and 129.1 (4 x CHarom), 132.3 
(Carom,quat), 158.6 (CaromO). IR (neat) νmax = 2960, 2927, 1612, 1511, 1454, 1244, 1172, 1035, 820 cm
-1
. 
MS m/z (%) 252 (M
+ 
+ 1, 100).  
 
 
 
5.19 Synthesis of N-tert-butoxycarbonyl-3-methoxy-3-methylazetidine 273 
 
3-Methoxy-3-methyl-1-[1(S)-phenylethyl]azetidine 272 (0.10 g, 0.49 mmol) was dissolved in EtOAc (15 
mL), after which 20 wt% Pd(OH)2 (25 mol%, 0.09 g) and Boc2O (0.11 g, 1 equiv) were added in small 
portions at 0 °C and the mixture was subjected to hydrogenation for 72 hours (4 bar, H2) at room 
temperature. The reaction mixture was first filtered through a small sintered funnel and thoroughly 
washed with ethyl acetate (30 mL). Subsequently, this filtrate was poured into water (20 mL) and 
extracted with Et2O (3 x 20 mL). The combined organic extracts were washed with H2O (2 x 15 mL) 
and brine (20 mL). Drying (MgSO4), filtration of the drying agent and evaporation of the solvent 
afforded N-butoxycarbonyl-3-methoxy-3-methylazetidine 273 (0.09 g, 95%), which was described 
based on the crude mixture. 
 
 
N
SEt
OMe
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N-tert-Butoxycarbonyl-3-methoxy-3-methylazetidine 273  
 
Light yellow oil, Yield 95%. 
1
H NMR (300 MHz, CDCl3) δ 1.44 (9H, s, (CH3)3C), 1.53 
(3H, s, CCH3), 3.23 (3H, s, OCH3), 3.66 (2H, d, J = 9.1 Hz, 2 x (HCH)Cquat), 3.91 (2H, 
d, J = 9.1 Hz, 2 x (HCH)Cquat); 
13
C NMR (75 MHz, CDCl3) δ 28.4 (C(CH3)3), 27.4 
(CCH3), 50.8 (OCH3), 60.5 (CH2NCH2), 72.6 (C(CH3)OCH3). IR (neat) νCO = 1703; 
νmax = 2977, 1809, 1395, 1370, 1114, 1065, cm
-1
. MS m/z (%) 202 (M
+ 
+ 1, 100). 
 
 
5.20 Synthesis of 3-bromo-3-methylazetidines 261 
 
As a representative example, the synthesis of 1-benzyl-3-bromo-3-methylazetidine 261a is described 
here. 1-Benzyl-2-bromomethyl-2-methylaziridine 260a (1.20 g, 5 mmol) was dissolved in acetonitrile 
(30 mL), and the mixture was heated at reflux temperature for 15 h. The reaction mixture was cooled 
to room temperature, poured into water (20 mL) and extracted with CH2Cl2 (3 × 20 mL). The combined 
organic extracts were washed with H2O (2 × 15 mL) and brine (20 mL). Drying (MgSO4), filtration of 
the drying agent and evaporation of the solvent in vacuo afforded 1-benzyl-3-bromo-3-methylazetidine 
261a (0.86 g, 72%), which was purified by silica gel column chromatography (petroleum ether/ethyl 
acetate 7/1) to obtain an analytically pure sample. 
 
1-Benzyl-3-bromo-3-methylazetidine 261a 
 
Yellow oil, Rf = 0.30 (petroleum ether/ethyl acetate 7/1), Yield 72%, isolated yield 62% 
(after purification). 
1
H NMR (300 MHz, CDCl3) δ 2.00 (3H, s, CCH3), 3.52 (2H, d, J = 9.1 
Hz, 2 x (HCH)Cquat), 3.69 (2H, d, J = 9.1 Hz, 2 x (HCH)Cquat), 3.71 (2H, s, NCH2Ar), 
7.21−7.33 (5H, m, CHarom). 
13
C NMR (75 MHz, ref = CDCl3) δ 31.6 (CCH3), 51.9 
(C(CH3)Br), 63.2 (NCH2Ar), 70.9 (CH2CquatCH2), 127.3 (2 × CHarom), 128.5 (3 × CHarom), 
137.8 (Carom,quat). IR (neat) νmax = 2924, 2844, 1495, 1453, 1362, 1245, 1208, 1181, 746, 
696 cm
−1
. MS m/z (%) 240/2 (M
+
 + 1, 100). 
 
3-Bromo-1-(4-methylbenzyl)-3-methylazetidine 261b 
 
Light-yellow oil, Rf = 0.41 (petroleum ether/ethyl acetate 7/1), Yield 78%. 
1
H NMR (300 
MHz, ref = CDCl3) δ 1.99 (3H, s, CCH3), 2.33 (3H, s, CH3Ar), 3.51 (2H, d, J = 8.2 Hz, 2 x 
(HCH)Cquat), 3.69 (2H, d, J = 8.2 Hz, 2 x (HCH)Cquat), 3.67 (2H, s, NCH2Ar), 7.10-7.18 (4H, 
m, CHarom). 
13
C NMR (75 MHz, ref = CDCl3) δ 21.2 (CH3Ar), 31.6 (CCH3), 52.0 (C(CH3)Br), 
63.0 (NCH2Ar), 70.8 (CH2CquatCH2), 128.5 and 129.2 (4 x CHarom), 134.6 and 136.9 (2 x 
Carom,quat). IR (neat) νmax = 2922, 2848, 2807, 1514, 1440, 1360, 1244, 1206, 1178, 806, 
734 cm
-1
. MS m/z (%) 254/6 (M
+ 
+ 1, 100). Anal. Calcd for C12H16BrN: C, 56.71; H, 6.35; 
N, 5.51. Found: C, 56.55; H, 6.54; N, 5.37. 
 
 
 
N
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3-Bromo-1-(4-methoxybenzyl)-3-methylazetidine 261c 
 
Yellow oil, Rf = 0.22 (petroleum ether/ethyl acetate 7/1), Yield 70%, isolated yield 59% 
(after purification). 
1
H NMR (300 MHz, CDCl3) δ 1.99 (3H, s, CCH3), 3.49 (2H, d, J = 9.1 
Hz, 2 x (HCH)Cquat), 3.67 (2H, d, J = 9.1 Hz, 2 x (HCH)Cquat), 3.64 (2H, s, NCH2Ar), 3.79 
(3H, s, OCH3), 6.83−6.86 and 7.18−7.20 (4H, 2 × m, CHarom). 
13
C NMR (75 MHz, ref = 
CDCl3) δ 31.6 (CCH3), 52.0 (C(CH3)Br), 55.3 (OCH3), 62.6 (NCH2Ar) 70.7 (CH2CquatCH2), 
113.8 (2 × CHarom), 129.7 (2 × CHarom), 129.1 (Carom,quat), 158.9 (CaromO). IR (neat) νmax = 
2930, 2835, 1612, 1511, 1243, 1171, 1034, 819, 738, 696 cm
−1
. MS m/z (%) 240/2 (M
+
 + 
1, 100). 
 
 
5.21 Synthesis of N-(2-chlorobenzyl)-N-(2,3-dibromo-2-methylpropyl)amine 
276 
 
2-Bromomethyl-1-(2-chlorobenzyl)-2-methylaziridine 260c (2.75 g, 10 mmol) was dissolved in CH2Cl2 
(30 mL), after which HBr (33% in AcOH) (3.24 g, 1.2 equiv) was added and the mixture was heated for 
24 hours under reflux. The reaction mixture was first neutralized with saturated aqueous solution of 
NaHCO3 (5 mL) and then poured into water (20 mL) and extracted with CH2Cl2 (3 x 20 mL). The 
combined organic extracts were washed with H2O (2 x 15 mL) and brine (20 mL). Drying (MgSO4), 
filtration of the drying agent and evaporation of the solvent afforded N-(2-chlorobenzyl)-N-(2,3-
dibromo-2-methylpropyl)amine 276 (3.47 g, 98%). 
 
N-(2-Chlorobenzyl)-N-(2,3-dibromo-2-methylpropyl)amine 276 
 
Dark-yellow oil, Yield 98%. 
1
H NMR (300 MHz, CDCl3) δ 1.70 (1H, br s, NH), 1.85 (3H, s, CCH3), 2.91 
and 2.96 (2H, 2 x d, J = 13.5 Hz, N(HCH)CBr), 3.79 (1H, d, J = 9.6 Hz, (HCH)Br), 
4.00 (2H, s, NCH2Ar), 4.23 (1H, d, J = 9.6 Hz, (HCH)Br), 7.18–7.48 (4H, m, 
CHarom). 
13
C NMR (75 MHz, CDCl3) δ 28.4 (CH3), 40.4 (CH2Br), 51.2 (NCH2Ar), 
57.4 (CH2CBr), 68.3 (CBr), 126.8, 128.4, 129.5 and 130.0 (4 x CHarom), 133.7 and 
137.4 (Carom,quat). IR (neat): νmax = 2839, 1443, 1050, 749 cm
–1
. MS (70 eV): m/z (%) = 354/356/358 
(100) (M
+ 
+ 1, 100).  
 
 
 
5.22 Synthesis of N,N-dibenzyl-N-(2,3-dibromo-2-methylpropyl)amines 275 
 
As a representative example the synthesis of N-benzyl-N-(2,3-dibromo-2-methylpropyl)-N-(4-methyl-
benzyl)amine 275a is described here. Benzyl bromide (1.71 g, 1 equiv) was added to a solution of 2-
bromomethyl-2-methyl-1-(4-methylbenzyl)aziridine 260b (2.54 g, 10 mmol) in acetonitrile (30 mL) at 
room temperature whilst stirring, and the resulting mixture was heated at reflux for 1 day. Afterward, 
the reaction mixture was poured into water (30 mL) and extracted with Et2O (3 x 30 mL). Drying 
(MgSO4), filtration of the drying agent and evaporation of the solvent afforded N-benzyl-N-(2,3-
N
Br
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dibromo-2-methylpropyl)-N-(4-methylbenzyl)amine 275a, which was purified by column 
chromatography on silica gel (hexane/ethyl acetate 4/1) to obtain an analytically pure sample (3.78 g, 
89%). 
 
 
N-Benzyl-(2,3-dibromo-2-methylpropyl)-N-(4-methylbenzyl)amine 275a  
 
Yellow oil, Rf = 0.78 (hexane/ethyl acetate 4/1), Yield 89%. 
1
H NMR (300 MHz, CDCl3) δ 1.74 (3H, s, 
CH3CBr), 2.36 (3H, s, CH3Ar), 3.06-3.18 (2H, m, NCH2CBr), 3.78 and 3.98 (2H, 
2 x d, J = 10.5 Hz, (HCH)Br), 3.82 (2H, s, NCH2Ar), 3.85 (2H, s, NCH2Ar), 7.14–
7.35 (9H, m, CHarom). 
13
C NMR (75 MHz, CDCl3) δ 21.1 (CH3Ar), 28.6 (CH3CBr), 
41.8 (CH2Br), 58.2 (CaromCH2N), 58.5 (CaromCH2N), 62.2 (NCH2CBr), 68.8 (CBr), 
127.1, 128.3, 129.0 and 129.2 (9 x CHarom), 135.4, 136.7 and 138.8 (3 x 
Carom,quat). IR (neat): vmax = 2924, 1737, 1452, 1373, 1240, 1041, 801, 737, 696 
cm
–1
. MS (70 eV): m/z (%) = 344/6 (100), 424/6/8 (10) (M
+ 
+ 1, 100).  
 
 
N-Benzyl-(2-chlorobenzyl)-N-(2,3-dibromo-2-methylpropyl)amine 275b  
 
Yellow oil. Rf = 0.62 (hexane/ethyl acetate 4/1), Yield 86%. 
1
H NMR (300 MHz, CDCl3) δ 1.70 (3H, s, 
CH3CBr), 3.15 and 3.22 (2H, 2 x d, J = 15.1 Hz, N(HCH)CBr), 3.75 and 3.90 (2H, 
2 x d, J = 10.5 Hz, (HCH)Br), 3.87 and 3.93 (2H, 2 x d, J = 14.3 Hz, 
Carom(HCH)N), 3.98 and 4.03 (2H, 2 x d, J = 15.4 Hz, Carom(HCH)N), 7.16–7.35 
and 7.59-7.62 (9H, 2 x m, CHarom). 
13
C NMR (75 MHz, CDCl3) δ 28.4 (CH3CBr), 
41.7 (CH2Br), 56.3 (NCH2Ar), 59.5 (NCH2Ar), 62.8 (NCH2CBr), 68.5 (CBr), 126.7, 
127.3, 128.2, 128.3, 129.4, 129.5 and 130.7 (9 x CHarom), 134.0, 136.6 and 138.2 
(3 x Carom,quat). IR (neat): vmax = 2834, 1443, 1377, 1038, 751, 698 cm
–1
. MS (70 
eV): m/z (%) = 364/6 (100), 444/6/8 (10) (M
+ 
+ 1, 100).  
 
 
 
5.23 Synthesis of N-(1-bromo-3-chloro-2-methylprop-2-yl)amines 279 
 
As representative example the synthesis of N-(1-bromo-3-chloro-2-methylprop-2-yl)-N-(2-
chlorobenzyl)amine 279b was described here. 2-Bromomethyl-1-(2-chlorobenzyl)-2-methylaziridine 
260c (2.75 g, 10 mmol) was dissolved in CH2Cl2 (30 mL), after which HCl (3M) (6.7 mL, 2 equiv) was 
added and the mixture was heated for 6 hours under reflux. The reaction mixture was first neutralized 
with saturated aqueous solution of NaHCO3 (5 mL) and then poured into water (20 mL) and extracted 
with CH2Cl2 (3 x 20 mL). The combined organic extracts were washed with H2O (2 x 15 mL) and brine 
(20 mL). Drying (MgSO4), filtration of the drying agent and evaporation of the solvent afforded N-(1-
bromo-3-chloro-2-methylprop-2-yl)-N-(2-chlorobenzyl)amine 279b (2.99 g, 96%), which was 
considered as analytically pure and described without prior purification. 
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N-(1-Bromo-3-chloro-2-methylprop-2-yl)-N-(4-methylbenzyl)amine 279a  
 
Light yellow oil, Yield 80%. 
1
H NMR (300 MHz, CDCl3) δ 1.30 (3H, s, CCH3), 2.33 (3H, s, CH3Ar), 3.62 
(2H, s, CH2Br), 3.63 (2H, s, CH2Cl), 3.67 (2H, s, NCH2Ar), 7.12-7.15 and 7.22-7.26 
(4H, m, CHarom). 
13
C NMR (75 MHz, ref = CDCl3) δ 20.5 (CCH3), 21.2 (CH3Ar), 46.3 
(CH2N), 48.9 (CH2Br and CH2Cl), 54.4 (CCH3), 127.7, 128.3, 129.2 and 129.3 (4 x 
CHarom), 132.2 and 137.0 (Carom,quat). IR (neat): vmax = 2959, 1443, 1377, 1049, 748 cm
–
1
. MS (70 eV): m/z (%) = 266/268/270 (100), 310/312/314 (M
+ 
+ 1, 23).  
 
 
 
N-(1-Bromo-3-chloro-2-methylprop-2-yl)-N-(2-chlorobenzyl)amine 279b  
 
Light yellow oil, Yield 96%. 
1
H NMR (300 MHz, CDCl3) δ 1.34 (3H, s, CCH3), 1.82 (1H, br s, NH), 3.63 
and 3.68 (4H, 2 x d, J = 11.6 Hz, CH2Br and CH2Cl), 3.84 (2H, s, CH2N), 7.19–7.28, 
7.35-7.38 and 7.45-7.48 (4H, m, CHarom). 
13
C NMR (75 MHz, ref = CDCl3) δ 20.4 
(CCH3), 43.9 (CH2N), 49.1 (CH2Br and CH2Cl), 57.3 (CCH3), 127.2, 128.6, 129.7 and 
130.2 (4 x CHarom), 133.7 and 137.6 (Carom,quat). IR (neat): vmax = 2959, 1443, 1377, 
1049, 748 cm
–1
. MS (70 eV): m/z (%) = 266/268/270 (100), 310/312/314 (M
+ 
+ 1, 23).  
 
 
 
5.24 Synthesis of 1-(2-chlorobenzyl)-2-(cyanomethyl)aziridine 282  
 
N-(1-Bromo-3-chloro-2-methylprop-2-yl)-N-(2-chlorobenzyl)amine 279b (2.75 g, 10 mmol) was 
dissolved in DMSO (20 mL), after which KCN (1.43 g, 2.2 equiv) was added and the mixture was 
heated for 5 hours at 60-70 °C. The reaction mixture was poured into water (20 mL) and extracted with 
Et2O (3 x 20 ml). The combined organic extracts were washed with H2O (2 x 15 mL) and brine (20 
mL). Drying (MgSO4), filtration of the drying agent and evaporation of the solvent afforded a mixture 1-
(2-chlorobenzyl)-2-(cyanomethyl)aziridine 282 and 2-(chloromethyl)-2-methylaziridine 281 (282/281 = 
3/1). 2-(1-(2-1-(2-Chlorobenzyl)-2-(cyanomethyl)aziridine 282 was described based on the crude 
mixture. 
 
1-(2-Chlorobenzyl)-2-(cyanomethyl)aziridine 282  
 
Light-yellow oil, Yield 60%. 
1
H NMR (300 MHz, CDCl3) δ 1.42 (1H, s, (HCH)CN), 1.44 (3H, s, CCH3), 
2.06 (1H, s, (HCH)Cquat), 2.51 and 2.60 (2H, 2 x s, (HCH)CN), 3.63 and 3.84 (2H, 2 
x d, J = 15.4 Hz, NCH2Ar), 7.18–7.35 and 7.62-7.65 (4H, m, CHarom). 
13
C NMR (75 
MHz, ref = CDCl3) δ 14.8 (CCH3), 29.3 (CquatCH2CN), 36.7 (CH2CquatN), 39.7 
(NCH2Cquat), 53.9 (NCH2Ar), 117.6 (CN), 127.1, 128.2, 129.0 and 129.2 (4 x CHarom), 
132.8 and 137.2 (2 x Carom,quat). IR (neat): νmax = 2916, 1469, 1443, 1350, 1048, 
1038, 751 cm
-1
. MS (70 eV): m/z (%) 221/3 (M
+ 
+ 1, 100).  
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5.25 Synthesis of N-(2-chlorobenzyl)-2-chloromethyl-2-methylaziridine 281  
 
N-(1-Bromo-3-chloro-2-methylprop-2-yl)-N-(2-chlorobenzyl)amine 279b (1.56 g, 5 mmol) was 
dissolved in dry THF (15 mL), after which KOtBu (0.62 g, 1.1 equiv) was added and the mixture was 
heated for 3 hours under reflux. The reaction mixture was poured into water (20 mL) and extracted 
with CH2Cl2 (3 x 20 mL). The combined organic extracts were washed with H2O (2 x 15 mL) and brine 
(20 mL). Drying (MgSO4), filtration of the drying agent and evaporation of the solvent afforded N-(2-
chlorobenzyl)-2-chloromethyl-2-methylaziridine 281 (1.06 g, 92%). 
. 
 
N-(2-Chlorobenzyl)-2-chloromethyl-2-methylaziridine 281  
 
Yellow oil, Yield 92%. 
1
H NMR (300 MHz, CDCl3) δ 1.34 (3H, s, CCH3), 1.41 (1H, s, (HCH)CN), 1.97 
(1H, s, (HCH)CN), 3.37 and 3.44 (2H, 2 x d, J = 11.0 Hz, (HCH)Cl), 3.58 and 3.74 (2H, 
2 x d, J = 15.7 Hz, N(HCH)Ar), 7.09-7.27 and 7.59-7.62 (4H, 2 x m, CHarom). 
13
C NMR 
(75 MHz, CDCl3) δ 12.9 (CCH3), 40.5 (CCH3), 40.7 (CH2CN), 54.1 and 54.3 (CH2Cl 
and NCH2Ar), 127.0, 128.0, 129.07 and 129.12 (4 x CHarom), 132.8 and 137.5 (2 x 
Carom,quat). IR (neat) νmax = 2965, 1469, 1443, 1349, 1257, 1048, 1038, 749, 698 cm
-1
. 
MS m/z (%) 230/2/4 (M
+ 
+ 1, 100).  
 
 
5.26 Synthesis of 3-methyl-3-thiocyanatoazetidines 284 
 
As a representative example, the synthesis of 1-(4-methoxybenzyl)-3-methyl-3-thiocyanatoazetidine 
284c is described here. 2-Bromomethyl-1-(4-methoxybenzyl)-2-methylaziridine 260d (1.35 g, 5 mmol) 
was dissolved in acetonitrile (30 mL), after which KSCN (0.49 g, 1 equiv) was added and the mixture 
was heated at reflux temperature for 4 h. The reaction mixture was cooled to room temperature, 
poured into water (20 mL) and extracted with CH2Cl2 (3 × 20 mL). The combined organic extracts were 
washed with H2O (2 × 15 mL) and brine (20 mL). Drying (MgSO4), filtration of the drying agent and 
evaporation of the solvent afforded a mixture of 1-(4-methoxybenzyl)-3-methyl-3-thiocyanatoazetidine 
284c and 2-methyl-2-(thiocyanatomethyl)aziridine 285c (284c/285c = ratio 67/33), from which 1-(4-
methoxybenzyl)-3-methyl-3-thiocyanatoazetidine 284c (0.94 g, 65%) was isolated in pure form by 
preparative thin layer chromatography on silica gel (hexane/ethyl acetate/triethylamine 1/1/0.01) to 
obtain an analytically pure sample. 
 
1-Benzyl-3-methyl-3-thiocyanatoazetidine 284a 
 
Yellow oil, Rf = 0.20 (hexane/ethyl acetate/triethylamine 1/1/0.01), Yield 45%, isolated 
yield 36% (after purification). 
1
H NMR (300 MHz, CDCl3) δ 1.79 (3H, s, CCH3), 3.35 (2H, 
d, J = 8.8 Hz, 2 x (HCH)Cquat), 3.47 (2H, d, J = 8.8 Hz, 2 x (HCH)Cquat), 3.69 (2H, s, 
NCH2Ar), 7.24−7.35 (5H, m, CHarom). 
13
C NMR (75 MHz, ref = CDCl3) δ 26.4 (CCH3), 47.5 
N
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(CCH3), 62.5 (NCH2Ar), 66.3 (CH2CquatCH2), 111.5 (SCN), 127.5, 128.5 and 128.6 (5 × CHarom), 137.2 
(Carom,quat). IR (neat) νSCN = 2151 cm
−1
. MS m/z (%) 219 (M
+
 + 1, 100). 
 
3-Methyl-1-(4-methybenzyl)-3-thiocyanatoazetidine 284b 
 
Yellow oil, Rf = 0.22 (hexane/ethyl acetate/triethylamine 1/1/0.01), Yield 55%, isolated yield 47% (after 
purification). 
1
H NMR (300 MHz, CDCl3) δ 1.78 (3H, s, CCH3), 2.33 (3H, s, CH3Ar), 3.33 
(2H, d, J = 8.8 Hz, 2 x (HCH)Cquat), 3.46 (2H, d, J = 8.8 Hz, 2 x (HCH)Cquat), 3.64 (2H, s, 
NCH2Ar), 7.11−7.18 (4H, m, CHarom). 
13
C NMR (75 MHz, ref = CDCl3) δ 21.2 (CH3Ar), 26.4 
(CCH3), 47.5 (CCH3), 62.3 (NCH2Ar), 66.2 (CH2CquatCH2), 111.5 (SCN), 128.5 and 129.2 
(4 × CHarom), 134.1 and 137.1 (2 x Carom,quat). IR (neat) νSCN = 2151 cm
−1
. MS m/z (%) 233 
(M
+
 +1, 100). 
 
 
1-(4-Methoxybenzyl)-3-methyl-3-thiocyanatoazetidine 284c 
 
Yellow oil, Rf = 0.18 (hexane/ethyl acetate/triethylamine 1/1/0.01), Yield 65%, isolated yield 52% (after 
purification). 
1
H NMR (300 MHz, CDCl3) δ 1.78 (3H, s, CCH3), 3.32 (2H, d, J = 9.4 Hz, 2 x 
(HCH)Cquat), 3.44 (2H, d, J = 9.4 Hz, 2 x (HCH)Cquat), 3.62 (2H, s, NCH2Ar), 3.80 (3H, s, 
OCH3), 6.84−6.87 and 7.18−7.20 (4H, 2 × m, CHarom). 
13
C NMR (75 MHz, ref = CDCl3) δ 
26.4 (CCH3), 47.5 (CCH3), 55.4 (OCH3), 61.9 (NCH2Ar), 66.1 (CH2CquatCH2), 111.5 (SCN), 
113.9 (2 × CHarom), 129.2 (Carom,quat), 129.8 (2 × CHarom), 159.0 (CaromO). IR (neat) νSCN = 
2151 cm
−1
. MS m/z (%) 249 (M
+
 + 1, 100). HRMS m/z (ESI) calculated for C13H16N2OS 
[MH]
+
 249.1062, found 249.1059. 
 
 
5.27 Synthesis of 2-methyl-2-(thiocyanatomethyl)aziridines 285 
 
As a representative example, the synthesis of 2-methyl-1-(4-methylbenzyl)-2-
(thiocyanatomethyl)aziridine 285b is described here. 2-Bromomethyl-2-methyl-1-(4-
methylbenzyl)aziridine 260b (1.27 g, 5 mmol) was dissolved in DMF (30 mL), after which KSCN (0.49 
g, 1 equiv) was added and the mixture was stirred at 60−70 °C for 15 h. The reaction mixture was 
cooled to room temperature, poured into water (20 mL) and extracted with CH2Cl2 (3 × 20 mL). The 
combined organic extracts were washed with H2O (2 × 15 mL) and brine (20 mL). Drying (MgSO4), 
filtration of the drying agent and evaporation of the solvent afforded 2-methyl-1-(4-methylbenzyl)-2-
(thiocyanatomethyl)aziridine 285b (0.91 g, 95%), which was purified by silica gel column 
chromatography (hexane/ethyl acetate/triethylamine 1/1/0.1) to obtain an analytically pure sample. It 
should be mentioned that aziridines 285a−c showed to be rather unstable on silica gel column during 
the purification process. 
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1-Benzyl-2-methyl-2-(thiocyanatomethyl)aziridine 285a 
 
Light-yellow oil, Rf = 0.43 (hexane/ethyl acetate/triethylamine 1/1/0.1), Yield 94%, isolated yield 41% 
(after purification). 
1
H NMR (300 MHz, CDCl3) δ 1.47 (1H and 3H, s, (HCH)CCH3 and CH3C), 2.08 (1H, 
s, (HCH)CCH3), 3.02 (H, d, J = 12.9 Hz, (HCH)S), 3.14 (H, d, J = 12.9 Hz, (HCH)S), 
3.53 (H, d, J = 13.8 Hz, (HCH)Ar), 3.78 (H, d, J = 13.8 Hz, (HCH)Ar), 7.26−7.35 (5H, m, 
CHarom). 
13
C NMR (75 MHz, ref = CDCl3) δ 14.0 (CCH3), 38.8 (CCH3), 40.3 
(CH2NCH2Carom), 45.1 (CH2S), 57.1 (CH2Carom), 113.1 (SCN), 127.2, 128.0 and 128.6 (5 
× CHarom), 139.3 (Carom,quat). IR (neat) νSCN = 2152 cm
−1
. MS m/z (%) 219 (M
+
 + 1, 100). 
HRMS m/z (ESI) calculated for C12H14N2S [MH]
+
 219.0956, found 219.0952. 
 
 
2-Methyl-1-(4-methylbenzyl)-2-(thiocyanatomethyl)aziridine 285b 
 
Light-yellow oil, Rf = 0.44 (hexane/ethyl acetate/triethylamine 1/1/0.1), Yield 95%, isolated yield 64% 
(after purification). 
1
H NMR (300 MHz, CDCl3) δ 1.46 (1H and 3H, s, (HCH)CCH3 and CH3C), 2.05 (1H, 
s, (HCH)CCH3), 2.34 (3H, s, CH3Ar), 3.02 (H, d, J = 12.7 Hz, (HCH)S), 3.13 (H, d, J = 12.7 Hz, 
(HCH)S), 3.49 (H, d, J = 13.2 Hz, (HCH)Ar), 3.73 (H, d, J = 13.2 Hz, (HCH)Ar), 
7.13−7.24 (4H, m, CHarom). 
13
C NMR (75 MHz, ref = CDCl3) δ 14.0 (CCH3), 21.2 (CH3Ar), 
38.8 (CCH3), 40.2 (CH2NCH2Carom), 45.2 (CH2S), 56.8 (CH2Carom), 113.1 (SCN), 127.9 
and 129.2 (4 × CHarom), 136.3 and 136.8 (2 x Carom,quat). IR (neat) νSCN = 2151 cm
−1
. MS 
m/z (%) 233 (M
+
 + 1, 100). HRMS m/z (ESI) calculated for C13H16N2S [MH]
+
 233.1112, 
found 233.1110. 
 
 
1-(4-Methoxybenzyl)-2-methyl-2-(thiocyanatomethyl)aziridine 285c 
 
Light-yellow oil, Rf = 0.36 (hexane/ethyl acetate/triethylamine 1/1/0.1), Yield 90%, isolated yield 37% 
(after purification). 
1
H NMR (300 MHz, CDCl3) δ 1.46 (1H and 3H, s, (HCH)CCH3 
and CH3C), 2.04 (1H, s, (HCH)CCH3), 3.00 (H, d, J = 12.9 Hz, (HCH)S), 3.12 (H, d, 
J = 12.9 Hz, (HCH)S), 3.45 (H, d, J = 13.2 Hz, (HCH)Ar), 3.71 (H, d, J = 13.2 Hz, 
(HCH)Ar), 3.81 (3H, s, OCH3), 6.86−6.89 and 7.25−7.28 (4H, 2 × m, CHarom). 
13
C 
NMR (75 MHz, ref = CDCl3) δ 14.0 (CCH3), 38.8 (CCH3), 40.2 (CH2NCH2Carom), 45.2 
(CH2S), 55.4 (OCH3), 56.5 (CH2Carom), 113.1 (SCN), 114.0 and 129.2 (4 × CHarom), 131.4 (Carom,quat), 
158.8 (CaromO). IR (neat) νSCN = 2153 cm
−1
. MS m/z (%) 249 (M
+
 + 1, 100). HRMS m/z (ESI) calculated 
for C13H16N2OS [MH]
+
 249,1062, found 249.1058. 
 
 
 
5.28 Synthesis of azetidine-3-carbonitriles 286 
 
As a representative example, the synthesis of 1-(4-methoxybenzyl)-3-methylazetidine-3-carbonitrile 
286b is described here. 2-Bromomethyl-1-(4-methoxybenzyl)-2-methylaziridine 260d (1.35 g, 5 mmol) 
was dissolved in acetonitrile (30 mL), after which KCN (0.64 g, 2 equiv) was added in small portions 
and the mixture was heated at reflux temperature for 26 h. The reaction mixture was cooled to room 
temperature, poured into water (20 mL) and extracted with CH2Cl2 (3 × 20 mL). The combined organic 
N
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extracts were washed with H2O (2 × 15 mL) and brine (20 mL). Drying (MgSO4), filtration of the drying 
agent and evaporation of the solvent afforded 1-(4-methoxybenzyl)-3-methylazetidine-3-carbonitrile 
286b (0.96 g, 95%), which was purified by silica gel column chromatography 
(dichloromethane/methanol 10/1) to obtain an analytically pure sample. 
 
3-Methyl-1-(4-methylbenzyl)azetidine-3-carbonitrile 286a 
 
Yellow oil, Rf = 0.28 (dichloromethane), Yield 96%, isolated yield 88% (after purification). 
1
H NMR (300 
MHz, CDCl3) δ 1.64 (3H, s, CCH3), 2.33 (3H, s, CH3Ar), 3.19 (2H, d, J = 6.9 Hz, 2 x 
(HCH)Cquat), 3.48 (2H, d, J = 6.9 Hz, 2 x (HCH)Cquat), 3.58 (2H, s, NCH2Ar), 7.04−7.24 
(4H, m, CHarom). 
13
C NMR (75 MHz, ref = CDCl3) δ 21.2 (CH3Ar), 22.9 (CCH3), 27.1 
(CCH3), 62.5 (NCH2Ar), 63.4 (CH2CquatCH2), 123.5 (CN), 128.4 and 129.2 (4 × CHarom), 
133.9 and 137.1 (2 x Carom,quat). IR (neat) νCN = 2238 cm
−1
. MS m/z (%) 201 (M
+
 + 1, 100). 
HRMS m/z (ESI) calculated for C13H16N2 [MH]
+
 201.1392, found 201.1389. 
 
 
1-(4-Methoxybenzyl)-3-methylazetidine-3-carbonitrile 286b 
 
Yellow oil, Rf = 0.60 (dichloromethane/methanol 10/1), Yield 95%, isolated yield 89% (after 
purification). 
1
H NMR (300 MHz, CDCl3) δ 1.64 (3H, s, CCH3), 3.18 (2H, d, J = 7.2 Hz, 2 x 
(HCH)Cquat), 3.48 (2H, d, J = 7.2 Hz, 2 x (HCH)Cquat), 3.56 (2H, s, NCH2Ar), 3.80 (3H, s, 
OCH3), 6.84−6.87 and 7.16−7.19 (4H, 2 × m, CHarom). 
13
C NMR (75 MHz, CDCl3) δ 22.7 
(CCH3), 27.0 (CCH3), 55.3 (OCH3), 62.1 (CH2Ar), 63.2 (CH2CquatCH2), 113.8 (2 × CHarom), 
123.4 (CN), 128.9 (Carom,quat), 129.6 (2 × CHarom), 158.9 (CaromO). IR (neat) νCN = 2238 
cm
−1
. MS m/z (%) 217 (M
+
 + 1, 100). HRMS m/z (ESI) calculated for C13H16N2O [MH]
+
 
217.1341, found 217.1340. 
 
 
5.29 Synthesis of 2-cyanomethyl-2-methylaziridines 287 
 
As a representative example, the synthesis of 2-cyanomethyl-2-methyl-1-(4-methylbenzyl)aziridine 
287a is described here. 2-Bromomethyl-2-methyl-1-(4-methylbenzyl)aziridine 260b (1.27 g, 5 mmol) 
was dissolved in DMF (30 mL), after which KCN (0.33 g, 1 equiv) was added and the mixture was 
stirred at 50−60 °C for 16 h. The reaction mixture was cooled to room temperature, poured into water 
(20 mL) and extracted with Et2O (3 × 20 mL). The combined organic extracts were washed with H2O 
(2 × 15 mL) and brine (20 mL). Drying (MgSO4), filtration of the drying agent and evaporation of the 
solvent afforded 2-cyanomethyl-2-methyl-1-(4-methylbenzyl)aziridine 287a (0.85 g, 85%), which was 
purified by silica gel column chromatography (hexane/ethyl acetate 1/1) to obtain an analytically pure 
sample. Aziridines 287a,b showed to be rather unstable on silica gel column during the purification 
process.  
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2-Cyanomethyl-2-methyl-1-(4-methylbenzyl)aziridine 287a 
 
Yellow oil, Rf = 0.29 (hexane/ethyl acetate 1/1), Yield 85%, isolated yield 36% (after purification). 
1
H 
NMR (300 MHz, CDCl3) δ 1.39 (1H, s, (HCH)CCH3), 1.43 (3H, s, CH3C), 1.96 (1H, s, (HCH)CCH3), 
2.33 (3H, s, CH3Ar), 2.40 (H, d, J = 16.8 Hz, (HCH)CN), 2.49 (H, d, J = 16.8 Hz, 
(HCH)CN), 3.52 (H, d, J = 13.8 Hz, (HCH)Ar), 3.69 (H, d, J = 13.8 Hz, (HCH)Ar), 
7.13−7.25 (4H, m, CHarom). 
13
C NMR (75 MHz, ref = CDCl3) δ 14.8 (CCH3), 21.2 (CH3Ar), 
29.4 (CH2CN), 36.7 (CCH3), 39.4 (CH2NCH2Carom), 56.7 (CH2Carom), 117.8 (CN), 127.7 
and 129.3 (4 × CHarom), 136.4 and 136.8 (2 x Carom,quat). IR (neat) νCN = 2250 cm
−1
. MS 
m/z (%) 201 (M
+
 + 1, 100). HRMS m/z (ESI) calculated for C13H16N2 [MH]
+
 201.1392, found 201.1386. 
 
 
2-Cyanomethyl-1-(4-methoxybenzyl)-2-methylaziridine 287b
 
 
Yellow oil, Rf = 0.21 (hexane/ethyl acetate 1/1), Yield 89%, isolated yield 42% (after purification). 
1
H 
NMR (300 MHz, CDCl3) δ 1.39 (1H, s, (HCH)CCH3), 1.44 (3H, s, CH3C), 1.96 (1H, s, (HCH)CCH3), 
2.41 (1H, d, J = 17.1 Hz, (HCH)CN), 2.49 (1H, d, J = 17.1 Hz, (HCH)CN), 3.49 (1H, d, 
J = 13.5 Hz, (HCH)Ar), 3.68 (1H, d, J = 13.5 Hz, (HCH)Ar), 3.81 (3H, s, OCH3), 
6.86−6.90 and 7.26−7.28 (4H, 2 × m, CHarom). 
13
C NMR (75 MHz, ref = CDCl3) δ 14.8 
(CCH3), 29.4 (CH2CN), 36.7 (CCH3), 39.4 (CH2NCH2Carom), 55.4 (OCH3), 56.4 
(CH2Carom), 114.0 (2 × CHarom), 117.8 (CN), 128.9 (2 × CHarom), 131.5 (Carom,quat), 
158.8 (CaromO). IR (neat) νCN = 2249 cm
−1
. MS m/z (%) 217 (M
+
 + 1, 100). HRMS m/z (ESI) calculated 
for C13H16N2O [MH]
+
 217.1341, found 217.1344. 
 
 
 
5.30 Synthesis of 3-methyl-3-phenoxyazetidines 288 
 
As a representative example, the synthesis of 1-(4-methoxybenzyl)-3-methyl-3-phenoxyazetidine 288b 
is described here. 2-Bromomethyl-1-(4-methoxybenzyl)-2-methylaziridine 260d (1.35 g, 5 mmol) was 
added to a mixture of phenol (1.04 g, 2.2 equiv) and K2CO3 (3.46 g, 5 equiv) dissolved in acetonitrile 
(30 mL), and the resulting suspension was heated at reflux temperature for 24 h. The reaction mixture 
was cooled to room temperature, poured into a NaOH solution (30 mL, 0.5M) and extracted with 
CH2Cl2 (3 × 20 mL). The combined organic extracts were washed with H2O (2 × 15 mL) and brine (20 
mL). Drying (MgSO4), filtration of the drying agent and evaporation of the solvent afforded a mixture of 
1-(4-methoxybenzyl)-3-methyl-3-phenoxyazetidine 288b and 1-(4-methoxybenzyl)-2-methyl-2-
(phenoxymethyl)aziridine 289b (288b/289b = ratio 67/33), from which 1-(4-methoxybenzyl)-3-methyl-
3-phenoxyazetidine 288b (0.93 g, 65%) was isolated in pure form by silica gel column 
chromatography (petroleum ether/ethyl acetate 4/1). 
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3-Methyl-1-(4-methylbenzyl)-3-phenoxyazetidine 288a 
 
Yellow oil, Rf = 0.25 (petroleum ether/ethyl acetate 4/1), Yield, 47%, isolated yield 37% (after 
purification). 
1
H NMR (300 MHz, CDCl3) δ 1.60 (3H, s, CCH3), 2.33 (3H, s, CH3Ar), 
3.29 (2H, d, J = 8.3 Hz, 2 x (HCH)Cquat), 3.55 (2H, d, J = 8.3 Hz, 2 x (HCH)Cquat), 
3.66 (2H, s, NCH2Ar), 6.67−6.70, 6.91−6.95 and 7.11−7.31 (9H, 3 × m, CHarom). 
13
C 
NMR (75 MHz, ref = CDCl3) δ 21.2 (CH3Ar), 22.0 (CCH3), 63.4 (NCH2Ar), 66.3 
(CH2CquatCH2), 73.6 (CCH3), 116.8, 120.9, 128.5, 129.1 and 129.5 (9 × CHarom), 
136.8 and 137.0 (2 x Carom,quat), 155.3 (Carom,quat). IR (neat) νmax = 2927, 2838, 1599, 
1587, 1514, 1494, 1456, 1241, 1223, 1170, 1034, 959, 803, 752, 692 cm
−1
. MS m/z 
(%) 268 (M
+
 + 1, 100). HRMS m/z (ESI) calculated for C18H21NO [MH]
+
 268.1701, found 268.1698. 
 
 
1-(4-Methoxybenzyl)-3-methyl-3-phenoxyazetidine 288b 
 
Yellow oil, Rf = 0.07 (petroleum ether/ethyl acetate 4/1), Yield 65%, isolated yield 42% (after 
purification). 
1
H NMR (300 MHz, CDCl3) δ 1.67 (3H, s, CCH3), 3.28 (2H, d, J = 8.3 Hz, 2 x (HCH)Cquat), 
3.53 (2H, d, J = 8.3 Hz, 2 x (HCH)Cquat), 3.63 (2H, s, NCH2Ar), 3.79 (3H, s, OCH3), 
6.67−6.70, 6.84−6.95 and 7.20−7.26 (9H, 3 × m, CHarom). 
13
C NMR (75 MHz, ref = 
CDCl3) δ 22.0 (CCH3), 55.3 (OCH3), 63.0 (NCH2Ar), 66.2 (CH2CquatCH2), 73.6 
(CCH3), 113.8, 116.8, 121.0, 129.5 and 129.8 (9 × CHarom), 130.2 (Carom,quat), 155.3 
(Carom,quat), 158.9 (CaromO). IR (neat) νmax = 2932, 2834, 2364, 1611, 1586, 1511, 
1493, 1242, 1223, 1204, 1171, 1034, 958, 818, 752, 693 cm
−1
. MS m/z (%) 284 (M
+
 
+ 1, 100). HRMS m/z (ESI) calculated for C18H21NO2 [MH]
+
 284.1651, found 
284.1645. 
 
 
 
5.31 Synthesis of 2-methyl-2-(phenoxymethyl)aziridines 289 
 
As a representative example, the synthesis of 1-(4-methoxybenzyl)-2-methyl-2-
(phenoxymethyl)aziridine 289b is described here. 2-Bromomethyl-1-(4-methoxybenzyl)-2-
methylaziridine 260d (1.35 g, 5 mmol) was added to a mixture of phenol (1.04 g, 2.2 equiv) and K2CO3 
(3.46 g, 5 equiv) in DMF (30 mL), and the resulting suspension was heated at 50 °C for 14 h. The 
reaction mixture was cooled to room temperature, poured into a NaOH solution (30 mL, 0.5 M) and 
extracted with Et2O (3 × 20 mL). The combined organic extracts were washed with H2O (2 × 15 mL) 
and brine (20 mL). Drying (MgSO4), filtration of the drying agent and evaporation of the solvent 
afforded 1-(4-methoxybenzyl)-2-methyl-2-(phenoxymethyl)aziridine 289b (1.27 g, 76%), which was 
purified by silica gel column chromatography (petroleum ether/ethyl acetate 4/1) to obtain an 
analytically pure sample. 
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2-Methyl-1-(4-methylbenzyl)-2-(phenoxymethyl)aziridine 289a 
 
Yellow oil, Rf = 0.17 (petroleum ether/ethyl acetate 4/1), Yield 85%, isolated yield 70% (after 
purification). 
1
H NMR (300 MHz, CDCl3) δ 1.42 (1H, s, (HCH)CCH3), 1.44 (3H, s, CH3C), 2.00 (1H, s, 
(HCH)CCH3), 2.34 (3H, s, CH3Ar), 3.60 (1H, d, J = 14.0 Hz, (HCH)Ar), 3.73 (1H, d, J 
= 14.0 Hz, (HCH)Ar), 3.75 (1H, d, J = 9.8 Hz, (HCH)O), 3.90 (1H, d, J = 9.8 Hz, 
(HCH)O), 6.88−6.96 and 7.11−7.30 (9H, 2 × m, CHarom). 
13
C NMR (75 MHz, ref = 
CDCl3) δ 13.0 (CCH3), 21.2 (CH3Ar), 38.9 (CH2NCH2Carom), 39.2 (CCH3), 56.3 
(CH2Carom), 75.8 (CH2O), 114.7, 120.8, 127.7, 129.1, 129.5 (9 × CHarom), 136.4 and 
137.0 (2 x Carom,quat), 159.1 (CaromO). IR (neat) νmax = 3030, 2922, 1599, 1586, 1495, 
1456, 1241, 1171, 1034, 1020, 798, 752, 691 cm
−1
; MS m/z (%) 268 (M
+
 + 1, 100). 
HRMS m/z (ESI) calculated for C18H21NO [MH]
+
 268.1701, found 268.1689. 
 
 
1-(4-Methoxybenzyl)-2-methyl-2-(phenoxymethyl)aziridine 289b 
 
Yellow oil, Rf = 0.31 (petroleum ether/ethyl acetate 4/1), Yield 90%, isolated yield 76% (after 
purification). 
1
H NMR (300 MHz, CDCl3) δ 1.41 (1H, s, (HCH)CCH3), 1.45 (3H, s, CH3C), 2.00 (1H, s, 
(HCH)CCH3), 3.56 (1H, d, J = 13.8 Hz, (HCH)Ar), 3.71 (1H, d, J = 13.8 Hz, (HCH)Ar), 3.76 (1H, d, J = 
9.4 Hz, (HCH)O), 3.81 (3H, s, OCH3), 3.89 (1H, d, J = 9.4 Hz, (HCH)O), 6.84−6.96 
and 7.24−7.33 (9H, 2 × m, CHarom). 
13
C NMR (75 MHz, ref = CDCl3) δ 13.0 (CCH3), 
38.9 (CH2NCH2Carom), 39.2 (CCH3), 55.4 (OCH3), 56.0 (CH2Carom), 75.9 (CH2O), 
113.9, 114.8, 120.8, 128.9 and 129.5 (9 × CHarom), 132.2 (Carom,quat), 158.6 and 
159.1 (2 x CaromO). IR (neat) νmax = 3038, 2930, 2835, 1599, 1586, 1511, 1496, 
1463, 1300, 1241, 1172, 1033, 819, 753, 691 cm
−1
. MS m/z (%) 284 (M
+
 + 1, 100). 
HRMS m/z (ESI) calculated for C18H21NO2 [MH]
+
 284.1651, found 284.1659. 
 
 
 
5.32 Synthesis of 3-acetoxy-3-methylazetidines 290  
 
As a representative example, the synthesis of 3-acetoxy-3-methyl-1-(4-methylbenzyl)azetidine 290a is 
described here. 2-Bromomethyl-2-methyl-1-(4-methylbenzyl)aziridine 260b (1.27 g, 5 mmol) was 
dissolved in acetonitrile (30 mL), after which NaOAc (0.45 g, 1.1 equiv) was added and the mixture 
was heated at reflux temperature for 24 h. The reaction mixture was cooled to room temperature, 
poured into water (20 mL) and extracted with CH2Cl2 (3 × 20 mL). The combined organic extracts were 
washed with H2O (2 × 15 mL) and brine (20 mL). Drying (MgSO4), filtration of the drying agent and 
evaporation of the solvent afforded 3-acetoxy-3-methyl-1-(4-methylbenzyl)azetidine 290a (1.10 g, 
87%), which was purified by silica gel column chromatography (petroleum ether/ethyl acetate 4/1) to 
obtain an analytically pure sample. 
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3-Acetoxy-3-methyl-1-(4-methylbenzyl)azetidine 290a 
 
Yellow oil, Rf = 0.11 (petroleum ether/ethyl acetate 4/1), Yield 95%, isolated yield 87% (after 
purification). 
1
H NMR (300 MHz, CDCl3) δ 1.64 (3H, s, CCH3), 2.01 (3H, s, CH3CO), 
2.32 (3H, s, CH3Ar), 3.13 (2H, d, J = 9.1 Hz, 2 x (HCH)Cquat), 3.46 (2H, d, J = 9.1 Hz, 
2 x (HCH)Cquat), 3.61 (2H, s, NCH2Ar), 7.09−7.17 (4H, m, CHarom). 
13
C NMR (75 MHz, 
ref = CDCl3) δ 21.2 (CH3Ar), 21.6 (CH3CO), 22.7 (CCH3), 63.3 (NCH2Ar), 65.8 
(CH2CquatCH2), 74.3 (CCH3), 128.5 and 129.1 (4 × CHarom), 135.0 and 136.8 (2 x 
Carom,quat), 169.7 (CO). IR (neat) νCO = 1737 cm
−1
. MS m/z (%) 234 (M
+
 + 1, 100). 
HRMS m/z (ESI) calculated for C14H19NO2 [MH]
+
 234.1494, found 234.1490. 
 
 
3-Acetoxy-1-(4-methoxybenzyl)-3-methylazetidine 290b 
 
Yellow oil, Rf = 0.06 (hexane/ethyl acetate 2/1) Yield 92%, isolated yield 84% (after purification). 
1
H 
NMR (300 MHz, CDCl3) δ 1.64 (3H, s, CCH3), 2.02 (3H, s, CH3CO), 3.12 (2H, d, J = 
9.4 Hz, 2 x (HCH)Cquat), 3.45 (2H, d, J = 9.4 Hz, 2 x (HCH)Cquat), 3.59 (2H, s, 
NCH2Ar), 3.79 (3H, s, OCH3), 6.83−6.86 and 7.17−7.20 (4H, 2 × m, CHarom). 
13
C NMR 
(75 MHz, ref = CDCl3) δ 21.6 (CH3CO), 22.6 (CCH3), 55.3 (OCH3), 62.9 (NCH2Ar), 
65.6 (CH2CquatCH2), 74.2 (CCH3), 113.8 and 129.7 (4 × CHarom), 130.0 (Carom,quat), 
158.8 (CaromO), 169.8 (CO). IR (neat) νCO = 1736 cm
−1
. MS m/z (%) 250 (M
+
 + 1, 100). 
HRMS m/z (ESI) calculated for C14H19NO3 [MH]
+
 250.1443, found 250.1444.  
 
 
5.33 Synthesis of 2-acetoxymethyl-2-methylaziridines 291 
 
As a representative example, the synthesis of 2-acetoxymethyl-2-methyl-1-(4-methylbenzyl)aziridine 
291a is described here. 2-Bromomethyl-2-methyl-1-(4-methylbenzyl)aziridine 260b (1.27 g, 5 mmol) 
was dissolved in DMSO (30 mL), after which NaOAc (0.45 g, 1.1 equiv) was added and the mixture 
was stirred at room temperature for 5 days. The reaction mixture was poured into water (20 mL) and 
extracted with Et2O (3 × 20 mL). The combined organic extracts were washed with H2O (2 × 15 mL) 
and brine (20 mL). Drying (MgSO4), filtration of the drying agent and evaporation of the solvent 
afforded a mixture of 3-acetoxy-3-methyl-1-(4-methylbenzyl)azetidine 290a and 2-acetoxymethyl-2-
methyl-1-(4-methylbenzyl)aziridine 291a (290a/291a = ratio 20/80), from which 2-acetoxymethyl-2-
methyl-1-(4-methylbenzyl)aziridine 291a could not be isolated in completely pure (purity <80%) form 
by silica gel column chromatography (petroleum ether/ethyl acetate 4/1).  
 
2-Acetoxymethyl-2-methyl-1-(4-methylbenzyl)aziridine 291a 
 
Yellow oil, Rf = 0.22 (petroleum ether/ethyl acetate 4/1). 
1
H NMR (300 MHz, CDCl3) δ 
1.31 (3H, s, CH3C), 1.35 (1H, s, (HCH)CCH3), 1.95 (1H, s, (HCH)CCH3), 2.07 (3H, s, 
CH3CO), 2.33 (3H, s, CH3Ar), 3.64 (2H, s, NCH2Ar), 3.89 (H, d, J = 11.3 Hz, (HCH)O), 
4.01 (H, d, J = 11.3 Hz, (HCH)O), 7.12−7.15 and 7.25−7.27 (4H, 2 × m, CHarom). 
13
C 
NMR (75 MHz, ref = CDCl3) δ 12.9 (CH3CO), 21.0 (CH3C), 21.2 (CH3Ar), 38.3 (CCH3), 
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38.6 (CH2NCH2Carom), 56.3 (CH2Carom), 71.9 (CH2O), 127.6 and 129.1 (4 × CHarom), 136.4 and 136.9 (2 
x Carom,quat), 171.1 (CO). IR (neat) νCO = 1737 cm
−1
. MS m/z (%) 234 (M
+
 + 1, 100). 
 
 
2-Acetoxymethyl-1-(4-methoxybenzyl)-2-methylaziridine 291b 
 
Yellow oil, Rf = 0.21 (petroleum ether/ethyl acetate 1/1). 
1
H NMR (300 MHz, CDCl3) δ 
1.31 (3H, s, CH3C), 1.34 (1H, s, (HCH)CCH3), 1.94 (1H, s, (HCH)CCH3), 2.07 (3H, s, 
CH3CO), 3.61 (2H, s, NCH2Ar), 3.80 (3H, s, OCH3), 3.88 (H, d, J = 11.3 Hz, 
(HCH)O), 4.00 (H, d, J = 11.3 Hz, (HCH)O), 6.85−6.88 and 7.26−7.31 (4H, 2 × m, 
CHarom). 
13
C NMR (75 MHz, ref = CDCl3) δ 12.9 (CH3CO), 21.0 (CH3C), 38.3 (CCH3), 
38.5 (CH2NCH2Carom), 55.4 (OCH3), 56.0 (CH2Carom), 71.8 (CH2O), 113.8 and 128.8 
(4 × CHarom), 132.1 (Carom,quat), 158.6 (CaromO), 171.1 (CO). IR (neat) νCO = 1736 cm
−1
. MS m/z (%) 250 
(M
+
 + 1, 100). 
 
 
 
5.34 Synthesis of 3-methyl-1-(4-methylbenzyl)-3-azetidinol 296 
 
3-Bromo-3-methyl-1-(4-methylbenzyl)azetidine 261b (1.27 g, 5 mmol) was added to a two-phase 
solvent system (H2O/CH2Cl2 9/1, 15 mL), after which KOH (1.40 g, 5 equiv) was added, and the 
mixture was stirred for 10 h under reﬂux. The reaction mixture was poured into water (15 mL) and 
extracted with CH2Cl2 (3 x 15 mL). The combined organic extracts were washed with H2O (2 x 15 mL) 
and brine (15 mL). Drying (MgSO4), ﬁltration of the drying agent and evaporation of the solvent 
afforded 3-methyl-1-(4-methylbenzyl)-3-azetidinol 296 as white crystals (0.92 g, purity >95% based on 
NMR analysis).  
 
3-Methyl-1-(4-methylbenzyl)-3-azetidinol 296 
 
White crystals, Mp = 85.3 °C, Yield 96%. 
1
H NMR (300 MHz, CDCl3) δ 1.40 (3H, s, OCCH3), 
2.25 (3H, s, CH3Ar), 2.99 (2H, d, J = 6.9 Hz, 2 x (HCH)Cquat), 3.20 (2H, d, J = 6.9 Hz, 2 x 
(HCH)Cquat), 3.53 (2H, s, NCH2Ar), 7.02–7.10 (4H, m, CHarom). 
13
C NMR (75 MHz, ref = 
CDCl3) δ 21.2 (CH3Ar), 26.1 (OCCH3), 63.2 (NCH2Ar), 68.0 (CH2CquatCH2), 68.9 (COH), 
128.6 and 128.8 (4 x CHarom), 134.9 and 136.8 (2 x Carom,quat). IR (neat) vOH = 3359 cm
−1
. MS 
(70 eV) m/z (%) 192 (M
+ 
+ 1, 100). 
 
 
5.35 Synthesis of 3-methyl-1-(4-methylbenzyl)azetidine-3-carboxamide 298 
and 3-methyl-1-(4-methylbenzyl)azetidine-3-carboxylic acid 297 
 
 
1-(4-Methylbenzyl)azetidine-3-carbonitrile 286a (0.20 g, 1 mmol) was dissolved in EtOH/H2O (5/1, 5 
mL), after which KOH (0.28 g, 5 equiv) was added. The mixture was placed in a 6-mL sealed glass 
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vessel, provided with an appropriate stirring bar and subjected to microwave conditions (150 °C, 10 
min, 150W). The reaction mixture was neutralized with a solution of hydrochloric acid (1 M) to pH = 7 
and extracted with CH2Cl2 (3 x 10 mL). The combined organic extracts were washed with H2O (2 x 15 
mL) and brine (15 mL). Drying (MgSO4), ﬁltration of the drying agent and evaporation of the solvent  
afforded 3-methyl-1-(4-methylbenzyl)azetidine-3-carboxamide 298 as white crystals (0.09 g, 40%). 
The water fraction was evaporated under high vacuum to provide azetidine-3-carboxylic acid 297 as a 
mixture of two isomeric structures (ratio 3/2) upon NMR analysis (CD3OD) (0.12 g, 55%).  
 
 
3-Methyl-1-(4-methylbenzyl)azetidine-3-carboxamide 298 
 
White solid, Yield 40%. 
1
H NMR (300 MHz, CD3OD) δ 1.36 (3H, s, CH3CCO), 1.85 
(2H, br s, NH2), 2.33 (3H, s, CH3Ar), 3.02 (2H, d, J = 8.0 Hz, 2 x (HCH)Cquat), 3.53 (2H, 
d, J = 8.0 Hz, 2 x (HCH)Cquat), 3.59 (2H, s, NCH2Ar), 7.09–7.22 (4H, m). 
13
C NMR (75 
MHz, ref = CD3OD) δ 21.2 (CH3CCO), 21.4 (CH3Ar), 40.9 (CH3CCO), 62.9 (NCH2Ar), 
64.4 (CH2CquatCH2), 128.4 and 129.2 (4 x CHarom), 134.5 and 137.0 (2 x Carom,quat), 
178.9 (CO). IR (neat) vCO = 1655 cm
-1
, vmax = 2922, 1618, 1455, 1228, 798. MS (70 
eV) m/z (%) 219 (M
+
 + 1, 100). 
 
 
3-Methyl-1-(4-methylbenzyl)azetidine-3-carboxylic acid 297 (described as a mixture of 
diastereomers) 
 
White crystals, Yield 55%. 
1
H NMR (300 MHz, CD3OD) δ 1.47 and 1.53 (3H, 2 x s, 
CH3CCO), 2.25 (3H, s, CH3Ar), 3.69-3.70 (1H, m, HCHN), 3.85-3.89 (2H, m, HCHN), 
4.00-4.4.03 (3H, m, CH2N and HCHN), 4.28-4.31 (3H, m, CH2), 7.15-7.18 and 7.31-
7.33 (4H, 2 x m, CHarom). 
13
C NMR (75 MHz, CD3OD) δ 21.3 and 21.5 (CH3CCO), 22.4 
(CH3Ar), 39.9 and 40.9 (CH3CCO), 59.2 and 59.6 (NCH2Ar), 61.8 and 62.5 
(CH2CquatCH2), 127.8 (Carom,quat), 131.0, 131.3, 131.4 (4 x CHarom), 141.3 (Carom,quat), 175.6 and 175.8 
(CO). IR (neat) vCO = 1730 cm
-1
, vOH = 3381, vmax =  2950, 2577, 1730, 1438, 1154. MS (70 eV) m/z 
(%) 220 (M
+
 + 1, 100). 
 
 
 
5.36 Synthesis of ammonium 3-methyl-1-(4-methylbenzyl)azetidine-3-
carboxylate 299 
 
 
1-(4-Methylbenzyl)azetidine-3-carbonitrile 286a (0.20 g, 1 mmol) was dissolved in EtOH/H2O (5/1, 5 
mL), after which KOH (0.28 g, 5 equiv) was added. The mixture was placed in a 6 mL sealed glass 
vessel, provided with an appropriate stirring bar and subjected to microwave conditions (150 °C, 20 
min, 150W). The reaction mixture was neutralized with a solution of hydrochloric acid (1 mL, 1 M) to 
pH = 7 and evaporated under high vacuum to provide a mixture of two isomeric structures (ratio 3/2) 
upon NMR analysis of azetidine-3-carboxylic acid 297. Puriﬁcation of amino acid 297 by means of ion-
N O
O
H
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exchange chromatography on Dowex H+ (50 x 8-100) afforded ammonium 3-methyl-1-(4-
methylbenzyl)azetidine-3-carboxylate 299 as a single isomer in pure form (0.20 g, 85%).  
 
 
Ammonium 3-methyl-1-(4-methylbenzyl)azetidine-3-carboxylate 299  
 
White crystals, Mp >350 °C, Yield 85%. 
1
H NMR (300 MHz, CD3OD) δ 1.41 (3H, s, 
CH3CCO), 2.24 (3H, s, CH3Ar), 3.73 (2H, d, J = 10.7 Hz, 2 x (HCH)Cquat), 4.20 (2H, 
d, J = 10.7 Hz, 2 x (HCH)Cquat), 4.20 (2H, s, NCH2Ar), 7.16–7.27 (4H, m, CHarom). 
13
C NMR (75 MHz, CD3OD) δ 21.3 (CH3CCO), 23.3 (CH3Ar), 42.3 (CH3CCO), 59.4 
(NCH2Ar), 63.7 (CH2CquatCH2), 128.6 (Carom,quat), 131.0 and 131.1 (4 x CHarom), 
141.2 (Carom,quat), 180.5 (CO). IR (neat) vCO = 1603 cm
-1
, vmax = 2965, 1439, 1379, 
1146, 770. MS (70 eV) m/z (%) 218 (M
+
 + 1, 100). 
 
 
5.37 Synthesis of 2-bromomethyl-2-ethylaziridines 303 
 
The synthesis of 2-bromomethyl-2-ethylaziridines 303 was performed according to the synthetic 
procedure for the preparation of 2-bromomethyl-2-methylaziridines 260 (see Section 5.13). As a 
representative example, the synthesis of 2-bromomethyl-2-ethyl-1-(4-methylbenzyl)aziridine 303b is 
described here. N-(2,3-Dibromo-2-ethylpropylidene)-4-methylbenzylamine 302b (3.47 g, 10 mmol) 
was dissolved in methanol (30 mL), after which NaBH4 (0.76 g, 2 molar equiv) was added in small 
portions at 0 °C and the mixture was stirred for 36 hours at room temperature. The reaction mixture 
was poured into water (20 mL) and extracted with CH2Cl2 (3 x 20 mL). The combined organic extracts 
were washed with H2O (2 x 15 mL) and brine (20 mL). Drying (MgSO4), filtration of the drying agent 
and evaporation of the solvent afforded 2-bromomethyl-1-(4-methylbenzyl)-2-ethylaziridine 303b (2.33 
g, 87%), as a mixture of two invertomers, which was purified by filtration through silica gel (petroleum 
ether/ethyl acetate 4/1) in order to obtain an analytically pure sample. 
 
 
1-Benzyl-2-bromomethyl-2-ethylaziridine 303a (described as a mixture of two invertomers, ratio 
63/37) 
 
Yellow oil, Rf = 0.56 (petroleum ether /ethyl acetate 2/1), Yield 85%. 
1
H NMR (300 MHz, CDCl3) δ 0.85 
(3H, t, J = 7.4 Hz, (CH3CH2)minor), 0.97 (3H, t, J = 7.4 Hz, (CH3CH2)major), 1.40 (1H, s, 
((HCH)CCH2Br)minor), 1.46 (1H, s, ((HCH)CCH2Br)major), 1.67-1.88 (2H, m, CH2CH3), 1.91 
(1H, s, ((HCH)CCH2Br)major), 1.94 (1H, s, ((HCH)CCH2Br)minor), 3.28 and 3.36 (2H, 2 x d, J 
= 10.2 Hz, CH2Br), 3.45 and 3.78 (2H, 2 x d, J = 13.8 Hz, (N(HCH)Ar)major), 3.41-3.48, 
3.75-3.78 and 4.03-4.07 (2H, 3 x m, (NCH2Ar)minor), 7.16-7.32 (5H, m, CHarom). 
13
C NMR 
(75 MHz, ref = CDCl3) δ 9.6 (CH3CH2)minor, 10.9 (CH3CH2)major, 20.0 (CH2CH3), 40.9 
(CH2CquatCH2Br), 41.3 (CH2Br), 43.9 (CCH2Br)minor, 44.3 (CCH2Br)major, 56.5 (NCH2Ar)minor, 56.8 
(NCH2Ar)major, 127.1, 128.0 and 128.5 (5 x CHarom), 139.7 (Carom,quat). IR (neat) νmax = 3026, 2967, 
2852, 1495, 1454, 1216, 731, 696 cm
-1
. MS m/z (%) 254/6 (M
+ 
+ 1, 100).  
N
Br
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2-Bromomethyl-2-ethyl-1-(4-methylbenzyl)aziridine 303b (described as a mixture of two 
invertomers, ratio 66/34) 
 
Light-yellow oil, Rf = 0.50 (petroleum ether /ethyl acetate 4/1), Yield 87%. 
1
H NMR (300 MHz, CDCl3) δ 
0.91 (3H, t, J = 7.4 Hz, (CH3CH2)minor), 1.04 (3H, t, J = 7.4 Hz, (CH3CH2)major), 1.44(1H, 
s, ((HCH)CCH2Br)minor), 1.49 (1H, s, ((HCH)CCH2Br)major), 1.71-1.90 (2H, m, CH2CH3), 
1.94 (1H, s, ((HCH)CCH2Br)major), 1.97 (1H, s, ((HCH)CCH2Br)minor), 2.33 (3H, s, 
CH3Ar), 3.35 and 3.40 (2H, 2 x d, J = 10.5 Hz, CH2Br), 3.46 and 3.81 (2H, 2 x d, J = 
13.8 Hz, (N(HCH)Ar)major), 3.51 and 4.06 (2H, 2 x d, J = 13.8 Hz, (N(HCH)Ar)minor), 
7.12-7.15 and 7.24-7.27 (4H, m, CHarom). 
13
C NMR (75 MHz, ref = CDCl3) δ 9.5 (CH3CH2)minor, 10.9 
(CH3CH2)major, 20.0 (CH3Ar)minor, 21.2 (CH3Ar)major, 28.7 (CH2CH3)minor, 40.9 (CH2CquatCH2Br), 41.2 
(CH2Br), 44.0 (CCH2Br)minor, 44.3 (CCH2Br)major, 56.3 (NCH2Ar)minor, 56.5 (NCH2Ar)major, 128.0 and 
129.1 (4 x CHarom), 136.6 (2 x Carom,quat). IR (neat) νmax = 3026, 2967, 2877, 1515, 1458, 143, 1216, 
797, 647 cm
-1
. MS m/z (%) 268/70 (M
+ 
+ 1, 100).  
 
 
 
5.38 Synthesis of 3-bromo-3-ethylazetidines 305 
 
As a representative example, the synthesis of 3-bromo-3-ethyl-1-(4-methylbenzyl)azetidine 305b is 
described here. 2-Bromomethyl-2-ethyl-1-(4-methylbenzyl)aziridine 303b (2.68 g, 10 mmol) was 
dissolved in acetonitrile (30 mL), and the mixture was heated at reflux temperature for 15 h. The 
reaction mixture was cooled to room temperature, poured into water (20 mL) and extracted with 
CH2Cl2 (3 × 20 mL). The combined organic extracts were washed with H2O (2 × 15 mL) and brine (20 
mL). Drying (MgSO4), filtration of the drying agent and evaporation of the solvent in vacuo afforded 3-
bromo-3-ethyl-1-(4-methylbenzyl)azetidine 305b (2.57 g, 96%), which was purified by silica gel column 
chromatography (petroleum ether/ethyl acetate 4/1) to obtain an analytically pure sample. 
 
1-Benzyl-3-bromo-3-ethylazetidine 305a 
 
Yellow oil, Rf = 0.52 (hexane/ethyl acetate 4/1), Yield 94%. 
1
H NMR (300 MHz, ref = 
CDCl3) δ 1.03 (3H, t, J = 7.2 Hz, CH3CH2), 2.10 (2H, q, J = 7.2 Hz, CH3CH2), 3.65 (2H, d, J 
= 9.9 Hz, 2 x (HCH)Cquat), 3.74 (2H, d, J = 9.9 Hz, 2 x (HCH)Cquat), 3.80 (2H, s, NCH2Ar), 
7.28−7.33 (5H, m, CHarom). 
13
C NMR (75 MHz, ref = CDCl3) δ 10.4 (CH3CH2), 36.1 
(CH2CH3), 59.1 (CCH2CH3), 63.2 (NCH2Ar), 69.2 (CH2CquatCH2), 127.3, 128.48 and 128.52 
(5 x CHarom), 137.7 (2 x Carom,quat). IR (neat) νmax = 2966, 2935, 1454, 1174, 732, 697 cm
−1
. 
MS m/z (%) 254/6 (M
+
 + 1, 100). 
 
 
3-Bromo-3-ethyl-1-(4-methylbenzyl)azetidine 305b 
 
Yellow oil, Rf = 0.50 (petroleum ether/ethyl acetate 4/1), Yield 96%. 
1
H NMR (300 MHz, 
CDCl3) δ 1.03 (3H, t, J = 7.2 Hz, CH3CH2), 2.10 (2H, q, J = 7.2 Hz, CH3CH2), 2.33 (3H, 
s, CH3Ar), 3.70 (2H, d, J = 8.8 Hz, 2 x (HCH)Cquat), 3.75 (2H, d, J = 8.8 Hz, 2 x 
(HCH)Cquat), 3.81 (2H, s, NCH2Ar), 7.12−7.23 (4H, m, CHarom). 
13
C NMR (75 MHz, ref = 
CDCl3) δ 10.3 (CH3CH2), 21.2 (CH3Ar), 35.9 (CH2CH3), 58.3 (CCH2CH3), 62.4 (NCH2Ar), 
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68.6 (CH2CquatCH2), 128.8 and 129.3 (4 x CHarom), 133.0 and 137.6 (2 x Carom,quat). IR (neat) νmax = 
3417, 2965, 2934, 1515, 1456, 1174, 809, 731 cm
−1
. MS m/z (%) 268/70 (M
+
 + 1, 100). 
 
 
 
5.39 Synthesis of 1-benzyl-3-ethyl-3-methoxyazetidine 306 
 
1-Benzyl-2-bromomethyl-2-ethylaziridine 303a (2.54 g, 10 mmol) was dissolved in methanol (30 mL), 
after which NaBH4 (1.13 g, 3 molar equiv) was added in small portions at 0 °C and the mixture was 
heated for 48 hours under reflux. The reaction mixture was poured into water (20 mL) and extracted 
with CH2Cl2 (3 x 20 mL). The combined organic extracts were washed with H2O (2 x 15 mL) and brine 
(20 mL). Drying (MgSO4), filtration of the drying agent and evaporation of the solvent afforded 1-
benzyl-3-ethyl-3-methoxyazetidine 306 (1.83 g, 89%). 
 
 
1-Benzyl-3-ethyl-3-methoxyazetidine 306  
 
Yellow oil, Rf = 0.39 (petroleum ether/ethyl acetate 4/1), Yield 89%. 
1
H NMR (300 MHz, CDCl3) δ 0.84 
(3H, t, J = 7.2 Hz, CH3CH2), 1.98 (2H, q, J = 7.2 Hz, CH2CH3), 3.17 (3H, s, OCH3), 3.48 
(2H, d, J = 10.5 Hz, 2 x (HCH)Cquat), 3.87 (2H, d, J = 10.5 Hz, 2 x (HCH)Cquat), 4.14 (2H, 
s, NCH2Ar), 7.27-7.42 (5H, m, CHarom). 
13
C NMR (75 MHz, ref = CDCl3) δ 6.8 (CH3CH2), 
25.6 (CH2CH3), 50.3 (OCH3), 60.7 (NCH2Ar), 61.8 (CH2CquatCH2), 75.2 (CO), 128.4 
(Carom,quat), 129.2, 129.3 and 129.9 (5 x CHarom). IR (neat) νmax = 2966, 2935, 1456, 
1070, 911, 729, 699 cm
-1
. MS m/z (%) 206 (M
+ 
+ 1, 100).  
 
 
 
5.40 Reactivity of 3-bromo-3-ethylazetidine 305 toward KOtBu in tBuOH 
 
 
In an ice-cooled solution of 1-benzyl-3-bromo-3-ethylazetidine 305a (1.27 g, 5 mmol) in tBuOH (30 
mL), KOtBu (2.8 g, 5 equiv) was slowly added and the mixture was heated for 20 hours under reflux. 
The reaction mixture was cooled to room temperature, filtered, poured into water (20 mL) and 
extracted with Et2O (3 × 20 mL). The combined organic extracts were washed with H2O (2 × 15 mL) 
and brine (20 mL). Drying (MgSO4), filtration of the drying agent and evaporation of the solvent in 
vacuo afforded a mixture of 1-benzyl-3-ethylazetidin-3-ol 308, 1-benzyl-3-ethylideneazetidine 307a 
and 3-(tert-butoxy)-3-ethylazetidine 309 (308/307a/309 = 3.4/1.5/1). Spectral data of 3-(tert-butoxy)-3-
ethylazetidine 309 and 1-benzyl-3-ethylazetidin-3-ol 308 were deduced from the crude reaction 
mixture. 
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1-Benzyl-3-ethylazetidin-3-ol 308 
 
Light-yellow oil, Yield 60%. 
1
H NMR (300 MHz, ref = CDCl3) δ 0.94 (3H, t, J = 7.4 Hz, 
CH3CH2), 1.77 (2H, q, J = 7.4 Hz, CH3CH2), 3.08 and 3.33 (4H, 2 x d, J = 8.5 Hz, 2 x 
CH2CquatCH2), 3.68 (2H, s, NCH2Ar), 7.22-7.34 (5H, m, CHarom). 
13
C NMR (75 MHz, ref = 
CDCl3) δ 7.8 (CH3CH2), 31.7 (CH3CH2), 66.4 (NCH2Ar and CH2CquatCH2), 71.6 (CO), 
127.3, 128.4 and 128.7 (5 x CHarom), 137.8 (Carom,quat). IR (neat) νOH = 3322 cm
-1
. MS m/z 
(%) 192 (M
+ 
+ 1, 100). 
 
 
 
3-(tert-Butoxy)-3-ethylazetidine 309  
 
Light-yellow oil, Yield 60%. 
1
H NMR (300 MHz, ref = CDCl3) δ 0.99 (3H, t, J = 7.4 Hz, 
CH3CH2), 1.23 (9H, s, C(CH3)3), 1.98 (2H, q, J = 7.4 Hz, CH3CH2), 2.98 and 3.40 (4H, 2 x 
d, J = 8.0 Hz, 2 x CH2CquatCH2), 3.68 (2H, s, NCH2Ar), 7.22-7.34 (5H, m, CHarom). 
13
C 
NMR (75 MHz, ref = CDCl3) δ 8.1 (CH3CH2), 30.1 (CH3CH2), 30.6 (C(CH3)3), 66.4 
(CH2CquatCH2), 63.5 (NCH2Ar), 71.6 (COCH2), 71.6 (COC(CH3)3), 127.3, 128.4 and 128.7 
(5 x CHarom), 137.8 (Carom,quat). IR (neat) νmax = 2962, 2934, 2828, 1453, 1362, 1184, 730, 
697 cm
-1
. MS m/z (%) 248 (M
+ 
+ 1, 100).  
 
 
 
5.41 Synthesis of 3-ethylideneazetidines 307 
 
As a representative example, the synthesis of 3-ethylidene-1-(4-methylbenzyl)azetidine 307b is 
described here. In an ice-cooled solution of 3-bromo-3-ethyl-1-(4-methylbenzyl)azetidine 305b (1.34 g, 
5 mmol) in dry THF (30 mL), KOtBu (0.84 g, 1.5 equiv) was slowly added and the mixture was 
subjected to microwave heating (150W) for 10 min at 120 °C. Afterward, the reaction mixture was 
cooled to room temperature, filtered and poured into water (20 mL) and extracted with Et2O (3 × 20 
mL). The combined organic extracts were washed with H2O (2 × 15 mL) and brine (20 mL). Drying 
(MgSO4), filtration of the drying agent and evaporation of the solvent in vacuo afforded 3-ethylidene-1-
(4-methyl-benzyl)azetidine 307b (0.88 g, 94%), which was purified by silica gel column 
chromatography (petroleum ether/ethyl acetate 4/1) to obtain an analytically pure sample. 
 
1-Benzyl-3-ethylideneazetidine 307a 
 
Light-yellow oil, Rf = 0.21 (petroleum ether /ethyl acetate 4/1), Yield 92%. 
1
H NMR (300 
MHz, CDCl3) δ 1.47-1.51 (3H, m, CH3CH=C), 3.72 (2H, s, NCH2Ar), 3.80-3.84 (4H, m, 
CH2CquatCH2), 5.15-5.25 (1H, m, CH=C), 7.21-7.34 (5H, m, CHarom). 
13
C NMR (75 MHz, 
ref = CDCl3) δ 13.6 (CH3CH=C), 60.9 (CH2C=CH), 62.3 (CH2C=CH), 63.5 (NCH2Ar), 
115.4 (CH=C), 127.2, 128.5 and 128.6 (5 x CHarom), 131.8 and 138.1 (Carom,quat and 
Cquat). IR (neat) νmax = 2918, 2808, 1453, 1274, 732, 697 cm
-1
. MS m/z (%) 174 (M
+ 
+ 1, 
100). HRMS m/z (ESI) calculated for C12H15N [MH]
+
 174.1277, found 174.1277. 
 
N
N
O
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3-Ethylidene-1-(4-methylbenzyl)azetidine 307b 
 
Light-yellow oil, Rf = 0.22 (petroleum ether /ethyl acetate 4/1), Yield 94%. 
1
H NMR (300 
MHz, ref = CDCl3) δ 1.46-1.51 (3H, m, CH3CH=C), 2.33 (3H, s, CH3Ar), 3.68 (2H, s, 
NCH2Ar), 3.79-3.82 (4H, m, CH2CquatCH2), 5.16-5.24 (1H, m, CH=C), 7.11-7.14 and 7.18-
7.21 (4H, m, CHarom). 
13
C NMR (75 MHz, ref = CDCl3) δ 13.6 (CH3CH=C), 21.2 (CH3Ar), 
60.8 (CH2C=CH), 62.2 (CH2C=CH), 63.5 (NCH2Ar), 115.1 (CH=C), 128.5 and 129.1 (4 x 
CHarom), 131.8, 135.7 and 136.7 (2 x Carom,quat and Cquat). IR (neat) νmax = 2917, 2805, 
1514, 1439, 1358, 1273, 1176, 1042, 1021, 806, 780, 753 cm
-1
. MS m/z (%) 188 (M
+ 
+ 1, 
100). HRMS m/z (ESI) calculated for C13H18N [MH]
+
 188.1434, found 188.1435.  
 
 
 
5.42 Synthesis of 3-ethyl-1-(4-methylbenzyl)azetidine 329 
 
 
3-Ethylidene-1-(4-methylbenzyl)azetidine 307b (0.2 g, 1 mmol) was dissolved in ethyl acetate (10 mL), 
10% Pd/C (0.07 g, 6 mol%) was added in small portions at 0 °C and the mixture was subjected to 
hydrogenation for 72 hours (5 bar, H2) at room temperature. The reaction mixture was first then filtered 
through a small sintered funnel and thoroughly washed with ethyl acetate (20 mL). Subsequently, the 
filtrate was poured into water (20 mL) and extracted with Et2O (3 x 20 mL). The combined organic 
extracts were washed with H2O (2 x 15 mL) and brine (20 mL). Drying (MgSO4), filtration of the drying 
agent and evaporation of the solvent afforded 3-ethyl-1-(4-methylbenzyl)azetidine 329 (0.08 g, 40%). 
 
 
3-Ethyl-1-(4-methylbenzyl)azetidine 329 
 
Light-yellow oil, Yield 40%. 
1
H NMR (300 MHz, ref = CDCl3) δ 0.73 (3H, t, J = 7.4 Hz, 
CH3CH2), 1.44 (2H, quin, J = 7.4 Hz, CHCH2CH3), 2.24 (3H, s, CH3Ar), 2.24-2.38 (1H, m, 
NCH2CHCH2), 2.64-2.69 and 3.32-3.37 (4H, 2 x m, CH2CHCH2), 3.46 (2H, s, NCH2Ar), 
7.02-7.10 (4H, m, CHarom). 
13
C NMR (75 MHz, ref = CDCl3) δ 11.6 (CH3CH2), 21.2 
(CH3Ar), 27.5 (CH2CH3), 32.8 (CHCH2), 60.4 (CH2CquatCH2), 63.8 (NCH2Ar), 128.6 and 
129.1 (4 x CHarom), 135.3 and 136.6 (2 x Carom,quat). IR (neat) νmax = 2954, 2929, 2808, 
1514, 1459, 1358, 1182, 806 cm
-1
. MS m/z (%) 190 (M
+ 
+ 1, 100). HRMS m/z (ESI) 
calculated for C13H19N [MH]
+
 190.1590, found 190.1593. 
 
 
 
5.43 Synthesis of N-benzyl-N-[2-(chloromethyl)but-2-enyl)]-2-
alkoxyacetamides 318 
 
 
To an ice-cooled mixture of methoxyacetyl chloride 315 (R = Me) (0.20 g, 1.9 mmol) in CH2Cl2, 
triethylamine (0.57 g, 3 equiv) was added and the mixture was stirred for 1 hour at room temperature. 
Subsequently, 3-ethylideneazetidine 307a (0.25 g, 1.5 mmol) was added and the resulting mixture 
N
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was stirred for 15 hours at room temperature. Afterward, the reaction mixture was poured into water 
(20 mL) and extracted with CH2Cl2 (3 × 20 mL). The combined organic extracts were washed with H2O 
(2 × 15 mL) and NaHCO3 (20 mL). Drying (MgSO4), filtration of the drying agent and evaporation of 
the solvent in vacuo afforded a mixture of N-benzyl-N-[2-(chloromethyl)but-2-enyl)]-2-
alkoxyacetamides 318a and 318b (R = Me) (Z/E = 1/1) (0.33 g, overall yield 78%), which was purified 
by silica gel column chromatography (petroleum ether/ethyl acetate 1/1) to obtain an analytically pure 
sample of the mixture of isomers. 
 
 
N-benzyl-N-[2-(chloromethyl)but-2-enyl)]-2-alkoxyacetamides 318a and 318b (R = Me) (described 
from the mixture of two isomers Z/E = 1/1)   
 
 
         and 
 
 
 
Yellow oil, Rf = 0.47 (petroleum ether/ethyl acetate 1/1), Yield 78%. 
1
H NMR (300 MHz, ref = CDCl3) δ 
1.56-1.63 (3H, m, CH3CH=C), 3.44 and 3.49 (3H, 2 x s, OCH3), 4.00-4.05 (2H, m, CH2), 4.16-4.21 
(2H, m, CH2), 4.30-4.34 (2H, m, CH2), 4.51-4.54 (2H, m, CH2), 5.90-5.94 (1H, m, CH=C), 7.17-7.37 
(5H, m, CHarom). 
13
C NMR (75 MHz, ref = CDCl3) δ 13.6 (CH3CH=C), 41.5 (CH2), 41.9 (CH2), 47.2 
(CH2), 47.4 (CH2), 48.3 (CH2), 49.5 (CH2), 59.4 (OCH3), 71.5 (CH2O), 126.4 (CH=C), 127.6, 127.8, 
128.2, 128.7, 129.1, 131.4, 131.6, 131.9 (5 x CHarom), 136.4 and 137.0 (Carom,quat and C=CH), 170.1 
(CO). IR (neat) vCO = 1649, νmax = 2930, 1449, 1196, 1128, 1108, 699 cm
-1
. MS m/z (%) 282/4 (M
+ 
+ 1, 
100). HRMS m/z (ESI) calculated for C15H20ClNO2 [MH]
+
 282.1255, found 282.1252. 
 
 
 
5.44 Synthesis of 2-benzyloxy-N-[(2-chloromethyl)but-2-enyl)]-N-(4-
methylbenzyl)acetamides 318 
 
 
To an ice-cooled mixture of benzoxyacetyl chloride 315 (R = Bn) (0.1 g, 0.5 mmol) in CH2Cl2, 
triethylamine (0.16 g, 3 equiv) was added and the mixture was stirred for 1 hour at room temperature. 
Subsequently, 3-ethylideneazetidine 307a (0.07 g, 0.38 mmol) was added and the resulting mixture 
was stirred for 15 hours at room temperature. Afterward, the reaction mixture was poured into water 
(20 mL) and extracted with CH2Cl2 (3 × 20 mL). The combined organic extracts were washed with H2O 
(2 × 15 mL) and NaHCO3 (20 mL). Drying (MgSO4), filtration of the drying agent and evaporation of 
the solvent in vacuo afforded a mixture of 2-benzyloxy-N-[(2-chloromethyl)but-2-enyl)]-N-(4-
methylbenzyl)acetamides 318a and 318b (R = Bn) (Z/E = 1/1) (0.11 g, overall yield 75%). 
 
 
N
MeO
O
Cl
N
MeO
O
Cl
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2-Benzyloxy-N-[(2-chloromethyl)but-2-enyl)]-N-(4-methylbenzyl)acetamides 318a and 318b (R = 
Me) (described from the mixture of two isomers Z/E = 1/1)   
 
 
                
                  and 
 
 
 
 
Dark-yellow oil, Rf = 0.30 (petroleum ether/ethyl acetate 4/1), Yield 75%. 
1
H NMR (300 MHz, ref = 
CDCl3) δ 1.49-1.61 (3H, m, CH3CH=C), 2.33 (3H, s, CH3Ar), 3.96-4.04 (2H, m, CH2), 4.09-4.10 (2H, 
m, CH2), 4.15-4.29 (2H, m, CH2), 4.35-4.67 (2H, m, CH2), 5.29 (2H, s, ArCH2O), 5.85-5.92 (1H, m, 
CH=C), 7.07-7.15 and 7.29-7.36 (9H, 2 x m, CHarom). 
13
C NMR (75 MHz, ref = CDCl3) δ 13.6 
(CH3CH=C), 41.6 (CH2), 41.8 (CH2), 53.5 (CH3Ar), 67.0 (CH2), 68.9 (CH2), 73.4 (CH2O), 126.4 
(CH=C), 128.0, 128.2, 128.5, 128.6 (9 x CHarom), 129.4, 129.7, 131.7 and 137.4 (3 x Carom,quat and 
C=CH), 170.2 (CO), 172.4 (CO). IR (neat) vCO = 1753, 1649 cm
-1
, νmax = 2925, 1454, 1205, 1118, 738, 
698 cm
-1
. MS m/z (%) 372/4 (M
+ 
+ 1, 100).  
 
 
 
 
5.45 Synthesis of N-benzyl-N-[(2-chloromethyl)but-2-enyl)]acetamides 323  
 
 
3-Ethylideneazetidine 307a (0.08 g, 0.5 mmol) was dissolved in CH2Cl2 (10 mL), acetyl chloride (0.06 
g, 1.5 equiv) was added and the mixture was stirred for 15 hours under reflux. The reaction mixture 
was then poured into water (20 mL) and extracted with CH2Cl2 (3 × 20 mL). The combined organic 
extracts were washed with H2O (2 × 15 mL) and NaHCO3 (20 mL). Drying (MgSO4), filtration of the 
drying agent and evaporation of the solvent in vacuo afforded a mixture of N-benzyl-N-[(2-
chloromethyl)but-2-enyl)]acetamides 323a and 323b (Z/E = 1/1) (0.12 g, overall yield 100%). 
 
N-benzyl-N-[(2-chloromethyl)but-2-enyl)]acetamides 323a and 323b 
 
 
  and 
 
 
 
 
Yellow oil, Rf = 0.18 (petroleum ether/ethyl acetate 4/1), Yield 100%. 
1
H NMR (300 MHz, ref = CDCl3) 
δ 1.49-1.53 (3H, m, CH3CH=C), 2.09 (3H, m, CH3CO), 2.24 (3H, m, CH3CO), 3.94 (2H, s, CH2), 3.97 
(2H, s, CH2), 4.14 (2H, s, CH2), 4.44-4.46 (2H, m CH2), 5.79-5.88 (1H, m, CH=C), 7.09-7.33 (5H, m, 
CHarom). 
13
C NMR (75 MHz, ref = CDCl3) δ 13.6 (CH3CH=C), 21.8 (CH3CO), 21.9 (CH3CO), 41.8 
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(CH2), 43.2 (CH2), 47.1 (CH2), 47.5 (CH2), 48.4 (CH2), 51.3 (CH2), 126.2 (CH=C), 127.5, 127.7, 128.1, 
128.6, 129.1, 131.0, 131.4 (5 x CHarom), 131.9, 132.4, 136.7, 137.3 (Carom,quat and C=CH), 171.5 (CO), 
171.7 (CO). IR (neat) vCO = 1645 cm
-1
, νmax = 2950, 1739, 1420, 1242, 733, 699 cm
-1
. MS m/z (%) 
252/4 (M
+ 
+ 1, 40). HRMS m/z (ESI) calculated for C14H18ClNO [MH]
+
 252.1150, found 252.1148. 
 
 
 
5.46 Synthesis of N,N-dibenzyl-N-[(2-bromomethyl)but-2-enyl)]amines 324  
 
3-Ethylideneazetidine 307a (0.09 g, 0.5 mmol) was dissolved in MeCN (10 mL), benzyl bromide (0.09 
g, 1 equiv) was added and the mixture was stirred for 15 hours under reflux. The reaction mixture was 
then poured into water (20 mL) and extracted with Et2O (3 × 20 mL). The combined organic extracts 
were washed with H2O (2 × 15 mL) and brine (20 mL). Drying (MgSO4), filtration of the drying agent 
and evaporation of the solvent in vacuo afforded a mixture of N,N-dibenzyl-N-[(2-bromomethyl)but-2-
enyl)]amines 324a and 324b (Z/E = 36/64 or vice versa) (0.17 g, overall yield 100%). 
 
N,N-Dibenzyl-N-[(2-bromomethyl)but-2-enyl)]amines 324a and 324b (described as a mixture of 2 
isomers, Z/E = 36/64 or vice versa)  
 
 
 
      and  
 
 
 
Yellow oil. Rf = 0.75 (petroleum ether/ethyl acetate 4/1), overall yield 100%. 
1
H NMR (300 MHz, ref = 
CDCl3) δ 1.60-1.62 (3H, m, (CH3CH=C)major), 1.676-1.681 and 1.700-1.703 (3H, m, (CH3CH=C)minor), 
3.00 (1H, s, (NCH2C=CH)major), 3.10 (1H, s, (NCH2C=CH)minor), 3.43 (4H, s, 2 x NCH2Ar), 4.04 (2H, s, 
(CH2Br)major), 4.09 (2H, s, (CH2Br)minor), 5.59-5.66 (1H, m, (CH=C)major), 5.77-5.84 (1H, m, (CH=C)minor), 
7.13-7.33 (10H, m, CHarom). 
13
C NMR (75 MHz, ref = CDCl3) δ 13.6 (CH3CH=C)major, 13.8 
(CH3CH=C)minor, 28.8 (CH2Br)major, 37.9 (CH2Br)minor, 58.3 (NCH2C=CH)major, 50.2 (NCH2C=CH)minor, 
58.0 (2 x NCH2Ar), 114.6 (CH=C), 126.99, 127.04, 128.4, 128.5, 128.9 and 129.1 (10 x CHarom), 137.9, 
139.5 and 139.4 (2 x Carom,quat and C=CH). IR (neat) νmax = 3058, 2919, 2795, 1494, 1453, 735, 697 
cm
-1
. MS m/z (%) 344/6 (M
+ 
+ 1, 70). HRMS m/z (ESI) calculated for C19H22BrN [MH]
+
 344.1014, found 
344.1013. 
 
 
 
5.47 Synthesis of methyl N-[(2-(chloromethyl)but-2-enyl)]carbamates 326  
 
As a representative example, the synthesis of N-benzyl-N-[(2-(chloromethyl)but-2-enyl)]carbamates 
326a and 326b (R = H) is described here. N-Benzyl-3-ethylideneazetidine 307a (0.07 g, 0.4 mmol) 
was dissolved in MeCN (10 mL), methyl chloroformate (0.06 g, 1.5 equiv) was added and the mixture 
was stirred for 15 hours under reflux. The reaction mixture was then poured into water (20 mL) and 
N
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extracted with Et2O (3 × 20 mL). The combined organic extracts were washed with H2O (2 × 15 mL) 
and NaHCO3 (20 mL). Drying (MgSO4), filtration of the drying agent and evaporation of the solvent in 
vacuo afforded a mixture of methyl N-benzyl-N-[(2-(chloromethyl)but-2-enyl)]carbamates 326a and 
326b (Z/E = 50/50) (0.11 g, overall yield 100%). 
 
Methyl N-benzyl-N-[(2-(chloromethyl)but-2-enyl)]carbamates 326a and 326b (R = H) (described as 
a mixture of isomers Z/E = 50/50) 
 
 
 and 
 
 
Yellow oil, Yield 100%. 
1
H NMR (300 MHz, ref = CDCl3) δ 1.52-1.54 (3H, m, CH3CH=C), 3.70 (OCH3), 
3.96 (4H, brs, CH2Cl and NCH2C=CH), 4.38 (NCH2Ar), 5.77-5.80 (1H, m, CH=C), 7.17-7.28 (5H, m, 
CHarom). 
13
C NMR (75 MHz, ref = CDCl3) δ 14.2 (CH3CH=C), 48.1 (CH2) and 49.7 (CH2), 52.2 (OCH3), 
53.9 (NCH2Ar), 127.5, 127.8 and 128.6 (5 x CHarom), 130.5 (CH=C), 132.4 and 137.5 (2 x Carom,quat), 
157.5 (CO). IR (neat) vCO = 1698 cm
-1
, νmax = 2956, 1467, 1452, 1405, 1242, 1117, 699 cm
-1
. MS m/z 
(%) 268/70 (M
+ 
+ 1, 100).  
 
 
Methyl N-(4-methylbenzyl)-N-[(2-(chloromethyl)but-2-enyl)]carbamates 326a and 326b (R = Me) 
(described as a mixture of isomers Z/E = 50/50) 
 
 and 
 
 
Yellow oil, Yield 100%. 
1
H NMR (300 MHz, ref = CDCl3) δ 1.61-1.63 (3H, m, CH3CH=C), 2.34 (CH3Ar), 
3.77 (OCH3), 4.03 (4H, brs, CH2Cl and NCH2C=CH), 4.41 (NCH2Ar), 5.83-5.89 (1H, m, CH=C), 7.06-
7.21 (4H, m, CHarom). MS m/z (%) 282 (M
+ 
+ 1, 100). HRMS m/z (ESI) calculated for C15H20ClNO2 
[MH]
+
 282.1255, found 282.1256. 
 
 
 
5.48 Synthesis of 5-ethylidene-1,3-oxazinan-2-ones 327  
 
As a representative example, the synthesis of 3-benzyl-5-ethylidene-1,3-oxazinan-2-ones 327a and 
327b (R = H) is described here. A mixture of methyl N-benzyl-N-[(2-(chloromethyl)but-2-
NMeO
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enyl)]carbamates 326a and 326b (0.08 g, 0.3 mmol) was dissolved in DMF (5 mL) and placed in 80 
mL sealed vessel, provided with an appropriate stirrer bar and subjected to microwave conditions (140 
°C, 150 Wmax) for 30 min. The resulting reaction mixture was subsequently poured into water (15 mL) 
and extracted with Et2O (3 x 15 mL). The combined organic extracts were thoroughly washed with 
H2O (2 × 15 mL) and brine (15 mL). Drying (MgSO4), filtration of the drying agent and evaporation of 
the solvent afforded a mixture of 3-benzyl-5-ethylidene-1,3-oxazinan-2-ones 327a and 327b (Z/E = 
50/50) (0.06 g, overall yield 96%), which was purified by filtration through silica gel (petroleum 
ether/ethyl acetate 1/1). 
 
3-Benzyl-5-ethylidene-1,3-oxazinan-2-ones 327a and 327b (R = H) (described as a mixture of 
isomers Z/E = 50/50) 
 
     and  
 
 
Yellow oil, Rf = 0.33 (petroleum ether/ethyl acetate 1/1), Yield 96%. 
1
H NMR (300 MHz, ref = CDCl3) δ 
1.48-1.50 (3H, m, CH3CH=C), 1.56-1.58 (3H, m, CH3CH=C), 3.79-3.81 (2H, m, NCH2C=CH), 4.56 (2H, 
s, CH2), 4.59 (2H, s, CH2), 5.05-5.115 (1H, m, CH=C), 5.57-5.63 (1H, m, CH=C), 7.27-7.39 (5H, m, 
CHarom). 
13
C NMR (75 MHz, ref = CDCl3) δ 13.3 (CH3), 18.1 (CH3), 45.9 (CH2N), 49.4 (CH2N), 52.3 
(CH2N), 52.7 (CH2N), 70.7 (CH2O), 74.8 (CH2O), 111.0 (CH=C), 123.2 (CH=C), 127.8, 126.2, 128.2 
and 128.8 (5 x CHarom), 136.5 and 138.3 (Carom,quat and C=CH), 155.5 (CO). IR (neat) vCO = 1689 cm
-1
, 
νmax = 2983, 1480, 1441, 1239, 1122, 704 cm
-1
. MS m/z (%) 218 (M
+ 
+ 1, 100). HRMS m/z (ESI) 
calculated for C13H15NO2 [MH]
+
 218.1176, found 218.1170. 
 
 
5-Ethylidene-3-(4-methylbenzyl)-1,3-oxazinan-2-ones 327a and 327b (R = Me) (described as a 
mixture of isomers Z/E = 50/50) 
 
  and   
 
 
Yellow oil, Rf = 0.42 (petroleum ether/ethyl acetate 1/1), Yield 85%. 
1
H NMR (300 MHz, ref = CDCl3) δ 
1.46-1.49 (3H, m, CH3CH=C), 1.55-1.58 (3H, m, CH3CH=C), 2.34 (3H, s, CH3Ar), 3.75-3.79 (2H, m, 
NCH2C=CH), 4.54 (4H, s, 2 x CH2), 5.04-5.10 (1H, m, CH=C), 5.55-5.62 (1H, m, CH=C), 7.13-7.23 
(4H, m, CHarom). 
13
C NMR (75 MHz, ref = CDCl3) δ 13.3 (CH3CH=C), 18.0 (CH3CH=C), 21.2 (CH3Ar), 
29.8 (CH3Ar), 45.8 (CH2N), 49.2 (CH2N), 52.0 (CH2N), 52.4 (CH2N), 70.7 (CH2O), 74.8 (CH2O), 111.0 
(CH=C), 123.1 (CH=C), 126.2, 128.3, 129.5 and 133.4 ((4 x CHarom)isomer1, (4 x CHarom)isomer2), 133.3, 
137.5, 137.6, 138.3 ((2 x Carom,quat)isomer1, (2 x Carom,quat)isomer2, and (C=CH)isomer1, (C=CH)isomer2), 154.4 
(CO), 155.5 (CO). IR (neat) vCO = 1688 cm
-1
, νmax = 2920, 1478, 1440, 1238, 1121, 762. MS m/z (%) 
218 (M
+ 
+ 1, 100).  
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 5.49 Synthesis of 1-benzyl-3-bromo-3-(1-bromoethyl)azetidine 332  
 
3-Ethylideneazetidine 307a (0.13 g, 0.7 mmol) was dissolved in CHCl3 (10 mL), NBS (0.26 g, 2 equiv) 
was added and the mixture was stirred for 20 hours under reflux. The reaction mixture was poured into 
water (15 mL) and extracted with CH2Cl2 (3 × 15 mL). The combined organic extracts were washed 
with H2O (2 × 15 mL) and brine (15 mL). Drying (MgSO4), filtration of the drying agent and evaporation 
of the solvent in vacuo afforded 1-benzyl-3-bromo-3-(1-bromoethyl)azetidine 332 (0.17 g, 70%), which 
was purified by filtration through silica gel (petroleum ether/ethyl acetate 4/1) in order to obtain an 
analytically pure sample. 
 
1-Benzyl-3-bromo-3-(1-bromoethyl)azetidine 332 
 
Yellow oil, Rf = 0.55 (petroleum ether/ethyl acetate 4/1), Yield 70%. 
1
H NMR (300 MHz, 
CDCl3) δ 1.66 (3H, d, J = 6.6 Hz, CH3), 3.53 (2H, d, J = 7.7 Hz, 2 x (HCH)Cquat), 3.66 
(2H, d, J = 7.7 Hz, 2 x (HCH)Cquat), 3.67 (2H, s, NCH2Ar), 4.42 (1H, q, J = 7.7 Hz, 
CHCH3), 7.18-7.26 (5H, m, CHarom). 
13
C NMR (75 MHz, ref = CDCl3) δ 22.7 (CH3), 56.0 
(CHCH3), 61.4 (CBr), 62.7 (CH2N), 66.8 (CH2N), 69.2 (CH2N), 127.5 and 128.6 (5 × 
CHarom), 137.2 (Carom,quat). IR (neat) νmax = 2925, 1495, 1452, 1378, 1364, 1206, 1177, 
1112, 1072, 755, 714, 697 cm
−1
. MS m/z (%) 332/4/6 (M
+
 + 1, 100). HRMS m/z (ESI) calculated for 
C12H15Br2N [MH]
+
 331.9644, found 331.9644 
 
 
5.50 Synthesis of 1-benzyl-3-chloro-3-(1-chloroethyl)azetidine 333  
 
3-Ethylideneazetidine 307a (0.11 g, 0.6 mmol) was dissolved in CH2Cl2 (10 mL) and gaseous HCl was 
introduced for 10 min. Subsequently, mCPBA (0.11 g, 1 equiv) was slowly added and the mixture was 
stirred for 24 hours under reflux. The reaction mixture was poured into water (15 mL) and extracted 
with CH2Cl2 (3 × 15 mL). The combined organic extracts were washed with NaHCO3 (3 x 15 mL). 
Drying (MgSO4), filtration of the drying agent and evaporation of the solvent in vacuo afforded 1-
benzyl-3-chloro-3-(1-chloroethyl)azetidine 333 (0.14 g, 92%), which was purified by filtration through 
silica gel (petroleum ether/ethyl acetate 4/1) in order to obtain an analytically pure sample. 
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1-Benzyl-3-chloro-3-(1-chloroethyl)azetidine 333 
 
Yellow oil, Rf = 0.52 (petroleum ether/ethyl acetate 4/1), Yield 92%. 
1
H NMR (300 MHz, 
CDCl3) δ 1.55 (3H, d, J = 6.6 Hz, CH3), 3.47 and 3.54 (2H, 2 x d, J = 8.8 Hz, CH2N), 
3.50 and 3.73 (2H, 2 x d, J = 11.6 Hz, CH2N), 3.71 (2H, s, CH2N), 4.54 (1H, q, J = 6.6 
Hz, CHCH3), 7.24-7.34 (5H, m, CHarom). 
13
C NMR (75 MHz, ref = CDCl3) δ 19.9 (CH3), 
62.4 (CHCH3), 62.9 (CH2N), 65.8 (CH2N), 66.8 (CCl), 66.9 (CH2N), 127.5 and 128.6 (5 x 
CHarom), 137.3 (Carom,quat). IR (neat) νmax = 2953, 2940, 2850, 1495, 1453, 1364, 1182, 
1074, 721, 697, 674 cm
−1
. MS m/z (%) 244/6 (M
+
 + 1, 100). HRMS m/z (ESI) calculated for C12H15Cl2N 
[MH]
+
 244.0654, found 244.0655. 
 
 
5.51 Synthesis of 3-hydroxy-3-(1-tosyloxyethyl)azetidines 334  
 
As a representative example the synthesis of 3-hydroxy-1-(4-methylbenzyl)-3-(1-
tosyloxyethyl)azetidine 334b was described here. 3-Ethylidene-(4-methylbenzyl)azetidine 307b (0.9 g, 
0.5 mmol) was dissolved in dry CH2Cl2 (15 mL), pTsOH (0.91 g, 1 equiv) was added and the mixture 
was stirred for 10 min at room temperature. Subsequently, mCPBA (1.25 g, 1.5 equiv) was slowly 
added and the mixture was stirred for 15 hours under reflux. The reaction mixture was poured into 
water (20 mL) and extracted with CH2Cl2 (3 × 20 mL). The combined organic extracts were washed 
with aqueous NaHCO3 (3 x 20 mL). Drying (MgSO4), filtration of the drying agent and evaporation of 
the solvent in vacuo afforded 3-hydroxy-1-(4-methylbenzyl)-3-(1-tosyloxyethyl)azetidine 334b (1.67 g, 
93%). 
 
 
1-Benzyl-3-hydroxy-3-(1-tosyloxyethyl)azetidine 334a 
 
Yellow oil, Yield 92%. 
1
H NMR (300 MHz, CDCl3) δ 1.19 (3H, d, J = 6.0 Hz, CH3CH), 
2.44 (3H, s, CH3Ar), 3.33-3.38 and 3.43-3.53 (4H, 2 x m, 2 x CH2N), 3.77-3.79 (2H, m, 
CH2N), 4.77 (1H, q, J = 6.3 Hz, CHCH3), 7.25-7.36 and 7.80-7.83 (9H, 2 x m, CHarom). 
13
C NMR (75 MHz, ref = CDCl3) δ 14.5 (CH3CH), 21.4 (CH3Ar), 60.9, 62.4 and 62.7 (3 
x CH2N), 71.8 (COH), 81.2 (CHO), 127.8, 128.0, 128.9, 129.1 and 130.1 (9 x CHarom), 
133.8, 134.9 and 145.3 (3 x Carom,quat). MS m/z (%) 362 (M
+
 + 1, 100). 
 
3-Hydroxy-1-(4-methylbenzyl)-3-(1-tosyloxyethyl)azetidine 334b 
 
Yellow oil, Yield 93%. 
1
H NMR (300 MHz, CDCl3) δ 1.19 (3H, d, J = 6.6 Hz, CH3CH), 
2.33 and 2.44 (6H, 2 x s, 2 x CH3Ar), 3.25-3.31 and 3.38-3.47 (4H, 2 x m, 2 x CH2N), 
3.65-3.74 (2H, m, CH2N), 4.75 (1H, q, J = 6.6 Hz, CHCH3), 7.11-7.36 and 7.80-7.83 
(8H, 2 x m, CHarom). 
13
C NMR (75 MHz, ref = CDCl3) δ 14.6 (CH3CH), 21.2 (CH3Ar), 
61.6 (CH2N), 62.3 (CH2N), 63.1 (CH2N), 71.9 (COH), 81.9 (CHO), 127.9, 128.8, 129.3 
and 130.1 (8 x CHarom), 132.9, 133.9, 137.5 and 145.2 (4 x Carom,quat). IR (neat) vOH = 
3295 cm
−1
, νmax = 2970, 2924, 1361, 1221, 1175, 1121, 1032, 1009, 909, 814, 730, 681 
cm
−1
. MS m/z (%) 376 (M
+
 + 1, 100). 
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5.52 Synthesis of 2-methyl-1-oxa-5-aza-spiro[2.3]hexanes 335  
 
As a representative example the synthesis of 5-benzyl-2-methyl-5-aza-1-oxaspiro[2.3]hexane 335a is 
described here. In an ice-cooled solution of 1-benzyl-3-hydroxy-3-(1-tosyloxyethyl)azetidine 307a 
(0.19 g, 0.5 mmol) in dry THF (15 mL), NaH (60% suspension) (0.02 g, 1 equiv) was slowly added and 
the mixture was stirred for 15 hours at room temperature. The reaction mixture was poured into water 
(20 mL) and extracted with Et2O (3 × 20 mL). The combined organic extracts were washed with H2O 
(2 × 15 mL) and brine (20 mL). Drying (MgSO4), filtration of the drying agent and evaporation of the 
solvent in vacuo afforded 5-benzyl-2-methyl-5-aza-1-oxaspiro[2.3]hexane 335a (0.10 g, 95%), which 
was purified by means of column chromatography on basic aluminium oxide (petroleum ether/ethyl 
acetate 4/1) in order to obtain an analytically pure sample. 
 
5-Benzyl-2-methyl-5-aza-1-oxaspiro[2.3]hexane 335a 
 
Light-yellow oil, Rf = 0.22 (petroleum ether/ethyl acetate 4/1), Yield 95%. 
1
H NMR (300 
MHz, CDCl3) δ 1.23 (3H, d, J = 5.5 Hz, CH3CH), 3.07 (1H, q, J = 5.5 Hz, CHCH3), 3.35-3.38 
and 3.43-3.46 (2H, 2 x m, 2 x (HCH)N), 3.60-3.66 (2H, m, 2 x (HCH)N), 3.76 (2H, s, CH2N), 
7.23-7.36 (5H, m, CHarom). 
13
C NMR (75 MHz, ref = CDCl3) δ 15.5 (CH3), 56.2 (CHCH3), 
59.5 (CH2CO), 60.4 (CO), 61.6 (CH2CO), 64.1 (NCH2Ar), 127.3 and 128.6 (5 x CHarom), 
138.2 (Carom,quat). IR (neat) νmax = 2925, 2831, 1495, 1453, 1363, 1161, 826, 725, 697 cm
−1
. 
MS m/z (%) 190 (M
+
 + 1, 100). HRMS m/z (ESI) calculated for C12H15NO [MH]
+
 190.1232, 
found 190.1232.  
 
2-Methyl-5-(4-methylbenzyl)-5-aza-1-oxaspiro[2.3]hexane 335b 
 
Light-yellow oil, Rf = 0.22 (petroleum ether/ethyl acetate 4/1), Yield 96%. 
1
H NMR (300 
MHz, CDCl3) δ 1.14 (3H, d, J = 5.0 Hz, CH3CH), 2.25 (3H, s, CH3Ar), 2.98 (1H, q, J = 5.0 
Hz, CHCH3), 3.25-3.28 and 3.34-3.37 (2H, 2 x m, 2 x (HCH)N), 3.50-3.57 (2H, m, 2 x 
(HCH)N), 3.64 (2H, s, CH2N), 7.03-7.13 (4H, m, CHarom). 
13
C NMR (75 MHz, ref = CDCl3) δ 
15.5 (CH3CH), 21.2 (CH3Ar), 56.2 (CHCH3), 59.4 (CH2CO), 60.3 (CO), 61.5 (CH2CO), 63.8 
(NCH2Ar), 128.6 and 129.2 (4 x CHarom), 135.0 and 137.20 (2 x Carom,quat). IR (neat) νmax = 
2925, 2852, 1515, 1449, 1377, 828, 809, 733 cm
−1
. MS m/z (%) 204 (M
+
 + 1, 100). HRMS 
m/z (ESI) calculated for C13H17NO [MH]
+
 204.1383, found 204.1382. 
 
 
5.53 Synthesis of 3-(1-azidoethyl)-1-(4-methylbenzyl)azetidin-3-ol 339 
 
In an ice-cooled mixture of 2-methyl-5-(4-methylbenzyl)-5-aza-1-oxaspiro[2.3]hexane 335b  (0.06 g, 
0.03 mmol) in Me2CO/H2O (8/1, 9 mL), NaN3 (0.06 g, 3 equiv) and NH4Cl (0.03 g, 2 equiv) were added 
and the mixture was stirred for 15 hours under reflux. The reaction mixture was poured into water (15 
N
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mL) and extracted with Et2O (3 × 15 mL). The combined organic extracts were washed with H2O (2 × 
15 mL) and brine (15 mL). Drying (MgSO4), filtration of the drying agent and evaporation of the solvent 
in vacuo afforded 3-(1-azidoethyl)-1-(4-methylbenzyl)azetidin-3-ol 339 (0.06 g, 80%). 
 
3-(1-Azidoethyl)-1-(4-methylbenzyl)azetidin-3-ol 339 
 
Yellow oil, Yield 80%. 
1
H NMR (300 MHz, CDCl3) δ 
1
H NMR (300 MHz, CDCl3) δ 1.31 
(3H, d, J = 6.6 Hz, CH3CH), 2.32 (3H, s, CH3Ar), 2.32-2.35 (1H, m, CHCH3), 3.02-3.06 
(2H, m, 2 x (HCH)N), 3.27-3.30 and 3.39-3.41 (2H, 2 x m, 2 x (HCH)N), 3.59 (2H, s, 
CH2N), 7.09-7.17 (4H, m, CHarom). MS m/z (%) 247 (M
+
 + 1, 100). 
 
 
 
5.54 Synthesis of 3-(1-hydroxyethyl)azetidin-3-ols 340  
 
As a representative example the synthesis of 1-benzyl-3-(1-hydroxyethyl)azetidin-3-ol 340a is 
described here. In an ice-cooled solution of 3-ethylidene-1-(4-methylbenzyl)azetidine 307a (0.16 g, 0.9 
mmol) in Me2CO/H2O (4/1, 10 mL), N-methylmorpholine-N-oxide (0.12 g, 1.1 equiv) and OsO4 (4% in 
water) (5 mol%, 0.58 g) were added and the mixture was stirred for 4 hours at room temperature. 
Subsequently, an aqueous saturated solution of Na2SO3 (7 mL) was added and the mixture was 
stirred for 10 min. The reaction mixture was filtered and the filtrate was extracted with CH2Cl2 (3 × 15 
mL). The combined organic extracts were washed with H2O (2 × 15 mL) and brine (15 mL). Drying 
(MgSO4), filtration of the drying agent and evaporation of the solvent in vacuo afforded 1-benzyl-3-(1-
hydroxyethyl)azetidin-3-ol 340a (0.15 g, 82%), which was purified by filtration through silica gel 
(dichloromethane/methanol = 9/1) to obtain an analytically pure sample. 
 
1-Benzyl-3-(1-hydroxyethyl)azetidin-3-ol 340a 
 
Dark yellow oil, Rf = 0.18 (dichloromethane/methanol 9/1), Yield 82%. 
1
H NMR (300 
MHz, CDCl3) δ 1.13 (3H, d, J = 5.0 Hz, CH3CH), 2.99-3.01 (2H, m, 2 x (HCH)N), 3.28-
3.31 and 3.38-3.40 (2H, 2 x m, 2 x (HCH)N), 3.58 (2H, s, NCH2Ar), 3.88 (1H, q, J = 5.0 
Hz, CHCH3), 7.18-7.24 (5H, m, CHarom). 
13
C NMR (75 MHz, ref = CDCl3) δ 16.8 
(CH3CH), 63.1 (CH2CquatCH2), 64.2 (NCH2Ar), 71.2 (CHOH), 72.7 (COH), 127.4, 128.5 
and 128.7 (5 x CHarom), 137.6 (Carom,quat). IR (neat) vOH = 3355 cm
−1
, νmax = 2963, 2930, 
2849, 1453, 1364, 1189, 1082, 1027, 733, 698 cm
−1
. MS m/z (%) 208 (M
+
 + 1, 100). 
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3-(1-Hydroxyethyl)-1-(4-methylbenzyl)azetidin-3-ol 340b 
 
Dark yellow oil, Rf = 0.19 (dichloromethane/methanol 9/1), Yield 84%. 
1
H NMR (300 
MHz, CDCl3) δ 1.20 (3H, d, J = 6.0 Hz, CH3CH), 2.33 (3H, s, CH3Ar), 3.07-3.11 (2H, m, 
2 x (HCH)N), 3.37-3.40 and 3.47-3.49 (2H, 2 x m, 2 x (HCH)N), 3.64 (2H, s, NCH2Ar), 
3.96 (1H, q, J = 6.0 Hz, CHCH3), 7.10-7.18 (4H, m, CHarom). 
13
C NMR (75 MHz, ref = 
CDCl3) δ 16.8 (CH3CH), 21.2 (CH3Ar), 62.7 (CH2Cquat) and 63.0 (CH2Cquat), 64.0 
(NCH2Ar), 71.1 (CHOH), 72.8 (COH), 128.7 and 129.2 (4 x CHarom), 134.2 and 137.1 (2 
x Carom,quat). IR (neat) vOH = 3352 cm
−1
, νmax = 2933, 2852, 1449, 1362, 1186, 1104, 731 
cm
−1
. MS m/z (%) 222 (M
+
 + 1, 100). HRMS m/z (ESI) calculated for C13H19NO2 [MH]
+
 222.1489, found 
222.1492. 
 
 
5.55 Synthesis of 6,6,8-trimethyl-2-aza-5,7-dioxaspiro[3.4]octane 342 
 
3-(1-Hydroxyethyl)-1-(4-methylbenzyl)azetidin-3-ol 340b (0.22 g, 1 mmol) was dissolved in acetone 
(15 mL), pTsOH (0.19 g, 1.1 equiv) and CuSO4 (0.80 g, 5 equiv) were added and the mixture was 
heated for 24 hours under reflux. Afterward, the reaction mixture was poured into water (15 mL) and 
extracted with CH2Cl2 (3 × 15 mL). The combined organic extracts were washed with H2O (2 × 15 mL) 
and brine (15 mL). Drying (MgSO4), filtration of the drying agent and evaporation of the solvent in 
vacuo afforded 6,6,8-trimethyl-2-(4-methylbenzyl)-2-aza-5,7-dioxaspiro[3.4]octane 342b (0.25 g, 96%) 
which was purified by filtration through silica gel (dichloromethane/methanol = 9/1) to obtain an 
analytically pure sample. 
 
1-(4-Methylbenzyl)-6,6,8-Trimethyl-2-aza-5,7-dioxaspiro[3.4]octane 342b 
 
Yellow oil, Rf = 0.22 (dichloromethane/methanol 9/1), Yield 96%. 
1
H NMR (300 MHz, 
CDCl3) δ 
1
H NMR (300 MHz, CDCl3) δ 1.24 and 1.28 (6H, 2 x s, C(CH3)2), 1.35 (3H, d, J 
= 6.6 Hz, CH3CH), 2.25 (3H, s, CH3Ar), 2.92 (1H, d, J = 8.0 Hz, (HCH)N), 3.20 and 3.30 
(2H, 2 x d, J = 7.7 Hz, (HCH)N), 3.47 (1H, d, J = 8.0 Hz, (HCH)N), 3.52 (2H, s, NCH2Ar), 
4.08 (1H, q, J = 6.6 Hz, CHCH3), 7.02-7.10 (4H, m, CHarom). 
13
C NMR (75 MHz, ref = 
CDCl3) δ 16.2 (CH3CH), 21.2 (CH3Ar), 26.4 and 28.2 (C(CH3)2), 61.8 (CH2Cquat), 63.4 
(CH2Cquat), 64.2 (NCH2Ar), 77.4 (CHCH3), 78.3 (CH2CO), 107.9 (C(CH3)2), 128.4 and 
129.1 (4 x CHarom), 135.2 and 136.7 (2 x Carom,quat). IR (neat) νmax = 2983, 2931, 2830, 
1378, 1370, 1224, 1171, 1099, 998, 810 cm
−1
. MS m/z (%) 262 (M
+
 + 1, 100). 
 
 
 
 
N
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5.56 Synthesis of 8-methyl-2-(4-methylbenzyl)-2-aza-5,7-dioxaspiro[3.4]octan-
6-one 345 
 
In an ice-cooled solution of 3-(1-Hydroxyethyl)-1-(4-methylbenzyl)azetidin-3-ol 340b (0.22 g, 1 mmol) 
in dry CH2Cl2 (15 mL), NaH (60% suspension) (0.04 g, 1 equiv) and triethylamine (0.30 g, 3 equiv) 
were added and the mixture was stirred for 5 min at 0 °C. Subsequently, oxalyl chloride (0.14 g, 1 
equiv) was added at 0 °C, and the mixture was stirred for 15 hours at room temperature. The reaction 
mixture was then poured into water and extracted with CH2Cl2 (3 × 15 mL). The combined organic 
extracts were washed with H2O (2 × 15 mL) and brine (15 mL). Drying (MgSO4), filtration of the drying 
agent and evaporation of the solvent in vacuo afforded 8-methyl-2-(4-methylbenzyl)-2-aza-5,7-
dioxaspiro[3.4]octan-6-one 345b (0.15 g, 60%). 
 
8-Methyl-2-(4-methylbenzyl)-2-aza-5,7-dioxaspiro[3.4]octan-6-one 345 
 
Yellow oil, Yield 60%, 
1
H NMR (300 MHz, CDCl3) δ 
1
H NMR (300 MHz, CDCl3) δ 1.47 
(3H, d, J = 6.6 Hz, CH3CH), 2.27 (3H, s, CH3Ar), 3.35 (2H, d, J = 9.4 Hz, 2 x 
(HCH)Cquat), 3.52 (2H, d, J = 9.4 Hz, 2 x (HCH)Cquat), 3.70 (2H, s, NCH2Ar), 4.78 (1H, q, 
J = 6.6 Hz, CHCH3), 7.06-7.12 (4H, m, CHarom). 
13
C NMR (75 MHz, ref = CDCl3) δ 16.6 
(CH3CH), 21.2 (CH3Ar), 58.9 (CH2Cquat), 62.0 (CH2Cquat), 63.7 (NCH2Ar), 77.3 (CHCH3), 
79.7 (CHCO), 128.9 and 129.5 (4 x CHarom), 130.1 and 137.8 (2 x Carom,quat), CO (not 
detected). IR (neat) vCO = 1807 cm
−1
, νmax = 2923, 2853, 1643, 1182, 1081 cm
−1
. MS 
m/z (%) 248 (M
+
 + 1, 100). 
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6  Summary 
 
Aziridines display an uncommon combination of reactivity, atom economy and synthetic utility related 
to the ring strain of this class of nitrogen-containing heterocycles. As a consequence, aziridines are 
frequently deployed as versatile synthetic intermediates for the preparation of a variety of ring-opened 
and ring-expanded amines via regio- and stereoselective transformations. Azetidines, the higher 
homologues of aziridines, have acquired a prominent position in organic chemistry as well. Next to 
their synthetic relevance, compounds containing an azetidine moiety have been shown to possess a 
wide range of biological activities. For example, 3-alkoxy- and 3-aryloxyazetidines have been 
described as G-protein coupled receptor agonists, inhibitors of stearoyl-coenzyme d-9 desaturase and 
antibacterial agents. 
Within the class of 2-substituted, non-activated aziridines, 2-(bromomethyl)aziridines are known to be 
good substrates for ring-opening reactions and nucleophilic substitutions, and these intriguing 
compounds have found many applications in synthetic chemistry. In particular, these compounds have 
been used as suitable synthons for the preparation of cyclopropanes, morpholines, pyrrolizidines, 
pyrrolidines, 2-imino-1,3-thiazoli(di)nes and piperidine derivatives.  
Bearing in mind the high synthetic potential of these strained species, 2-(bromomethyl)aziridines were 
used as valuable synthons towards biologically and synthetically relevant species. In particular, the 
unexplored behavior of aziridines with regard to complex metal hydrides was addressed in this work.   
Thus, in the first part of this PhD thesis, aziridines i were first transformed to the corresponding 2-
(acetoxymethyl)aziridines ii, which were then subjected to regioselective ring opening with LiAlH4 
under microwave irradiation to provide useful β-amino alcohols iii (Scheme 1). β-Amino alcohols are 
applied extensively in organic chemistry as building blocks in designing natural and biologically active 
substances, and their chiral versions are also used in catalytic asymmetric synthesis. Subsequently, 
these compounds iii were used as suitable substrates for the preparation of six-membered 
oxazaheterocycles iv through the reaction with glyoxal. In light of the importance of chirality in 
medicinal chemistry, the synthesis of enantiopure amino alcohols vi and morpholin-2-ones vii was 
also explored starting from the commercially available 2-(hydroxymethyl)aziridines v using the same 
synthetic approach (i.e., reductive ring opening by LiAlH4). 
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Scheme 1 
 
In comparison with the reactivity of activated aziridines, i.e., aziridines bearing an electron-withdrawing 
substituent at the nitrogen atom, the reactivity profile of non-activated aziridines has been examined to 
a far lesser extent in the chemical literature. Non-activated aziridines require activation toward 
intermediate aziridinium salts for nucleophilic ring-opening reactions, whereas activated aziridines do 
not. In that respect, the ring opening of aziridinium salts by halides constitutes a convenient approach 
towards -halo amines, which are generally recognized as useful building blocks in organic chemistry 
and valuable targets in medicinal chemistry (nitrogen mustards – chemotherapy agents). Although the 
issue of regioselectivity in the ring opening of 2-substituted non-activated aziridines had been 
addressed in a number of literature reports, no systematic study has been performed in which 
aziridinium substrates deriving from non-activated aziridines are subjected to ring opening by fluoride, 
chloride, bromide and iodide. 
 
Therefore, in the second part of this work, the systematic study of the ring opening of in situ generated 
aziridinium salts viii by halides was investigated. As depicted in Scheme 2, the ring opening of 
aziridinium salts viii can occur at either the unsubstituted (path a) or substituted aziridine carbon atom 
(path b), leading either to primary halides x (path a) or secondary halides ix (path b). The different 
regioselectivity controlled by the type of nucleophile (halide) used in the ring opening of 2-
(aryloxymethyl)aziridinium ion viii was discussed and the results were elucidated by means of 
molecular modelling calculations performed at the Center for Molecular Modeling of Ghent University 
(Prof. V. Van Speybroeck and Prof.  M. Waroquier).  
Both experimental and computational evidence was provided for the fact that product stabilities dictate 
the reaction outcome through thermodynamic control in the chloride, bromide and iodide case, 
involving rearrangement of the initially formed primary halides x to the more stable secondary halides 
ix via a thermodynamic equilibrium (Scheme 2). The ring opening of the same aziridinium salts by 
fluoride, however, was shown to be mediated by steric interactions (kinetic control), and primary 
fluorides x were formed as major products. In this way, the synthesis of a wide range of novel 
secondary β-bromo amines, β-chloro amines, β-iodo amines ix (X = Br, Cl, I) and primary β-fluoro 
amines x (as major products) was performed.  
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The reactivity of 2-(bromomethyl)aziridines i and their synthesis through the NaBH4-reduction of N-
alkylidene-(2,3-dibromopropyl)amines xi (R
2
 = H) in methanol under reflux has been the subject of 
many literature reports. On the other hand, in a preliminary study at the Department of Sustainable 
Organic Chemistry and Technology, it has been shown that structurally similar N-alkylidene-(2,3-
dibromo-2-methylpropyl)amines xi (R
1
 = iPr, CHEt2, R
2
 = Me) afforded 3-methoxyazetidines xii under 
the same reaction conditions (Scheme 3), although the factors governing this peculiar reactivity 
remained unclear. 
MeOH, 
N
OMe
R1
xi
MeOH, 
N
R1
Br
R2 = MeR2 = H
i xii
 NaBH4NaBH4
R1 H
N Br
R2 Br
 
Scheme 3 
 
In order to elucidate this unexpected reactivity of imines xi (R
2
 = Me) and the influence of an additional 
methyl substituent in these substrates xi on the reaction outcome, the kinetically controlled synthesis 
of 2-bromomethyl-2-methylaziridines xv, as potential intermediates in this reaction was investigated in 
the third part of this PhD thesis. For this purpose, 2-bromomethyl-2-methylaziridines xv were prepared 
in an efficient way, comprising bromination of 2-methylacrolein viii, imination and subsequent NaBH4-
mediated ring closure of the corresponding imines xiv at room temperature (Scheme 4). This result 
clearly showed the intermediacy of aziridines xv in the formation of 3-methoxyazetidines xii. 
Furthermore, upon treatment of 2-bromomethyl-2-methylaziridines xv with NaBH4 in methanol under 
reflux, 3-methoxy-3-methylazetidines xii were obtained, showing these species to be the 
thermodynamic products of the NaBH4-mediated reduction of imines xiv. The theoretical elucidation of 
the reaction mechanism at the Center for Molecular Modeling (UGent) supported the intermediacy of 
bicyclic aziridinium ions xvi in this aziridine to azetidine ring rearrangement.  
In addition, the propensity of aziridines xv to undergo ring expansion thorough the formation of 
intermediates xvi was also shown in the formation of 3-bromo-3-methylazetidines xvii obtained upon 
heating of these aziridines in acetonitrile under reflux (Scheme 4). 
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Scheme 4 
 
The high synthetic potential of 2-bromomethyl-2-methylaziridines with respect to the ring expansion to 
3-substituted azetidines made these substrates valuable for further elaboration in terms of azetidine 
synthesis. The limited number of reports regarding aziridine to azetidine ring expansions and the 
mainly unexplored synthetic potential of 2-bromomethyl-2-methylaziridines opened a new possibility to 
access a novel class of 3-functionalized azetidines in an efficient way.  
Therefore, in the fourth part of this work, the reactivity of 2-bromomethyl-2-methylaziridines xv toward 
different oxygen, sulfur and carbon nucleophiles in different solvent systems was envisaged. 
Surprisingly, it was shown that the choice of the solvent has a profound influence on the reaction 
outcome. In this way, the selective formation of functionalized aziridines xviii in dimethylformamide 
(DMF) and 3-substituted azetidines xix in acetonitrile (MeCN) was enabled (Scheme 5). The formation 
of aziridines xviii and azetidines xix in different solvents was studied by the high-level molecular 
modeling calculations at the Center for Molecular Modeling (UGent).  
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Scheme 5 
 
Bearing in mind the broad synthetic potential of 3-haloazetidines, 3-bromo-3-methylazetidine xvii was 
used as a suitable synthon to access a window of novel 3-functionalized azetidines. Treatment of 
azetidine xvii with phenoxide or hydroxide nucleophiles afforded 3-phenoxy- and 3-hydroxyazetidines 
xx and xxi, respectively (Scheme 6). 3-Bromo-3-methylazetidine xvii was also shown to be a good 
substrate for the synthesis of azetidine-3-carbonitriles xxii upon treatment with KCN in acetonitrile. 
The hydrolysis of the cyano group in latter azetidines xxii provided a convenient approach toward 
cyclic amino acids xxiii, which can be considered as analogue of azetidine-2-carboxylic acid, a natural 
molecule isolated from Convallaria majalis (lily of the valley) with impressive biological properties 
(Scheme 6). 
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Scheme 6 
 
In addition, 3-alkyl-3-bromoazetidines can be considered as useful starting synthons for the 
preparation of the corresponding 3-alkylideneazetidines as versatile synthetic intermediates. 3-
Alkylideneazetidines are strained cyclic allylamines and only limited information on the reactivity of this 
class of compounds is present in the literature. In most cases, the 3-alkylideneazetidine moiety was 
incorporated in the structure of more complex molecules, and no special attention has been devoted 
to the chemical nature of this strained system. In addition, the incorporation of conformational 
constraint at the 3-position of azetidine rings is known to increase the potency of human and rat FAAH 
inhibitors and showed to be an important structural feature of some drugs. 
In the last part of this PhD work, a facile and efficient synthesis of 3-ethylideneazetidines xxvii was 
reported starting from the corresponding 3-bromo-3-ethylazetidines xxvi, obtained via ring expansion 
of aziridines xxv prepared by a synthetic methodology previously established in this PhD thesis 
(Scheme 7). Although the combination of two functionalities, i.e., an azetidine moiety and an exocyclic 
double bond, might result in unstable structures, this type of substrates was considered to be valuable 
for further study.  
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Scheme 7 
 
Therefore, two aspects of the reactivity of 3-ethylideneazetidines were separately studied, i.e., the 
activation and subsequent ring opening of the azetidine moiety on the one hand, and functionalization 
of the exocyclic double bond on the other. In this way, azetidines xxvii were used as eligible 
substrates for the synthesis of a range of novel ring-opened amines xxviii, cyclic carbamates xxix, 
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cyclic carbonates xxx, 5,7-dioxa-2-azaspiro[3.4]octanes xxxi, 1-oxa-5-azaspiro[2,3]hexanes xxxii, 3-
halo-3-(1-haloethyl)azetidines xxxiii and 3-(1-hydroxyethyl)-azetidin-3-ols xxxiv (Scheme 8).   
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In this PhD thesis, the high synthetic potential of non-activated 2-(bromomethyl)aziridines and 2-
bromomethyl-2-methylaziridines as fruitful synthons in organic chemistry has been illustrated by 
means of their elaboration toward a vast number of novel synthetically and biologically interesting 
nitrogen-containing compounds, which provide an entry to novel chemical space and diversity. In that 
respect, these non-activated aziridines, and especially the less known 2-bromomethyl-2-
methylaziridines, should be recognized as important building blocks for further elaboration in the 
future. 
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7  Samenvatting 
 
Aziridinen verenigen een aantal interessante eigenschappen, zoals reactiviteit, atoomeconomie en 
synthetische toepasbaarheid te danken aan de ringspanning in deze stikstofbevattende 
heterocyclische verbindingen. Bijgevolg worden aziridinen vaak aangewend als veelzijdige 
precursoren in de synthese van ringgeopende en ringgeëxpandeerde structuren, via regio- en 
stereoselectieve transformaties. Azetidinen, de hogere homologen van aziridinen, hebben ook een 
prominente plaats in de organische chemie verworven. Naast hun synthetische toepasbaarheid 
bezitten vele verbindingen met een azetidinering in hun structuur een interessante biologische 
activiteit. Zo zijn 3-alkoxy- en 3-aryloxyazetidinen gekend als agonisten van G-proteïne-gekoppelde 
receptoren, inhibitoren van stearoylcoenzyme d-9 desaturase en antibacteriële middelen. 
 
Binnen de klasse van 2-gesubstitueerde, niet-geactiveerde aziridinen staan 2-(broommethyl)aziridinen 
bekend als goede substraten voor ringopeningsreacties en nucleofiele substituties. Deze interessante 
verbindingen vonden reeds een groot aantal toepassingen in de synthetische chemie. In het bijzonder 
werden deze verbindingen in het verleden reeds gebruikt als synthon voor de bereiding van 
cyclopropanen, morfolinen, pyrrolizidinen, pyrrolidinen, 2-imino-1,3-thiazoli(di)nen en 
piperidinederivaten. 
 
Omwille van hun groot potentieel werden 2-(broommethyl)aziridinen in dit werk aangewend als 
waardevolle bouwstenen voor de synthese van biologisch en synthetisch relevante verbindingen. In 
het bijzonder werd de tot hier toe onbekende reactiviteit van aziridinen ten aanzien van complexe 
metaalhydriden bestudeerd. 
 
In het eerste deel van het onderzoek werden aziridinen i omgezet tot de overeenkomstige 
2-(acetoxymethyl)aziridinen ii, die vervolgens regioselectief werden ringgeopend met LiAlH4 bij 
verhoogde temperatuur onder microgolfbestraling. Deze transformatie gaf aanleiding tot de vorming 
van interessante β-aminoalcoholen iii (Schema 1); deze klasse van verbindingen kent een breide 
toepasbaarheid in de organische chemie als synthon in de bereiding van natuurproducten en 
biologisch actieve stoffen en chirale β-aminoalcoholen worden ook gebruikt in katalytische 
asymmetrische synthese. Vervolgens werden deze verbindingen iii gebruikt als substraat in de 
bereiding van zesatooms oxazaheterocyclische verbindingen iv, via reactie met glyoxaal. Gezien het 
belang van chiraliteit in de medicinale chemie werd de synthese van enantiomeer zuivere 
aminoalcoholen vi en oxazolinonen vii eveneens onderzocht, uitgaande van commercieel 
beschikbare 2-(hydroxymethyl)aziridinen v, via dezelfde syntheseweg (LiAlH4-gemedieerde reductieve 
ringopening). 
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Schema 1 
 
In vergelijking met de geactiveerde aziridinen, met een elektronenzuigende substituent op het 
stikstofatoom, genoot het reactiviteitsprofiel van niet-geactiveerde aziridinen tot op heden veel minder 
aandacht in de chemische literatuur. Niet-geactiveerde aziridinen moeten worden geactiveerd tot de 
overeenkomstige aziridiniumzouten alvorens ze nucleofiele ringopening kunnen ondergaan, terwijl bij 
geactiveerde aziridinen geen activatie tot een aziridiniumzout nodig is. In dat opzicht is de ringopening 
van aziridiniumzouten door middel van halogeniden een handige methode voor de synthese van 
-halogeenaminen. Deze laatste verbindingen worden algemeen erkend als bruikbare bouwstenen in 
de organische chemie en vormen een waardevolle doelstructuur in de medicinale chemie 
(chemotherapeutica). Hoewel de regioselectiviteit bij ringopening van 2-gesubstitueerde niet-
geactiveerde aziridinen reeds in het verleden behandeld werd, is tot nu toe nog geen systematisch 
onderzoek uitgevoerd waarbij aziridiniumsubstraten, bereid uit niet-geactiveerde aziridinen, 
ringopening ondergaan door middel van fluoride, chloride, bromide en jodide. 
 
Daarom werd in het tweede deel van dit werk een systematische studie van de ringopening van in situ 
bereide aziridiniumzouten xviii door middel van halogeniden uitgewerkt. Zoals weergegeven in 
Schema 2 kan de ringopening van aziridiniumzouten xviii zowel op het ongesubstitueerd (pad a) of op 
het gesubstitueerd aziridinekoolstofatoom (pad b) gebeuren, hetgeen respectievelijk in primaire x en 
secundaire halogeniden ix resulteert. Het verschil in regioselectiviteit bij de ringopening van 
2-(aryloxymethyl)aziridiniumionen xviii, afhankelijk van het type nucleofiel (halide), werd besproken. 
Deze resultaten zijn onderbouwd met theoretische berekeningen uitgevoerd aan het centrum voor 
Moleculaire Modellering van de Universiteit Gent (Prof V. Van Speybroeck en Prof. M. Waroquier). 
 
De experimentele en computationele gegevens bevestigden dat de reactie-uitkomst bepaald werd 
door thermodynamische controle indien chloride, bromide of jodide gebruikt werden als nucleofiel. 
Daarbij vindt een omzetting van de initieel gevormde primaire halogeniden x tot de meer stabiele 
secundaire halogeniden ix plaats (Schema 2). De ringopening van dezelfde aziridiniumzouten door 
middel van fluoride werd echter gecontroleerd door sterische interacties (kinetische controle), met 
vorming van primaire fluoriden x als hoofdproducten. Uit deze studie werden een groot aantal nieuwe 
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secundaire β-broomaminen, β-chlooraminen, β-joodaminen ix (X = Br, Cl, I) en primaire β-fluoraminen 
x (als belangrijkste producten) bekomen. 
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De reactiviteit van 2-(broommethyl)aziridinen i, alsook hun synthese via NaBH4-gemedieerde reductie 
van N-alkylideen-(2,3-dibroompropyl)aminen xi (R
2
 = H) in methanol onder reflux is reeds beschreven 
in de literatuur. In een preliminaire studie aan de vakgroep Duurzame Organische Chemie en 
Technologie, bleek echt dat structureel vergelijkbare N-alkylideen-(2,3-dibroom-
2-methylpropyl)aminen xi (R
2
 = Me) onder dezelfde reactieomstandigheden 3-methoxyazetidinen xii 
leveren (Schema 3). De reden voor deze onverwachte reactiviteit bleef tot op heden onduidelijk.  
 
 
MeOH, 
N
OMe
R1
xi
MeOH, 
N
R1
Br
R2 = MeR2 = H
i xii
 NaBH4NaBH4
R1 H
N Br
R2 Br
 
Schema 3 
 
Om deze onverwachte reactiviteit van iminen xi (R
2
 = Me), en de invloed van een extra 
methylsubstituent in substraten xi op de reactie-uitkomst te onderzoeken, werd in het derde deel van 
dit doctoraatsproefschrift de kinetisch gecontroleerde synthese van 2-broommethyl-2-methylaziridinen 
xv als potentiële tussenproducten van deze reactie bestudeerd. Hiertoe werden 2-broommethyl-
2-methylaziridinen xv op een efficiënte manier bereid, via bromering van 2-methylacroleine xviii, 
iminering en daaropvolgende NaBH4-gemedieerde ringsluiting van iminen xiv (Schema 4). Dit 
resultaat toonde het bestaan van aziridinen xv als intermediairen in de vorming van 
3-methoxyazetidinen xii aan. Bovendien werden, na behandeling van 2-broommethyl-
2-methylaziridinen xv met NaBH4 in methanol onder reflux, 3-methoxy-3-methylazetidinen xii 
verkregen. Deze waarneming bevestigt dat producten xii worden gevormd als gevolg van de 
thermodynamisch gecontroleerde, NaBH4-gemedieerde reductie van iminen xiv. Een theoretische 
studie van het reactiemechanisme, uitgevoerd aan het centrum voor Moleculaire Modellering (UGent), 
bevestigde de aanwezigheid van bicyclische aziridiniumionen xvi in de ringexpansie van aziridinen xv 
tot azetidinen xii en xvii. 
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Bovendien is het ook aangetoond dat aziridinen xv ringexpansie kunnen ondergaan met vorming van 
3-broom-3-methylazetidinen xvii via intermediairen xvi. Deze reactie gaat door bij verhitting van 
aziridinen xv onder reflux in acetonitril (Schema 4). 
 
O
H
xiii
N
Br
Ar
NaBH4 
MeOH, 
xv
N
Ar
xvi
N
Ar
OMe
xii
or
MeCN, Br
N
Ar
Br
xvii
N
HBr
Br
NaBH4 
MeOH, r.t.
Ar
xiv
MeCN
MeOH
 
Schema 4 
 
Het aldus aangetoonde potentieel van 2-broommethyl-2-methylaziridinen om ringexpansie tot 
3-gesubstitueerde azetidinen te ondergaan opent nieuwe wegen op het gebied van de 
azetidinesynthese. Het beperkt aantal publicaties, die de ringexpansie van aziridinen tot azetidinen 
beschrijven en het (grotendeels) niet-onderzocht synthetische potentieel van 2-broommethyl-
2-methylaziridinen, zorgde voor een efficiënte toetreding tot een nieuwe klasse van 
3-gefunctionaliseerde azetidinen.   
 
Bijgevolg werd in het vierde deel van dit werk de reactiviteit van 2-broommethyl-2-methylaziridinen xv 
ten opzichte van andere zuurstof-, zwavel- en koolstofnucleofielen in verschillende solventen 
geëvalueerd. Verrassend genoeg is gebleken dat de keuze van het solvent een grote invloed heeft op 
de reactie-uitkomst. Zo werd de selectieve vorming van gefunctionaliseerde aziridinen xviii in 
dimethylformamide (DMF) en 3-gesubstitueerde azetidinen xix in acetonitril (MeCN) gediscussieerd 
(Schema 5). Een verklaring voor de vorming van aziridinen xviii en azetidinen xix in verschillende 
solventen werd gezocht met behulp van de theoretische berekeningen, uitgevoerd aan het centrum 
voor Moleculaire Modellering (UGent). 
 
Ar
N
Br
N
Nu
Nu Nu
Ar
N
Nu DMF
Ar
Nu =  Br, OMe, CN
         OAc, OPh, SCN
MeCN or 
MeOH
Nu =  CN, OPh
         SCN, OAc
xv xixxviii
 
Schema 5 
 
Gezien het grote synthetische belang van 3-haloazetidinen werd 3-broom-3-methylazetidine xvii 
bestudeerd als een geschikt synthon voor de bereiding van nieuwe 3-gefunctionaliseerde azetidinen. 
De behandeling van azetidine xvii met fenoxide of hydroxide als nucleofielen leverde respectievelijk 
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3-fenoxy- en 3-hydroxyazetidinen xx en xxi (Schema 6). 3-Broom-3-methylazetidine xvii bleek ook 
een goed substraat te zijn voor de synthese van azetidine-3-carbonitrillen xxii na behandeling met 
KCN in acetonitril. De hydrolyse van de cyaangroep in deze azetidinen xxii bleek een geschikte 
manier voor de synthese van cyclische aminozuren xxiii, die beschouwd kunnen worden als analogen 
van azetidine-2-carbonzuur, een natuurproduct met bijzondere biologische eigenschappen geïsoleerd 
uit Convallaria majalis (lelietje-van-dalen) (Schema 6). 
 
N
Br
N
O
K2CO3, CH3CN
KOH
H2O/CH2Cl2 
(9/1)
N
OH
 xxi (96%)  xx (92%)
Ar
xvii
N
CN
N O
O
xxii (80%)
KCN, MeCN
1) KOH, EtOH/H2O
2) Dowex H+ (NH4OH)
fenol
Ar
Ar
Ar
Ar
NH4
xxiii
85%
 
Schema 6 
 
Daarnaast kunnen 3-alkyl-3-bromoazetidinen beschouwd worden als nuttige synthons voor de 
bereiding van de overeenkomstige 3-alkylideenazetidinen. 3-Alkylideenazetidinen zijn gespannen 
cyclische allylaminen met potentieel als veelzijdige synthetische bouwstenen die tot op heden echter 
weinig bestudeerd zijn in de literatuur. In de meeste gevallen werd de 3-alkylideenazetidine-eenheid 
opgenomen in meer complexe moleculen, en werd geen speciale aandacht besteed aan de 
chemische aard van dit gespannen systeem. Bovendien is gebleken dat de introductie van een 
conformationele beperking op de 3-plaats van azetidineringen FAAH-inhibitie in mens en rat versterkt; 
dit motief bleek reeds vak ook een belangrijke structurele eigenschap van sommige geneesmiddelen 
te zijn. 
 
In het laatste deel van dit onderzoek werd een gemakkelijke en efficiënte synthese van 
3-ethylideenazetidinen xxvii ontwikkeld uitgaande van de overeenkomstige 3-broom-3-ethylazetidinen 
xxvi. Deze bereiding verloopt via ringexpansie van aziridinen xxv, die eerder in dit 
doctoraatsonderzoek werden gesynthetiseerd (Schema 7). Hoewel de combinatie van een 
azetidinegroep en een exocyclische dubbele binding kan resulteren in instabiele structuren, werd de 
studie van dit type substraten toch als waardevol beschouwd. 
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O
H
Ar
N
Br
xxiv
N
Br
Ar
xxv xxvi
N
Ar
xxvii
1) Br2
2) RNH2
3) NaBH4
MeCN
KOtBu
THF
 
Schema 7 
Omwille van voornoemde instabiliteit werden twee aspecten van de reactiviteit van 
3-ethylideenazetidinen afzonderlijk onderzocht: de activering en daaropvolgende ringopening van de 
azetidinegroep enerzijds, en de functionalisering van de exocyclische dubbele binding anderzijds. Uit 
deze studie blijkt dat azetidinen xxvii geschikte substraten zijn voor de synthese van een reeks van 
nieuwe aminen xxviii, cyclische carbamaten xxix, cyclische carbonaten xxx, 5,7-dioxa-
2-azaspiro[3.4]octanen xxxi, 1-oxa-5-azaspiro[2,3]hexanen xxxii, 3-halogeen-3-(1-
halogeenethyl)azetidinen xxxiii en 3-(1-hydroxyethyl)-azetidin-3-olen xxxiv (Schema 8). 
N
Ar
xxvii
N
Ar
N O
O
Ar
N
E
Cl
Ar
O
N
O
O
Ar
N
Ar
O
O
O
N
Ar
OH
OH
N
Ar
X
X
xxix
xxxiv
xxxiii
xxxi
xxxiixxviii
xxx
X = Cl, Br  
Schema 8 
 
In dit doctoraatsproefschrift werd het rijke potentieel van niet-geactiveerde 2-(broommethyl)aziridinen 
en 2-broommethyl-2-methylaziridinen als synthons in de organische chemie geïllustreerd, door hun 
derivatisatie naar een groot aantal nieuwe synthetisch en biologisch interessante stikstofverbindingen 
te bewerkstelligen. Deze verbindingen dragen bij tot de verdere expansie van de chemische ruimte. 
Aldus verdienen de niet-geactiveerde aziridinen, en vooral de minder bekende 2-broommethyl-
2-methylaziridinen, verdere uitwerking in de toekomst. 
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